
<html lang="en"     class="pb-page"  data-request-id="99e863ff-aa70-435a-91b2-afc0e8e23bc4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b01985;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-15;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands" /></meta><meta name="dc.Creator" content="Maxwell D.  Cummings" /></meta><meta name="dc.Creator" content="Sivakumar  Sekharan" /></meta><meta name="dc.Description" content="Interest is growing in the use of macrocycles in pharmaceutical discovery. Macrocylization may provide a gateway to an expanded chemical space for small-molecule drug discovery, and this could be b..." /></meta><meta name="Description" content="Interest is growing in the use of macrocycles in pharmaceutical discovery. Macrocylization may provide a gateway to an expanded chemical space for small-molecule drug discovery, and this could be b..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 12, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01985" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01985" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01985" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01985" /></link>
        
    
    

<title>Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01985" /></meta><meta property="og:title" content="Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0005.jpeg" /></meta><meta property="og:description" content="Interest is growing in the use of macrocycles in pharmaceutical discovery. Macrocylization may provide a gateway to an expanded chemical space for small-molecule drug discovery, and this could be beneficial in prosecuting difficult targets, e.g., protein–protein interactions. Most, but not all, macrocycle drugs are derived from natural products. Studies on synthetic drug-like small-molecule macrocycles are limited, and our current understanding of macrocycle drugs is similarly limited. Following some background discussion, we review several examples of the structure-based design of synthetic macrocycles. Our opinion is that in conformationally suitable systems macrocycles are an analog class worthy of consideration. We then summarize an approach for the initial evaluation of molecules as candidates for macrocyclization." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Interest is growing in the use of macrocycles in pharmaceutical discovery. Macrocylization may provide a gateway to an expanded chemical space for small-molecule drug discovery, and this could be beneficial in prosecuting difficult targets, e.g., protein–protein interactions. Most, but not all, macrocycle drugs are derived from natural products. Studies on synthetic drug-like small-molecule macrocycles are limited, and our current understanding of macrocycle drugs is similarly limited. Following some background discussion, we review several examples of the structure-based design of synthetic macrocycles. Our opinion is that in conformationally suitable systems macrocycles are an analog class worthy of consideration. We then summarize an approach for the initial evaluation of molecules as candidates for macrocyclization." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0005.jpeg" /></meta><meta name="twitter:title" content="Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01985"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01985">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01985&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01985&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01985&amp;href=/doi/10.1021/acs.jmedchem.8b01985" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 6843-6853</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01673" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b00208" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Maxwell D. Cummings</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maxwell D. Cummings</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Janssen Research and Development, LLC, Welsh and McKean Roads, Spring House, Pennsylvania 19477, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: 215-628-6269<a href="/cdn-cgi/l/email-protection#7e131d0b131317104f3e170a0d50141014501d1113"><span class="__cf_email__" data-cfemail="d7bab4a2bababeb9e697bea3a4f9bdb9bdf9b4b8ba">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maxwell+D.++Cummings">Maxwell D. Cummings</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4646-3903" title="Orcid link">http://orcid.org/0000-0002-4646-3903</a></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Sivakumar Sekharan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sivakumar Sekharan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Cambridge Crystallographic Data Centre, 252 Nassau Street, Princeton, New Jersey 08542, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sivakumar++Sekharan">Sivakumar Sekharan</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01985&amp;href=/doi/10.1021%2Facs.jmedchem.8b01985" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 6843–6853</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 12, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 December 2018</li><li><span class="item_label"><b>Published</b> online</span>12 March 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 August 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01985" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01985</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6843%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaxwell%2BD.%2BCummings%252C%2BSivakumar%2BSekharan%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D15%26contentID%3Dacs.jmedchem.8b01985%26title%3DStructure-Based%2BMacrocycle%2BDesign%2Bin%2BSmall-Molecule%2BDrug%2BDiscovery%2Band%2BSimple%2BMetrics%2BTo%2BIdentify%2BOpportunities%2Bfor%2BMacrocyclization%2Bof%2BSmall-Molecule%2BLigands%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6853%26publicationDate%3DAugust%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01985"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6153</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01985" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maxwell&quot;,&quot;last_name&quot;:&quot;D. Cummings&quot;},{&quot;first_name&quot;:&quot;Sivakumar&quot;,&quot;last_name&quot;:&quot;Sekharan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;6843-6853&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01985&quot;},&quot;abstract&quot;:&quot;Interest is growing in the use of macrocycles in pharmaceutical discovery. Macrocylization may provide a gateway to an expanded chemical space for small-molecule drug discovery, and this could be beneficial in prosecuting difficult targets, e.g., protein–protein interactions. Most, but not all, macrocycle drugs are derived from natural products. Studies on synthetic drug-like small-molecule macrocycles are limited, and our current understanding of macrocycle drugs is similarly limited. Following some background discussion, we review several examples of the structure-based design of synthetic macrocycles. Our opinion is that in conformationally suitable systems macrocycles are an analog class worthy of consideration. We then summarize an approach for the initial evaluation of molecules as candidates for macrocyclization.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01985&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01985" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01985&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01985" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01985&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01985" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01985&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01985&amp;href=/doi/10.1021/acs.jmedchem.8b01985" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01985" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01985" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01985%26sid%3Dliteratum%253Aachs%26pmid%3D30860377%26genre%3Darticle%26aulast%3DCummings%26date%3D2019%26atitle%3DStructure-Based%2BMacrocycle%2BDesign%2Bin%2BSmall-Molecule%2BDrug%2BDiscovery%2Band%2BSimple%2BMetrics%2BTo%2BIdentify%2BOpportunities%2Bfor%2BMacrocyclization%2Bof%2BSmall-Molecule%2BLigands%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D15%26spage%3D6843%26epage%3D6853%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a>,</li><li><a href="/action/doSearch?ConceptID=291434" title="Macrocyclization">Macrocyclization</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291163" title="Macrocycles">Macrocycles</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/15" title="Go to Volume 62, Issue 15"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/jmcmar.2019.62.issue-15/20190808/jmcmar.2019.62.issue-15.largecover.jpg" alt="Go to Volume 62, Issue 15"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Interest is growing in the use of macrocycles in pharmaceutical discovery. Macrocylization may provide a gateway to an expanded chemical space for small-molecule drug discovery, and this could be beneficial in prosecuting difficult targets, e.g., protein–protein interactions. Most, but not all, macrocycle drugs are derived from natural products. Studies on synthetic drug-like small-molecule macrocycles are limited, and our current understanding of macrocycle drugs is similarly limited. Following some background discussion, we review several examples of the structure-based design of synthetic macrocycles. Our opinion is that in conformationally suitable systems macrocycles are an analog class worthy of consideration. We then summarize an approach for the initial evaluation of molecules as candidates for macrocyclization.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The field of macrocycle drugs has emerged as a distinct area of interest for pharmaceutical researchers. Recent reviews covering known macrocycle drugs have fostered the idea that this promising molecular class is underexploited in drug discovery and worthy of further attention.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1−5)</a> One developing theme in the field is that standard small-molecule oral drug property rules (e.g., Lipinski’s rule of five<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a>) are somewhat relaxed (or modified) for macrocycle drugs, with these molecules residing in a “beyond rule of five” region of chemical space.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref7">(1−5,7)</a> The apparent attractiveness of macrocyclic small-molecule drugs stems, at least in part, from the alluring idea that macrocycles represent an opportunity to find and develop small-molecule drugs with properties well outside the conventional conception of druglikeness. This inarguably tantalizing idea is not entirely unfounded, but much work remains to adequately explore this whole area of drug science.</div><div class="NLM_p">Contemporaneous with this ongoing coalescence of the field of “macrocycle drugs”, drug discovery scientists are being challenged by the new class of drug targets known as protein–protein interactions. Protein–protein interaction (PPI) targets for drug discovery are distinct from the classical enzyme–substrate or receptor–ligand interactions most typically targeted by small-molecule chemotherapeutics. While there are notable exceptions (e.g., p53-HDM2<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>), the interaction sites of PPI partners typically do not include the relatively small and concave surface pockets commonly observed for proteins that have evolved to bind natural small-molecules and that are exploited by many small-molecule drugs.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Overall, this new class of protein targets appears to be less druggable when viewed in the light of “classical” small-molecule drug discovery. Although published data supportive of this contention seem (understandably) sparse, the success rate of screening small-molecule compound collections against these new targets may be lower than for more conventional targets.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9−11)</a> Nevertheless, biology implicates a growing number of PPIs as worthy targets for chemotherapeutic intervention, based on key roles in metabolism and/or disease.<a onclick="showRef(event, 'ref9 ref10 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref12">(9,10,12)</a> As this compelling yet challenging target class expands and matures, pharmaceutical researchers are exploring new molecular strategies for drug discovery aimed at these targets.</div><div class="NLM_p">One developing theme of PPI-targeted drug discovery is that because the protein interaction sites are large and lack clearly defined binding pockets, small-molecule ligands must be larger (e.g., MW > 500) to achieve affinity levels commensurate with therapeutic efficacy.<a onclick="showRef(event, 'ref1 ref5 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref5 ref13">(1,5,13)</a> Recent drug discovery examples in the PPI area encourage this thinking (e.g., BCL-2<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>). Driven in part, perhaps, by the stapled peptide macrocycles targeted at MDM2-p53, peptide-based drug discovery has also begun to expand its niche in small-molecule drug discovery. At the same time, experience with “classical” targets (e.g., HCV protease, HIV protease) also supports the contention that generic physicochemical property rules for oral drug discovery (e.g., Lipinski’s rule of five<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a>) offer some latitude.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> For better or worse,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> we have come to expect that some larger small-molecules are developable as oral drugs.</div><div class="NLM_p">As “larger small-molecules” with some precedent of effectiveness in human therapeutics, macrocycles may have a role to play in this milieu; there is some theoretical underpinning to this assertion. Jacobson, Lokey, and colleagues have been groundbreakers in this area. Their computational and structural studies with cyclic peptides indicated that membrane permeability could be facilitated by conformational shifts involving significant changes in the chemical nature of the exposed surface of the peptides.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Such shifts were shown to be dependent on intramolecular transannular hydrogen bonds for these cyclic peptides. Other groups extended these ideas to broader analyses of small-molecules in drug-like and beyond rule of five chemical space, including macrocycles. Kuhn et al.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> explored intramolecular hydrogen bonding in small-molecule drugs, and Alex et al.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> later extended this to beyond rule of five chemical space. More recently, Whitty and colleagues formalized the conformation/property shift phenomenon with the term “chameleonic behavior” as a guiding principle for molecular design in the macrocycle and beyond rule of five chemical space.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Kihlberg et al. has also explored molecular properties of macrocycles and beyond rule of five small-molecules,<a onclick="showRef(event, 'ref2 ref22'); return false;" href="javascript:void(0);" class="ref ref2 ref22">(2,22)</a> and one of us collaborated with Kihlberg’s group on a study of the application of conformational analysis tools in conjunction with macrocycle property calculations.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Still, much remains to be learned about the effects of macrocyclization on pharmaceutically relevant properties of small-molecules. Macrocyclization can have profound effects on the conformational space accessible to a molecule, serving to both lock in and lock out conformations. It is becoming increasingly apparent that the resultant reduced flexibility, altered molecular shape(s), and modified surface properties can impact pharmaceutically relevant properties (e.g., stability, both on- and off-target binding affinity, membrane permeability) in many systems.</div><div class="NLM_p last">Our perspective is that several current areas of activity in drug discovery research converge on macrocycles. First, an apparently vast new class of therapeutic targets, protein–protein interactions, is emerging. It is accepted, justifiably or not, that oral small-molecule effectors for these targets may have to be larger and less “drug-like” than historical oral small-molecule drugs. Macrocyclization is one strategy that may be useful in improving the pharmaceutical properties of a larger small-molecule, thereby facilitating oral administration. Second, peptides are obvious starting points for many target-based discovery efforts, and peptides are undergoing somewhat of a renaissance in small-molecule drug discovery.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Peptides do, unfortunately, suffer from some drug developability challenges; one strategy applied in peptide-based drug discovery is peptide cyclization, leading to macrocyclic peptides.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> Third, property analyses have shown that “beyond rule of five” “chemical space” is real and useful in drug development, and macrocyclization appears to be useful in exploiting this expanded space. Finally, recent analyses of approved drugs show that oral drugs that lie outside typical rule of five bounds are enriched in macrocycles.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Also noteworthy in this context, although beyond the scope of the present brief Perspective, are technological advances in ring-closing metathesis chemistry,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> a methodology that is fundamentally enabling in macrocycle synthesis.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Origins of Macrocycle Drugs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Besides containing macrocycles, to what chemical classes do macrocycle drugs belong? Where did current macrocycle drugs and drug candidates come from? How were they discovered? Whatever a “typical” or “normal” drug discovery process is, can it lead to a macrocycle drug? Since macrocycles are often discussed as a single chemotype in the context of drug discovery and are considered attractive for some new protein targets, it seems reasonable to ponder thus as we seek to discover new macrocycle drugs.</div><div class="NLM_p">A recent survey lists 68 marketed macrocycle drugs and 35 macrocycles in clinical development.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Most of these molecules are either macrolides or cyclic peptides. Natural products of these and other chemical classes have traditionally been discovered through the application of iterative bioassay-guided fractionation of natural materials (e.g., soil, plants),<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> ultimately arriving at the identification of a pure compound. Natural products are structurally distinct from synthetic small-molecule drugs and small-molecule drug candidates, tending, for example, to contain more chiral centers and to be relatively oxygen rich and sulfur poor.<a onclick="showRef(event, 'ref5 ref29 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref5 ref29 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38">(5,29,31−38)</a> The discovery path for a natural product-based drug is likewise distinct from that of synthetic small-molecule drugs. Grasping this etiological difference seems apropos, as pharmaceutical researchers study current macrocycle drugs and seek new ones.</div><div class="NLM_p">In the natural-product-based drug discovery paradigm,<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> molecular structure is not a direct consideration during the initial hit or lead identification phase of drug discovery. Some focus or direction with respect to chemical structure may derive from screening extracts from selected species or locations, but the unknown active molecular species may be simple or complex. When a natural-product-based program culminates in an approved drug, the final drug molecule is typically a component of the initial screening hit or a very close analog of the active component of the initial screening hit mixture.</div><div class="NLM_p">In the medicinal-chemistry-based drug discovery paradigm, early stage hit or lead identification is applied to known chemical matter, e.g., a corporate compound collection, and the molecules being screened are pure and fully or largely characterized (chemically) in advance. When a medicinal-chemistry-based drug discovery program culminates in an approved drug, the final drug is often chemically distant from the initial screening hit or lead, as hundreds to thousands of molecular analogs are designed, synthesized, and tested on the optimization path from initial hit to final drug.</div><div class="NLM_p">Natural products are often larger and typically are more complex (see above) than “drug-like” small-molecule drugs. Generally, the synthesis of natural products is more difficult than that of synthetic drug-like small-molecules.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> “Analoging” around a hit or lead, fundamental to modern medicinal chemistry-based drug discovery, is likely to be impractical if not essentially impossible with a natural product lead. Despite these challenges, the importance of natural products to human health and drug discovery cannot be overstated. Pharmaceuticals and drug discovery are rooted in natural products; historically, most drugs can be traced to a natural product origin.<a onclick="showRef(event, 'ref29 ref34 ref36'); return false;" href="javascript:void(0);" class="ref ref29 ref34 ref36">(29,34,36)</a> While there frequently is still a strong connection between new drugs and their natural product origin or inspiration, in recent times modern synthetic chemistry has usurped nature as the primary source of new leads for drug discovery.<a onclick="showRef(event, 'ref30 ref32 ref34 ref39'); return false;" href="javascript:void(0);" class="ref ref30 ref32 ref34 ref39">(30,32,34,39)</a> In many settings, unless they are exquisitely potent, natural products or natural-product-like molecules are likely to be deprioritized when they arise as hits in a screening campaign (for reasons including excessive MW and synthetic accessibility). Thus, current pharmaceutical discovery efforts are largely focused on approaches that seem exclusive of the paradigm that has generated most known macrocycle drugs.</div><div class="NLM_p">A small subset of the macrocyclic molecules reviewed by Kihlberg and colleagues<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> are described as “de novo designed” molecules. Unlike small-molecule macrocycle drugs with natural product origins, these synthetic molecules arose from relatively recent medicinal-chemistry-based drug discovery efforts, familiar to most drug hunters currently working in pharmaceutical discovery. In this traditional paradigm, iterative medicinal-chemistry-based “analoging” can include macrocyclization directed toward discovering a molecule with optimal properties for the intended therapeutic application.</div><div class="NLM_p last">In the following section we review examples of the rational design of small-molecule macrocycles. In these cases, macrocyclization arose as a plausible route to addressing one or more drug development hurdles and ultimately proved successful in advancing compounds toward clinical evaluation.</div></div><div id="sec1_1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Structure-Based Design of Small-Molecule Macrocycles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="secz" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">3.1.  Example 1: HCV Protease</h3><div class="NLM_p">Treatment of HCV infection has improved dramatically in the past several years. Five small-molecule inhibitors of the NS3 protease have been approved as drugs since 2011, and three of these are macrocyclic small-molecules. This recent advance for HCV patients is a striking example of <i>designed</i> macrocycles having great positive impact on human life. Retrospectively, the story of the early days HCV NS3 protease inhibitor-based drug discovery is enlightening and relevant to both peptide-based discovery and macrocycles.</div><div class="NLM_p">Researchers from Boehringer Ingelheim have described their early work on HCV NS3 protease drug discovery, arriving at a macrocyclic tetrapeptide inhibitor that subsequently served as molecular template for many other research groups.<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a> This design process began with the observation that hydrolysis products of selected peptide substrates acted as inhibitors of the NS3 protease. Peptide truncation studies, depeptidization through incorporation of non-natural amino acids, and elaboration of side chains with synthetic substituents gave potent inhibitors. Unfortunately these molecules were limited by poor biopharmaceutical properties, consistently lacking activity in cell-based assays. NMR- and computational-chemistry-guided structural studies led to additional depeptidization strategies, among them rigidification through macrocyclization. Emerging from a clear and rational structure-based foundation, macrocyclization proved to be an important molecular design advance in this peptide-based drug discovery effort.</div><div class="NLM_p">During the course of their program to optimize a substrate-based inhibitor of HCV NS3 protease into a drug, the Boehringer Ingelheim group applied NMR studies to understand peptide rigidification upon binding to the protease. One result of this work<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> was the observation of the close proximity of two side chains of a peptide inhibitor when bound to the protease. (While they are not the molecules studied in the original work from the Boehringer Ingelheim group, the comparison of two NS3 protease-bound inhibitors in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> highlights this feature.) Previous studies from the Fairlie group on peptide macrocycles had provided structural insights and guidelines on macrocyclization of protease substrates,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and application of this approach led the Boehringer Ingelheim group to the discovery of a macrocyclic variant of their peptide-based scaffold.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Some of the initial macrocyclic inhibitors arising from this effort maintained and in some cases showed slightly improved enzyme inhibition. Most importantly, a subset of these macrocycles were the first NS3 protease inhibitors to show antiviral activity in the cell-based replicon assay.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of HCV NS3 protease-bound inhibitors shows the alkyl macrocycle linker of simeprevir (orange color by atom) occupying the region between the two alkyl side chain moieties of boceprevir (green color by atom), similar to the original observation<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a> that initiated research into macrocyclic inhibitors of NS3 protease (see text for discussion); overlay based solely on protein atoms (not shown) from the complex structures (simeprevir PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KEE">3KEE</a>;<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> boceprevir PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LOX">3LOX</a><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These early studies paved the way for the subsequent extensive research into macrocyclic inhibitors of HCV NS3 protease. As the HCV protease inhibitor field matured, both the initial and later alternative macrocyclization schemes were employed with peptide-based molecules by many pharmaceutical industry discovery groups,<a onclick="showRef(event, 'ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53">(46−53)</a> eventually leading to the discovery of several FDA-approved drugs. Efforts at Janssen (initiated at Tibotec, in collaboration with Medivir) in this area led to the discovery of simeprevir, the first macrocyclic NS3 inhibitor to be approved by the FDA for HCV therapy (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref54 ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref55 ref56">(54−56)</a></div><div class="NLM_p">Macrocyclization has been explored as a drug design strategy for other proteases. James and colleagues studied the entropic effect of macrocyclization on a peptide inhibitor of the aspartic protease penicillopepsin, concluding that partial rigidification was responsible for a significant enhancement in inhibitor potency.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Fairlie and colleagues have been pioneers on many fronts in this field, and have reviewed protease crystal structures and macrocyclic peptide inhibitors of proteases.<a onclick="showRef(event, 'ref43 ref58'); return false;" href="javascript:void(0);" class="ref ref43 ref58">(43,58)</a> These reports highlight how macrocyclization can enforce the extended conformation required for peptide binding in protease active sites. Thus, macrocyclization seems suited to broad application in peptide-based protease-targeted drug discovery (see also <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Additional Examples of Structure-Based Design of Small-Molecule Macrocycles</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">protein target</th><th class="colsep0 rowsep0" align="center">macrocycle details</th><th class="colsep0 rowsep0" align="center">ref</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">factor XIa</td><td class="colsep0 rowsep0" align="left">generic linker optimized to form specific intramolecular hydrogen bond; improved inhibitory and anticoagulant potency and better selectivity versus related proteases</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">factor VIIa</td><td class="colsep0 rowsep0" align="left">optimization of macrocycle led to improved inhibitory and anticoagulant potency and better selectivity versus related proteases</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HIV-1 protease</td><td class="colsep0 rowsep0" align="left">peptidic P1–P3 side chain-cyclized macrocycles with improved affinity and antiretroviral potency</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">β-secretase</td><td class="colsep0 rowsep0" align="left">cross-linking of P1–P3 side chains and additional optimization yield BACE-1 inhibitor with promising activity in Alzheimer’s disease-related mouse model</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BCL-6</td><td class="colsep0 rowsep0" align="left">macrocyclization to favor binding conformation; high affinity inhibitors for a relatively new PPI target</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p53-MDM2</td><td class="colsep0 rowsep0" align="left">computational method-based approach to discovery of novel, nonpeptidic macrocycles with modest “lead-like” affinities</td><td class="colsep0 rowsep0" align="left"><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></td></tr></tbody></table></div></div></div><div id="sec1_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.2.  Example 2: Kinase Inhibitors</h3><div class="NLM_p">Kinase-inhibitor-based small-molecule drug discovery emerged in the late 1980s and has since been a consistently active and productive area of drug discovery, yielding more than two dozen FDA-approved drugs<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and a wealth of scientific literature. The three-dimensional structures of kinase-inhibitor complexes have been extensively studied and thoroughly reviewed.<a onclick="showRef(event, 'ref60 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62 ref63">(60−63)</a> Given the level of activity in the kinase field and the recent interest in macrocycles in drug discovery, it is perhaps not surprising that macrocyclization has found application in the kinase-inhibitor field. However, as one of us noted in a recent publication,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> an in-depth analysis of kinase-inhibitor binding modes and macrocyclization is unprecedented. Specifically, the U-shaped binding mode frequently observed for kinase inhibitors has not been widely recognized as a general phenomenon with broad applicability to the design of macrocyclic small-molecule kinase inhibitors.</div><div class="NLM_p">A recent survey listed four macrocyclic kinase inhibitors in clinical development, including the JAK2/FLT3 inhibitor pacritinib.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Here we briefly summarize some aspects of pacritinib macrocycle design and note a few additional kinase systems that illustrate the applicability of macrocyclization to kinase-inhibitor-based drug discovery.</div><div class="NLM_p">In discovering pacritinib, William and colleagues initiated their effort with a phenylaminopyrimidine screening hit that showed a promising kinase activity profile. They noted the congested patent space around this chemotype, a potentially prohibitive issue at the early stage of a drug discovery effort.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> To address this challenge, a combination of modeling with available 3D structures of kinase-inhibitor complexes, small-molecule conformational analysis, and automated docking results led to a macrocyclization design scheme (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). While not explicitly described as a “U-shaped conformation”, in this design work William and colleagues exploited the U-shaped conformation predicted for their initial phenylaminopyrimidine screening hit in their subsequent macrocycle designs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Pursuit of this general approach proved fruitful, yielding multiple clinical candidates. Macrocycle linker characteristics including length, chemical nature, and rigidity were all shown to be relevant to both kinase affinity and selectivity and also allowed modulation of cLogP. Exocyclic substituents on a macrocycle linker heteroatom were also useful in modulating kinase affinity and selectivity, as well as affecting cLogP and solubility.<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65,66)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overall macrocycle design strategy that led to the discovery of pacritinib. A modification of the table-of-contents figure and Figure 1 from ref <a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a>. Reproduced with permission from <i>Journal of Medicinal Chemistry</i>.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Copyright 2011 American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Johnson and colleagues at Pfizer described their work on ALK inhibitors, with the crystal structure of a nonmacrocyclic inhibitor complex providing a foundation for macrocycle design.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> These authors explicitly noted that bound linear inhibitors adopted a U-shaped conformation, positioning the two terminal inhibitor moieties in close proximity to each other. As with the pacritinib study, the macrocycle linker was useful in modulating both kinase affinity and selectivity, and CNS availability was also modulated by linker variation. Notably, lipophilic efficiency was a critical metric during compound optimization.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> This effort led to the discovery of a clinical candidate with improved kinase selectivity, enhanced resistance and ADME profiles as well as the desired CNS availability.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> This designed macrocyclic kinase inhibitor, lorlatinib, was recently approved by the U.S. FDA for second- or third-line treatment of (ALK)-positive metastatic non-small-cell lung cancer.,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p">In describing a complex with the spleen tyrosine kinase Syk, the authors observed that bound imatinib (Gleevec) adopts a relatively compact “U-shaped” or “<i>cis</i>” conformation, in contrast to the more extended conformation observed originally in the Abl complex.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> A U-shaped conformation was also observed for a covalent analog of imatinib bound to JNK3.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p last">Overall, then, some small-molecule kinase inhibitors have been observed to adopt a U-shaped conformation when bound at the kinase hinge region. This specific shape feature has been exploited for designing purely synthetic macrocyclic kinase inhibitors. These observations have been strictly isolated on a case-by-case basis. Prior to a recent publication from one of us,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> it has not previously been formally recognized that this phenomenon may be general and represent a foundation for a broadly applicable kinase inhibitor design approach. Results reported to date for designed macrocyclic kinase inhibitors establish that such molecules can offer advantages in the areas of kinase affinity and selectivity, ADME properties, CNS availability, and patentability. Thus, macrocyclic analogs of synthetic small-molecule kinase inhibitors represent a viable approach for kinase-inhibitor-based drug discovery.</div></div><div id="sec1_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.3.  Example 3: HCV Polymerase</h3><div class="NLM_p">In the early to-mid 2000s research into hepatitis C viral proteins surged, as direct acting antiviral agents for HCV therapy gained interest. As part of a multifaceted drug discovery effort targeting HCV, our group at Tibotec (now Janssen) explored inhibitors of the viral polymerase enzyme. At the time this protein was being intensively studied as a target for HCV therapy, and various data had established the presence of multiple druggable allosteric sites on the viral enzyme. One such site was known to bind a series of indoles and related benzimidazoles, and our group used public information around these compounds to launch a new drug discovery program aimed at overcoming the developability challenges for the known compounds.<a onclick="showRef(event, 'ref44 ref72'); return false;" href="javascript:void(0);" class="ref ref44 ref72">(44,72)</a> Ultimately this approach yielded an efficacious indole-based macrocycle with an improved pharmaceutical profile.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a></div><div class="NLM_p">The published indole/benzimidazole polymerase inhibitors showed promising levels of enzyme inhibition and antiviral activity but were hampered by structural features and/or physicochemical properties problematic for drug development.<a onclick="showRef(event, 'ref44 ref72'); return false;" href="javascript:void(0);" class="ref ref44 ref72">(44,72)</a> Thus, we found ourselves in a situation frequently encountered in early drug discovery: a promising lead molecule or chemotype emerges but with one or more undesirable features. At the time, the enzyme had already been extensively characterized. As part of our background research we had compiled a data set of the available 3D structures of NS5B polymerase–inhibitor complexes.<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> The single inhibitors display flexible polar moieties projecting away from the binding surface toward bulk solvent, from two distinct regions of the common core binding element (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Overlay of all three structures offered a striking perspective, suggestive of cyclization between two solvent-exposed moieties to form a macrocycle (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Further analysis and modeling based on these three public 3D structures led us to postulate that macrocyclization of the known compounds would lead to macrocyclic analogs that maintained all of the binding interactions observed for the nonmacrocyclic parents. We also expected the new macrocycles to have altered physicochemical property profiles.<a onclick="showRef(event, 'ref1 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref5">(1,5)</a> Pursuing these ideas, we designed and synthesized several different macrocyclic “linkers” that appeared to fit our overall strategy for targeting this site on the polymerase. In this case macrocyclization led to the discovery of potent inhibitors with improved oral bioavailability and liver distribution,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> the latter property being key for a hepatitis chemotherapeutic.<a onclick="showRef(event, 'ref44 ref72'); return false;" href="javascript:void(0);" class="ref ref44 ref72">(44,72)</a> Application of this approach led our research program to a clinical candidate relatively rapidly.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure-based design of a macrocyclic HCV NS5B polymerase inhibitor. Overlay of public structures 2BRK<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> (green color by atom), 2BRL<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> (cyan color by atom) and 2DXS<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> (purple color by atom); likely regions for macrocyclization highlighted with shaded background spheres; designed macrocycle from 4DRU<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> shown in orange color by atom; protein surfaces from the respective complexes shown in gray; superpositions based strictly on protein backbone atoms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.4.  Additional Examples and Summary</h3><div class="NLM_p">We have described three cases in some detail. Further detailed review is beyond the scope of the present overview. Prior to summarizing this section, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> lists a few additional examples that may be of interest to some readers.<named-content content-type="anchor" rid="tbl1" type="simple"></named-content></div><div class="NLM_p last">The macrocycle design examples outlined above are founded on 3D structural data. One or more observed small-molecule binding modes indicated that two ends or moieties of the bound small-molecule ligand could be connected, with the new macrocyclic molecule maintaining the bound conformation and binding interactions observed for the nonmacrocyclic parent. This is essentially structure-based design. In the most typical small-molecule structure-based drug design (SBDD) scenario, 3D information about a protein–ligand complex is used to design new small-molecule ligands with increased binding affinities through added or modified binding interactions. In this macrocycle design variation of SBDD, 3D information guides ligand modification to form a macrocycle (cf. <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The aim of this type of structure-based macrocycle design effort <i>could be</i> to alter or add intermolecular binding interactions to improve binding affinity or selectivity, as in the most typical application of SBDD. Other objectives may include improved affinity through rigidification (decreased entropic penalty of binding), altered physicochemical properties, altered tissue distribution including CNS penetration, enhanced proteolytic stability (especially for peptidic molecules), and new intellectual property based on molecular novelty (references noted above).</div></div></div><div id="sec1_1_4_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">4.  Identification of Opportunities for the Structure-Based Design of New Macrocycles</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the preceding sections we have outlined some aspects of the current status of macrocyclic small-molecules in drug discovery. Interest in macrocycles for drug discovery has been increasing. Macrocycles are conceptually attractive because they may provide access to an expanded (“beyond rule of 5”) chemical space for small-molecule drug discovery, which in turn may be advantageous for drug discovery targeting protein–protein interactions. Macrocycle drugs and clinical compounds are largely natural products or cyclic peptides; a few rationally designed macrocycles in clinical development or on the market are more similar to typical synthetic small-molecule drugs. The discovery paths for natural products and synthetic drugs are very different. Only a few of the macrocycles in clinical development are based on a molecular design approach where an identifiable nonmacrocycle “parent” molecule gave rise, through iterative design, synthesis, and testing, to a macrocyclic analog. We outlined representative examples of precisely this scenario, wherein structure-based design led to the discovery of macrocyclic analogs derived from nonmacrocyclic “parent” small-molecule ligands. Furthermore, in these cases the resulting macrocyclic analogs were shown to represent advances in their respective drug discovery areas. To summarize, in these cases one or more 3D structures of relevant protein–ligand complexes provided the foundation for the structure-based design of a macrocyclic analog.</div><div class="NLM_p">If macrocycles are indeed of interest for small-molecule drug discovery, then we can postulate that sources of new macrocycles are also of interest. The study of new macrocycles may lead to further insights into the properties of such molecules and may open new avenues of drug discovery. In small-molecule drug discovery in pharmaceutical research, opportunities to apply a structure-guided approach to macrocycle design are not uncommon. 3D structure-enabled projects frequently yield bound ligand conformations that seem consistent with or predisposed toward macrocyclization.</div><div class="NLM_p">In principle, of course, any small-molecule can be (macro-)cyclized. Bound small-molecule ligand conformations will fall somewhere on the spectrum ranging from “linear and maximally extended” to “partially folded and slightly or somewhat C-shaped” to “folded back on itself and U-shaped”. In a drug discovery context where 3D structural information becomes available for a small-molecule chemotype of interest, drug discovery scientists exploit this information toward various ends including improved affinity, alternative physicochemical properties, and novelty (e.g., defensible intellectual property). For bound small-molecules that are somewhat folded back upon themselves, macrocyclization represents a feasible approach that may address one or more of these common drug discovery objectives.</div><div class="NLM_p">In the macrocycle design examples detailed above, the original nonmacrocyclic “parent” molecules tend toward “partially folded and C-shaped” to “folded and U-shaped”. From these examples we can distill a simple algorithm that facilitates the detection of bound ligand conformations that appear well-suited for modification into macrocycles. Thus, for any pair of atoms within a bound ligand, we can consider the through-space distance between the two atoms and the number of bonds comprising the shortest through-bond path between the same two atoms. If the through-space distance is relatively short for a given through-bond path, then this is indicative of a compact or folded ligand conformation, and the atom pair represents candidate positions for intramolecular connection to form a macrocycle. This simple approach can serve to identify small-molecule conformations that appear to be consistent with, or preorganized for, macrocyclization.</div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows examples of ligands and conformations that can be identified with this kind of analysis,<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> consistent with the idea that relatively simple metrics can identify bound small-molecules that show some conformational predisposition toward macrocyclization. Our preliminary analysis of the full PDB<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>) indicates a rich vein to mine for such small-molecule structures (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>; additional results not shown). In the overall process of macrocyclic drug discovery, identification of such starting points is one of the first and, arguably, one of the easiest of many steps in this challenging process.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Examples of bound ligands showing a conformational predisposition to macrocyclization. C-shaped or folded conformations of protein-bound small-molecule ligands showing one or more atom–atom pairs with relatively short atom–atom through-space distances for the corresponding through-bond paths (see text; distances in Å). PDB codes are the following (left to right): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4P38">4P38</a>,<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KJS">3KJS</a>,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU4">2XU4</a>,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FZ7">4FZ7</a>.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">When a candidate molecule has been selected as the foundation for a macrocycle, designing the macrocyclic connection is the next step. In some cases, connection schemes to consider may be dictated by the protein–ligand system. For example, in the HCV protease system described above, connection of two hydrophobic alkyl side chains that bind in close proximity to each other and contact a hydrophobic region of the enzyme binding site mandated a relatively small hydrophobic linker (protein not shown, but see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Overlays with related protein–ligand complex structures may also be suggestive. Visual inspection of the small-molecule and likely macrocyclization connection points along with the 3D structure of the complex with the target protein will assuredly lead to ideas for possible connection schemes in many protein–ligand systems. Typical interactive SBDD involving overlays and molecule building, cut-and-paste strategies, and small-molecule conformational analysis will find application in this macrocycle design context. Several of the major molecular modeling software packages (e.g., CCG,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Openeye,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Schrodinger<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a>) have utilities or protocols that can be applied to the construction of macrocycle linkers, and specific tools for macrocycle linker construction have started to emerge.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Alternatively, this part of the structure-based macrocycle design process can be viewed as a pharmacophoric search problem, and relevant computational tools can be brought to bear. We recently described the application of the pharmacophore search tool CSD-Crossminer<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> to this problem,<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> and other researchers have also begun to address this problem with a pharmacophore search-based approach.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">5.  Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Historically, most macrocyclic drugs have been natural products and peptides. Purely synthetic macrocyclic small-molecule drugs are rare but not unknown, and interest in this area is being driven by multiple factors. Difficult new targets including protein–protein interactions, interest in expanded chemical space beyond rule of five limits for small-molecule drug discovery, advances in synthetic chemistry technology as well as developments in drug formulation and delivery are all driving or enabling exploration of synthetic small-molecule macrocycles in drug discovery.</div><div class="NLM_p last">The PDB<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> contains more than 145 000 3D protein structures, including more than 26 000 unique protein-bound ligands. The CSD<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> (<a href="http://www.ccdc.cam.ac.uk" class="extLink">www.ccdc.cam.ac.uk</a>) is approaching 1 000 000 small-molecule entries. These vast treasures of 3D structural information are powerfully enabling in many aspects of small-molecule drug discovery. Our personal experience over decades of pharmaceutical research has been that in structure-enabled drug discovery programs, macrocycle-like conformations are often observed for non-macrocycle small-molecule ligands bound to their protein targets. In this brief Perspective we have outlined several cases exemplifying the use of 3D structural information in the design of synthetic small-molecule macrocycles that advanced drug discovery efforts. We then went on to describe one approach to the systematic identification, and prioritization, of macrocycle-like conformations of small-molecules. Our primary interest is in analyzing protein–ligand complexes, but the method is also applicable to small-molecule crystal structures. Overall, our goal is to highlight the great potential we see for the application of SBDD to the design and discovery of new small-molecule macrocycles. Structure-based analysis indicates that there are many opportunities for macrocyclization in the set of protein–ligand complexes currently available at the PDB. This may be useful in studies aimed at gaining general understanding of how macrocyclization alters molecular properties. Finally, we encourage readers to consider structure-based design of macrocycles as one approach to overcoming molecular property challenges in small-molecule drug discovery.</div></div><div class="NLM_back"><div class="NLM_notes" id="NOTES-d7e759-autogenerated"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01985" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87076" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87076" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maxwell D. Cummings</span> - <span class="hlFld-Affiliation affiliation">Janssen
Research and Development, LLC, Welsh and McKean Roads, Spring House, Pennsylvania 19477, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4646-3903" title="Orcid link">http://orcid.org/0000-0002-4646-3903</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3f525c4a525256510e7f564b4c11555155115c5052"><span class="__cf_email__" data-cfemail="264b45534b4b4f4817664f5255084c484c0845494b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sivakumar Sekharan</span> - <span class="hlFld-Affiliation affiliation">Cambridge
Crystallographic Data Centre, 252 Nassau Street, Princeton, New Jersey 08542, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40253" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40253" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Maxwell D. Cummings</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=BIO-d7e749-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Max Cummings</b> is a Computational Chemist at Janssen R&D in Pennsylvania, working on drug discovery in various therapeutic areas. He received his Ph.D. in Biochemistry in 1996 from the University of Alberta, Canada, applying computational docking to molecular recognition problems in the areas of ubiquitin protein–protein interactions and bacterial toxin receptor binding. Dr. Cummings worked at SynPhar (now NAEJA), Edmonton, Canada, from 1988 to 1996 and at SmithKline Beecham (now GSK), King of Prussia, U.S., from 1997 to 2000. In 2000 he joined 3-Dimensional Pharmaceuticals, Exton, U.S., which later become part of Johnson & Johnson. In 2007 he moved to Tibotec BVBA, a J&J company, in Mechelen, Belgium, and in 2011 returned to the Janssen R&D site in Spring House, U.S.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Sivakumar Sekharan</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=BIO-d7e754-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sivakumar Sekharan</b> is a Research and Applications Scientist at the Cambridge Crystallographic Data Centre (CCDC) in New Jersey. He received his Ph.D. in Theoretical Chemistry in 2007 at the University of Duisburg-Essen, Germany, where he applied ab initio QM methods to the study of mammalian photoreceptors. Following postdoctoral fellowships at the Max-Planck Institute for Polymer Research and Emory University, Dr. Sekharan joined the Department of Chemistry at Yale University in 2012 as an Associate Research Scientist where he applied homology modeling, QM/MM methods, and MD simulations to the study of olfactory receptors and GPCRs. In 2015 he joined Cloud Pharmaceuticals, applying artificial-intelligence-based methods to drug design. Since 2016 he has been at the CCDC working at the interface between research, software development, and user services.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors appreciate the review and comments as well as the ongoing support of Dr. Jason Cole (CCDC) and Dr. Renee L. DesJarlais (Janssen R&D). We also appreciate the extensive constructive comments of two of the Reviewers, many of which were incorporated into the final version of our manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations used</td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">p53</td><td class="NLM_def"><p class="first last">tumor suppressor p53</p></td></tr><tr><td class="NLM_term">HDM2</td><td class="NLM_def"><p class="first last">human double minute 2 homolog</p></td></tr><tr><td class="NLM_term">MDM2</td><td class="NLM_def"><p class="first last">mouse double minute 2 homolog</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">BCL-2</td><td class="NLM_def"><p class="first last">B-cell lymphoma 2 protein</p></td></tr><tr><td class="NLM_term">HCV</td><td class="NLM_def"><p class="first last">hepatitis C virus</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">NS3</td><td class="NLM_def"><p class="first last">nonstructural protein 3</p></td></tr><tr><td class="NLM_term">NS5b</td><td class="NLM_def"><p class="first last">nonstructural protein 5b (RNA polymerase)</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">U.S. Food and Drug Administration</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase 2</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">fms-like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">ALK</td><td class="NLM_def"><p class="first last">anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">Syk</td><td class="NLM_def"><p class="first last">spleen tyrosine kinase</p></td></tr><tr><td class="NLM_term">Abl</td><td class="NLM_def"><p class="first last">Abelson murine leukemia viral oncogene homolog 1</p></td></tr><tr><td class="NLM_term">JNK3</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase 3</p></td></tr><tr><td class="NLM_term">BCL-6</td><td class="NLM_def"><p class="first last">B-cell lymphoma 6 protein</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">3D</td><td class="NLM_def"><p class="first last">three-dimensional</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">RCSB Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>)</p></td></tr><tr><td class="NLM_term">CSD</td><td class="NLM_def"><p class="first last">Cambridge Structural Database (<a href="http://www.ccdc.cam.ac.uk" class="extLink">www.ccdc.cam.ac.uk</a>)</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 97 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Driggers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span> <span> </span><span class="NLM_article-title">The exploration of macrocycles for drug discovery--an underexploited structural class</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1038/nrd2590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=18591981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFShsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=608-624&author=E.+M.+Driggersauthor=S.+P.+Haleauthor=J.+Leeauthor=N.+K.+Terrett&title=The+exploration+of+macrocycles+for+drug+discovery%2D%2Dan+underexploited+structural+class&doi=10.1038%2Fnrd2590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The exploration of macrocycles for drug discovery - an underexploited structural class</span></div><div class="casAuthors">Driggers, Edward M.; Hale, Stephen P.; Lee, Jinbo; Terrett, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">608-624</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products comprised of a macrocycle ring structure have proven their therapeutic applications as antibiotics, immunosuppressants as well as anticancer agents.  Despite this, macrocyclic compds. remain under-explored.  Terrett and colleagues review the properties and features of current macrocycle drugs, emphasizing the vast potential of synthetic macrocycles in drug discovery.  Macrocyclic natural products have evolved to fulfil numerous biochem. functions, and their profound pharmacol. properties have led to their development as drugs.  A macrocycle provides diverse functionality and stereochem. complexity in a conformationally pre-organized ring structure.  This can result in high affinity and selectivity for protein targets, while preserving sufficient bioavailability to reach intracellular locations.  Despite these valuable characteristics, and the proven success of more than 100 marketed macrocycle drugs derived from natural products, this structural class has been poorly explored within drug discovery.  This is in part due to concerns about synthetic intractability and non-drug-like properties.  This Review describes the growing body of data in favor of macrocyclic therapeutics, and demonstrates that this class of compds. can be both fully drug-like in its properties and readily prepd. owing to recent advances in synthetic medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDtW8LpE4ru7Vg90H21EOLACvtfcHk0lhrKkp1GfuD9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFShsbc%253D&md5=16e091818053e5b163b81078a8d03094</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2590%26sid%3Dliteratum%253Aachs%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DHale%26aufirst%3DS.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26atitle%3DThe%2520exploration%2520of%2520macrocycles%2520for%2520drug%2520discovery--an%2520underexploited%2520structural%2520class%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D608%26epage%3D624%26doi%3D10.1038%2Fnrd2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1021/jm400887j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400887j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGnurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=278-295&author=F.+Giordanettoauthor=J.+Kihlberg&title=Macrocyclic+drugs+and+clinical+candidates%3A+what+can+medicinal+chemists+learn+from+their+properties%3F&doi=10.1021%2Fjm400887j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?</span></div><div class="casAuthors">Giordanetto, Fabrizio; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-295</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles are ideal in efforts to tackle difficult targets, but our understanding of what makes them cell permeable and orally bioavailable is limited.  Anal. of approx. 100 macrocyclic drugs and clin. candidates revealed that macrocycles are predominantly used for infectious disease and in oncol. and that most belong to the macrolide or cyclic peptide class.  A significant no. (N = 34) of these macrocycles are administered orally, revealing that oral bioavailability can be obtained at mol. wts. up to and above 1 kDa and polar surface areas ranging toward 250 Å2.  Moreover, insight from a group of de novo designed oral macrocycles in clin. studies and understanding of how cyclosporin A and model cyclic hexapeptides cross cell membranes may unlock wider opportunities in drug discovery.  However, the no. of oral macrocycles is still low and it remains to be seen if they are outliers or if macrocycles will open up novel oral druggable space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaeM2DXwvmiLVg90H21EOLACvtfcHk0lg8MyUIpyfxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGnurjI&md5=a3e1743bd5ba34f73d8e78f8cb1bee5f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm400887j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400887j%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520drugs%2520and%2520clinical%2520candidates%253A%2520what%2520can%2520medicinal%2520chemists%2520learn%2520from%2520their%2520properties%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D278%26epage%3D295%26doi%3D10.1021%2Fjm400887j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Macrocycles in new drug discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.93</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.4155%2Ffmc.12.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=22857532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCht7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1409-1438&author=J.+Mallinsonauthor=I.+Collins&title=Macrocycles+in+new+drug+discovery&doi=10.4155%2Ffmc.12.93"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles in new drug discovery</span></div><div class="casAuthors">Mallinson, Jamie; Collins, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1409-1438</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The use of drug-like macrocycles is emerging as an exciting area of medicinal chem., with several recent examples highlighting the favorable changes in biol. and physicochem. properties that macrocyclization can afford.  Natural product macrocycles and their synthetic derivs. have long been clin. useful and attention is now being focused on the wider use of macrocyclic scaffolds in medicinal chem. in the search for new drugs for increasingly challenging targets.  With the increasing awareness of concepts of drug-likeness and the dangers of mol. obesity', functionalized macrocyclic scaffolds could provide a way to generate ligand-efficient mols. with enhanced properties.  In this review we will sep. discuss the effects of macrocyclization upon potency, selectivity and physicochem. properties, concg. on recent case histories in oncol. drug discovery.  Addnl., we will highlight selected advances in the synthesis of macrocycles and provide an outlook on the future use of macrocyclic scaffolds in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrzcbKW7Tc7Vg90H21EOLACvtfcHk0lg8MyUIpyfxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCht7rO&md5=63ad275af92ac89ae6b36c5071b578f8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.93%26sid%3Dliteratum%253Aachs%26aulast%3DMallinson%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMacrocycles%2520in%2520new%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1409%26epage%3D1438%26doi%3D10.4155%2Ffmc.12.93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span> <span> </span><span class="NLM_article-title">Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1961</span>– <span class="NLM_lpage">2004</span>, <span class="refDoi"> DOI: 10.1021/jm1012374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+are+great+cycles%3A+applications%2C+opportunities%2C+and+challenges+of+synthetic+macrocycles+in+drug+discovery&doi=10.1021%2Fjm1012374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0lg8MyUIpyfxlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520are%2520great%2520cycles%253A%2520applications%252C%2520opportunities%252C%2520and%2520challenges%2520of%2520synthetic%2520macrocycles%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1961%26epage%3D2004%26doi%3D10.1021%2Fjm1012374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wessjohann, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruijter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Rivera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, W.</span></span> <span> </span><span class="NLM_article-title">What can a chemist learn from nature’s macrocycles?--a brief, conceptual view</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1007/s11030-005-1314-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1007%2Fs11030-005-1314-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15789564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslels7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=171-186&author=L.+A.+Wessjohannauthor=E.+Ruijterauthor=D.+Garcia-Riveraauthor=W.+Brandt&title=What+can+a+chemist+learn+from+nature%E2%80%99s+macrocycles%3F%2D%2Da+brief%2C+conceptual+view&doi=10.1007%2Fs11030-005-1314-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">What can a chemist learn from nature's macrocycles? - A brief, conceptual view</span></div><div class="casAuthors">Wessjohann, Ludger A.; Ruijter, Eelco; Garcia-Rivera, Daniel; Brandt, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Diversity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">171-186</span>CODEN:
                <span class="NLM_cas:coden">MODIF4</span>;
        ISSN:<span class="NLM_cas:issn">1381-1991</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Macrocyclic natural products often display remarkable biol. activities, and many of these compds. (or their derivs.) are used as drugs.  The chem. diversity of these compds. is immense and may provide inspiration for innovative drug design.  Therefore, a database of naturally occurring macrocycles was analyzed for ring size, mol. wt. distribution, and the frequency of some common substructural motifs.  The underlying principles of the chem. diversity are reviewed in terms of biosynthetic origin and nature's strategies for diversity and complexity generation in relation to the structural diversity and similarities found in the macrocycle database.  Finally, it is suggested that synthetic chemists should use not only nature's mols., but also nature's strategies as a source of inspiration.  To illustrate this, the biosynthesis of macrocycles by non-ribosomal peptide synthetases and terpene and polyketide cyclases, as well as recent advances of these strategies in an integrated synthesis/biotechnol. approach are briefly reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVB4g1QplcWLVg90H21EOLACvtfcHk0livtZhH2JiFAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslels7w%253D&md5=88df3ca095b446e3781369708ccddfd2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs11030-005-1314-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-005-1314-x%26sid%3Dliteratum%253Aachs%26aulast%3DWessjohann%26aufirst%3DL.%2BA.%26aulast%3DRuijter%26aufirst%3DE.%26aulast%3DGarcia-Rivera%26aufirst%3DD.%26aulast%3DBrandt%26aufirst%3DW.%26atitle%3DWhat%2520can%2520a%2520chemist%2520learn%2520from%2520nature%25E2%2580%2599s%2520macrocycles%253F--a%2520brief%252C%2520conceptual%2520view%26jtitle%3DMol.%2520Diversity%26date%3D2005%26volume%3D9%26spage%3D171%26epage%3D186%26doi%3D10.1007%2Fs11030-005-1314-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0livtZhH2JiFAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobritzsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">How beyond rule of 5 drugs and clinical candidates bind to their targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2312</span>– <span class="NLM_lpage">2327</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2312-2327&author=B.+C.+Doakauthor=J.+Zhengauthor=D.+Dobritzschauthor=J.+Kihlberg&title=How+beyond+rule+of+5+drugs+and+clinical+candidates+bind+to+their+targets&doi=10.1021%2Facs.jmedchem.5b01286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets</span></div><div class="casAuthors">Doak, Bradley C.; Zheng, Jie; Dobritzsch, Doreen; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2312-2327</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve discovery of drugs for difficult targets, the opportunities of chem. space beyond the rule of 5 (bRo5) were examd. by retrospective anal. of a comprehensive set of structures for complexes between drugs and clin. candidates and their targets.  The anal. illustrates the potential of compds. far beyond rule of 5 space to modulate novel and difficult target classes that have large, flat, and groove-shaped binding sites.  However, ligand efficiencies are significantly reduced for flat- and groove-shape binding sites, suggesting that adjustments of how to use such metrics are required.  Ligands bRo5 appear to benefit from an appropriate balance between rigidity and flexibility to bind with sufficient affinity to their targets, with macrocycles and nonmacrocycles being found to have similar flexibility.  However, macrocycles were more disk- and spherelike, which may contribute to their superior binding to flat sites, while rigidification of nonmacrocycles lead to rodlike ligands that bind well to groove-shaped binding sites.  These insights should contribute to altering perceptions of what targets are considered "druggable" and provide support for drug design in beyond rule of 5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZD-h9VodiPLVg90H21EOLACvtfcHk0livtZhH2JiFAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F&md5=a417b605d1a3ffbc7ee84706401f01f4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01286%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DDobritzsch%26aufirst%3DD.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DHow%2520beyond%2520rule%2520of%25205%2520drugs%2520and%2520clinical%2520candidates%2520bind%2520to%2520their%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2312%26epage%3D2327%26doi%3D10.1021%2Facs.jmedchem.5b01286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kussie, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marechal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elenbaas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1126/science.274.5289.948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1126%2Fscience.274.5289.948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=8875929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=948-953&author=P.+H.+Kussieauthor=S.+Gorinaauthor=V.+Marechalauthor=B.+Elenbaasauthor=J.+Moreauauthor=A.+J.+Levineauthor=N.+P.+Pavletich&title=Structure+of+the+MDM2+oncoprotein+bound+to+the+p53+tumor+suppressor+transactivation+domain&doi=10.1126%2Fscience.274.5289.948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span></div><div class="casAuthors">Kussie, Paul H.; Gorina, Svetlana; Marechal, Vincent; Elenbaas, Brian; Moreau, Jacque; Levine, Arnold J.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5289</span>),
    <span class="NLM_cas:pages">948-953</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The MDM2 oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.  In certain cancers, MDM2 amplification is a common event and contributes to the inactivation of p53.  The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic α helix.  The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 α helix and, in particular, on a triad of p53 amino acids - Phe19, Trp23, and Leu26 - which insert deep into the MDM2 cleft.  These same p53 residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates p53 by concealing its transactivation domain.  The structure also suggests that the amphipathic α helix may be a common structural motif in the binding of a diverse family of transactivation factors to the TATA-binding protein-assocd. factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotkRIRDnQnX7Vg90H21EOLACvtfcHk0lgDOmkHjlyb1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D&md5=3702422b0a761617cff1498f47f30eeb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5289.948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5289.948%26sid%3Dliteratum%253Aachs%26aulast%3DKussie%26aufirst%3DP.%2BH.%26aulast%3DGorina%26aufirst%3DS.%26aulast%3DMarechal%26aufirst%3DV.%26aulast%3DElenbaas%26aufirst%3DB.%26aulast%3DMoreau%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520MDM2%2520oncoprotein%2520bound%2520to%2520the%2520p53%2520tumor%2520suppressor%2520transactivation%2520domain%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D948%26epage%3D953%26doi%3D10.1126%2Fscience.274.5289.948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurst, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. S.</span></span> <span> </span><span class="NLM_article-title">Expanding the range of “druggable” targets with natural product-based libraries: an academic perspective</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2010.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.cbpa.2010.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=20202892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=308-314&author=R.+A.+Bauerauthor=J.+M.+Wurstauthor=D.+S.+Tan&title=Expanding+the+range+of+%E2%80%9Cdruggable%E2%80%9D+targets+with+natural+product-based+libraries%3A+an+academic+perspective&doi=10.1016%2Fj.cbpa.2010.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the range of druggable' targets with natural product-based libraries: an academic perspective</span></div><div class="casAuthors">Bauer, Renato A.; Wurst, Jacqueline M.; Tan, Derek S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-314</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Existing drugs address a relatively narrow range of biol. targets.  As a result, libraries of drug-like mols. have proven ineffective against a variety of challenging targets, such as protein-protein interactions, nucleic acid complexes, and antibacterial modalities.  In contrast, natural products are known to be effective at modulating such targets, and new libraries are being developed based on underrepresented scaffolds and regions of chem. space assocd. with natural products.  This has led to several recent successes in identifying new chem. probes that address these challenging targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpegWvUnIjr37Vg90H21EOLACvtfcHk0lgDOmkHjlyb1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsL4%253D&md5=0d2e6076ede53bf3a61c95bd3c08d05c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DR.%2BA.%26aulast%3DWurst%26aufirst%3DJ.%2BM.%26aulast%3DTan%26aufirst%3DD.%2BS.%26atitle%3DExpanding%2520the%2520range%2520of%2520%25E2%2580%259Cdruggable%25E2%2580%259D%2520targets%2520with%2520natural%2520product-based%2520libraries%253A%2520an%2520academic%2520perspective%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D308%26epage%3D314%26doi%3D10.1016%2Fj.cbpa.2010.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makley, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gestwicki, J. E.</span></span> <span> </span><span class="NLM_article-title">Expanding the number of “druggable” targets: non-enzymes and protein-protein interactions</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1111%2Fcbdd.12066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=23253128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=22-32&author=L.+N.+Makleyauthor=J.+E.+Gestwicki&title=Expanding+the+number+of+%E2%80%9Cdruggable%E2%80%9D+targets%3A+non-enzymes+and+protein-protein+interactions&doi=10.1111%2Fcbdd.12066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the number of "druggable" targets: non-enzymes and protein-protein interactions</span></div><div class="casAuthors">Makley, Leah N.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Following sequencing and assembly of the human genome, the preferred methods for identification of new drug targets have changed dramatically.  Modern tactics such as genome-wide assocn. studies (GWAS) and deep sequencing are fundamentally different from the pharmacol.-guided approaches used previously, in which knowledge of small mol. ligands acting at their cellular targets was the primary discovery engine.  A consequence of the "target-first, pharmacol.-second" strategy is that many predicted drug targets are non-enzymes, such as scaffolding, regulatory or structural proteins, and their activities are often dependent on protein-protein interactions (PPIs).  These types of targets create unique challenges to drug discovery efforts because enzymic turnover cannot be used as a convenient surrogate for compd. potency.  Moreover, it is often challenging to predict how ligand binding to non-enzymes might affect changes in protein function and/or pathobiol.  Thus, in the postgenomic era, targets might be strongly implicated by mol. biol.-based methods, yet they often later earn the designation of "undruggable".  Can the scope of available targets be widened to include these promising, but challenging, non-enzymes.  In this review, we discuss advances in high-throughput screening (HTS) technol. and chem. library design that are emerging to deal with these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMtMz2zhY_vLVg90H21EOLACvtfcHk0lgDOmkHjlyb1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ymtQ%253D%253D&md5=9e8a15432b02550dca5c9e4668d99038</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12066%26sid%3Dliteratum%253Aachs%26aulast%3DMakley%26aufirst%3DL.%2BN.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DExpanding%2520the%2520number%2520of%2520%25E2%2580%259Cdruggable%25E2%2580%259D%2520targets%253A%2520non-enzymes%2520and%2520protein-protein%2520interactions%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D22%26epage%3D32%26doi%3D10.1111%2Fcbdd.12066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClendon, C. L.</span></span> <span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein-protein interfaces</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>450</i></span>,  <span class="NLM_fpage">1001</span>– <span class="NLM_lpage">1009</span>, <span class="refDoi"> DOI: 10.1038/nature06526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnature06526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=18075579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVaqtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein-protein+interfaces&doi=10.1038%2Fnature06526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Reaching for high-hanging fruit in drug discovery at protein-protein interfaces</span></div><div class="casAuthors">Wells, James A.; McClendon, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7172</span>),
    <span class="NLM_cas:pages">1001-1009</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting the interfaces between proteins has huge therapeutic potential, but discovering small-mol. drugs that disrupt protein-protein interactions is an enormous challenge.  Several recent success stories, however, indicate that protein-protein interfaces might be more tractable than has been thought.  These studies discovered small mols. that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein-protein interactions.  Remarkably, these small mols. bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner.  Some of these small mols. are now making their way through clin. trials, so this high-hanging fruit might not be far out of reach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-nGR3BqqkrVg90H21EOLACvtfcHk0lhrS4WJAMzRmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVaqtr7F&md5=e7ed69fd8c362a71c4b99f029c16a6fc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature06526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06526%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein-protein%2520interfaces%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D1001%26epage%3D1009%26doi%3D10.1038%2Fnature06526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidmore, J.</span></span> <span> </span><span class="NLM_article-title">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd.2016.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27050677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=533-550&author=D.+E.+Scottauthor=A.+R.+Baylyauthor=C.+Abellauthor=J.+Skidmore&title=Small+molecules%2C+big+targets%3A+drug+discovery+faces+the+protein-protein+interaction+challenge&doi=10.1038%2Fnrd.2016.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span></div><div class="casAuthors">Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-550</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biol. systems and are consequently implicated in the development of disease states.  Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clin. development.  In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class.  For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK-aGzHa9mP7Vg90H21EOLACvtfcHk0lhrS4WJAMzRmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D&md5=9f0953567ae9338b8b36aa78b8160655</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DBayly%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3DSmall%2520molecules%252C%2520big%2520targets%253A%2520drug%2520discovery%2520faces%2520the%2520protein-protein%2520interaction%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D533%26epage%3D550%26doi%3D10.1038%2Fnrd.2016.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuenemann, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbe, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerdan, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, O.</span></span> <span> </span><span class="NLM_article-title">Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">23815</span>, <span class="refDoi"> DOI: 10.1038/srep23815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fsrep23815" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27034268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1KktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=23815&author=M.+A.+Kuenemannauthor=C.+M.+Labbeauthor=A.+H.+Cerdanauthor=O.+Sperandio&title=Imbalance+in+chemical+space%3A+How+to+facilitate+the+identification+of+protein-protein+interaction+inhibitors&doi=10.1038%2Fsrep23815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors</span></div><div class="casAuthors">Kuenemann, Melaine A.; Labbe, Celine M.; Cerdan, Adrien H.; Sperandio, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23815</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) play vital roles in life and provide new opportunities for therapeutic interventions.  In this large data anal., 3,300 inhibitors of PPIs (iPPIs) were compared to 17 ref. datasets of collectively ∼566,000 compds. (including natural compds., existing drugs, active compds. on conventional targets, etc.) using a chemoinformatics approach.  Using this procedure, we showed that comparable classes of PPI targets can be formed using either the similarity of their ligands or the shared properties of their binding cavities, constituting a proof-of-concept that not only can binding pockets be used to group PPI targets, but that these pockets certainly condition the properties of their corresponding ligands.  These results demonstrate that matching regions in both chem. space and target space can be found.  Such identified classes of targets could lead to the design of PPI-class-specific chem. libraries and therefore facilitate the development of iPPIs to the stage of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB7AWb8BfwxrVg90H21EOLACvtfcHk0lhrS4WJAMzRmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1KktLg%253D&md5=e08f767f9408cd68b2010d5a831a73cf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsrep23815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep23815%26sid%3Dliteratum%253Aachs%26aulast%3DKuenemann%26aufirst%3DM.%2BA.%26aulast%3DLabbe%26aufirst%3DC.%2BM.%26aulast%3DCerdan%26aufirst%3DA.%2BH.%26aulast%3DSperandio%26aufirst%3DO.%26atitle%3DImbalance%2520in%2520chemical%2520space%253A%2520How%2520to%2520facilitate%2520the%2520identification%2520of%2520protein-protein%2520interaction%2520inhibitors%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D23815%26doi%3D10.1038%2Fsrep23815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashkenazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd.2016.253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=28209992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislynu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=273-284&author=A.+Ashkenaziauthor=W.+J.+Fairbrotherauthor=J.+D.+Leversonauthor=A.+J.+Souers&title=From+basic+apoptosis+discoveries+to+advanced+selective+BCL-2+family+inhibitors&doi=10.1038%2Fnrd.2016.253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors</span></div><div class="casAuthors">Ashkenazi, Avi; Fairbrother, Wayne J.; Leverson, Joel D.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the B cell lymphoma 2 (BCL-2) gene family have a central role in regulating programmed cell death by controlling pro-apoptotic and anti-apoptotic intracellular signals.  In cancer, apoptosis evasion through dysregulation of specific BCL-2 family genes is a recurring event; accordingly, selective inhibition of specific anti-apoptotic BCL-2 family proteins represents an exciting therapeutic opportunity.  A combination of NMR (NMR)-based screening and structure-based drug design has yielded the first bona fide BCL-2 homol. 3 (BH3) mimetics, including the BCL-2 and BCL-XL dual antagonist navitoclax, which is the first BCL-2 family inhibitor to show efficacy in patients with cancer.  Clin. experience with navitoclax prompted the generation of the highly selective BCL-2 inhibitor venetoclax, which is now approved in the United States for the treatment of patients with chronic lymphocytic leukemia with 17p deletion who have received at least one prior therapy.  Recent advances have also been made in the development of potent and selective inhibitors of BCL-XL and myeloid cell leukemia 1 (MCL1), which are addnl. BCL-2 family members with established anti-apoptotic roles in cancer.  Here we review the latest progress in direct and selective targeting of BCL-2 family proteins for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXzAZwyiZQ9LVg90H21EOLACvtfcHk0lhrS4WJAMzRmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislynu7g%253D&md5=ac65b9fbff59988cafb9e381dc0de405</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.253%26sid%3Dliteratum%253Aachs%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DFrom%2520basic%2520apoptosis%2520discoveries%2520to%2520advanced%2520selective%2520BCL-2%2520family%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D273%26epage%3D284%26doi%3D10.1038%2Fnrd.2016.253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vierling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of HIV protease inhibitors</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1755</span>– <span class="NLM_lpage">1770</span>, <span class="refDoi"> DOI: 10.2174/1381612033454441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.2174%2F1381612033454441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=12871195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1GgtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1755-1770&author=P.+Vierlingauthor=J.+Greiner&title=Prodrugs+of+HIV+protease+inhibitors&doi=10.2174%2F1381612033454441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of HIV protease inhibitors</span></div><div class="casAuthors">Vierling, Pierre; Greiner, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1755-1770</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite the efficiency of the present polytherapies against AIDS, HIV replication continues indicating difficulties in drug adherence, drug-drug interactions, resistance issues, and the existence of reservoirs or sanctuaries for the virus.  Moreover, most of the current FDA-approved HIV protease inhibitors (PIs) display disadvantageous physicochem. and pharmacol. properties such as low water soly., low oral bioavailability and/or low level of penetration into the HIV sanctuaries resulting from their in vivo binding to the plasma proteins and to the Multi-Drug-Resistant P-glycoprotein, their rapid metabolization and inactivation by the liver cytochrome P 450 enzymes.  To overcome these suboptimal pharmacokinetics, high daily doses must be ingested, which complicate patient adherence to the prescribed regimen and contribute to the appearance of serious long-term metabolic complications and to the decrease of the viral treatment outcome.  Another attractive alternative aimed at improving the safety, pharmacokinetics, and therapeutic potency of the current PIs is to modify these PIs into pharmacol. inactive prodrugs which are converted in vivo into their parent active drug.  The present review is dedicated to the different prodrug approaches, including the "lipophilic", "hydrophilic", "active transport" and "double-drug" prodrug strategies, which have been applied more particularly to the current HIV PIs used in clinic.  Among the strategies explored up to now, the most successful one was the "hydrophilic" prodrug approach which has led to the discovery of fosamprenavir, a phosphate ester prodrug of amprenavir, which has reached phase III clin. trials.  This success gives strong support for the search of PI prodrugs as a therapeutic alternative in addn. to the development of new and well-tolerated PIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppWLr-UkVzlLVg90H21EOLACvtfcHk0liLI5g47WRBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1GgtLY%253D&md5=8a365aa7f60e6d29d673fe8546bf1cf1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1381612033454441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612033454441%26sid%3Dliteratum%253Aachs%26aulast%3DVierling%26aufirst%3DP.%26aulast%3DGreiner%26aufirst%3DJ.%26atitle%3DProdrugs%2520of%2520HIV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D1755%26epage%3D1770%26doi%3D10.2174%2F1381612033454441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walters, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M. A.</span></span> <span> </span><span class="NLM_article-title">What do medicinal chemists actually make? A 50-year retrospective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6405</span>– <span class="NLM_lpage">6416</span>, <span class="refDoi"> DOI: 10.1021/jm200504p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200504p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWjsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6405-6416&author=W.+P.+Waltersauthor=J.+Greenauthor=J.+R.+Weissauthor=M.+A.+Murcko&title=What+do+medicinal+chemists+actually+make%3F+A+50-year+retrospective&doi=10.1021%2Fjm200504p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">What Do Medicinal Chemists Actually Make? A 50-Year Retrospective</span></div><div class="casAuthors">Walters, W. Patrick; Green, Jeremy; Weiss, Jonathan R.; Murcko, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6405-6416</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite the dramatically increasing costs of pharmaceutical R&D productivity, as measured by the no. of new drugs approved each year, has languished during the past decade.  Many different explanations have been proposed to account for this decline, such as increasing regulatory scrutiny, the inherent inefficiency of very large organizations, the pursuit of highly speculative targets identified from genomics, and more objective decision-making about advancing marginal compds. into latest age clin. trials.  Another factor often cited to help explain low pharmaceutical productivity is that, paradoxically, many compds. synthesized by medicinal chemists are not "druglike", at least as measured by various criteria.  The authors discuss the past, present and perspectives in the development of medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5xuF4wHqKrVg90H21EOLACvtfcHk0liLI5g47WRBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWjsr7O&md5=33109f9d55967be0d34f377f433621e4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm200504p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200504p%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DW.%2BP.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DJ.%2BR.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26atitle%3DWhat%2520do%2520medicinal%2520chemists%2520actually%2520make%253F%2520A%252050-year%2520retrospective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6405%26epage%3D6416%26doi%3D10.1021%2Fjm200504p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span> <span> </span><span class="NLM_article-title">Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">14073</span>– <span class="NLM_lpage">14080</span>, <span class="refDoi"> DOI: 10.1021/ja063076p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja063076p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14073-14080&author=T.+Rezaiauthor=J.+E.+Bockauthor=M.+V.+Zhouauthor=C.+Kalyanaramanauthor=R.+S.+Lokeyauthor=M.+P.+Jacobson&title=Conformational+flexibility%2C+internal+hydrogen+bonding%2C+and+passive+membrane+permeability%3A+successful+in+silico+prediction+of+the+relative+permeabilities+of+cyclic+peptides&doi=10.1021%2Fja063076p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span></div><div class="casAuthors">Rezai, Taha; Bock, Jonathan E.; Zhou, Mai V.; Kalyanaraman, Chakrapani; Lokey, R. Scott; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">14073-14080</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report an atomistic phys. model for the passive membrane permeability of cyclic peptides.  The computational modeling was performed in advance of the expts. and did not involve the use of "training data".  The model explicitly treats the conformational flexibility of the peptides by extensive conformational sampling in low (membrane) and high (water) dielec. environments.  The passive membrane permeabilities of 11 cyclic peptides were obtained exptl. using a parallel artificial membrane permeability assay (PAMPA) and showed a linear correlation with the computational results with R2 = 0.96.  In general, the results support the hypothesis, already well established in the literature, that the ability to form internal hydrogen bonds is crit. for passive membrane permeability and can be the distinguishing factor among closely related compds., such as those studied here.  However, we have found that the no. of internal hydrogen bonds that can form in the membrane and the solvent-exposed polar surface area correlate more poorly with PAMPA permeability than our model, which quant. ests. the solvation free energy losses upon moving from high-dielec. water to the low-dielec. interior of a membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofxfL018o86rVg90H21EOLACvtfcHk0liLI5g47WRBkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I&md5=78d4b4082e6a72b288d4b6dac933ca35</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja063076p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063076p%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DBock%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BV.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DConformational%2520flexibility%252C%2520internal%2520hydrogen%2520bonding%252C%2520and%2520passive%2520membrane%2520permeability%253A%2520successful%2520in%2520silico%2520prediction%2520of%2520the%2520relative%2520permeabilities%2520of%2520cyclic%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14073%26epage%3D14080%26doi%3D10.1021%2Fja063076p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millhauser, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2510</span>– <span class="NLM_lpage">2511</span>, <span class="refDoi"> DOI: 10.1021/ja0563455</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0563455" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=2510-2511&author=T.+Rezaiauthor=B.+Yuauthor=G.+L.+Millhauserauthor=M.+P.+Jacobsonauthor=R.+S.+Lokey&title=Testing+the+conformational+hypothesis+of+passive+membrane+permeability+using+synthetic+cyclic+peptide+diastereomers&doi=10.1021%2Fja0563455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers</span></div><div class="casAuthors">Rezai, Taha; Yu, Bin; Millhauser, Glenn L.; Jacobson, Matthew P.; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2510-2511</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Little is known about the effect of conformation on passive membrane diffusion rates in small mols.  Evidence suggests that intramol. hydrogen bonding may play a role by reducing the energetic cost of desolvating hydrogen bond donors, esp. amide N-H groups.  We set out to test this hypothesis by investigating the passive membrane diffusion characteristics of a series of cyclic peptide diastereomers based on the sequence cyclo[Leu-Leu-Leu-Leu-Pro-Tyr].  We identified two cyclic hexapeptide diastereomers based on this sequence, whose membrane diffusion rates differed by nearly two log units.  Results of soln. NMR studies and hydrogen/deuterium (H/D) exchange expts. showed that membrane diffusion rates correlated with the degree of intramol. hydrogen bonding and H/D exchange rates.  The most permeable diastereomer, cyclo[D-Leu-D-Leu-Leu-D-Leu-Pro-Tyr], exhibited a passive membrane diffusion rate comparable to that of the orally available drug cyclosporine A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqooDObTy1BXrVg90H21EOLACvtfcHk0lhRGBgB6d7qiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGqu7k%253D&md5=52e5cac6648efb70e743f294e3f8c4ec</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja0563455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0563455%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DMillhauser%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DTesting%2520the%2520conformational%2520hypothesis%2520of%2520passive%2520membrane%2520permeability%2520using%2520synthetic%2520cyclic%2520peptide%2520diastereomers%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D2510%26epage%3D2511%26doi%3D10.1021%2Fja0563455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2601</span>– <span class="NLM_lpage">2611</span>, <span class="refDoi"> DOI: 10.1021/jm100087s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry&doi=10.1021%2Fjm100087s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0lhRGBgB6d7qiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611%26doi%3D10.1021%2Fjm100087s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1039/c1md00093d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space&doi=10.1039%2Fc1md00093d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span></div><div class="casAuthors">Alex, Alexander; Millan, David S.; Perez, Manuel; Wakenhut, Florian; Whitlock, Gavin A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">669-674</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Utilizing 'beyond rule of five' chem. space is becoming increasingly important in drug design, but is usually at odds with good oral absorption.  The formation of intramol. hydrogen bonds in drug mols. is hypothesised to shield polarity facilitating improved membrane permeability and intestinal absorption.  NMR based evidence for intramol. hydrogen bonding in several 'beyond rule of five' oral drugs is described.  Furthermore, the propensity for these drugs to form intramol. hydrogen bonds could be predicted for through modeling the lowest energy conformation in the gas phase.  The modulation of apparent lipophilicity through intramol. hydrogen bonding in these mols. is supported by intrinsic cell permeability and intestinal absorption data in rat and human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp93l2KJMdB2bVg90H21EOLACvtfcHk0lhRGBgB6d7qiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D&md5=3effbdd29832ac7b57eabbc26c66217b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674%26doi%3D10.1039%2Fc1md00093d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viarengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beglov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span> <span> </span><span class="NLM_article-title">Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.drudis.2016.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=26891978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVKrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=712-717&author=A.+Whittyauthor=M.+Zhongauthor=L.+Viarengoauthor=D.+Beglovauthor=D.+R.+Hallauthor=S.+Vajda&title=Quantifying+the+chameleonic+properties+of+macrocycles+and+other+high-molecular-weight+drugs&doi=10.1016%2Fj.drudis.2016.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs</span></div><div class="casAuthors">Whitty, Adrian; Zhong, Mengqi; Viarengo, Lauren; Beglov, Dmitri; Hall, David R.; Vajda, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">712-717</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Key to the pharmaceutical utility of certain macrocyclic drugs is a 'chameleonic' ability to change their conformation to expose polar groups in aq. soln., but bury them when traversing lipid membranes.  Based on anal. of the structures of 20 macrocyclic compds. that are approved oral drugs, we propose that good soly. requires a topol. polar surface area (TPSA, in Å2) of ≥0.2 × mol. wt. (MW).  Meanwhile, good passive membrane permeability requires a mol. (i.e., 3D) PSA in nonpolar environments of ≤140 Å2.  We show that one or other of these limits is almost invariably violated for compds. with MW > 600 Da, suggesting that some degree of chameleonic behavior is required for most high MW oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlN7rCqts5wLVg90H21EOLACvtfcHk0ljnM2C0lxiMFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVKrurs%253D&md5=024476298f7b72efa3f0a9303bed5900</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DViarengo%26aufirst%3DL.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DD.%2BR.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DQuantifying%2520the%2520chameleonic%2520properties%2520of%2520macrocycles%2520and%2520other%2520high-molecular-weight%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D712%26epage%3D717%26doi%3D10.1016%2Fj.drudis.2016.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Drug discovery beyond the rule of 5 - Opportunities and challenges</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1080/17460441.2017.1264385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1080%2F17460441.2017.1264385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27883294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A280%3ADC%252BC2sjgtVejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=115-119&author=B.+C.+Doakauthor=J.+Kihlberg&title=Drug+discovery+beyond+the+rule+of+5+-+Opportunities+and+challenges&doi=10.1080%2F17460441.2017.1264385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery beyond the rule of 5 - Opportunities and challenges</span></div><div class="casAuthors">Doak Bradley C; Kihlberg Jan</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-119</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRw3tmClaGOihOk4JA3soTqfW6udTcc2ea61L8hBhwfnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sjgtVejtw%253D%253D&md5=bccc3e6cb938479044d18a2b25df9c1f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1264385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1264385%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DDrug%2520discovery%2520beyond%2520the%2520rule%2520of%25205%2520-%2520Opportunities%2520and%2520challenges%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D115%26epage%3D119%26doi%3D10.1080%2F17460441.2017.1264385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danelius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peintner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaraz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wlodek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdelyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Conformational sampling of macrocyclic drugs in different environments: can we find the relevant conformations?</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">11742</span>– <span class="NLM_lpage">11757</span>, <span class="refDoi"> DOI: 10.1021/acsomega.8b01379</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.8b01379" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslKhtrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=11742-11757&author=V.+Poongavanamauthor=E.+Daneliusauthor=S.+Peintnerauthor=L.+Alcarazauthor=G.+Caronauthor=M.+D.+Cummingsauthor=S.+Wlodekauthor=M.+Erdelyiauthor=P.+C.+D.+Hawkinsauthor=G.+Ermondiauthor=J.+Kihlberg&title=Conformational+sampling+of+macrocyclic+drugs+in+different+environments%3A+can+we+find+the+relevant+conformations%3F&doi=10.1021%2Facsomega.8b01379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?</span></div><div class="casAuthors">Poongavanam, Vasanthanathan; Danelius, Emma; Peintner, Stefan; Alcaraz, Lilian; Caron, Giulia; Cummings, Maxwell D.; Wlodek, Stanislaw; Erdelyi, Mate; Hawkins, Paul C. D.; Ermondi, Giuseppe; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">11742-11757</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conformational flexibility is a major determinant of the properties of macrocycles and other drugs in beyond rule of 5 (bRo5) space.  Prediction of conformations is essential for design of drugs in this space and the authors have evaluated three tools for conformational sampling of a set of ten bRo5 drugs and clin. candidates in polar and apolar environments.  The distance-geometry based OMEGA was found to yield ensembles spanning larger structure and property spaces than the two MD based methods, MOE-LowMode MD (MOE) and MacroModel-Macrocycle Conformational Sampling (MC).  Both MC and OMEGA, but not MOE, generated different ensembles for polar and apolar environments.  All three conformational search methods generated conformers similar to the crystal structure conformers for nine of the ten compds., with OMEGA performing somewhat better than MOE and MC.  MOE and OMEGA found all six conformers of roxithromycin that were identified by NMR in aq. solns., while only OMEGA sampled the three conformers obsd. in chloroform.  The authors suggest that characterization of conformers using mol. descriptors, e.g. the radius of gyration (Rgyr) and polar surface area (PSA), is preferred to energy- or RMSD-based methods for selection of biol. relevant conformers in drug discovery in bRo5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoetOG-yDeciLVg90H21EOLACvtfcHk0ljnM2C0lxiMFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslKhtrnI&md5=a8722551b161e907daf55146f22b6d57</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facsomega.8b01379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.8b01379%26sid%3Dliteratum%253Aachs%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DDanelius%26aufirst%3DE.%26aulast%3DPeintner%26aufirst%3DS.%26aulast%3DAlcaraz%26aufirst%3DL.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DWlodek%26aufirst%3DS.%26aulast%3DErdelyi%26aufirst%3DM.%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DConformational%2520sampling%2520of%2520macrocyclic%2520drugs%2520in%2520different%2520environments%253A%2520can%2520we%2520find%2520the%2520relevant%2520conformations%253F%26jtitle%3DACS%2520Omega%26date%3D2018%26volume%3D3%26spage%3D11742%26epage%3D11757%26doi%3D10.1021%2Facsomega.8b01379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otvos, L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, J. D.</span></span> <span> </span><span class="NLM_article-title">Current challenges in peptide-based drug discovery</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">62</span>, <span class="refDoi"> DOI: 10.3389/fchem.2014.00062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.3389%2Ffchem.2014.00062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=25152873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FkvVWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=62&author=L.+Otvosauthor=J.+D.+Wade&title=Current+challenges+in+peptide-based+drug+discovery&doi=10.3389%2Ffchem.2014.00062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Current challenges in peptide-based drug discovery</span></div><div class="casAuthors">Otvos Laszlo Jr; Wade John D</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62</span>
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdBTaiObNX6fIW7hznt0zpfW6udTcc2ea61L8hBhwfnrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FkvVWquw%253D%253D&md5=02484893d0ab296edf6190171cf1c88d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2014.00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2014.00062%26sid%3Dliteratum%253Aachs%26aulast%3DOtvos%26aufirst%3DL.%26aulast%3DWade%26aufirst%3DJ.%2BD.%26atitle%3DCurrent%2520challenges%2520in%2520peptide-based%2520drug%2520discovery%26jtitle%3DFront.%2520Chem.%26date%3D2014%26volume%3D2%26spage%3D62%26doi%3D10.3389%2Ffchem.2014.00062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudin, A. K.</span></span> <span> </span><span class="NLM_article-title">Contemporary strategies for peptide macrocyclization</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1038/nchem.1062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnchem.1062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=21697871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFWjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=509-524&author=C.+J.+Whiteauthor=A.+K.+Yudin&title=Contemporary+strategies+for+peptide+macrocyclization&doi=10.1038%2Fnchem.1062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Contemporary strategies for peptide macrocyclization</span></div><div class="casAuthors">White, Christopher J.; Yudin, Andrei K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">509-524</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Peptide macrocycles have found applications that range from drug discovery to nanomaterials.  These ring-shaped mols. have shown remarkable capacity for functional fine-tuning.  Such capacity is enabled by the possibility of adjusting the peptide conformation using the techniques of chem. synthesis.  Cyclic peptides have been difficult, and often impossible, to prep. using traditional synthetic methods.  For macrocyclization to occur, the activated peptide must adopt an entropically disfavored pre-cyclization conformation before forming the desired product.  Here, recent solns. to some of the major challenges in this important area of contemporary synthesis were reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUTda6OkfQprVg90H21EOLACvtfcHk0lhFyt3Pzv0r6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFWjtrc%253D&md5=32dfd94692ca20901dc8828bcd27ae8c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1062%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DC.%2BJ.%26aulast%3DYudin%26aufirst%3DA.%2BK.%26atitle%3DContemporary%2520strategies%2520for%2520peptide%2520macrocyclization%26jtitle%3DNat.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D509%26epage%3D524%26doi%3D10.1038%2Fnchem.1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoermer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Orally absorbed cyclic peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">8094</span>– <span class="NLM_lpage">8128</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00838</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00838" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=8094-8128&author=D.+S.+Nielsenauthor=N.+E.+Shepherdauthor=W.+Xuauthor=A.+J.+Luckeauthor=M.+J.+Stoermerauthor=D.+P.+Fairlie&title=Orally+absorbed+cyclic+peptides&doi=10.1021%2Facs.chemrev.6b00838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Absorbed Cyclic Peptides</span></div><div class="casAuthors">Nielsen, Daniel S.; Shepherd, Nicholas E.; Xu, Weijun; Lucke, Andrew J.; Stoermer, Martin J.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8094-8128</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptides and proteins are not orally bioavailable in mammals, although a few peptides are intestinally absorbed in small amts.  Polypeptides are generally too large and polar to passively diffuse through lipid membranes, while most known active transport mechanisms facilitate cell uptake of only very small peptides.  Systematic evaluations of peptides with mol. wts. above 500 Da are needed to identify parameters that influence oral bioavailability.  Here we describe 125 cyclic peptides contg. four to thirty-seven amino acids that are orally absorbed by mammals.  Cyclization minimizes degrdn. in the gut, blood and tissues by removing cleavable N- and C-termini and by shielding components from metabolic enzymes.  Cyclization also folds peptides into bioactive conformations that det. exposure of polar atoms to solvation by water and lipids, and therefore should influence oral bioavailability.  Key chem. properties thought to influence oral absorption and bioavailability are analyzed, including mol. wt., octanol-water partitioning, hydrogen bond donors/acceptors, rotatable bonds and polar surface area.  The cyclic peptides violated to different degrees all of the limits traditionally considered to be important for oral bioavailability of drug-like small mols., although fewer hydrogen bond donors and reduced flexibility generally favored oral absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprHf1YVkf7ErVg90H21EOLACvtfcHk0lhFyt3Pzv0r6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot12lurY%253D&md5=38af1945471e5ddffd3ae630ebbe129b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00838%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DD.%2BS.%26aulast%3DShepherd%26aufirst%3DN.%2BE.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLucke%26aufirst%3DA.%2BJ.%26aulast%3DStoermer%26aufirst%3DM.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DOrally%2520absorbed%2520cyclic%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D8094%26epage%3D8128%26doi%3D10.1021%2Facs.chemrev.6b00838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ene, D.</span></span> <span> </span><span class="NLM_article-title">Olefin metathesis in drug discovery and development - examples from recent patent literature</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1938</span>– <span class="NLM_lpage">1962</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.7b00319</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.7b00319" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2gsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=1938-1962&author=D.+Hughesauthor=P.+Wheelerauthor=D.+Ene&title=Olefin+metathesis+in+drug+discovery+and+development+-+examples+from+recent+patent+literature&doi=10.1021%2Facs.oprd.7b00319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Olefin Metathesis in Drug Discovery and Development-Examples from Recent Patent Literature</span></div><div class="casAuthors">Hughes, David; Wheeler, Philip; Ene, Doina</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1938-1962</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review that summarizes applications of the metathesis reactions in drug discovery and development in the pharmaceutical industry disclosed in the patent literature from Jan. 2016 to August 2017.  The olefin metathesis reaction is finding increasing use in drug discovery and process chem., with a no. of applications now implemented at com. manufg. scale.  Catalyst improvements over the past decade have allowed use of the metathesis reaction with highly functionalized substrates, allowing chemists to access increasingly diverse chem. space, including most notably macrocycles, constrained small ring spirocycles, and fused-ring systems.  For scientists employed in the pharmaceutical industry, the patent literature is the primary avenue for communication of synthetic routes to drug candidates.  While most examples of the metathesis reaction in the patent literature offer only sketchy exptl. details and provide little context on reaction development, the wide scope of substrates within the pharmaceutical patent literature provides a true indication of reaction scope and functional group compatibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwS-l_9Wgak7Vg90H21EOLACvtfcHk0lhFyt3Pzv0r6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2gsrbP&md5=8fcebbc4105e77751d56724d758535ac</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.7b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.7b00319%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DD.%26aulast%3DWheeler%26aufirst%3DP.%26aulast%3DEne%26aufirst%3DD.%26atitle%3DOlefin%2520metathesis%2520in%2520drug%2520discovery%2520and%2520development%2520-%2520examples%2520from%2520recent%2520patent%2520literature%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2017%26volume%3D21%26spage%3D1938%26epage%3D1962%26doi%3D10.1021%2Facs.oprd.7b00319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogba, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubbs, R. H.</span></span> <span> </span><span class="NLM_article-title">Recent advances in ruthenium-based olefin metathesis</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">4510</span>– <span class="NLM_lpage">4544</span>, <span class="refDoi"> DOI: 10.1039/C8CS00027A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1039%2FC8CS00027A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=29714397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFyqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=4510-4544&author=O.+M.+Ogbaauthor=N.+C.+Warnerauthor=D.+J.+O%E2%80%99Learyauthor=R.+H.+Grubbs&title=Recent+advances+in+ruthenium-based+olefin+metathesis&doi=10.1039%2FC8CS00027A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in ruthenium-based olefin metathesis</span></div><div class="casAuthors">Ogba, O. M.; Warner, N. C.; O'Leary, D. J.; Grubbs, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4510-4544</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ruthenium-based olefin metathesis catalysts, known for their functional group tolerance and broad applicability in org. synthesis and polymer science, continue to evolve as an enabling technol. in these areas.  A discussion of recent mechanistic investigations is followed by an overview of selected applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0jCz26VHJ7Vg90H21EOLACvtfcHk0lhFyt3Pzv0r6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFyqs7c%253D&md5=c7b8d582c3b5eb57b430825a2288f1d2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC8CS00027A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CS00027A%26sid%3Dliteratum%253Aachs%26aulast%3DOgba%26aufirst%3DO.%2BM.%26aulast%3DWarner%26aufirst%3DN.%2BC.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DD.%2BJ.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DRecent%2520advances%2520in%2520ruthenium-based%2520olefin%2520metathesis%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2018%26volume%3D47%26spage%3D4510%26epage%3D4544%26doi%3D10.1039%2FC8CS00027A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dias, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roessner, U.</span></span> <span> </span><span class="NLM_article-title">A historical overview of natural products in drug discovery</span>. <i>Metabolites</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.3390/metabo2020303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.3390%2Fmetabo2020303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=24957513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1SltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=303-336&author=D.+A.+Diasauthor=S.+Urbanauthor=U.+Roessner&title=A+historical+overview+of+natural+products+in+drug+discovery&doi=10.3390%2Fmetabo2020303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A historical overview of natural products in drug discovery</span></div><div class="casAuthors">Dias, Daniel A.; Urban, Sylvia; Roessner, Ute</div><div class="citationInfo"><span class="NLM_cas:title">Metabolites</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-336</span>CODEN:
                <span class="NLM_cas:coden">METALU</span>;
        ISSN:<span class="NLM_cas:issn">2218-1989</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Historically, natural products have been used since ancient times and in folklore for the treatment of many diseases and illnesses.  Classical natural product chem. methodologies enabled a vast array of bioactive secondary metabolites from terrestrial and marine sources to be discovered.  Many of these natural products have gone on to become current drug candidates.  This brief review aims to highlight historically significant bioactive marine and terrestrial natural products, their use in folklore and dereplication techniques to rapidly facilitate their discovery.  Furthermore a discussion of how natural product chem. has resulted in the identification of many drug candidates; the application of advanced hyphenated spectroscopic techniques to aid in their discovery, the future of natural product chem. and finally adopting metabolomic profiling and dereplication approaches for the comprehensive study of natural product exts. will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsKveZ4J9wU7Vg90H21EOLACvtfcHk0lgHkQJZNmb6Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1SltLs%253D&md5=d02ea918e56b6cc7de17053adaf47650</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3390%2Fmetabo2020303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmetabo2020303%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DD.%2BA.%26aulast%3DUrban%26aufirst%3DS.%26aulast%3DRoessner%26aufirst%3DU.%26atitle%3DA%2520historical%2520overview%2520of%2520natural%2520products%2520in%2520drug%2520discovery%26jtitle%3DMetabolites%26date%3D2012%26volume%3D2%26spage%3D303%26epage%3D336%26doi%3D10.3390%2Fmetabo2020303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koehn, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">The evolving role of natural products in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nrd1657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd1657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15729362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslSnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=206-220&author=F.+E.+Koehnauthor=G.+T.+Carter&title=The+evolving+role+of+natural+products+in+drug+discovery&doi=10.1038%2Fnrd1657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The evolving role of natural products in drug discovery</span></div><div class="casAuthors">Koehn, Frank E.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-220</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their derivs. have historically been invaluable as a source of therapeutic agents.  However, in the past decade, research into natural products in the pharmaceutical industry has declined, owing to issues such as the lack of compatibility of traditional natural-product ext. libraries with high-throughput screening.  However, as discussed in this review, recent technol. advances that help to address these issues, coupled with unrealized expectations from current lead-generation strategies, have led to a renewed interest in natural products in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRGIXVxX38LVg90H21EOLACvtfcHk0lgHkQJZNmb6Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslSnsrg%253D&md5=ce80052abaa76430220ee5981138053e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd1657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1657%26sid%3Dliteratum%253Aachs%26aulast%3DKoehn%26aufirst%3DF.%2BE.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DThe%2520evolving%2520role%2520of%2520natural%2520products%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D206%26epage%3D220%26doi%3D10.1038%2Fnrd1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">From complex natural products to simple synthetic mimetics by computational de novo design</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6789</span>– <span class="NLM_lpage">6792</span>, <span class="refDoi"> DOI: 10.1002/anie.201601941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.201601941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28Xms1OisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=6789-6792&author=L.+Friedrichauthor=T.+Rodriguesauthor=C.+S.+Neuhausauthor=P.+Schneiderauthor=G.+Schneider&title=From+complex+natural+products+to+simple+synthetic+mimetics+by+computational+de+novo+design&doi=10.1002%2Fanie.201601941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">From Complex Natural Products to Simple Synthetic Mimetics by Computational De Novo Design</span></div><div class="casAuthors">Friedrich, Lukas; Rodrigues, Tiago; Neuhaus, Claudia S.; Schneider, Petra; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6789-6792</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors present the computational de novo design of synthetically accessible chem. entities that mimic the complex sesquiterpene natural product (-)-Englerin A.  The authors synthesized lead-like probes from com. available building blocks and profiled them for activity against a computationally predicted panel of macromol. targets.  Both the design template (-)-Englerin A and its low-mol. wt. mimetics presented nanomolar binding affinities and antagonized the transient receptor potential calcium channel TRPM8 in a cell-based assay, without showing target promiscuity or frequent-hitter properties.  This proof-of-concept study outlines an expeditious soln. to obtaining natural-product-inspired chem. matter with desirable properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBDJqrkHVbAbVg90H21EOLACvtfcHk0lgHkQJZNmb6Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xms1OisL4%253D&md5=7c1af0c6a47b8dc7241737e41a9e5e3b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601941%26sid%3Dliteratum%253Aachs%26aulast%3DFriedrich%26aufirst%3DL.%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DNeuhaus%26aufirst%3DC.%2BS.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DFrom%2520complex%2520natural%2520products%2520to%2520simple%2520synthetic%2520mimetics%2520by%2520computational%2520de%2520novo%2520design%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D6789%26epage%3D6792%26doi%3D10.1002%2Fanie.201601941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">The impact of natural products upon modern drug discovery</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2008.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.cbpa.2008.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=18423384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1ersrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=306-317&author=A.+Ganesan&title=The+impact+of+natural+products+upon+modern+drug+discovery&doi=10.1016%2Fj.cbpa.2008.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of natural products upon modern drug discovery</span></div><div class="casAuthors">Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-317</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the period 1970-2006, a total of 24 unique natural products were discovered that led to an approved drug.  We analyze these successful leads in terms of drug-like properties, and show that they can be divided into two equal subsets.  The first falls in the Lipinski universe' and complies with the Rule of Five.  The second is a parallel universe' that violates the rules.  Nevertheless, the latter compds. remain largely compliant in terms of log P and H-bond donors, highlighting the importance of these two metrics in predicting bioavailability.  Natural products are often cited as an exception to Lipinski's rules.  We believe this is because nature has learned to maintain low hydrophobicity and intermol. H-bond donating potential when it needs to make biol. active compds. with high mol. wt. and large nos. of rotatable bonds.  In addn., natural products are more likely than purely synthetic compds. to resemble biosynthetic intermediates or endogenous metabolites, and hence take advantage of active transport mechanisms.  Interestingly, the natural product leads in the Lipinski and parallel universe had an identical success rate (50%) in delivering an oral drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXd8x0Vy0yerVg90H21EOLACvtfcHk0lgHkQJZNmb6Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1ersrk%253D&md5=8cdde276c59d84071ea2d6f572d10088</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DThe%2520impact%2520of%2520natural%2520products%2520upon%2520modern%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D306%26epage%3D317%26doi%3D10.1016%2Fj.cbpa.2008.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vederas, J. C.</span></span> <span> </span><span class="NLM_article-title">Drug discovery and natural products: end of an era or an endless frontier?</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1126/science.1168243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1126%2Fscience.1168243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=19589993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVGmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=161-165&author=J.+W.+Liauthor=J.+C.+Vederas&title=Drug+discovery+and+natural+products%3A+end+of+an+era+or+an+endless+frontier%3F&doi=10.1126%2Fscience.1168243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery and natural products end of an era or an endless frontier?</span></div><div class="casAuthors">Li, Jess W.-H.; Vederas, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5937</span>),
    <span class="NLM_cas:pages">161-165</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr90S_IHvC-8bVg90H21EOLACvtfcHk0ljk5wxKO-Sozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVGmsrc%253D&md5=92cbb0ae2947501b031a99b774d2adfb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168243%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BW.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26atitle%3DDrug%2520discovery%2520and%2520natural%2520products%253A%2520end%2520of%2520an%2520era%2520or%2520an%2520endless%2520frontier%253F%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D161%26epage%3D165%26doi%3D10.1126%2Fscience.1168243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the 30 years from 1981 to 2010</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1021/np200906s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200906s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVeku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=311-335&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+30+years+from+1981+to+2010&doi=10.1021%2Fnp200906s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">311-335</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This review is an updated and expanded version of the three prior reviews that were published in this journal in 1997, 2003, and 2007.  In the case of all approved therapeutic agents, the time frame has been extended to cover the 30 years from Jan. 1, 1981, to Dec. 31, 2010, for all diseases worldwide, and from 1950 (earliest so far identified) to Dec. 2010 for all approved antitumor drugs worldwide.  We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions and have added a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixts." that have now been recognized as drug entities by the FDA and similar organizations.  From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well.  Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 175 small mols., 131, or 74.8%, are other than "S" (synthetic), with 85, or 48.6%, actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compd. approved as a drug in this 30-yr time frame.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5OzO0oiD5sLVg90H21EOLACvtfcHk0ljk5wxKO-Sozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVeku78%253D&md5=395ac7378f07d122a5789d7b440f858d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fnp200906s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200906s%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%252030%2520years%2520from%25201981%2520to%25202010%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D311%26epage%3D335%26doi%3D10.1021%2Fnp200906s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">Counting on natural products for drug design</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchem.2479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnchem.2479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27219696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=531-541&author=T.+Rodriguesauthor=D.+Rekerauthor=P.+Schneiderauthor=G.+Schneider&title=Counting+on+natural+products+for+drug+design&doi=10.1038%2Fnchem.2479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Counting on natural products for drug design</span></div><div class="casAuthors">Rodrigues, Tiago; Reker, Daniel; Schneider, Petra; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their mol. frameworks have a long tradition as valuable starting points for medicinal chem. and drug discovery.  Recently, there has been a revitalization of interest in the inclusion of these chemotypes in compd. collections for screening and achieving selective target modulation.  Here the authors discuss natural-product-inspired drug discovery with a focus on recent advances in the design of synthetically tractable small mols. that mimic nature's chem.  The authors highlight the potential of innovative computational tools in processing structurally complex natural products to predict their macromol. targets and attempt to forecast the role that natural-product-derived fragments and fragment-like natural products will play in next-generation drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNR16z66-NgLVg90H21EOLACvtfcHk0ljk5wxKO-Sozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D&md5=3f6391192d648de2a54524afafd6203a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2479%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DReker%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DCounting%2520on%2520natural%2520products%2520for%2520drug%2520design%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D531%26epage%3D541%26doi%3D10.1038%2Fnchem.2479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. S.</span></span> <span> </span><span class="NLM_article-title">Cheminformatic comparison of approved drugs from natural product versus synthetic origins</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4802</span>– <span class="NLM_lpage">4807</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.bmcl.2015.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=26254944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4802-4807&author=C.+F.+Strattonauthor=D.+J.+Newmanauthor=D.+S.+Tan&title=Cheminformatic+comparison+of+approved+drugs+from+natural+product+versus+synthetic+origins&doi=10.1016%2Fj.bmcl.2015.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cheminformatic comparison of approved drugs from natural product versus synthetic origins</span></div><div class="casAuthors">Stratton, Christopher F.; Newman, David J.; Tan, Derek S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4802-4807</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite the recent decline of natural product discovery programs in the pharmaceutical industry, approx. half of all new drug approvals still trace their structural origins to a natural product.  Herein, we use principal component anal. to compare the structural and physicochem. features of drugs from natural product-based vs. completely synthetic origins that were approved between 1981 and 2010.  Drugs based on natural product structures display greater chem. diversity and occupy larger regions of chem. space than drugs from completely synthetic origins.  Notably, synthetic drugs based on natural product pharmacophores also exhibit lower hydrophobicity and greater stereochem. content than drugs from completely synthetic origins.  These results illustrate that structural features found in natural products can be successfully incorporated into synthetic drugs, thereby increasing the chem. diversity available for small-mol. drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc6Ar3gQVrDrVg90H21EOLACvtfcHk0lhpv0UQuZPJaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOmur3I&md5=9fe156eef0e6c57aabe2bfe65aae948c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DStratton%26aufirst%3DC.%2BF.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DTan%26aufirst%3DD.%2BS.%26atitle%3DCheminformatic%2520comparison%2520of%2520approved%2520drugs%2520from%2520natural%2520product%2520versus%2520synthetic%2520origins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4802%26epage%3D4807%26doi%3D10.1016%2Fj.bmcl.2015.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuffenhauer, A.</span></span> <span> </span><span class="NLM_article-title">Natural product-likeness score and its application for prioritization of compound libraries</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1021/ci700286x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700286x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=68-74&author=P.+Ertlauthor=S.+Roggoauthor=A.+Schuffenhauer&title=Natural+product-likeness+score+and+its+application+for+prioritization+of+compound+libraries&doi=10.1021%2Fci700286x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries</span></div><div class="casAuthors">Ertl, Peter; Roggo, Silvio; Schuffenhauer, Ansgar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-74</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural products (NPs) have been optimized in a very long natural selection process for optimal interactions with biol. macromols.  NPs are therefore an excellent source of validated substructures for the design of novel bioactive mols.  Various cheminformatics techniques can provide useful help in analyzing NPs, and the results of such studies may be used with advantage in the drug discovery process.  In the present study we describe a method to calc. the natural product-likeness score-a Bayesian measure which allows for the detn. of how mols. are similar to the structural space covered by natural products.  This score is shown to efficiently sep. NPs from synthetic mols. in a cross-validation expt.  Possible applications of the NP-likeness score are discussed and illustrated on several examples including virtual screening, prioritization of compd. libraries toward NP-likeness, and design of building blocks for the synthesis of NP-like libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre4QzdpRURjbVg90H21EOLACvtfcHk0lhpv0UQuZPJaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtLfP&md5=0ecfc66d9cd731fcd5c131cd246d7dcf</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fci700286x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700286x%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DSchuffenhauer%26aufirst%3DA.%26atitle%3DNatural%2520product-likeness%2520score%2520and%2520its%2520application%2520for%2520prioritization%2520of%2520compound%2520libraries%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D68%26epage%3D74%26doi%3D10.1021%2Fci700286x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span> <span> </span><span class="NLM_article-title">Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1021/ci0200467</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci0200467" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlOksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=218-227&author=M.+Feherauthor=J.+M.+Schmidt&title=Property+distributions%3A+differences+between+drugs%2C+natural+products%2C+and+molecules+from+combinatorial+chemistry&doi=10.1021%2Fci0200467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry</span></div><div class="casAuthors">Feher, Miklos; Schmidt, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">218-227</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The differences between three different compd. classes, natural products, mols. from combinatorial synthesis, and drug mols., were investigated.  The major structural differences between natural and combinatorial compds. originate mainly from properties introduced to make combinatorial synthesis more efficient.  These include the no. of chiral centers, the prevalence of arom. rings, the introduction of complex ring systems, and the degree of the satn. of the mol. as well as the no. and ratios of different heteroatoms.  As drug mols. derive from both natural and synthetic sources, they cover a joint area in property space of natural and combinatorial compds.  A PCA-based scheme is presented that differentiates the three classes of compds.  It is suggested that by mimicking certain distribution properties of natural compds., combinatorial products might be made that are substantially more diverse and have greater biol. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpma3fkS14voLVg90H21EOLACvtfcHk0lhpv0UQuZPJaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlOksLg%253D&md5=eb86ed83699fc487dfb7f2cb55296e69</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fci0200467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0200467%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26atitle%3DProperty%2520distributions%253A%2520differences%2520between%2520drugs%252C%2520natural%2520products%252C%2520and%2520molecules%2520from%2520combinatorial%2520chemistry%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2003%26volume%3D43%26spage%3D218%26epage%3D227%26doi%3D10.1021%2Fci0200467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edrada-Ebel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">The re-emergence of natural products for drug discovery in the genomics era</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1038/nrd4510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd4510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=25614221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVarsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=111-129&author=A.+L.+Harveyauthor=R.+Edrada-Ebelauthor=R.+J.+Quinn&title=The+re-emergence+of+natural+products+for+drug+discovery+in+the+genomics+era&doi=10.1038%2Fnrd4510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The re-emergence of natural products for drug discovery in the genomics era</span></div><div class="casAuthors">Harvey, Alan L.; Edrada-Ebel, RuAngelie; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-129</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Natural products have been a rich source of compds. for drug discovery.  However, their use has diminished in the past two decades, in part because of tech. barriers to screening natural products in high-throughput assays against mol. targets.  Here, we review strategies for natural product screening that harness the recent tech. advances that have reduced these barriers.  We also assess the use of genomic and metabolomic approaches to augment traditional methods of studying natural products, and highlight recent examples of natural products in antimicrobial drug discovery and as inhibitors of protein-protein interactions.  The growing appreciation of functional assays and phenotypic screens may further contribute to a revival of interest in natural products for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkQ8QarpZ6orVg90H21EOLACvtfcHk0liAQnFPl3n_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVarsbg%253D&md5=b871148315dc0623683498fa15205b14</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrd4510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4510%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DA.%2BL.%26aulast%3DEdrada-Ebel%26aufirst%3DR.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520re-emergence%2520of%2520natural%2520products%2520for%2520drug%2520discovery%2520in%2520the%2520genomics%2520era%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D111%26epage%3D129%26doi%3D10.1038%2Fnrd4510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamarre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordingley, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudreau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukolj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagace, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poupart, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rancourt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sentjens, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St George, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibeault, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weldon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas-Brunet, M.</span></span> <span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>426</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1038/nature02099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+Bosauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.+M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagaceauthor=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.+A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.+L.+Yongauthor=M.+Llinas-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus&doi=10.1038%2Fnature02099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0liAQnFPl3n_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189%26doi%3D10.1038%2Fnature02099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span> <span> </span><span class="NLM_article-title">The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1002/bip.20127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fbip.20127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15386268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVSnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2004&pages=309-323&author=Y.+S.+Tsantrizos&title=The+design+of+a+potent+inhibitor+of+the+hepatitis+C+virus+NS3+protease%3A+BILN+2061%2D%2Dfrom+the+NMR+tube+to+the+clinic&doi=10.1002%2Fbip.20127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061 - From the NMR tube to the clinic</span></div><div class="casAuthors">Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-323</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The virally encoded serine protease NS3/NS4A is essential to the life cycle of the hepatitis C virus (HCV), an important human pathogen causing chronic hepatitis, cirrhosis of the liver, and hepatocellular carcinoma.  Until very recently, the design of inhibitors for the HCV NS3 protease was limited to large peptidomimetic compds. with poor pharmacokinetic properties, making drug discovery an extremely challenging endeavor.  In our quest for the discovery of a small-mol. lead that could block replication of the hepatitis C virus by binding to the HCV NS3 protease, the crit. protein-polypeptide interactions between the virally encoded NS3 serine protease and its polyprotein substrate were investigated.  Lead optimization of a substrate-based hexapeptide, guided by structural data, led to the understanding of the mol. dynamics and electronic effects that modulate the affinity of peptidomimetic ligands for the active site of this enzyme.  Macrocyclic β-strand scaffolds were designed that allowed the discovery of potent, highly selective, and orally bioavailable compds.  These mols. were the first HCV NS3 protease inhibitors reported that inhibit replication of HCV subgenomic RNA in a cell-based replicon assay at low nanomolar concns.  Optimization of their biopharmaceutical properties led to the discovery of the clin. candidate BILN 2061.  Oral administration of BILN 2061 to patients infected with the hepatitis C genotype 1 virus resulted in an impressive redn. of viral RNA levels, establishing proof-of-concept for HCV NS3 protease inhibitors as therapeutic agents in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxxZEqYR5XlrVg90H21EOLACvtfcHk0liAQnFPl3n_pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVSnsLk%253D&md5=94dc1ba22bec28da890d081c2cd9efee</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fbip.20127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.20127%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DThe%2520design%2520of%2520a%2520potent%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520BILN%25202061--from%2520the%2520NMR%2520tube%2520to%2520the%2520clinic%26jtitle%3DBiopolymers%26date%3D2004%26volume%3D76%26spage%3D309%26epage%3D323%26doi%3D10.1002%2Fbip.20127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudreau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukolj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas-Brunet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamarre, D.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1356</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1002/anie.200390347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.200390347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1356-1360&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+inhibitors+of+the+NS3+protease+as+potential+therapeutic+agents+of+hepatitis+C+virus+infection&doi=10.1002%2Fanie.200390347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span></div><div class="casAuthors">Tsantrizos, Youla S.; Bolger, Gordon; Bonneau, Pierre; Cameron, Dale R.; Goudreau, Nathalie; Kukolj, George; LaPlante, Steven R.; Llinas-Brunet, Montse; Nar, Herbert; Lamarre, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1356-1360</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel class of selective inhibitors of the hepatitis C virus NS3 protease, an enzyme which is essential for viral replication in vivo, was developed.  The inhibitors are based on the structure-activity relationship between a substrate-based peptidomimetic ligand and the HCV NS3 serine protease.  The designed HCV inhibitor and its satd. analogs are the first inhibitors of the NS3 protease which inhibit HCV RNA replication in the cell-based replicon assay.  In addn., they are orally absorbed and stable to metabolic breakdown.  Thus, these compds. show many of the desirable properties of a druglike archetype and could lead t a clin. useful antiviral agent for the treatment of hepatitis C viral infections in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCij3shP5tmLVg90H21EOLACvtfcHk0ljs_u7GVkMBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D&md5=e0a3c98ee0096bfc3d058bf0b92b81c3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.200390347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200390347%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520the%2520NS3%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1356%26epage%3D1360%26doi%3D10.1002%2Fanie.200390347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tyndall, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">907</span>, <span class="refDoi"> DOI: 10.2174/0929867013372715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.2174%2F0929867013372715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=11375757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVeiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=893-907&author=J.+D.+Tyndallauthor=D.+P.+Fairlie&title=Macrocycles+mimic+the+extended+peptide+conformation+recognized+by+aspartic%2C+serine%2C+cysteine+and+metallo+proteases&doi=10.2174%2F0929867013372715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases</span></div><div class="casAuthors">Tyndall, Joel D. A.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">893-907</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with refs.  It has been previously demonstrated that aspartic, serine, metallo and cysteine proteases bind to their inhibitors and substrate analogs in a single conformation, the saw-tooth or extended beta-strand.  Consequently a generic approach to the development of protease inhibitors is the use of constraints that conformationally restrict putative inhibitor mols. to an extended form.  In this way the inhibitor is pre-organized for binding to a protease and does not need to rearrange its structure.  One constraining device that has proven to be effective for such pre-organization is macrocyclization.  This article illustrates the general principle that macrocycles, esp. those composed of 3-4 amino acids and usually 13-17 ring atoms, can effectively mimic the extended conformation of short peptide sequences.  Such structure-stabilizing macrocycles are stable to degrdn. by proteases, valuable components of potent protease inhibitors, and in many cases they are also bioavailable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyuoMyDlMrlbVg90H21EOLACvtfcHk0ljs_u7GVkMBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVeiur4%253D&md5=2525f64466090d8f371452ed9f0d676c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2174%2F0929867013372715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013372715%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DMacrocycles%2520mimic%2520the%2520extended%2520peptide%2520conformation%2520recognized%2520by%2520aspartic%252C%2520serine%252C%2520cysteine%2520and%2520metallo%2520proteases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D893%26epage%3D907%26doi%3D10.2174%2F0929867013372715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amssoms, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Last, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devogelaere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijgen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berke, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehertogh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleiren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Helm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Emelen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyanguile, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based macrocyclization yields hepatitis C virus NS5B inhibitors with improved binding affinities and pharmacokinetic properties</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4637</span>– <span class="NLM_lpage">4640</span>, <span class="refDoi"> DOI: 10.1002/anie.201200110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.201200110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVGltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=4637-4640&author=M.+D.+Cummingsauthor=T.+I.+Linauthor=L.+Huauthor=A.+Tahriauthor=D.+McGowanauthor=K.+Amssomsauthor=S.+Lastauthor=B.+Devogelaereauthor=M.+C.+Rouanauthor=L.+Vijgenauthor=J.+M.+Berkeauthor=P.+Dehertoghauthor=E.+Fransenauthor=E.+Cleirenauthor=L.+Van+Der+Helmauthor=G.+Fanningauthor=K.+Van+Emelenauthor=O.+Nyanguileauthor=K.+Simmenauthor=P.+Raboissonauthor=S.+Vendeville&title=Structure-based+macrocyclization+yields+hepatitis+C+virus+NS5B+inhibitors+with+improved+binding+affinities+and+pharmacokinetic+properties&doi=10.1002%2Fanie.201200110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties</span></div><div class="casAuthors">Cummings, Maxwell D.; Lin, Tse-I.; Hu, Lili; Tahri, Abdellah; McGowan, David; Amssoms, Katie; Last, Stefaan; Devogelaere, Benoit; Rouan, Marie-Claude; Vijgen, Leen; Berke, Jan Martin; Dehertogh, Pascale; Fransen, Els; Cleiren, Erna; van der Helm, Liesbet; Fanning, Gregory; Van Emelen, Kristof; Nyanguile, Origene; Simmen, Kenny; Raboisson, Pierre; Vendeville, Sandrine</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4637-4640, S4637/1-S4637/20</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Macrocyclization is one mol. design strategy that can be used to improve the drug-related characteristics of small mols. and peptides,'1"4' and thus may provide a route to a less restrictive "drug-likeness space".  Structure-based design is typically focused on the optimization of a chem. series to increase affinity toward a target protein: modification to gain addnl. binding contacts and rigidification to favor a bio-active conformation are two common strategies.  In addn. to affinity for the primary target, a 3D structure of a relevant protein-small mol. complex can be used to guide the optimization of other pharmaceutical properties.  Substituent positions that project away from the binding site may be chem. exploited to alter one or more PK- or ADME-related properties (e.g. "solubilizing groups") while having minimal effect on the therapeutically relevant binding interaction (PK = pharmacokinetics; ADME = absorption, distribution, metab., and excretion).  Pursuing a design strategy based on publicly available 3D structures, we combined rigidification and the introduction of a PK-enhancing group in a single modification by forming a macrocycle between two solvent-exposed substituent positions of a small-mol. inhibitor of an essential viral enzyme.  In the present work we have used structure-based design to guide macrocyclization, leading to the discovery of new inhibitors that maintain potency while showing substantially improved pharmacokinetic behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr70QpVIVUDr7Vg90H21EOLACvtfcHk0ljs_u7GVkMBgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGltLc%253D&md5=1dc1c86dcc8f22d406256e4a779e9e6e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fanie.201200110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201200110%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DAmssoms%26aufirst%3DK.%26aulast%3DLast%26aufirst%3DS.%26aulast%3DDevogelaere%26aufirst%3DB.%26aulast%3DRouan%26aufirst%3DM.%2BC.%26aulast%3DVijgen%26aufirst%3DL.%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26aulast%3DDehertogh%26aufirst%3DP.%26aulast%3DFransen%26aufirst%3DE.%26aulast%3DCleiren%26aufirst%3DE.%26aulast%3DVan%2BDer%2BHelm%26aufirst%3DL.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DVan%2BEmelen%26aufirst%3DK.%26aulast%3DNyanguile%26aufirst%3DO.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DVendeville%26aufirst%3DS.%26atitle%3DStructure-based%2520macrocyclization%2520yields%2520hepatitis%2520C%2520virus%2520NS5B%2520inhibitors%2520with%2520improved%2520binding%2520affinities%2520and%2520pharmacokinetic%2520properties%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D4637%26epage%3D4640%26doi%3D10.1002%2Fanie.201200110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosise, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taremi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarosh-Tomaine, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senior, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasappan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saksena, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2310</span>– <span class="NLM_lpage">2318</span>, <span class="refDoi"> DOI: 10.1021/jm060173k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060173k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlyjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2310-2318&author=A.+J.+Prongayauthor=Z.+Guoauthor=N.+Yaoauthor=J.+Pichardoauthor=T.+Fischmannauthor=C.+Stricklandauthor=J.+Myersauthor=P.+C.+Weberauthor=B.+M.+Beyerauthor=R.+Ingramauthor=Z.+Hongauthor=W.+W.+Prosiseauthor=L.+Ramanathanauthor=S.+S.+Taremiauthor=T.+Yarosh-Tomaineauthor=R.+Zhangauthor=M.+Seniorauthor=R.+S.+Yangauthor=B.+Malcolmauthor=A.+Arasappanauthor=F.+Bennettauthor=S.+L.+Bogenauthor=K.+Chenauthor=E.+Jaoauthor=Y.+T.+Liuauthor=R.+G.+Loveyauthor=A.+K.+Saksenaauthor=S.+Venkatramanauthor=V.+Girijavallabhanauthor=F.+G.+Njorogeauthor=V.+Madison&title=Discovery+of+the+HCV+NS3%2F4A+protease+inhibitor+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-+%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-+6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28Sch+503034%29+II.+Key+steps+in+structure-based+optimization&doi=10.1021%2Fjm060173k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the HCV NS3/4A Protease Inhibitor (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034). Key Steps in Structure-Based Optimization</span></div><div class="casAuthors">Prongay, Andrew J.; Guo, Zhuyan; Yao, Nanhua; Pichardo, John; Fischmann, Thierry; Strickland, Corey; Myers, Joseph, Jr.; Weber, Patricia C.; Beyer, Brian M.; Ingram, Richard; Hong, Zhi; Prosise, Winifred W.; Ramanathan, Lata; Taremi, S. Shane; Yarosh-Tomaine, Taisa; Zhang, Rumin; Senior, Mary; Yang, Rong-Sheng; Malcolm, Bruce; Arasappan, Ashok; Bennett, Frank; Bogen, Stephane L.; Chen, Kevin; Jao, Edwin; Liu, Yi-Tsung; Lovey, Raymond G.; Saksena, Anil K.; Venkatraman, Srikanth; Girijavallabhan, Viyyoor; Njoroge, F. George; Madison, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2310-2318</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The structures of both the native holo-HCV NS3/4A protease domain and the protease domain with a serine 139 to alanine (S139A) mutation were solved to high resoln.  Subsequently, structures were detd. for a series of ketoamide inhibitors in complex with the protease.  The changes in the inhibitor potency were correlated with changes in the buried surface area upon binding the inhibitor to the active site.  The largest contribution to the binding energy arises from the hydrophobic interactions of the P1 and P2 groups as they bind to the S1 and S2 pockets [the numbering of the subsites is as defined in Berger, A.; Schechter, I. Philos. Trans. R. Soc. London, Ser. B 1970, 257, 249-264].  This correlation of the changes in potency with increased buried surface area contributed directly to the design of a potent tripeptide inhibitor of the HCV NS3/4A protease that is currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjU_OrFFP_JrVg90H21EOLACvtfcHk0lga-sTLQ9b3iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlyjt7c%253D&md5=9df7e3bc9b4973c82daf88d8fcf16b35</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm060173k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060173k%26sid%3Dliteratum%253Aachs%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DYarosh-Tomaine%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSenior%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.%2BS.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%2BT.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520the%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%2520%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-%25206%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528Sch%2520503034%2529%2520II.%2520Key%2520steps%2520in%2520structure-based%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2310%26epage%3D2318%26doi%3D10.1021%2Fjm060173k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span> <span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">4607</span>– <span class="NLM_lpage">4609</span>, <span class="refDoi"> DOI: 10.1021/ja711120r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFygur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.+S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.+L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease&doi=10.1021%2Fja711120r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease</span></div><div class="casAuthors">Liverton, Nigel J.; Holloway, M. Katharine; McCauley, John A.; Rudd, Michael T.; Butcher, John W.; Carroll, Steven S.; DiMuzio, Jillian; Fandozzi, Christine; Gilbert, Kevin F.; Mao, Shi-Shan; McIntyre, Charles J.; Nguyen, Kevin T.; Romano, Joseph J.; Stahlhut, Mark; Wan, Bang-Lin; Olsen, David B.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4607-4609</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. modeling of inhibitor bound full length HCV NS3/4A protease structures proved to be a valuable tool in the design of a new series of potent NS3 protease inhibitors.  Optimization of initial compds. provided 25a.  The in vitro activity and selectivity as well as the rat pharmacokinetic profile of 25a compare favorably with the data for other NS3/4A protease inhibitors currently in clin. development for the treatment of HCV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppYenMBNqdeLVg90H21EOLACvtfcHk0lga-sTLQ9b3iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFygur8%253D&md5=5e7bb98bdb19c30bebb30f03a702838d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.%2BS.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609%26doi%3D10.1021%2Fja711120r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasappan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vibulbhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parekh, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span> <span> </span><span class="NLM_article-title">Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1021/jm050820s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050820s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XitV2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=995-1005&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=A.+Arasappanauthor=S.+Venkatramanauthor=B.+Vibulbhanauthor=W.+Yangauthor=T.+N.+Parekhauthor=J.+Pichardoauthor=A.+Prongayauthor=K.+C.+Chengauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Novel+potent+hepatitis+C+virus+NS3+serine+protease+inhibitors+derived+from+proline-based+macrocycles&doi=10.1021%2Fjm050820s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Potent Hepatitis C Virus NS3 Serine Protease Inhibitors Derived from Proline-Based Macrocycles</span></div><div class="casAuthors">Chen, Kevin X.; Njoroge, F. George; Arasappan, Ashok; Venkatraman, Srikanth; Vibulbhan, Bancha; Yang, Weiying; Parekh, Tejal N.; Pichardo, John; Prongay, Andrew; Cheng, Kuo-Chi; Butkiewicz, Nancy; Yao, Nanhua; Madison, Vincent; Girijavallabhan, Viyyoor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">995-1005</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS3 protease is essential for viral replication.  It has been a target of choice for intensive drug discovery research.  On the basis of an active pentapeptide inhibitor, I, we envisioned that macrocyclization from the P2 proline to P3 capping could enhance binding to the backbone Ala156 residue and the S4 pocket.  Thus, a no. of P2 proline-based macrocyclic α-ketoamide inhibitors were prepd. and investigated in an HCV NS3 serine protease continuous assay (Ki*).  The biol. activity varied substantially depending on factors such as the ring size, no. of amino acid residues, no. of Me substituents, type of heteroatom in the linker, P3 residue, and configuration at the proline C-4 center.  The pentapeptide inhibitors were very potent, with the C-terminal acids and amides being the most active ones [II; R = H, R1 = cyclohexyl, R2 = NH-Gly-Phg-NMe2 (24), Ki* = 8 nM].  The tetrapeptides and tripeptides were less potent.  Sixteen- and seventeen-membered macrocyclic compds. were equally potent, while fifteen-membered analogs were slightly less active.  Gem-Di-Me substituents at the linker improved the potency of all inhibitors [the best compd. was II (R = Me, R1 = cyclohexyl, R2 = NH-Gly-Phg-NMe2) (45), Ki* = 6 nM].  The combination of tert-leucine at P3 and di-Me substituents at the linker in compd. II (R = Me, R1 = t-Bu, R2 = NH-Gly-Phg-NMe2) realized a selectivity of 307 against human neutrophil elastase.  Compd. 45 had an IC50 of 130 nM in a cellular replicon assay, while IC50 for 24 was 400 nM.  Several compds. had excellent s.c. AUC and bioavailability in rats.  Although tripeptide compd. II (R = Me, R1 = cyclohexyl, R2 = NH-allyl) was 97% orally bioavailable, larger pentapeptides generally had low oral bioavailability.  The X-ray crystal structure of compds. 24 and 45 bound to the protease demonstrated the close interaction of the macrocycle with the Ala156 Me group and S4 pocket.  The strategy of macrocyclization has been proved to be successful in improving potency (>20-fold greater than that of I) and in structural depeptization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdS3he5kAl_bVg90H21EOLACvtfcHk0liYMEbKn-HK1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitV2mtQ%253D%253D&md5=113c44a06c8018697ee83ae8614b6a95</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm050820s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050820s%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%2BN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DNovel%2520potent%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%2520inhibitors%2520derived%2520from%2520proline-based%2520macrocycles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D995%26epage%3D1005%26doi%3D10.1021%2Fjm050820s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6229</span>– <span class="NLM_lpage">6235</span>, <span class="refDoi"> DOI: 10.1021/jm050323b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVGhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6229-6235&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Design%2C+synthesis%2C+and+biological+activity+of+m-tyrosine-based+16-+and+17-membered+macrocyclic+inhibitors+of+hepatitis+C+virus+NS3+serine+protease&doi=10.1021%2Fjm050323b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of m-Tyrosine-Based 16- and 17-Membered Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease</span></div><div class="casAuthors">Chen, Kevin X.; Njoroge, F. George; Pichardo, John; Prongay, Andrew; Butkiewicz, Nancy; Yao, Nanhua; Madison, Vincent; Girijavallabhan, Viyyoor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6229-6235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The limited efficacy and considerable side effects of currently available therapies for the treatment of hepatitis C virus (HCV) infection have prompted significant efforts toward the development of safe and effective new therapeutics.  Towards that goal, m-tyrosine-based 17-membered macrocycles I (R = OBu-t, OH, NHMe, NMe2) and 16-membered macrocycles II (R = OBu-t, OH) were prepd. from m-tyrosine Me ester as HCV inhibitors.  I and II were tested in an HCV protease continuous assay.  The binding consts. indicated that II were less potent than I.  It was also evident that C-terminal acids and amides (binding const. range: 0.16-0.31 μM) were much better inhibitors than tert-Bu esters.  The x-ray crystal structure of I (R = OH) bound to the enzyme revealed that the macrocycle formed a "donut"-shaped ring around the Me group of Ala156; P2' Ph and P1 Pr groups wrapped around the Lys136 side chain, forming a "C"-shaped clamp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsFwPDh8XiLrVg90H21EOLACvtfcHk0liYMEbKn-HK1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVGhtL0%253D&md5=a39ea79e72e9066c0f8e7891fe6733ea</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm050323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050323b%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520m-tyrosine-based%252016-%2520and%252017-membered%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6229%26epage%3D6235%26doi%3D10.1021%2Fjm050323b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span> <span> </span><span class="NLM_article-title">Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 protease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1021/jm050520a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050520a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=567-574&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Potent+7-hydroxy-1%2C2%2C3%2C4-tetrahydroisoquinoline-3-carboxylic+acid-based+macrocyclic+inhibitors+of+hepatitis+C+virus+NS3+protease&doi=10.1021%2Fjm050520a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 protease</span></div><div class="casAuthors">Chen, Kevin X.; Njoroge, F. George; Pichardo, John; Prongay, Andrew; Butkiewicz, Nancy; Yao, Nanhua; Madison, Vincent; Girijavallabhan, Viyyoor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">567-574</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The NS3 protease of hepatitis C virus (HCV) has emerged as one of the best characterized targets for next-generation HCV therapy.  The tetrapeptide and pentapeptide contg. Tic moiety (Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylamide) are α-ketoamide-type HCV serine protease inhibitors with modest potency.  We envisioned that the Tic moiety could be cyclized to the P3 capping group.  The resulting macrocycle could enhance the binding through its extra contact with the Ala156 Me group.  The precursor of the macrocycle was prepd. by capping obtained by amino acids coupling dipeptide I (Boc = tert-butoxycarbonyl) as hept-6-enoylamid, following by hydrogenation of the double bond.  The macrocyclization was achieved under Mitsunobu conditions (PPh3, ADDP).  The macrocyclic acid was then combined with appropriate right-hand fragments, which were prepd. from common intermediate BocNHCH(n-Pr)CH(OH)CO2H.  Finally, oxidn., deprotection, and amidation of α-hydroxyamide provided target inhibitors, e. g. II (R2 = Ot-Bu, OH, NMe2), which were tested in HCV NS3 protease continuous assay and showed a very good inhibitory activity against HCV NS3 protease.  The X-ray crystal structure of compd. II (R2 = NMe2) bound to the protease revealed that the macrocycle adopted a donut-like conformation and had close contact with the Ala156 Me group.  The ketone carbonyl formed a reversible covalent bond with Ser139.  The n-Pr of P1 norvaline and the arom. ring of P2' phenylglycine formed a C-shaped clamp around the Lys136 side chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiekDRG7PAMLVg90H21EOLACvtfcHk0liYMEbKn-HK1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant73P&md5=3cec0c957614ed76433764467dfac1ae</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm050520a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050520a%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DPotent%25207-hydroxy-1%252C2%252C3%252C4-tetrahydroisoquinoline-3-carboxylic%2520acid-based%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D567%26epage%3D574%26doi%3D10.1021%2Fjm050520a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Francesco, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessole, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Muzio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span> <span> </span><span class="NLM_article-title">Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1,3-thiazole as a P4 carbamate replacement</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7014</span>– <span class="NLM_lpage">7028</span>, <span class="refDoi"> DOI: 10.1021/jm900524b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900524b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7014-7028&author=M.+E.+Di%0AFrancescoauthor=G.+Dessoleauthor=E.+Niziauthor=P.+Paceauthor=U.+Kochauthor=F.+Fioreauthor=S.+Pesciauthor=J.+Di+Muzioauthor=E.+Monteagudoauthor=M.+Rowleyauthor=V.+Summa&title=Novel+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease+featuring+a+2-amino-1%2C3-thiazole+as+a+P4+carbamate+replacement&doi=10.1021%2Fjm900524b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement</span></div><div class="casAuthors">Di Francesco, M. Emilia; Dessole, Gabriella; Nizi, Emanuela; Pace, Paola; Koch, Uwe; Fiore, Fabrizio; Pesci, Silvia; Di Muzio, Jillian; Monteagudo, Edith; Rowley, Michael; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7014-7028</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of P2-P4 macrocyclic inhibitors of HCV NS3/4A protease characterized by high levels of potency and liver exposure was recently reported.  Within this novel class of inhibitors, a structurally diverse series of compds. I [X = isoquinoline-1,7-diyl, 2-phenylquinoline-4,6-diyl, 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)2, (CH2)3, CH2CMe2; Z = thiazol-2,4-diyl, 1,3,4-oxadiazol-2,5-diyl; R1 = i-Pr, t-Bu, cyclohexyl, (S)-EtCHMe, cyclopentyl; R2 = H2C:CH, Et] featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4 was identified.  Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogs characterized by excellent levels of enzyme and cellular activity.  Among these, I [double bond; X = 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)3; Z = thiazol-2,4-diyl; R1 = (S)-EtCHMe; R2 = H2C:CH] displayed an attractive pharmacokinetic profile in preclin. species and showed sustained liver levels following oral administration in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFtigQW8FUrVg90H21EOLACvtfcHk0lhz223TTDgR-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN&md5=76e409fa1d0e9812ee78c4eeabca21ce</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm900524b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900524b%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DDessole%26aufirst%3DG.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DNovel%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%2520featuring%2520a%25202-amino-1%252C3-thiazole%2520as%2520a%2520P4%2520carbamate%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7014%26epage%3D7028%26doi%3D10.1021%2Fjm900524b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroski, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serebryany, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenglowsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madduru, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodard, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck Do, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandhuber, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiwert, S. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1753</span>– <span class="NLM_lpage">1769</span>, <span class="refDoi"> DOI: 10.1021/jm400164c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400164c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFaku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1753-1769&author=Y.+Jiangauthor=S.+W.+Andrewsauthor=K.+R.+Condroskiauthor=B.+Buckmanauthor=V.+Serebryanyauthor=S.+Wenglowskyauthor=A.+L.+Kennedyauthor=M.+R.+Madduruauthor=B.+Wangauthor=M.+Lyonauthor=G.+A.+Dohertyauthor=B.+T.+Woodardauthor=C.+Lemieuxauthor=M.+Geck+Doauthor=H.+Zhangauthor=J.+Ballardauthor=G.+Vigersauthor=B.+J.+Brandhuberauthor=P.+Stengelauthor=J.+A.+Joseyauthor=L.+Beigelmanauthor=L.+Blattauthor=S.+D.+Seiwert&title=Discovery+of+danoprevir+%28ITMN-191%2FR7227%29%2C+a+highly+selective+and+potent+inhibitor+of+hepatitis+C+virus+%28HCV%29+NS3%2F4A+protease&doi=10.1021%2Fjm400164c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease</span></div><div class="casAuthors">Jiang, Yutong; Andrews, Steven W.; Condroski, Kevin R.; Buckman, Brad; Serebryany, Vlad; Wenglowsky, Steve; Kennedy, April L.; Madduru, Machender R.; Wang, Bin; Lyon, Michael; Doherty, George A.; Woodard, Benjamin T.; Lemieux, Christine; Do, Mary Geck; Zhang, Hailong; Ballard, Joshua; Vigers, Guy; Brandhuber, Barbra J.; Stengel, Peter; Josey, John A.; Beigelman, Leonid; Blatt, Lawrence; Seiwert, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1753-1769</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HCV serine protease NS3 represents an attractive drug target because it is not only essential for viral replication but also implicated in the viral evasion of the host immune response pathway through direct cleavage of key proteins in the human innate immune system.  Through structure-based drug design and optimization, macrocyclic peptidomimetic mols. bearing both a lipophilic P2 isoindoline carbamate and a P1/P1' acylsulfonamide/acylsulfamide carboxylic acid bioisostere were prepd. that possessed subnanomolar potency against the NS3 protease in a subgenomic replicon-based cellular assay (Huh-7).  Danoprevir (compd. 49) was selected as the clin. development candidate for its favorable potency profile across multiple HCV genotypes and key mutant strains and for its good in vitro ADME profiles and in vivo target tissue (liver) exposures across multiple animal species.  X-ray crystallog. studies elucidated several key features in the binding of danoprevir to HCV NS3 protease and proved invaluable to the iterative structure-based design strategy of the authors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplS3sgoIBu_7Vg90H21EOLACvtfcHk0lhz223TTDgR-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFaku7w%253D&md5=2a979cd1202b9360bcef316dddd8382f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm400164c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400164c%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DBuckman%26aufirst%3DB.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DWenglowsky%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DA.%2BL.%26aulast%3DMadduru%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DM.%26aulast%3DDoherty%26aufirst%3DG.%2BA.%26aulast%3DWoodard%26aufirst%3DB.%2BT.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DGeck%2BDo%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520danoprevir%2520%2528ITMN-191%252FR7227%2529%252C%2520a%2520highly%2520selective%2520and%2520potent%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1753%26epage%3D1769%26doi%3D10.1021%2Fjm400164c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swestock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2443</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.1021/jm9015526</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9015526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2443-2463&author=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.+L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=S.+S.+Maoauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+vaniprevir+%28MK-7009%29%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor&doi=10.1021%2Fjm9015526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">McCauley, John A.; McIntyre, Charles J.; Rudd, Michael T.; Nguyen, Kevin T.; Romano, Joseph J.; Butcher, John W.; Gilbert, Kevin F.; Bush, Kimberly J.; Holloway, M. Katharine; Swestock, John; Wan, Bang-Lin; Carroll, Steven S.; DiMuzio, Jillian M.; Graham, Donald J.; Ludmerer, Steven W.; Mao, Shi-Shan; Stahlhut, Mark W.; Fandozzi, Christine M.; Trainor, Nicole; Olsen, David B.; Vacca, Joseph P.; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2443-2463</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a mol.-modeling derived strategy.  Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compds. via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate vaniprevir, MK-7009, which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_2CVs9I1H_7Vg90H21EOLACvtfcHk0lhz223TTDgR-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D&md5=dc820c588d5482f6913091a87eaf9af1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMao%26aufirst%3DS.%2BS.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520vaniprevir%2520%2528MK-7009%2529%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2443%26epage%3D2463%26doi%3D10.1021%2Fjm9015526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1021/jm800940u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800940u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFals7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=336-346&author=S.+Venkatramanauthor=F.+Velazquezauthor=W.+Wuauthor=M.+Blackmanauthor=K.+X.+Chenauthor=S.+Bogenauthor=L.+Nairauthor=X.+Tongauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=J.+Pichardoauthor=A.+Prongayauthor=K.+C.+Chengauthor=V.+Girijavallabhanauthor=J.+Piwinskiauthor=N.+Y.+Shihauthor=F.+G.+Njoroge&title=Discovery+and+structure-activity+relationship+of+P1-P3+ketoamide+derived+macrocyclic+inhibitors+of+hepatitis+C+virus+NS3+protease&doi=10.1021%2Fjm800940u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity Relationship of P1-P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease</span></div><div class="casAuthors">Venkatraman, Srikanth; Velazquez, Francisco; Wu, Wanli; Blackman, Melissa; Chen, Kevin X.; Bogen, Stephane; Nair, Latha; Tong, Xiao; Chase, Robert; Hart, Andrea; Agrawal, Sony; Pichardo, John; Prongay, Andrew; Cheng, Kuo-Chi; Girijavallabhan, Viyyoor; Piwinski, John; Shih, Neng-Yang; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">336-346</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, and affects more than 200 million people worldwide.  Although combination therapy of interferon-α and ribavirin is reasonably successful in treating majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virol. response.  Herein, the SAR leading to the discovery of a series of ketoamide derived P1-P3 macrocyclic inhibitors that are more potent than the first generation clin. candidate, boceprevir (Sch 503034), is discussed.  The optimization of these macrocyclic inhibitors identified a P3 imide capped analog (I) that was 20 times more potent than boceprevir and demonstrated good oral pharmacokinetics in rats.  X-ray structure of I bound to NS3 protease and biol. data are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJWmH7aKVi7bVg90H21EOLACvtfcHk0lgcpulWRx6nug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFals7fF&md5=377bc2c7a1635fe7e1df893692f84bf5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm800940u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800940u%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DBlackman%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DNair%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DN.%2BY.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationship%2520of%2520P1-P3%2520ketoamide%2520derived%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D336%26epage%3D346%26doi%3D10.1021%2Fjm800940u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilja, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellander, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraznenok, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nystrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span> <span> </span><span class="NLM_article-title">Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1652</span>– <span class="NLM_lpage">1655</span>, <span class="refDoi"> DOI: 10.1002/anie.200906696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.200906696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1652-1655&author=M.+D.+Cummingsauthor=J.+Lindbergauthor=T.+I.+Linauthor=H.+De+Kockauthor=O.+Lenzauthor=E.+Liljaauthor=S.+Fellanderauthor=V.+Baraznenokauthor=S.+Nystromauthor=M.+Nilssonauthor=L.+Vrangauthor=M.+Edlundauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+Raboissonauthor=K.+Simmen&title=Induced-fit+binding+of+the+macrocyclic+noncovalent+inhibitor+TMC435+to+its+HCV+NS3%2FNS4A+protease+target&doi=10.1002%2Fanie.200906696"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target</span></div><div class="casAuthors">Cummings, Maxwell D.; Lindberg, Jimmy; Lin, Tse-I.; de Kock, Herman; Lenz, Oliver; Lilja, Elisabet; Fellander, Sara; Baraznenok, Vera; Nystrom, Susanne; Nilsson, Magnus; Vrang, Lotta; Edlund, Michael; Rosenquist, Asa; Samuelsson, Bertil; Raboisson, Pierre; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1652-1655, S1652/1-S1652/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have detd. the crystal structure of the macrocyclic inhibitor TMC435 bound to its HCV NS3/4A protease target at a resoln. of 2.4 Å, providing at. detail of induced fit to an extended S2 subsite.  The complex structure helps to rationalize the impact of key modifications in the optimization path that led to 1, and is guiding our understanding of resistance patterns.  Future modeling and structure-based design efforts aimed at NS3/NS4A protease should benefit from the new structure, which represents the first example of a noncovalent NS3/NS4A protease-inhibitor complex deposited in the PDB and details the induced fit involved in accommodating a large P2 substituent.  Inhibitors with large P2 groups that occupy the extended S2 subsite probe the crystallog. obsd. helicase-protease interface, and it is hoped that future studies will clarify the relevance of interfacial contacts to protease activity and protease inhibitor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEYqCPA57hLVg90H21EOLACvtfcHk0lgcpulWRx6nug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D&md5=535b340784d1af62df32e8cf3bd3fe87</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906696%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLindberg%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DDe%2BKock%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DLilja%26aufirst%3DE.%26aulast%3DFellander%26aufirst%3DS.%26aulast%3DBaraznenok%26aufirst%3DV.%26aulast%3DNystrom%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DInduced-fit%2520binding%2520of%2520the%2520macrocyclic%2520noncovalent%2520inhibitor%2520TMC435%2520to%2520its%2520HCV%2520NS3%252FNS4A%2520protease%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D1652%26epage%3D1655%26doi%3D10.1002%2Fanie.200906696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvador-Oden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickstrom, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamelink, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Vreken, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delouvroy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pille, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surleraux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigerinck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4853</span>– <span class="NLM_lpage">4858</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.bmcl.2008.07.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=18678486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+De+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.+I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure-activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350&doi=10.1016%2Fj.bmcl.2008.07.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span></div><div class="casAuthors">Raboisson, Pierre; de Kock, Herman; Rosenquist, Asa; Nilsson, Magnus; Salvador-Oden, Lourdes; Lin, Tse-I.; Roue, Natalie; Ivanov, Vladimir; Wahling, Horst; Wickstrom, Kristina; Hamelink, Elizabeth; Edlund, Michael; Vrang, Lotta; Vendeville, Sandrine; Van de Vreken, Wim; McGowan, David; Tahri, Abdellah; Hu, Lili; Boutton, Carlo; Lenz, Oliver; Delouvroy, Frederic; Pille, Geert; Surleraux, Dominique; Wigerinck, Piet; Samuelsson, Bertil; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4853-4858</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">SAR anal. performed with a limited set of cyclopentane-contg. macrocycles led to the identification of TMC435350 (I) as a potent inhibitor of HCV NS3/4A protease (Ki = 0.36 nM) and viral replication (replicon EC50 = 7.8 nM).  TMC435350 also displayed low in vitro clearance and high permeability, which were confirmed by in vivo pharmacokinetic studies.  TMC435350 is currently being evaluated in the clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbRb8GhLBkJ7Vg90H21EOLACvtfcHk0lhl5BBfIZtGvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbvE&md5=001abd8307658a926479ff77496b6ff9</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.088%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DDe%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure-activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858%26doi%3D10.1016%2Fj.bmcl.2008.07.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmeijer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De La Rosa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beumont-Mauviel, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1693</span>, <span class="refDoi"> DOI: 10.1021/jm401507s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401507s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1673-1693&author=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+O.+Johanssonauthor=M.+D.+Cummingsauthor=O.+Lenzauthor=P.+Raboissonauthor=K.+Simmenauthor=S.+Vendevilleauthor=H.+De+Kockauthor=M.+Nilssonauthor=A.+Horvathauthor=R.+Kalmeijerauthor=G.+De+La+Rosaauthor=M.+Beumont-Mauviel&title=Discovery+and+development+of+simeprevir+%28TMC435%29%2C+a+HCV+NS3%2F4A+protease+inhibitor&doi=10.1021%2Fjm401507s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor</span></div><div class="casAuthors">Rosenquist, Aasa; Samuelsson, Bertil; Johansson, Per-Ola; Cummings, Maxwell D.; Lenz, Oliver; Raboisson, Pierre; Simmen, Kenny; Vendeville, Sandrine; de Kock, Herman; Nilsson, Magnus; Horvath, Andras; Kalmeijer, Ronald; de la Rosa, Guy; Beumont-Mauviel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1673-1693</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus is a blood-borne infection and the leading cause of chronic liver disease (including cirrhosis and cancer) and liver transplantation.  Since the identification of HCV in 1989, there has been an extensive effort to identify and improve treatment options.  An important milestone was reached in 2011 with the approval of the first-generation HCV NS3/4A protease inhibitors.  However, new therapies are needed to improve cure rates, shorten treatment duration, and improve tolerability.  Here we summarize the extensive medicinal chem. effort to develop novel P2 cyclopentane macrocyclic inhibitors guided by HCV NS3 protease assays, the cellular replicon system, structure-based design, and a panel of DMPK assays.  The selection of compd. 29 (simeprevir, TMC435) as clin. candidate was based on its excellent biol., PK, and safety pharmacol. profile.  Compd. 29 has recently been approved for treatment of chronic HCV infection in combination with pegylated interferon-α and ribavirin in Japan, Canada, and USA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryCRg3NRRjzrVg90H21EOLACvtfcHk0lhl5BBfIZtGvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslekuw%253D%253D&md5=fd9c1df095e47a111d9680af4c40ccc6</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm401507s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401507s%26sid%3Dliteratum%253Aachs%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DJohansson%26aufirst%3DP.%2BO.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DDe%2BKock%26aufirst%3DH.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DKalmeijer%26aufirst%3DR.%26aulast%3DDe%2BLa%2BRosa%26aufirst%3DG.%26aulast%3DBeumont-Mauviel%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520development%2520of%2520simeprevir%2520%2528TMC435%2529%252C%2520a%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1673%26epage%3D1693%26doi%3D10.1021%2Fjm401507s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, M.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. N.</span></span> <span> </span><span class="NLM_article-title">Overcoming the unfavourable entropic contribution of ligand binding with a macrocyclic inhibitor bound to penicillopepsin</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>436</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1007/978-1-4615-5373-1_50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1007%2F978-1-4615-5373-1_50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=9561242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFKnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=1998&pages=355-359&author=M.%0AE.+Fraserauthor=J.+H.+Meyerauthor=P.+A.+Bartlettauthor=M.+N.+James&title=Overcoming+the+unfavourable+entropic+contribution+of+ligand+binding+with+a+macrocyclic+inhibitor+bound+to+penicillopepsin&doi=10.1007%2F978-1-4615-5373-1_50"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming the unfavorable entropic contribution of ligand binding with a macrocyclic inhibitor bound to penicillopepsin</span></div><div class="casAuthors">Fraser, Marie F.; Meyer, J. Hoyt; Bartlett, Paul A.; James, Michael N. G.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">Aspartic Proteinases</span>),
    <span class="NLM_cas:pages">355-359</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">One way to improve the binding of a ligand to its protein receptor is by forcing the unbound ligand to adopt the same conformation as it has when bound to the receptor.  The conformational constraint then reduces the entropic disadvantage of ordered binding to the protein.  The constraint should change the structure of the ligand as little as possible, so as to retain the favorable enthalpic interactions of the ligand with the receptor.  Including a ring structure in the design of a ligand can reduce its conformational flexibility and it may be possible to introduce the ring without changing how the ligand binds to the receptor.  A macrocyclic inhibitor of penicillopepsin, as well as two acyclic analogs, were synthesized.  Availability of the macrocyclic inhibitor and the acyclic analogs make it possible to evaluate the entropic effect of the cyclization, provided that they bind to penicillopepsin in the same manner.  Enzyme inhibition by the various inhibitors was evaluated, and the crystal structure of the macrocyclic inhibitor co-crystd. with penicillopepsin was detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqywUc6QyslELVg90H21EOLACvtfcHk0lhl5BBfIZtGvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFKnsrY%253D&md5=7d64b9744103afdb02bb131109050bfe</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2F978-1-4615-5373-1_50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4615-5373-1_50%26sid%3Dliteratum%253Aachs%26aulast%3DFraser%26aufirst%3DM.%2BE.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DBartlett%26aufirst%3DP.%2BA.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DOvercoming%2520the%2520unfavourable%2520entropic%2520contribution%2520of%2520ligand%2520binding%2520with%2520a%2520macrocyclic%2520inhibitor%2520bound%2520to%2520penicillopepsin%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1998%26volume%3D436%26spage%3D355%26epage%3D359%26doi%3D10.1007%2F978-1-4615-5373-1_50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tyndall, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Proteases universally recognize beta strands in their active sites</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">973</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1021/cr040669e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr040669e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=973-999&author=J.+D.+Tyndallauthor=T.+Nallauthor=D.+P.+Fairlie&title=Proteases+universally+recognize+beta+strands+in+their+active+sites&doi=10.1021%2Fcr040669e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases universally recognize beta strands in their active sites</span></div><div class="casAuthors">Tyndall, Joel D. A.; Nall, Tessa; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">973-999</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Proteases account for a significant proportion (∼2%) of the human genome with >550 defined members and a further ∼100 predicted human proteases.  Proteases also represent 1-5% of the genomes of infectious organisms such as bacteria, parasites, and viruses.  They are categorized by the nature of their active site catalytic residue(s) as metallo (34%), serine (30%), cysteine (26%), aspartic (4%), and the less characterized threonine (5%).  Mammalian proteases, of which ∼20% are membrane-bound, are aberrantly expressed or underregulated during many disease conditions, suggesting that inhibitors of specific proteases might be able to control irregular mammalian physiol.  Alternatively, since there are now >50 human proteases where one or more genetic mutations have been found to lead to hereditary diseases, gene therapy may be a useful approach when it eventually becomes technol. feasible.  The goal of protease inhibitor design is to develop potent inhibitors of the offending or mammalian protease but with accompanying selectivity to avoid inhibiting very similar host proteases required for normal host physiol.  This review summarizes an anal. of >1500 3-dimensional crystal (x-ray) and soln. (NMR) structures from the Protein Data Bank of substrates, products, and inhibitors bound in the active sites of all 5 protease classes.  Most of the active sites, with few exceptions, have been found to recognize peptidic and non-peptidic ligands in an extended β-strand conformation.  Such conformational selection of ligands explains the resistance of folded/structured regions of proteins to proteolytic degrdn., the susceptibility of denatured proteins to processing, and the higher affinity of conformationally constrained 'extended' inhibitors/substrates for proteases.  On the basis of the results presented by the authors, one would predict that the use of various approaches to fix an extended β-strand ligand conformation should produce high-affinity inhibitors even for proteases of unknown structure, provided that the substrate specificity and protease type is known.  This inference should be extremely valuable, particularly when the structure of a protease is not known and inhibitor design has to be based solely on substrate preferences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uFIrmHewBrVg90H21EOLACvtfcHk0libx-GLJorkhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D&md5=67da540a9c260f7c80d9a2f7128dfc15</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcr040669e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040669e%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%26aulast%3DNall%26aufirst%3DT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DProteases%2520universally%2520recognize%2520beta%2520strands%2520in%2520their%2520active%2520sites%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D973%26epage%3D999%26doi%3D10.1021%2Fcr040669e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.drudis.2015.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=26210956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=5-10&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=Small-molecule+kinase+inhibitors%3A+an+analysis+of+FDA-approved+drugs&doi=10.1016%2Fj.drudis.2015.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors (SMKIs), 28 of which are approved by the US Food and Drug Administration (FDA), have been actively pursued as promising targeted therapeutics.  Here, we assess the key structural and physicochem. properties, target selectivity and mechanism of function, and therapeutic indications of these approved inhibitors.  Our anal. showed that >30% of approved SMKIs have a mol. wt. (MW) exceeding 500 and all have a total ring count of between three and five.  The assumption that type II inhibitors tend to be more selective than type I inhibitors has been proved to be unreliable.  Although previous SMKI research was concd. on tyrosine kinase inhibitors for cancer treatment, recent progress indicates diversification of SMKI research in terms of new targets, mechanistic types, and therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZrY68ZOI2xLVg90H21EOLACvtfcHk0libx-GLJorkhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P&md5=228524fa464393053ecbfac19e994929</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%253A%2520an%2520analysis%2520of%2520FDA-approved%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.drudis.2015.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1096/fasebj.9.8.7768349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1096%2Ffasebj.9.8.7768349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=7768349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1ajsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=576-596&author=S.+K.+Hanksauthor=T.+Hunter&title=Protein+kinases+6.+The+eukaryotic+protein+kinase+superfamily%3A+kinase+%28catalytic%29+domain+structure+and+classification&doi=10.1096%2Ffasebj.9.8.7768349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases. 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</span></div><div class="casAuthors">Hanks, Steven K.; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">576-96</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 48 refs.  The eukaryotic protein kinases make up a large superfamily of homologous proteins.  They are related by virtue of their kinase domains (also known as catalytic domains), which consist of ∼250-300 amino acid residues.  The kinase domains that define this group of enzymes contain 12 conserved subdomains that fold into a common catalytic core structure, as revealed by the 3-dimensional structures of several protein-serine kinases.  There are 2 main subdivisions within the superfamily: the protein-serine/threonine kinases and the protein-tyrosine kinases.  A classification scheme can be founded on a kinase domain phylogeny, which reveals families of enzymes that have related substrate specificities and modes of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxv30nsEyVU7Vg90H21EOLACvtfcHk0libx-GLJorkhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1ajsbc%253D&md5=869a3926ba04f288947f80616bdcfb98</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.9.8.7768349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.9.8.7768349%26sid%3Dliteratum%253Aachs%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DProtein%2520kinases%25206.%2520The%2520eukaryotic%2520protein%2520kinase%2520superfamily%253A%2520kinase%2520%2528catalytic%2529%2520domain%2520structure%2520and%2520classification%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26spage%3D576%26epage%3D596%26doi%3D10.1096%2Ffasebj.9.8.7768349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noble, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L. N.</span></span> <span> </span><span class="NLM_article-title">Protein kinase inhibitors: insights into drug design from structure</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1800</span>– <span class="NLM_lpage">1805</span>, <span class="refDoi"> DOI: 10.1126/science.1095920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1126%2Fscience.1095920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15031492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFehurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1800-1805&author=M.+E.+Nobleauthor=J.+A.+Endicottauthor=L.+N.+Johnson&title=Protein+kinase+inhibitors%3A+insights+into+drug+design+from+structure&doi=10.1126%2Fscience.1095920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Kinase Inhibitors: Insights into Drug Design from Structure</span></div><div class="casAuthors">Noble, Martin E. M.; Endicott, Jane A.; Johnson, Louise N.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5665</span>),
    <span class="NLM_cas:pages">1800-1805</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Protein kinases are targets for treatment of a no. of diseases.  This review focuses on kinase inhibitors that are in the clinic or in clin. trials and for which structural information is available.  Structures have informed drug design and have illuminated the mechanism of inhibition.  We review progress with the receptor tyrosine kinases (growth factor receptors EGFR, VEGFR, and FGFR) and nonreceptor tyrosine kinases (Bcr-Abl), where advances have been made with cancer therapeutic agents such as Herceptin and Gleevec.  Among the serine-threonine kinases, p38, Rho-kinase, cyclin-dependent kinases, and Chk1 have been targeted with productive results for inflammation and cancer.  Structures have provided insights into targeting the inactive or active form of the kinase, for targeting the global constellation of residues at the ATP site or less conserved addnl. pockets or single residues, and into targeting noncatalytic domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqtKz7cvN_rVg90H21EOLACvtfcHk0libx-GLJorkhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFehurc%253D&md5=7fd3f60bee46e59307436eeed285d6ae</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscience.1095920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1095920%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26atitle%3DProtein%2520kinase%2520inhibitors%253A%2520insights%2520into%2520drug%2520design%2520from%2520structure%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D1800%26epage%3D1805%26doi%3D10.1126%2Fscience.1095920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1038/nrc2559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors&doi=10.1038%2Fnrc2559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lgrlKeNql3xrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39%26doi%3D10.1038%2Fnrc2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1241</span>, <span class="refDoi"> DOI: 10.1021/cb500129t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500129t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtV2nt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1230-1241&author=Z.+Zhaoauthor=H.+Wuauthor=L.+Wangauthor=Y.+Liuauthor=S.+Knappauthor=Q.+Liuauthor=N.+S.+Gray&title=Exploration+of+type+II+binding+mode%3A+A+privileged+approach+for+kinase+inhibitor+focused+drug+discovery%3F&doi=10.1021%2Fcb500129t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?</span></div><div class="casAuthors">Zhao, Zheng; Wu, Hong; Wang, Li; Liu, Yi; Knapp, Stefan; Liu, Qingsong; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1230-1241</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The ATP site of kinases displays remarkable conformational flexibility when accommodating chem. diverse small mol. inhibitors.  The so-called activation segment, whose conformation controls catalytic activity and access to the substrate binding pocket, can undergo a large conformational change with the active state assuming a 'DFG-in' and an inactive state assuming a 'DFG-out' conformation.  Compds. that preferentially bind to the DFG-out conformation are typically called 'type II' inhibitors in contrast to 'type I' inhibitors that bind to the DFG-in conformation.  This review surveys the large no. of type II inhibitors that have been developed and provides an anal. of their crystallog. detd. binding modes.  Using a small library of type II inhibitors, we demonstrate that more than 200 kinases can be targeted, suggesting that type II inhibitors may not be intrinsically more selective than type I inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jYt6Db3Ap7Vg90H21EOLACvtfcHk0lgrlKeNql3xrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtV2nt7s%253D&md5=95bf185ff7f973eda5a65f4096bfaa82</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fcb500129t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500129t%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DExploration%2520of%2520type%2520II%2520binding%2520mode%253A%2520A%2520privileged%2520approach%2520for%2520kinase%2520inhibitor%2520focused%2520drug%2520discovery%253F%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1230%26epage%3D1241%26doi%3D10.1021%2Fcb500129t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacoby, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wroblowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buyck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefs, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vlijmen, H.</span></span> <span> </span><span class="NLM_article-title">Protocols for the design of kinase-focused compound libraries</span>. <i>Mol. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>, <span class="NLM_elocation-id">e1700119</span> <span class="refDoi"> DOI: 10.1002/minf.201700119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fminf.201700119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=29116686" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&author=E.+Jacobyauthor=B.+Wroblowskiauthor=C.+Buyckauthor=J.+M.+Neefsauthor=C.+Meyerauthor=M.+D.+Cummingsauthor=H.+Van+Vlijmen&title=Protocols+for+the+design+of+kinase-focused+compound+libraries&doi=10.1002%2Fminf.201700119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fminf.201700119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201700119%26sid%3Dliteratum%253Aachs%26aulast%3DJacoby%26aufirst%3DE.%26aulast%3DWroblowski%26aufirst%3DB.%26aulast%3DBuyck%26aufirst%3DC.%26aulast%3DNeefs%26aufirst%3DJ.%2BM.%26aulast%3DMeyer%26aufirst%3DC.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DVan%2BVlijmen%26aufirst%3DH.%26atitle%3DProtocols%2520for%2520the%2520design%2520of%2520kinase-focused%2520compound%2520libraries%26jtitle%3DMol.%2520Inf.%26date%3D2018%26volume%3D37%26doi%3D10.1002%2Fminf.201700119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">William, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasha, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajulu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6). 1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4638</span>– <span class="NLM_lpage">4658</span>, <span class="refDoi"> DOI: 10.1021/jm200326p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200326p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1ent7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4638-4658&author=A.+D.+Williamauthor=A.+C.+Leeauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=E.+Tanauthor=D.+Chenauthor=M.+Williamsauthor=E.+T.+Sunauthor=K.+C.+Gohauthor=W.+C.+Ongauthor=S.+K.+Gohauthor=S.+Hartauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+macrocycle+11-%282-pyrrolidin-1-yl-ethoxy%29-14%2C19-dioxa-5%2C7%2C26-triaza-tetracyclo%5B19.3.1.1%282%2C6%29.+1%288%2C12%29%5Dheptacosa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2C10%2C12%2827%29%2C16%2C21%2C23-decaene+%28SB1518%29%2C+a+potent+Janus+kinase+2%2Ffms-like+tyrosine+kinase-3+%28JAK2%2FFLT3%29+inhibitor+for+the+treatment+of+myelofibrosis+and+lymphoma&doi=10.1021%2Fjm200326p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma</span></div><div class="casAuthors">William, Anthony D.; Lee, Angeline C.-H.; Blanchard, Stephanie; Poulsen, Anders; Teo, Ee Ling; Nagaraj, Harish; Tan, Evelyn; Chen, Dizhong; Williams, Meredith; Sun, Eric T.; Goh, Kee Chuan; Ong, Wai Chung; Goh, Siok Kun; Hart, Stefan; Jayaraman, Ramesh; Pasha, Mohammed Khalid; Ethirajulu, Kantharaj; Wood, Jeanette M.; Dymock, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4638-4658</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Discovery of the activating mutation V617F in Janus Kinase 2 (JAK2V617F), a tyrosine kinase critically involved in receptor signaling, recently ignited interest in JAK2 inhibitor therapy as a treatment for myelofibrosis (MF).  Herein, we describe the design and synthesis of a series of small mol. 4-aryl-2-aminopyrimidine macrocycles and their biol. evaluation against the JAK family of kinase enzymes and FLT3.  The most promising leads were assessed for their in vitro ADME properties culminating in the discovery of I, a potent JAK2 (IC50 = 23 and 19 nM for JAK2WT and JAK2V617F, resp.) and FLT3 (IC50 = 22 nM) inhibitor with selectivity against JAK1 and JAK3 (IC50 = 1280 and 520 nM, resp.).  Further profiling of I in preclin. species and mouse xenograft and allograft models is described.  Compd. I (SB1518) was selected as a development candidate and progressed into clin. trials where it is currently in phase 2 for MF and lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXtMiC4eaIMLVg90H21EOLACvtfcHk0lgp1sgBLsBFCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1ent7c%253D&md5=1fa1a5250cae6ec8c59db67e593fb1f6</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm200326p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200326p%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%2BC.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DOng%26aufirst%3DW.%2BC.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520macrocycle%252011-%25282-pyrrolidin-1-yl-ethoxy%2529-14%252C19-dioxa-5%252C7%252C26-triaza-tetracyclo%255B19.3.1.1%25282%252C6%2529.%25201%25288%252C12%2529%255Dheptacosa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252C10%252C12%252827%2529%252C16%252C21%252C23-decaene%2520%2528SB1518%2529%252C%2520a%2520potent%2520Janus%2520kinase%25202%252Ffms-like%2520tyrosine%2520kinase-3%2520%2528JAK2%252FFLT3%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520myelofibrosis%2520and%2520lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4638%26epage%3D4658%26doi%3D10.1021%2Fjm200326p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">William, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasha, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajulu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptaco sa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a potent inhibitor of cyclin dependent kinases (CDKs), Janus kinase 2 (JAK2), and fms-like tyrosine kinase-3 (FLT3) for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1021/jm201112g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201112g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=169-196&author=A.+D.+Williamauthor=A.+C.+Leeauthor=K.+C.+Gohauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=C.+P.+Leeauthor=H.+Wangauthor=M.+Williamsauthor=E.+T.+Sunauthor=C.+Huauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+kinase+spectrum+selective+macrocycle+%2816E%29-14-methyl-20-oxa-5%2C7%2C14%2C26-tetraazatetracyclo%5B19.3.1.1%282%2C6%29.1%288%2C12%29%5Dheptaco+sa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2827%29%2C9%2C11%2C16%2C21%2C23-decaene+%28SB1317%2FTG02%29%2C+a+potent+inhibitor+of+cyclin+dependent+kinases+%28CDKs%29%2C+Janus+kinase+2+%28JAK2%29%2C+and+fms-like+tyrosine+kinase-3+%28FLT3%29+for+the+treatment+of+cancer&doi=10.1021%2Fjm201112g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Kinase Spectrum Selective Macrocycle (16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a Potent Inhibitor of Cyclin Dependent Kinases (CDKs), Janus Kinase 2 (JAK2), and Fms-like Tyrosine Kinase-3 (FLT3) for the Treatment of Cancer</span></div><div class="casAuthors">William, Anthony D.; Lee, Angeline C.-H.; Goh, Kee Chuan; Blanchard, Stephanie; Poulsen, Anders; Teo, Ee Ling; Nagaraj, Harish; Lee, Chai Ping; Wang, Haishan; Williams, Meredith; Sun, Eric T.; Hu, Changyong; Jayaraman, Ramesh; Pasha, Mohammed Khalid; Ethirajulu, Kantharaj; Wood, Jeanette M.; Dymock, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we describe the design, synthesis, and SAR of a series of unique small mol. macrocycles that show spectrum selective kinase inhibition of CDKs, JAK2, and FLT3.  The most promising leads were assessed in vitro for their inhibition of cancer cell proliferation, soly., CYP450 inhibition, and microsomal stability.  This screening cascade revealed 26h (I) as a preferred compd. with target IC50 of 13, 73, and 56 nM for CDK2, JAK2 and FLT3, resp.  Pharmacokinetic (PK) studies of 26h in preclin. species showed good oral exposures.  Oral efficacy was obsd. in colon (HCT-116) and lymphoma (Ramos) xenograft studies, in line with the obsd. PK/PD correlation.  26H (SB1317/TG02) was progressed into development in 2010 and is currently undergoing phase 1 clin. trials in advanced leukemias and multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMvOv-_pFzbVg90H21EOLACvtfcHk0lgp1sgBLsBFCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylur7P&md5=50affe14bd28594735131d6b5841502a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm201112g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201112g%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%2BC.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DC.%2BP.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520kinase%2520spectrum%2520selective%2520macrocycle%2520%252816E%2529-14-methyl-20-oxa-5%252C7%252C14%252C26-tetraazatetracyclo%255B19.3.1.1%25282%252C6%2529.1%25288%252C12%2529%255Dheptaco%2520sa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252827%2529%252C9%252C11%252C16%252C21%252C23-decaene%2520%2528SB1317%252FTG02%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520cyclin%2520dependent%2520kinases%2520%2528CDKs%2529%252C%2520Janus%2520kinase%25202%2520%2528JAK2%2529%252C%2520and%2520fms-like%2520tyrosine%2520kinase-3%2520%2528FLT3%2529%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D169%26epage%3D196%26doi%3D10.1021%2Fjm201112g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deal, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(m etheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4720</span>– <span class="NLM_lpage">4744</span>, <span class="refDoi"> DOI: 10.1021/jm500261q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.+L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28m+etheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5D-benzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+macrocyclic+inhibitor+of+anaplastic+lymphoma+kinase+%28ALK%29+and+c-ros+oncogene+1+%28ROS1%29+with+preclinical+brain+exposure+and+broad-spectrum+potency+against+ALK-resistant+mutations&doi=10.1021%2Fjm500261q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations</span></div><div class="casAuthors">Johnson, Ted W.; Richardson, Paul F.; Bailey, Simon; Brooun, Alexei; Burke, Benjamin J.; Collins, Michael R.; Cui, J. Jean; Deal, Judith G.; Deng, Ya-Li; Dinh, Dac; Engstrom, Lars D.; He, Mingying; Hoffman, Jacqui; Hoffman, Robert L.; Huang, Qinhua; Kania, Robert S.; Kath, John C.; Lam, Hieu; Lam, Justine L.; Le, Phuong T.; Lingardo, Laura; Liu, Wei; McTigue, Michele; Palmer, Cynthia L.; Sach, Neal W.; Smeal, Tod; Smith, Graham L.; Stewart, Albert E.; Timofeevski, Sergei; Zhu, Huichun; Zhu, Jinjiang; Zou, Helen Y.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4720-4744</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-pos. non-small-cell lung carcinoma patients, progression during treatment eventually develops.  Resistant patient samples revealed a variety of point mutations in the kinase domain of ALK, including the L1196M gatekeeper mutation.  In addn., some patients progress due to cancer metastasis in the brain.  Using structure-based drug design, lipophilic efficiency, and phys.-property-based optimization, highly potent macrocyclic ALK inhibitors were prepd. with good absorption, distribution, metab., and excretion (ADME), low propensity for p-glycoprotein 1-mediated efflux, and good passive permeability.  These structurally unusual macrocyclic inhibitors were potent against wild-type ALK and clin. reported ALK kinase domain mutations.  Significant synthetic challenges were overcome, utilizing novel transformations to enable the use of these macrocycles in drug discovery paradigms.  This work led to the discovery of 8k (PF-06463922), combining broad-spectrum potency, central nervous system ADME, and a high degree of kinase selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqXkb49ad31bVg90H21EOLACvtfcHk0lgp1sgBLsBFCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSgtL4%253D&md5=db21844f8e9a2f9ca5953bca56ad7b1c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528m%2520etheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520macrocyclic%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520and%2520c-ros%2520oncogene%25201%2520%2528ROS1%2529%2520with%2520preclinical%2520brain%2520exposure%2520and%2520broad-spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4720%26epage%3D4744%26doi%3D10.1021%2Fjm500261q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappin, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affolter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charest, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span> <span> </span><span class="NLM_article-title">PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">3493</span>– <span class="NLM_lpage">3498</span>, <span class="refDoi"> DOI: 10.1073/pnas.1420785112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1073%2Fpnas.1420785112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=25733882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Grur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=3493-3498&author=H.+Y.+Zouauthor=Q.+Liauthor=L.+D.+Engstromauthor=M.+Westauthor=V.+Applemanauthor=K.+A.+Wongauthor=M.+McTigueauthor=Y.+L.+Dengauthor=W.+Liuauthor=A.+Broounauthor=S.+Timofeevskiauthor=S.+R.+McDonnellauthor=P.+Jiangauthor=M.+D.+Falkauthor=P.+B.+Lappinauthor=T.+Affolterauthor=T.+Nicholsauthor=W.+Huauthor=J.+Lamauthor=T.+W.+Johnsonauthor=T.+Smealauthor=A.+Charestauthor=V.+R.+Fantin&title=PF-06463922+is+a+potent+and+selective+next-generation+ROS1%2FALK+inhibitor+capable+of+blocking+crizotinib-resistant+ROS1+mutations&doi=10.1073%2Fpnas.1420785112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Engstrom, Lars D.; West, Melissa; Appleman, Vicky; Wong, Katy A.; McTigue, Michele; Deng, Ya-Li; Liu, Wei; Brooun, Alexei; Timofeevski, Sergei; McDonnell, Scott R. P.; Jiang, Ping; Falk, Matthew D.; Lappin, Patrick B.; Affolter, Timothy; Nichols, Tim; Hu, Wenyue; Lam, Justine; Johnson, Ted W.; Smeal, Tod; Charest, Al; Fantin, Valeria R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3493-3498</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Oncogenic c-ros oncogene 1 (ROS1) fusion kinases have been identified in a variety of human cancers and are attractive targets for cancer therapy.  The MET/ALK/ROS1 inhibitor crizotinib (Xalkori, PF-02341066) has demonstrated promising clin. activity in ROS1 fusion-pos. non-small cell lung cancer.  However, emerging clin. evidence has shown that patients can develop resistance by acquiring secondary point mutations in ROS1 kinase.  In this study the authors characterized the ROS1 activity of PF-06463922, a novel, orally available, CNS-penetrant, ATP-competitive small-mol. inhibitor of ALK/ROS1.  In vitro, PF-06463922 exhibited subnanomolar cellular potency against oncogenic ROS1 fusions and inhibited the crizotinib-refractory ROS1G2032R mutation and the ROS1G2026M gatekeeper mutation.  Compared with crizotinib and the second-generation ALK/ROS1 inhibitors ceritinib and alectinib, PF-06463922 showed significantly improved inhibitory activity against ROS1 kinase.  A crystal structure of the PF-06463922-ROS1 kinase complex revealed favorable interactions contributing to the high-affinity binding.  In vivo, PF-06463922 showed marked antitumor activity in tumor models expressing FIG-ROS1, CD74-ROS1, and the CD74-ROS1G2032R mutation.  Furthermore, PF-06463922 demonstrated antitumor activity in a genetically engineered mouse model of FIG-ROS1 glioblastoma.  Taken together, the authors' results indicate that PF-06463922 has potential for treating ROS1 fusion-pos. cancers, including those requiring agents with CNS-penetrating properties, as well as for overcoming crizotinib resistance driven by ROS1 mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5t2o5BKPhK7Vg90H21EOLACvtfcHk0lhWuc9zhbagOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Grur8%253D&md5=8f549572dfac12c74b88705d57979c09</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1420785112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1420785112%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DWest%26aufirst%3DM.%26aulast%3DAppleman%26aufirst%3DV.%26aulast%3DWong%26aufirst%3DK.%2BA.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DFalk%26aufirst%3DM.%2BD.%26aulast%3DLappin%26aufirst%3DP.%2BB.%26aulast%3DAffolter%26aufirst%3DT.%26aulast%3DNichols%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DLam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DCharest%26aufirst%3DA.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26atitle%3DPF-06463922%2520is%2520a%2520potent%2520and%2520selective%2520next-generation%2520ROS1%252FALK%2520inhibitor%2520capable%2520of%2520blocking%2520crizotinib-resistant%2520ROS1%2520mutations%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D3493%26epage%3D3498%26doi%3D10.1073%2Fpnas.1420785112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><a href="https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm625027.htm" class="extLink">https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm625027.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.fda.gov%2FDrugs%2FInformationOnDrugs%2FApprovedDrugs%2Fucm625027.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feil, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froning, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Dieckmann, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nienaber, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noland, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajashankar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burley, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, S. G.</span></span> <span> </span><span class="NLM_article-title">A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">55827</span>– <span class="NLM_lpage">55832</span>, <span class="refDoi"> DOI: 10.1074/jbc.M409792200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1074%2Fjbc.M409792200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15507431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeisL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=55827-55832&author=S.+Atwellauthor=J.+M.+Adamsauthor=J.+Badgerauthor=M.+D.+Buchananauthor=I.+K.+Feilauthor=K.+J.+Froningauthor=X.+Gaoauthor=J.+Hendleauthor=K.+Keeganauthor=B.+C.+Leonauthor=H.+J.+Muller-Dieckmannauthor=V.+L.+Nienaberauthor=B.+W.+Nolandauthor=K.+Postauthor=K.+R.+Rajashankarauthor=A.+Ramosauthor=M.+Russellauthor=S.+K.+Burleyauthor=S.+G.+Buchanan&title=A+novel+mode+of+Gleevec+binding+is+revealed+by+the+structure+of+spleen+tyrosine+kinase&doi=10.1074%2Fjbc.M409792200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase</span></div><div class="casAuthors">Atwell, Shane; Adams, Jason M.; Badger, John; Buchanan, Michelle D.; Feil, Ingeborg K.; Froning, Karen J.; Gao, Xia; Hendle, Joerg; Keegan, Kevin; Leon, Barbara C.; Mueller-Dieckmann, Hans J.; Nienaber, Vicki L.; Noland, Brian W.; Post, Kai; Rajashankar, K. R.; Ramos, Aurora; Russell, Marijane; Burley, Stephen K.; Buchanan, Sean G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">55827-55832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a non-receptor tyrosine kinase required for signaling from immunoreceptors in various hematopoietic cells.  Phosphorylation of two tyrosine residues in the activation loop of the Syk kinase catalytic domain is necessary for signaling, a phenomenon typical of tyrosine kinase family members.  Syk in vitro enzyme activity, however, does not depend on phosphorylation (activation loop tyrosine phenylalanine mutants retain catalytic activity).  We have detd. the x-ray structure of the unphosphorylated form of the kinase catalytic domain of Syk.  The enzyme adopts a conformation of the activation loop typically seen only in activated, phosphorylated tyrosine kinases, explaining why Syk does not require phosphorylation for activation.  We also demonstrate that Gleevec (STI-571, Imatinib) inhibits the isolated kinase domains of both unphosphorylated Syk and phosphorylated Abl with comparable potency.  Gleevec binds Syk in a novel, compact cis-conformation that differs dramatically from the binding mode obsd. with unphosphorylated Abl, the more Gleevec-sensitive form of Abl.  This finding suggests the existence of two distinct Gleevec binding modes: an extended, trans-conformation characteristic of tight binding to the inactive conformation of a protein kinase and a second compact, cis-conformation characteristic of weaker binding to the active conformation.  Finally, the Syk-bound cis-conformation of Gleevec bears a striking resemblance to the rigid structure of the nonspecific, natural product kinase inhibitor staurosporine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7D3dM-QQRHLVg90H21EOLACvtfcHk0lhWuc9zhbagOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeisL7N&md5=b55eefe8790607cb5c8ae7be8795a83b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409792200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409792200%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBadger%26aufirst%3DJ.%26aulast%3DBuchanan%26aufirst%3DM.%2BD.%26aulast%3DFeil%26aufirst%3DI.%2BK.%26aulast%3DFroning%26aufirst%3DK.%2BJ.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHendle%26aufirst%3DJ.%26aulast%3DKeegan%26aufirst%3DK.%26aulast%3DLeon%26aufirst%3DB.%2BC.%26aulast%3DMuller-Dieckmann%26aufirst%3DH.%2BJ.%26aulast%3DNienaber%26aufirst%3DV.%2BL.%26aulast%3DNoland%26aufirst%3DB.%2BW.%26aulast%3DPost%26aufirst%3DK.%26aulast%3DRajashankar%26aufirst%3DK.%2BR.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26atitle%3DA%2520novel%2520mode%2520of%2520Gleevec%2520binding%2520is%2520revealed%2520by%2520the%2520structure%2520of%2520spleen%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D55827%26epage%3D55832%26doi%3D10.1074%2Fjbc.M409792200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inesta-Vaquera, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niepel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughlin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomanbhoy, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorger, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective covalent inhibitors of JNK</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.chembiol.2011.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=22284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=140-154&author=T.+Zhangauthor=F.+Inesta-Vaqueraauthor=M.+Niepelauthor=J.+Zhangauthor=S.+B.+Ficarroauthor=T.+Machleidtauthor=T.+Xieauthor=J.+A.+Martoauthor=N.+Kimauthor=T.+Simauthor=J.+D.+Laughlinauthor=H.+Parkauthor=P.+V.+LoGrassoauthor=M.+Patricelliauthor=T.+K.+Nomanbhoyauthor=P.+K.+Sorgerauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Discovery+of+potent+and+selective+covalent+inhibitors+of+JNK&doi=10.1016%2Fj.chembiol.2011.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Covalent Inhibitors of JNK</span></div><div class="casAuthors">Zhang, Tinghu; Inesta-Vaquera, Francisco; Niepel, Mario; Zhang, Jianming; Ficarro, Scott B.; Machleidt, Thomas; Xie, Ting; Marto, Jarrod A.; Kim, Nam Doo; Sim, Taebo; Laughlin, John D.; Park, Hajeung; LoGrasso, Philip V.; Patricelli, Matt; Nomanbhoy, Tyzoon K.; Sorger, Peter K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-154</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response.  Here, we report the discovery of irreversible inhibitors of JNK1/2/3.  We describe two JNK3 cocrystal structures at 2.60 and 2.97 Å resoln. that show the compds. form covalent bonds with a conserved cysteine residue.  JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue.  Extensive biochem., cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compd. will be broadly useful as a pharmacol. probe of JNK-dependent signal transduction.  Potential lead compds. have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXs0FY7FSmt7Vg90H21EOLACvtfcHk0lgFR0htw_qDMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D&md5=f7d9647fb2be162c637b1d31a778ceb4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DInesta-Vaquera%26aufirst%3DF.%26aulast%3DNiepel%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DLaughlin%26aufirst%3DJ.%2BD.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DPatricelli%26aufirst%3DM.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520covalent%2520inhibitors%2520of%2520JNK%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D140%26epage%3D154%26doi%3D10.1016%2Fj.chembiol.2011.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amssoms, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Last, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devogelaere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijgen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berke, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehertogh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleiren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der
Helm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyanguile, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Remoortere, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span> <span> </span><span class="NLM_article-title">Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1880</span>– <span class="NLM_lpage">1892</span>, <span class="refDoi"> DOI: 10.1021/jm401396p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401396p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1880-1892&author=M.+D.+Cummingsauthor=T.+I.+Linauthor=L.+Huauthor=A.+Tahriauthor=D.+McGowanauthor=K.+Amssomsauthor=S.+Lastauthor=B.+Devogelaereauthor=M.+C.+Rouanauthor=L.+Vijgenauthor=J.+M.+Berkeauthor=P.+Dehertoghauthor=E.+Fransenauthor=E.+Cleirenauthor=L.+Van+Der%0AHelmauthor=G.+Fanningauthor=O.+Nyanguileauthor=K.+Simmenauthor=P.+Van+Remoortereauthor=P.+Raboissonauthor=S.+Vendeville&title=Discovery+and+early+development+of+TMC647055%2C+a+non-nucleoside+inhibitor+of+the+hepatitis+C+virus+NS5B+polymerase&doi=10.1021%2Fjm401396p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Early Development of TMC647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase</span></div><div class="casAuthors">Cummings, Maxwell D.; Lin, Tse-I.; Hu, Lili; Tahri, Abdellah; McGowan, David; Amssoms, Katie; Last, Stefaan; Devogelaere, Benoit; Rouan, Marie-Claude; Vijgen, Leen; Berke, Jan Martin; Dehertogh, Pascale; Fransen, Els; Cleiren, Erna; van der Helm, Liesbet; Fanning, Gregory; Nyanguile, Origene; Simmen, Kenny; Van Remoortere, Pieter; Raboisson, Pierre; Vendeville, Sandrine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1880-1892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based macrocyclization of a 6-carboxylic acid indole chemotype has yielded potent and selective finger-loop inhibitors of the hepatitis C virus (HCV) NS5B polymerase.  Lead optimization in conjunction with in vivo evaluation in rats identified several compds. showing (i) nanomolar potency in HCV replicon cells, (ii) limited toxicity and off-target activities, and (iii) encouraging preclin. pharmacokinetic profiles characterized by high liver distribution.  This effort culminated in the identification of TMC647055 (I), a nonzwitterionic 17-membered-ring macrocycle characterized by high affinity, long polymerase residence time, and broad genotypic coverage.  In vitro results of the combination of I with the HCV protease inhibitor TMC435 (simeprevir) supported an evaluation of this combination in patients with regard to virus suppression and resistance emergence.  In a phase 1b trial with HCV genotype 1-infected patients, I was considered to be safe and well-tolerated and demonstrated potent antiviral activity, which was further enhanced in a combination study with TMC435.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFfQhbJ5iLObVg90H21EOLACvtfcHk0lgFR0htw_qDMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktLnJ&md5=2b41cdc2df2fde1d8462e2d3a97033ab</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm401396p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401396p%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DAmssoms%26aufirst%3DK.%26aulast%3DLast%26aufirst%3DS.%26aulast%3DDevogelaere%26aufirst%3DB.%26aulast%3DRouan%26aufirst%3DM.%2BC.%26aulast%3DVijgen%26aufirst%3DL.%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26aulast%3DDehertogh%26aufirst%3DP.%26aulast%3DFransen%26aufirst%3DE.%26aulast%3DCleiren%26aufirst%3DE.%26aulast%3DVan%2BDer%2BHelm%26aufirst%3DL.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DNyanguile%26aufirst%3DO.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DVan%2BRemoortere%26aufirst%3DP.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DVendeville%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520early%2520development%2520of%2520TMC647055%252C%2520a%2520non-nucleoside%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1880%26epage%3D1892%26doi%3D10.1021%2Fjm401396p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="note"><p class="first last">Clinical development of this compound was suspended for business-related reasons.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Marco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Francesco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliaccio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carfi, A.</span></span> <span> </span><span class="NLM_article-title">Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">29765</span>– <span class="NLM_lpage">29770</span>, <span class="refDoi"> DOI: 10.1074/jbc.M505423200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1074%2Fjbc.M505423200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15955819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1Sltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=29765-29770&author=S.+Di%0AMarcoauthor=C.+Volpariauthor=L.+Tomeiauthor=S.+Altamuraauthor=S.+Harperauthor=F.+Narjesauthor=U.+Kochauthor=M.+Rowleyauthor=R.+De+Francescoauthor=G.+Migliaccioauthor=A.+Carfi&title=Interdomain+communication+in+hepatitis+C+virus+polymerase+abolished+by+small+molecule+inhibitors+bound+to+a+novel+allosteric+site&doi=10.1074%2Fjbc.M505423200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site</span></div><div class="casAuthors">Di Marco, Stefania; Volpari, Cinzia; Tomei, Licia; Altamura, Sergio; Harper, Steven; Narjes, Frank; Koch, Uwe; Rowley, Michael; De Francesco, Raffaele; Migliaccio, Giovanni; Carfi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">29765-29770</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase is required for replication of the viral genome and is a key target for therapeutic intervention against HCV.  We have detd. the crystal structures of the HCV polymerase complexed with two indole-based allosteric inhibitors at 2.3- and 2.4-Å resoln.  The structures show that these inhibitors bind to a site on the surface of the thumb domain.  A cyclohexyl and Ph ring substituents, bridged by an indole moiety, fill two closely spaced pockets, whereas a carboxylate substituent forms a salt bridge with an exposed arginine side chain.  Interestingly, in the apoenzyme, the inhibitor binding site is occupied by a small α-helix at the tip of the N-terminal loop that connects the fingers and thumb domains.  Thus, these mols. inhibit the enzyme by preventing formation of intramol. contacts between these two domains and consequently precluding their coordinated movements during RNA synthesis.  Our structures identify a novel mechanism by which a new class of allosteric inhibitors inhibits the HCV polymerase and open the way to the development of novel antiviral agents against this clin. relevant human pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHS1-2Y1C8LVg90H21EOLACvtfcHk0lhZSsAxob8J3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1Sltr0%253D&md5=1192532b3624ec0032d9dff24c19a704</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M505423200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M505423200%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DCarfi%26aufirst%3DA.%26atitle%3DInterdomain%2520communication%2520in%2520hepatitis%2520C%2520virus%2520polymerase%2520abolished%2520by%2520small%2520molecule%2520inhibitors%2520bound%2520to%2520a%2520novel%2520allosteric%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D29765%26epage%3D29770%26doi%3D10.1074%2Fjbc.M505423200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikegashira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6950</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1021/jm0610245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0610245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6950-6953&author=K.+Ikegashiraauthor=T.+Okaauthor=S.+Hirashimaauthor=S.+Nojiauthor=H.+Yamanakaauthor=Y.+Haraauthor=T.+Adachiauthor=J.+Tsuruhaauthor=S.+Doiauthor=Y.+Haseauthor=T.+Noguchiauthor=I.+Andoauthor=N.+Oguraauthor=S.+Ikedaauthor=H.+Hashimoto&title=Discovery+of+conformationally+constrained+tetracyclic+compounds+as+potent+hepatitis+C+virus+NS5B+RNA+polymerase+inhibitors&doi=10.1021%2Fjm0610245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</span></div><div class="casAuthors">Ikegashira, Kazutaka; Oka, Takahiro; Hirashima, Shintaro; Noji, Satoru; Yamanaka, Hiroshi; Hara, Yoshinori; Adachi, Tsuyoshi; Tsuruha, Jun-Ichiro; Doi, Satoki; Hase, Yasunori; Noguchi, Toru; Ando, Izuru; Ogura, Naoki; Ikeda, Satoru; Hashimoto, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6950-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a new series of hepatitis C virus NS5B RNA polymerase inhibitors contg. a conformationally constrained tetracyclic scaffold.  SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (I and II) bearing a basic pendent group with high biochem. and cellular potencies.  These compds. displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF0S142h4FZLVg90H21EOLACvtfcHk0lhZSsAxob8J3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF&md5=18234c5535779cf60484899c6e63770f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm0610245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610245%26sid%3Dliteratum%253Aachs%26aulast%3DIkegashira%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DY.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DTsuruha%26aufirst%3DJ.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DOgura%26aufirst%3DN.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520conformationally%2520constrained%2520tetracyclic%2520compounds%2520as%2520potent%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA%2520polymerase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6950%26epage%3D6953%26doi%3D10.1021%2Fjm0610245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="note"><p class="first last">The nature of the macrocycle linker was shown to have profound effects on oral bioavailability, clearance, liver microsomal stability, liver/plasma partitioning, and total liver accumulation. These results are discussed in detail in ref <a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and references therein.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="note"><p class="first last">TMC647055 progressed into phase 2 clinical trials. Development was discontinued for strategic reasons.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corte, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozarth, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiffert, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decicco, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, M. L.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of macrocyclic factor XIa inhibitors: discovery of the macrocyclic amide linker</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1075</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01460</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01460" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1060-1075&author=J.+R.+Corteauthor=T.+Fangauthor=H.+Osunaauthor=D.+J.+Pintoauthor=K.+A.+Rossiauthor=J.+E.+Myersauthor=S.+Sheriffauthor=Z.+Louauthor=J.+J.+Zhengauthor=T.+W.+Harperauthor=J.+M.+Bozarthauthor=Y.+Wuauthor=J.+M.+Luettgenauthor=D.+A.+Seiffertauthor=C.+P.+Deciccoauthor=R.+R.+Wexlerauthor=M.+L.+Quan&title=Structure-based+design+of+macrocyclic+factor+XIa+inhibitors%3A+discovery+of+the+macrocyclic+amide+linker&doi=10.1021%2Facs.jmedchem.6b01460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker</span></div><div class="casAuthors">Corte, James R.; Fang, Tianan; Osuna, Honey; Pinto, Donald J. P.; Rossi, Karen A.; Myers, Joseph E.; Sheriff, Steven; Lou, Zhen; Zheng, Joanna J.; Harper, Timothy W.; Bozarth, Jeffrey M.; Wu, Yiming; Luettgen, Joseph M.; Seiffert, Dietmar A.; Decicco, Carl P.; Wexler, Ruth R.; Quan, Mimi L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1060-1075</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of macrocyclic FXIa inhibitors was designed based on our lead acyclic Ph imidazole chemotype.  Our initial macrocycles, which were double-digit nanomolar FXIa inhibitors, were further optimized with assistance from utilization of structure-based drug design and ligand bound X-ray crystal structures.  This effort resulted in the discovery of a macrocyclic amide linker which was found to form a key hydrogen bond with the carbonyl of Leu41 in the FXIa active site, resulting in potent FXIa inhibitors.  The macrocyclic FXIa series, exemplified by compd. 16, had a FXIa Ki = 0.16 nM with potent anticoagulant activity in an in vitro clotting assay (aPTT EC1.5x = 0.27 μM) and excellent selectivity against the relevant blood coagulation enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSUGpFskDtZLVg90H21EOLACvtfcHk0liy_FRfgpVpxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKisrk%253D&md5=82f615b27494ac96c0ba3ce0e40f010b</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01460%26sid%3Dliteratum%253Aachs%26aulast%3DCorte%26aufirst%3DJ.%2BR.%26aulast%3DFang%26aufirst%3DT.%26aulast%3DOsuna%26aufirst%3DH.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DMyers%26aufirst%3DJ.%2BE.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26aulast%3DHarper%26aufirst%3DT.%2BW.%26aulast%3DBozarth%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DSeiffert%26aufirst%3DD.%2BA.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26atitle%3DStructure-based%2520design%2520of%2520macrocyclic%2520factor%2520XIa%2520inhibitors%253A%2520discovery%2520of%2520the%2520macrocyclic%2520amide%2520linker%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1060%26epage%3D1075%26doi%3D10.1021%2Facs.jmedchem.6b01460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priestley, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLucca, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of macrocyclic coagulation factor VIIa inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6225</span>– <span class="NLM_lpage">6236</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6225-6236&author=E.+S.+Priestleyauthor=D.+L.+Cheneyauthor=I.+DeLuccaauthor=A.+Weiauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=P.+C.+Wongauthor=R.+R.+Wexler&title=Structure-based+design+of+macrocyclic+coagulation+factor+VIIa+inhibitors&doi=10.1021%2Facs.jmedchem.5b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors</span></div><div class="casAuthors">Priestley, E. Scott; Cheney, Daniel L.; DeLucca, Indawati; Wei, Anzhi; Luettgen, Joseph M.; Rendina, Alan R.; Wong, Pancras C.; Wexler, Ruth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6225-6236</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of a crystal structure of a phenylpyrrolidine lead and subsequent mol. modeling results, we designed and synthesized a novel series of macrocyclic FVIIa inhibitors.  The optimal 16-membered macrocycle was 60-fold more potent than an acyclic analog.  Further potency optimization by incorporation of P1' alkyl sulfone and P2 Me groups provided a macrocycle with TF/FVIIa Ki = 1.6 nM, excellent selectivity against a panel of seven serine proteases, and FVII-deficient prothrombin time EC2x = 1.2 μM.  Discovery of this potent, selective macrocyclic scaffold opens new possibilities for the development of orally bioavailable FVIIa inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIZvUgkobQ3bVg90H21EOLACvtfcHk0liy_FRfgpVpxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb%252FM&md5=881772bfb89d6097de1cfc14f6c7bb8b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DDeLucca%26aufirst%3DI.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DStructure-based%2520design%2520of%2520macrocyclic%2520coagulation%2520factor%2520VIIa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6225%26epage%3D6236%26doi%3D10.1021%2Facs.jmedchem.5b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motwani, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of P1′-functionalized macrocyclic transition-state mimicking HIV-1 protease inhibitors encompassing a tertiary alcohol</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6444</span>– <span class="NLM_lpage">6457</span>, <span class="refDoi"> DOI: 10.1021/jm500434q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500434q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2lsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6444-6457&author=M.+De%0ARosaauthor=J.+Ungeauthor=H.+V.+Motwaniauthor=A.+Rosenquistauthor=L.+Vrangauthor=H.+Wallbergauthor=M.+Larhed&title=Synthesis+of+P1%E2%80%B2-functionalized+macrocyclic+transition-state+mimicking+HIV-1+protease+inhibitors+encompassing+a+tertiary+alcohol&doi=10.1021%2Fjm500434q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of P1'-Functionalized Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol</span></div><div class="casAuthors">De Rosa, Maria; Unge, Johan; Motwani, Hitesh V.; Rosenquist, Aasa; Vrang, Lotta; Wallberg, Hans; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6444-6457</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Seven novel tertiary alc.-contg. linear HIV-1 protease inhibitors (PIs), decorated at the para position of the benzyl group in the P1' side with (hetero)arom. moieties, were synthesized and biol. evaluated.  To study the inhibition and antiviral activity effect of P1-P3 macrocyclization, 14- and 15-membered macrocyclic PIs were prepd. by ring-closing metathesis of the corresponding linear PIs.  The macrocycles were more active than the linear precursors and compd. 10f, with a 2-thiazolyl group in the P1' position, was the most potent PI of this new series (Ki = 2.2 nM, EC50 0.2 μM).  Co-crystd. complexes of both linear and macrocyclic PIs with the HIV-1 protease enzyme were prepd. and analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxGfX47dsVkLVg90H21EOLACvtfcHk0liy_FRfgpVpxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2lsbnM&md5=072cfae220ae6d3355a2c4bc74a4bf3a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm500434q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500434q%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DUnge%26aufirst%3DJ.%26aulast%3DMotwani%26aufirst%3DH.%2BV.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DWallberg%26aufirst%3DH.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520P1%25E2%2580%25B2-functionalized%2520macrocyclic%2520transition-state%2520mimicking%2520HIV-1%2520protease%2520inhibitors%2520encompassing%2520a%2520tertiary%2520alcohol%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6444%26epage%3D6457%26doi%3D10.1021%2Fjm500434q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stachel, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankaranarayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrak, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espeseth, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic inhibitors of beta-secretase: functional activity in an animal model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6147</span>– <span class="NLM_lpage">6150</span>, <span class="refDoi"> DOI: 10.1021/jm060884i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060884i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVymtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6147-6150&author=S.+J.+Stachelauthor=C.+A.+Coburnauthor=S.+Sankaranarayananauthor=E.+A.+Priceauthor=B.+L.+Pietrakauthor=Q.+Huangauthor=J.+Linebergerauthor=A.+S.+Espesethauthor=L.+Jinauthor=J.+Ellisauthor=M.+K.+Hollowayauthor=S.+Munshiauthor=T.+Allisonauthor=D.+Hazudaauthor=A.+J.+Simonauthor=S.+L.+Grahamauthor=J.+P.+Vacca&title=Macrocyclic+inhibitors+of+beta-secretase%3A+functional+activity+in+an+animal+model&doi=10.1021%2Fjm060884i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of β-secretase: functional activity in an animal model</span></div><div class="casAuthors">Stachel, Shawn J.; Coburn, Craig A.; Sankaranarayanan, Sethu; Price, Eric A.; Pietrak, Beth L.; Huang, Qian; Lineberger, Janet; Espeseth, Amy S.; Jin, Lixia; Ellis, Joan; Holloway, M. Katharine; Munshi, Sanjeev; Allison, Timothy; Hazuda, Daria; Simon, Adam J.; Graham, Samuel L.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6147-6150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A macrocyclic inhibitor of β-secretase was designed by covalently crosslinking the P1 and P3 side chains of an isophthalamide-based inhibitor.  Macrocyclization resulted in significantly improved potency and phys. properties when compared to the initial lead structures.  More importantly, these macrocyclic inhibitors also displayed in vivo amyloid lowering when dosed in a murine model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMxrOyVlJE6bVg90H21EOLACvtfcHk0liQ1dTndawrlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVymtbw%253D&md5=68e93484eb2d6e3c1d00b917aac763d8</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm060884i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060884i%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DAllison%26aufirst%3DT.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520beta-secretase%253A%2520functional%2520activity%2520in%2520an%2520animal%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6147%26epage%3D6150%26doi%3D10.1021%2Fjm060884i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoull, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Code, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmitt, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raubo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrazolo[1,5-a]pyrimidine B-cell lymphoma 6 (BCL6) binders and optimization to high affinity macrocyclic inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4386</span>– <span class="NLM_lpage">4402</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFOmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4386-4402&author=W.+McCoullauthor=R.+D.+Abramsauthor=E.+Andersonauthor=K.+Bladesauthor=P.+Bartonauthor=M.+Boxauthor=J.+Burgessauthor=K.+Bythauthor=Q.+Caoauthor=C.+Chuaquiauthor=R.+J.+Carbajoauthor=T.+Cheungauthor=E.+Codeauthor=A.+D.+Fergusonauthor=S.+Filleryauthor=N.+O.+Fullerauthor=E.+Ganglauthor=N.+Gaoauthor=M.+Gristauthor=D.+Hargreavesauthor=M.+R.+Howardauthor=J.+Huauthor=P.+D.+Kemmittauthor=J.+E.+Nelsonauthor=N.+O%E2%80%99Connellauthor=D.+B.+Princeauthor=P.+Rauboauthor=P.+B.+Rawlinsauthor=G.+R.+Robbauthor=J.+Shiauthor=M.+J.+Waringauthor=D.+Whittakerauthor=M.+Wylotauthor=X.+Zhu&title=Discovery+of+pyrazolo%5B1%2C5-a%5Dpyrimidine+B-cell+lymphoma+6+%28BCL6%29+binders+and+optimization+to+high+affinity+macrocyclic+inhibitors&doi=10.1021%2Facs.jmedchem.7b00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors</span></div><div class="casAuthors">McCoull, William; Abrams, Roman D.; Anderson, Erica; Blades, Kevin; Barton, Peter; Box, Matthew; Burgess, Jonathan; Byth, Kate; Cao, Qing; Chuaqui, Claudio; Carbajo, Rodrigo J.; Cheung, Tony; Code, Erin; Ferguson, Andrew D.; Fillery, Shaun; Fuller, Nathan O.; Gangl, Eric; Gao, Ning; Grist, Matthew; Hargreaves, David; Howard, Martin R.; Hu, Jun; Kemmitt, Paul D.; Nelson, Jennifer E.; O'Connell, Nichole; Prince, D. Bryan; Raubo, Piotr; Rawlins, Philip B.; Robb, Graeme R.; Shi, Junjie; Waring, Michael J.; Whittaker, David; Wylot, Marta; Zhu, Xiahui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4386-4402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the protein-protein interaction between B-cell lymphoma 6 (BCL6) and corepressors has been implicated as a therapeutic target in diffuse large B-cell lymphoma (DLBCL) cancers and profiling of potent and selective BCL6 inhibitors are crit. to test this hypothesis.  We identified a pyrazolo[1,5-a]pyrimidine series of BCL6 binders from a fragment screen in parallel with a virtual screen.  Using structure-based drug design, binding affinity was increased 100000-fold.  This involved displacing crystallog. water, forming new ligand-protein interactions and a macrocyclization to favor the bioactive conformation of the ligands.  Optimization for slow off-rate const. kinetics was conducted as well as improving selectivity against an off-target kinase, CK2.  Potency in a cellular BCL6 assay was further optimized to afford highly selective probe mols.  Only weak antiproliferative effects were obsd. across a no. of DLBCL lines and a multiple myeloma cell line without a clear relationship to BCL6 potency.  As a result, we conclude that the BCL6 hypothesis in DLBCL cancer remains unproven.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWp2OlXAZDFLVg90H21EOLACvtfcHk0liQ1dTndawrlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFOmsbo%253D&md5=fc4142453a0580edbf04802e15d4d9aa</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00359%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DAbrams%26aufirst%3DR.%2BD.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBox%26aufirst%3DM.%26aulast%3DBurgess%26aufirst%3DJ.%26aulast%3DByth%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DCarbajo%26aufirst%3DR.%2BJ.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DCode%26aufirst%3DE.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DN.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DM.%2BR.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DNelson%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DN.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DRaubo%26aufirst%3DP.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWylot%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520B-cell%2520lymphoma%25206%2520%2528BCL6%2529%2520binders%2520and%2520optimization%2520to%2520high%2520affinity%2520macrocyclic%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4386%26epage%3D4402%26doi%3D10.1021%2Facs.jmedchem.7b00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Estrada-Ortiz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neochoritis, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twarda-Clapa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musielak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holak, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domling, A.</span></span> <span> </span><span class="NLM_article-title">Artificial macrocycles as potent p53-MDM2 Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1025-1030&author=N.+Estrada-Ortizauthor=C.+G.+Neochoritisauthor=A.+Twarda-Clapaauthor=B.+Musielakauthor=T.+A.+Holakauthor=A.+Domling&title=Artificial+macrocycles+as+potent+p53-MDM2+Inhibitors&doi=10.1021%2Facsmedchemlett.7b00219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Artificial Macrocycles as Potent p53-MDM2 Inhibitors</span></div><div class="casAuthors">Estrada-Ortiz, Natalia; Neochoritis, Constantinos G.; Twarda-Clapa, Aleksandra; Musielak, Bogdan; Holak, Tad A.; Doemling, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on a combination of an Ugi four component reaction and a ring closing metathesis, a library of novel artificial macrocyclic inhibitors of the p53-MDM2 interaction was designed and synthesized.  These macrocycles, alternatively to stapled peptides, target for the first time the large hydrophobic surface area formed by Tyr67, Gln72, His73, Val93, and Lys94 yielding derivs. with affinity to MDM2 in the nanomolar range.  Their binding affinity with MDM2 was evaluated using fluorescence polarization (FP) assay and 1H-15N two-dimensional HSQC NMR expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWgHNqMYuVkrVg90H21EOLACvtfcHk0lhahsISie33hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbrO&md5=ff61cf19c704714d2175a1a760f2867b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00219%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada-Ortiz%26aufirst%3DN.%26aulast%3DNeochoritis%26aufirst%3DC.%2BG.%26aulast%3DTwarda-Clapa%26aufirst%3DA.%26aulast%3DMusielak%26aufirst%3DB.%26aulast%3DHolak%26aufirst%3DT.%2BA.%26aulast%3DDomling%26aufirst%3DA.%26atitle%3DArtificial%2520macrocycles%2520as%2520potent%2520p53-MDM2%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Facsmedchemlett.7b00219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Schoolmeester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgour, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhardt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogg, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selmi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swales, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittamore, P. R.</span></span> <span> </span><span class="NLM_article-title">Novel acidic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10136</span>– <span class="NLM_lpage">10147</span>, <span class="refDoi"> DOI: 10.1021/jm301252n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301252n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10136-10147&author=J.+S.+Scottauthor=J.+De+Schoolmeesterauthor=E.+Kilgourauthor=R.+M.+Mayersauthor=M.+J.+Packerauthor=D.+Hargreavesauthor=S.+Gerhardtauthor=D.+J.+Oggauthor=A.+Reesauthor=N.+Selmiauthor=A.+Stockerauthor=J.+G.+Swalesauthor=P.+R.+Whittamore&title=Novel+acidic+11beta-hydroxysteroid+dehydrogenase+type+1+%2811beta-HSD1%29+inhibitor+with+reduced+acyl+glucuronide+liability%3A+the+discovery+of+4-%5B4-%282-adamantylcarbamoyl%29-5-tert-butyl-pyrazol-1-yl%5Dbenzoic+acid+%28AZD8329%29&doi=10.1021%2Fjm301252n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor with Reduced Acyl Glucuronide Liability: The Discovery of 4-[4-(2-Adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic Acid (AZD8329)</span></div><div class="casAuthors">Scott, James S.; deSchoolmeester, Joanne; Kilgour, Elaine; Mayers, Rachel M.; Packer, Martin J.; Hargreaves, David; Gerhardt, Stefan; Ogg, Derek J.; Rees, Amanda; Selmi, Nidhal; Stocker, Andrew; Swales, John G.; Whittamore, Paul R. O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10136-10147</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of 11β-HSD1 is viewed as a potential target for the treatment of obesity and other elements of the metabolic syndrome.  We report here the optimization of a carboxylic acid class of inhibitors from AZD4017 (I) to the development candidate AZD8329 (II).  A structural change from pyridine to pyrazole together with structural optimization led to an improved tech. profile in terms of both soly. and pharmacokinetics.  The extent of acyl glucuronidation was reduced through structural optimization of both the carboxylic acid and amide substituents, coupled with a redn. in lipophilicity leading to an overall increase in metabolic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKFfab5QO3Q7Vg90H21EOLACvtfcHk0lhahsISie33hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChsrbF&md5=c48d951089cae3c4ad95c938ecaaf8e5</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm301252n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301252n%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DDe%2BSchoolmeester%26aufirst%3DJ.%26aulast%3DKilgour%26aufirst%3DE.%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOgg%26aufirst%3DD.%2BJ.%26aulast%3DRees%26aufirst%3DA.%26aulast%3DSelmi%26aufirst%3DN.%26aulast%3DStocker%26aufirst%3DA.%26aulast%3DSwales%26aufirst%3DJ.%2BG.%26aulast%3DWhittamore%26aufirst%3DP.%2BR.%26atitle%3DNovel%2520acidic%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%2520%252811beta-HSD1%2529%2520inhibitor%2520with%2520reduced%2520acyl%2520glucuronide%2520liability%253A%2520the%2520discovery%2520of%25204-%255B4-%25282-adamantylcarbamoyl%2529-5-tert-butyl-pyrazol-1-yl%255Dbenzoic%2520acid%2520%2528AZD8329%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10136%26epage%3D10147%26doi%3D10.1021%2Fjm301252n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schormann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velu, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senkovich, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenna, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinkre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4056</span>– <span class="NLM_lpage">4066</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.bmc.2010.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=20452776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslOisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4056-4066&author=N.+Schormannauthor=S.+E.+Veluauthor=S.+Murugesanauthor=O.+Senkovichauthor=K.+Walkerauthor=B.+C.+Chennaauthor=B.+Shinkreauthor=A.+Desaiauthor=D.+Chattopadhyay&title=Synthesis+and+characterization+of+potent+inhibitors+of+Trypanosoma+cruzi+dihydrofolate+reductase&doi=10.1016%2Fj.bmc.2010.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase</span></div><div class="casAuthors">Schormann, Norbert; Velu, Sadanandan E.; Murugesan, Srinivasan; Senkovich, Olga; Walker, Kiera; Chenna, Bala C.; Shinkre, Bidhan; Desai, Amar; Chattopadhyay, Debasish</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4056-4066</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dihydrofolate reductase (DHFR) of the parasite Trypanosoma cruzi (T. cruzi) is a potential target for developing drugs to treat Chagas' disease.  We have undertaken a detailed structure-activity study of this enzyme.  We report here synthesis and characterization of six potent inhibitors of the parasitic enzyme.  Inhibitory activity of each compd. was detd. against T. cruzi and human DHFR.  One of these compds., Et 4-(5-[(2,4-diamino-6-quinazolinyl)methyl]amino-2-methoxyphenoxy)butanoate (6b) was co-crystd. with the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of T. cruzi and the crystal structure of the ternary enzyme:cofactor:inhibitor complex was detd.  Mol. docking was used to analyze the potential interactions of all inhibitors with T. cruzi DHFR and human DHFR.  Inhibitory activities of these compds. are discussed in the light of enzyme-ligand interactions.  Binding affinities of each inhibitor for the resp. enzymes were calcd. based on the exptl. or docked binding mode.  An estd. 60-70% of the total binding energy is contributed by the 2,4-diaminoquinazoline scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsx5O48H5w7rVg90H21EOLACvtfcHk0lgQlkFtxrM6dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslOisLY%253D&md5=9e468f0fd4674cfd0c6c37916c7106bb</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DSchormann%26aufirst%3DN.%26aulast%3DVelu%26aufirst%3DS.%2BE.%26aulast%3DMurugesan%26aufirst%3DS.%26aulast%3DSenkovich%26aufirst%3DO.%26aulast%3DWalker%26aufirst%3DK.%26aulast%3DChenna%26aufirst%3DB.%2BC.%26aulast%3DShinkre%26aufirst%3DB.%26aulast%3DDesai%26aufirst%3DA.%26aulast%3DChattopadhyay%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520potent%2520inhibitors%2520of%2520Trypanosoma%2520cruzi%2520dihydrofolate%2520reductase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4056%26epage%3D4066%26doi%3D10.1016%2Fj.bmc.2010.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardegger, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinnler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anselm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecabert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plancher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Systematic investigation of halogen bonding in protein-ligand interactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1002/anie.201006781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.201006781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1alu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=314-318&author=L.+A.+Hardeggerauthor=B.+Kuhnauthor=B.+Spinnlerauthor=L.+Anselmauthor=R.+Ecabertauthor=M.+Stihleauthor=B.+Gsellauthor=R.+Thomaauthor=J.+Diezauthor=J.+Benzauthor=J.+M.+Plancherauthor=G.+Hartmannauthor=D.+W.+Bannerauthor=W.+Haapauthor=F.+Diederich&title=Systematic+investigation+of+halogen+bonding+in+protein-ligand+interactions&doi=10.1002%2Fanie.201006781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions</span></div><div class="casAuthors">Hardegger, Leo A.; Kuhn, Bernd; Spinnler, Beat; Anselm, Lilli; Ecabert, Robert; Stihle, Martine; Gsell, Bernard; Thoma, Ralf; Diez, Joachim; Benz, Joerg; Plancher, Jean-Marc; Hartmann, Guido; Banner, David W.; Haap, Wolfgang; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">314-318, S314/1-S314/145</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Halogen bonding triggers activity.  Increasing binding affinity was obsd. for a series of covalent human Cathepsin L inhibitors by exchanging an aryl ring H atom with Cl, Br, and I, which undergo halogen bonding with the C=O group of Gly61 in the S3 pocket of the enzyme.  Fluorine, in contrast, strongly avoids halogen bonding.  The strong distance and angle dependence of halogen bonding was confirmed for biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsbCNMQhVu7Vg90H21EOLACvtfcHk0lgQlkFtxrM6dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1alu73N&md5=1a7f2983a386fd133be0663657fc486b</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fanie.201006781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201006781%26sid%3Dliteratum%253Aachs%26aulast%3DHardegger%26aufirst%3DL.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DSpinnler%26aufirst%3DB.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DEcabert%26aufirst%3DR.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DDiez%26aufirst%3DJ.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DPlancher%26aufirst%3DJ.%2BM.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DSystematic%2520investigation%2520of%2520halogen%2520bonding%2520in%2520protein-ligand%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D314%26epage%3D318%26doi%3D10.1002%2Fanie.201006781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span>, <span class="NLM_string-name">Slade, M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of spleen tyrosine kinase complexed with 6-((1R,2S)-2-Amino-cyclohexylamino)-4-(6-ethyl-pyridin-2-ylamino)-pyridazine-3-carboxylic acid amide</span>. To be published.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kuglstatter%2C+A.%2C+Slade%2C+M.+Crystal+structure+of+spleen+tyrosine+kinase+complexed+with+6-%28%281R%2C2S%29-2-Amino-cyclohexylamino%29-4-%286-ethyl-pyridin-2-ylamino%29-pyridazine-3-carboxylic+acid+amide.+To+be+published."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520spleen%2520tyrosine%2520kinase%2520complexed%2520with%25206-%2528%25281R%252C2S%2529-2-Amino-cyclohexylamino%2529-4-%25286-ethyl-pyridin-2-ylamino%2529-pyridazine-3-carboxylic%2520acid%2520amide" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="note"><p class="first last">The details of this and related analyes will be published elsewhere.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berman, H.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindyalov, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, P. E.</span></span> <span> </span><span class="NLM_article-title">The protein data bank</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.%0AM.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+protein+data+bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lgQlkFtxrM6dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520protein%2520data%2520bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><a href="http://www.chemcomp.com" class="extLink">www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><a href="http://www.eyesopen.com" class="extLink">www.eyesopen.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.eyesopen.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><a href="http://www.schrodinger.com" class="extLink">www.schrodinger.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.schrodinger.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jantz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rarey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, C. D.</span></span> <span> </span><span class="NLM_article-title">Computational macrocyclization: from de novo macrocycle generation to binding affinity estimation</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1866</span>– <span class="NLM_lpage">1872</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fcmdc.201700478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=28977738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSktbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1866-1872&author=V.+Wagnerauthor=L.+Jantzauthor=H.+Briemauthor=K.+Sommerauthor=M.+Rareyauthor=C.+D.+Christ&title=Computational+macrocyclization%3A+from+de+novo+macrocycle+generation+to+binding+affinity+estimation&doi=10.1002%2Fcmdc.201700478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Macrocyclization: From de novo Macrocycle Generation to Binding Affinity Estimation</span></div><div class="casAuthors">Wagner, Vincent; Jantz, Linda; Briem, Hans; Sommer, Kai; Rarey, Matthias; Christ, Clara D.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1866-1872</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Macrocycles play an increasing role in drug discovery, but their synthesis is often demanding.  Computational tools that suggest macrocyclization based on a known binding mode and that est. the binding affinity of these macrocycles could have a substantial impact on the medicinal chem. design process.  For both tasks, we established a workflow with high practical value.  For five diverse pharmaceutical targets we show that the effect of macrocyclization on binding can be calcd. robustly and accurately.  Applying this method to macrocycles designed by LigMac, a search tool for de novo macrocyclization, our results suggest that we have a robust protocol in hand to design macrocycles and prioritize them prior to synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonKcpGd8uDs7Vg90H21EOLACvtfcHk0liSf4X4ku98_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSktbnI&md5=30f49d08b16cd5473ea69de3e975ebee</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700478%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DV.%26aulast%3DJantz%26aufirst%3DL.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DSommer%26aufirst%3DK.%26aulast%3DRarey%26aufirst%3DM.%26aulast%3DChrist%26aufirst%3DC.%2BD.%26atitle%3DComputational%2520macrocyclization%253A%2520from%2520de%2520novo%2520macrocycle%2520generation%2520to%2520binding%2520affinity%2520estimation%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D1866%26epage%3D1872%26doi%3D10.1002%2Fcmdc.201700478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korb, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Interactive and versatile navigation of structural databases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4257</span>– <span class="NLM_lpage">4266</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01756</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01756" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4257-4266&author=O.+Korbauthor=B.+Kuhnauthor=J.+Hertauthor=N.+Taylorauthor=J.+Coleauthor=C.+Groomauthor=M.+Stahl&title=Interactive+and+versatile+navigation+of+structural+databases&doi=10.1021%2Facs.jmedchem.5b01756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Interactive and Versatile Navigation of Structural Databases</span></div><div class="casAuthors">Korb, Oliver; Kuhn, Bernd; Hert, Jerome; Taylor, Neil; Cole, Jason; Groom, Colin; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4257-4266</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present CSD-CrossMiner, a novel tool for pharmacophore-based searches in crystal structure databases.  Intuitive pharmacophore queries describing, among others, protein-ligand interaction patterns, ligand scaffolds, or protein environments can be built and modified interactively.  Matching crystal structures are overlaid onto the query and visualized as soon as they are available, enabling the researcher to quickly modify a hypothesis on the fly.  We exemplify the utility of the approach by showing applications relevant to real-world drug discovery projects, including the identification of novel fragments for a specific protein environment or scaffold hopping.  The ability to concurrently search protein-ligand binding sites extd. from the Protein Data Bank (PDB) and small org. mols. from the Cambridge Structural Database (CSD) using the same pharmacophore query further emphasizes the flexibility of CSD-CrossMiner.  We believe that CSD-CrossMiner closes an important gap in mining structural data and will allow users to ext. more value from the growing no. of available crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVHoEyOPb96bVg90H21EOLACvtfcHk0liSf4X4ku98_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGms70%253D&md5=1b872969057778cbcc0be80db9bb2bd3</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01756%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DN.%26aulast%3DCole%26aufirst%3DJ.%26aulast%3DGroom%26aufirst%3DC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DInteractive%2520and%2520versatile%2520navigation%2520of%2520structural%2520databases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4257%26epage%3D4266%26doi%3D10.1021%2Facs.jmedchem.5b01756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekharan, S.</span>; <span class="NLM_string-name">Sykes, R.</span>; <span class="NLM_string-name">Sanschagrin, P.</span>; <span class="NLM_string-name">Cummings, M.</span></span> <span> </span><span class="NLM_article-title">Simple metrics to identify opportunities for macrocyclization of small-molecule ligands</span>. Presented at the 256th National Meeting and Exposition of the American Chemical Society, Boston, MA, <span class="NLM_year">2018</span>; COMP-227.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Sekharan&author=R.+Sykes&author=P.+Sanschagrin&author=M.+Cummings&title=Simple+metrics+to+identify+opportunities+for+macrocyclization+of+small-molecule+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSekharan%26aufirst%3DS.%26atitle%3DSimple%2520metrics%2520to%2520identify%2520opportunities%2520for%2520macrocyclization%2520of%2520small-molecule%2520ligands%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scoffin, R.</span>; <span class="NLM_string-name">Bauer, M.</span>; <span class="NLM_string-name">Mackey, M.</span>; <span class="NLM_string-name">Sciammetta, S.</span>; <span class="NLM_string-name">Tedesco, G.</span></span> <span> </span><span class="NLM_article-title">Rapid and accessible in silico macrocycle design</span>. Presented at the 256th National Meeting and Exposition of the American Chemical Society, <span class="NLM_year">2018</span>; COMP-226.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+Scoffin&author=M.+Bauer&author=M.+Mackey&author=S.+Sciammetta&author=G.+Tedesco&title=Rapid+and+accessible+in+silico+macrocycle+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DScoffin%26aufirst%3DR.%26atitle%3DRapid%2520and%2520accessible%2520in%2520silico%2520macrocycle%2520design%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lightfoot, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. C.</span></span> <span> </span><span class="NLM_article-title">The cambridge structural database</span>. <i>Acta Crystallogr., Sect. B: Struct. Sci., Cryst. Eng. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1107/S2052520616003954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1107%2FS2052520616003954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27048719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Kntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=171-179&author=C.+R.+Groomauthor=I.+J.+Brunoauthor=M.+P.+Lightfootauthor=S.+C.+Ward&title=The+cambridge+structural+database&doi=10.1107%2FS2052520616003954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">The Cambridge Structural Database</span></div><div class="casAuthors">Groom, Colin R.; Bruno, Ian J.; Lightfoot, Matthew P.; Ward, Suzanna C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science, Crystal Engineering and Materials</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-179</span>CODEN:
                <span class="NLM_cas:coden">ACSBDA</span>;
        ISSN:<span class="NLM_cas:issn">2052-5206</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The Cambridge Structural Database (CSD) contains a complete record of all published org. and metal-org. small-mol. crystal structures.  The database has been in operation for over 50 years and continues to be the primary means of sharing structural chem. data and knowledge across disciplines.  As well as structures that are made public to support scientific articles, it includes many structures published directly as CSD Communications.  All structures are processed both computationally and by expert structural chem. editors prior to entering the database.  A key component of this processing is the reliable assocn. of the chem. identity of the structure studied with the exptl. data.  This important step helps ensure that data is widely discoverable and readily reusable.  Content is further enriched through selective inclusion of addnl. exptl. data.  Entries are available to anyone through free CSD community web services.  Linking services developed and maintained by the CCDC, combined with the use of std. identifiers, facilitate discovery from other resources.  Data can also be accessed through CCDC and third party software applications and through an application programming interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvlnx06ebv_bVg90H21EOLACvtfcHk0lhezkixbwm1bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Kntro%253D&md5=f9c65ab86fc9db429588c95b0da3f9b2</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1107%2FS2052520616003954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052520616003954%26sid%3Dliteratum%253Aachs%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DBruno%26aufirst%3DI.%2BJ.%26aulast%3DLightfoot%26aufirst%3DM.%2BP.%26aulast%3DWard%26aufirst%3DS.%2BC.%26atitle%3DThe%2520cambridge%2520structural%2520database%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%253A%2520Struct.%2520Sci.%252C%2520Cryst.%2520Eng.%2520Mater.%26date%3D2016%26volume%3D72%26spage%3D171%26epage%3D179%26doi%3D10.1107%2FS2052520616003954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':[],'ref74':['cit74'],'ref75':['cit75'],'ref76':[],'ref77':[],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':[],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hao Zhang, Hao-Chi Hsu, Shoshanna C. Kahne, Ryoma Hara, Wenhu Zhan, Xiuju Jiang, Kristin Burns-Huang, Tierra Ouellette, Toshihiro Imaeda, Rei Okamoto, Masanori Kawasaki, Mayako Michino, Tzu-Tshin Wong, Akinori Toita, Takafumi Yukawa, Francesca Moraca, Jeremie Vendome, Priya Saha, Kenjiro Sato, Kazuyoshi Aso, John Ginn, Peter T. Meinke, Michael Foley, Carl F. Nathan, K. Heran Darwin, Huilin Li, <span class="NLM_string-name hlFld-ContribAuthor">Gang Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclic Peptides that Selectively Inhibit the Mycobacterium tuberculosis Proteasome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 6262-6272. <a href="https://doi.org/10.1021/acs.jmedchem.1c00296" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00296%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMacrocyclic%252BPeptides%252Bthat%252BSelectively%252BInhibit%252Bthe%252BMycobacterium%252Btuberculosis%252BProteasome%26aulast%3DZhang%26aufirst%3DHao%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15022021%26date%3D05052021%26volume%3D64%26issue%3D9%26spage%3D6262%26epage%3D6272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xi Xu, Jubo Wang, Min Wang, Xinyu Yuan, Lei Li, Chao Zhang, Huidan Huang, Tian Jing, Chenchen Wang, Chao Tong, Liwen Zhou, Ying Meng, Pengfei Xu, Junping Kou, Zhixia Qiu, Zhiyu Li, <span class="NLM_string-name hlFld-ContribAuthor">Jinlei Bian</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4588-4611. <a href="https://doi.org/10.1021/acs.jmedchem.0c02044" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02044%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Enabled%252BDiscovery%252Bof%252BNovel%252BMacrocyclic%252BInhibitors%252BTargeting%252BGlutaminase%252B1%252BAllosteric%252BBinding%252BSite%26aulast%3DXu%26aufirst%3DXi%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D25112020%26date%3D01042021%26volume%3D64%26issue%3D8%26spage%3D4588%26epage%3D4611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dan Liu, Nan Jiang, Wen Dou Huang, Ji Wen Li, Wen Jing Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Ren Xiang Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Ionic-Liquid-Catalyzed Access to CTr: An Antitumor Agent. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2021,</strong> <em>9 </em>
                                    (14)
                                     , 5138-5147. <a href="https://doi.org/10.1021/acssuschemeng.1c00191" title="DOI URL">https://doi.org/10.1021/acssuschemeng.1c00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.1c00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.1c00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DIonic-Liquid-Catalyzed%252BAccess%252Bto%252BCTr%25253A%252BAn%252BAntitumor%252BAgent%26aulast%3DLiu%26aufirst%3DDan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D10012021%26date%3D17022021%26date%3D26032021%26volume%3D9%26issue%3D14%26spage%3D5138%26epage%3D5147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael Bauder, Christian Meyners, Patrick L. Purder, Stephanie Merz, Wisely Oki Sugiarto, Andreas M. Voll, Tim Heymann, <span class="NLM_string-name hlFld-ContribAuthor">Felix Hausch</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of High-Affinity Macrocyclic FKBP51 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (6)
                                     , 3320-3349. <a href="https://doi.org/10.1021/acs.jmedchem.0c02195" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02195%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BHigh-Affinity%252BMacrocyclic%252BFKBP51%252BInhibitors%26aulast%3DBauder%26aufirst%3DMichael%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D19122020%26date%3D05032021%26volume%3D64%26issue%3D6%26spage%3D3320%26epage%3D3349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David S. Peters, Cody Ross Pitts, Kyle S. McClymont, Thomas P. Stratton, Cheng Bi, <span class="NLM_string-name hlFld-ContribAuthor">Phil S. Baran</span>. </span><span class="cited-content_cbyCitation_article-title">Ideality in Context: Motivations for Total Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (3)
                                     , 605-617. <a href="https://doi.org/10.1021/acs.accounts.0c00821" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00821%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DIdeality%252Bin%252BContext%25253A%252BMotivations%252Bfor%252BTotal%252BSynthesis%26aulast%3DPeters%26aufirst%3DDavid%2BS.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D05122020%26date%3D21012021%26volume%3D54%26issue%3D3%26spage%3D605%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hao Chen, Jeff B. Smaill, Tongzheng Liu, Ke Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoyun Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14404-14424. <a href="https://doi.org/10.1021/acs.jmedchem.0c01312" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01312%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252BDirectly%252BTargeting%252BKRAS%252Bas%252BAnticancer%252BTherapeutics%26aulast%3DChen%26aufirst%3DHao%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D23112020%26volume%3D63%26issue%3D23%26spage%3D14404%26epage%3D14424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dan Sindhikara, Michael Wagner, Paraskevi Gkeka, Stefan Güssregen, Garima Tiwari, Gerhard Hessler, Engin Yapici, Ziyu Li, <span class="NLM_string-name hlFld-ContribAuthor">Andreas Evers</span>. </span><span class="cited-content_cbyCitation_article-title">Automated Design of Macrocycles for Therapeutic Applications: From Small Molecules to Peptides and Proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 12100-12115. <a href="https://doi.org/10.1021/acs.jmedchem.0c01500" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01500</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01500%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAutomated%252BDesign%252Bof%252BMacrocycles%252Bfor%252BTherapeutic%252BApplications%25253A%252BFrom%252BSmall%252BMolecules%252Bto%252BPeptides%252Band%252BProteins%26aulast%3DSindhikara%26aufirst%3DDan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27082020%26date%3D05102020%26volume%3D63%26issue%3D20%26spage%3D12100%26epage%3D12115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shuzhe Wang, Jagna Witek, Gregory A. Landrum, <span class="NLM_string-name hlFld-ContribAuthor">Sereina Riniker</span>. </span><span class="cited-content_cbyCitation_article-title">Improving Conformer Generation for Small Rings and Macrocycles Based on Distance Geometry and Experimental Torsional-Angle Preferences. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (4)
                                     , 2044-2058. <a href="https://doi.org/10.1021/acs.jcim.0c00025" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00025%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DImproving%252BConformer%252BGeneration%252Bfor%252BSmall%252BRings%252Band%252BMacrocycles%252BBased%252Bon%252BDistance%252BGeometry%252Band%252BExperimental%252BTorsional-Angle%252BPreferences%26aulast%3DWang%26aufirst%3DShuzhe%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09012020%26date%3D20032020%26date%3D10032020%26volume%3D60%26issue%3D4%26spage%3D2044%26epage%3D2058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radka Houštecká, Martin Hadzima, Jindřich Fanfrlík, Jiří Brynda, Lenka Pallová, Iva Hánová, Helena Mertlíková-Kaiserová, Martin Lepšík, Martin Horn, Martin Smrčina, Pavel Majer, <span class="NLM_string-name hlFld-ContribAuthor">Michael Mareš</span>. </span><span class="cited-content_cbyCitation_article-title">Biomimetic Macrocyclic Inhibitors of Human Cathepsin D: Structure–Activity Relationship and Binding Mode Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (4)
                                     , 1576-1596. <a href="https://doi.org/10.1021/acs.jmedchem.9b01351" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01351%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiomimetic%252BMacrocyclic%252BInhibitors%252Bof%252BHuman%252BCathepsin%252BD%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Band%252BBinding%252BMode%252BAnalysis%26aulast%3DHou%25C5%25A1teck%25C3%25A1%26aufirst%3DRadka%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30082019%26date%3D13022020%26date%3D31012020%26volume%3D63%26issue%3D4%26spage%3D1576%26epage%3D1596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Amber Y. S. Balazs, Rodrigo J. Carbajo, Nichola L. Davies, Yu Dong, Alexander W. Hird, Jeffrey W. Johannes, Michelle L. Lamb, William McCoull, Piotr Raubo, Graeme R. Robb, Martin J. Packer, <span class="NLM_string-name hlFld-ContribAuthor">Elisabetta Chiarparin</span>. </span><span class="cited-content_cbyCitation_article-title">Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9418-9437. <a href="https://doi.org/10.1021/acs.jmedchem.9b00716" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFree%252BLigand%252B1D%252BNMR%252BConformational%252BSignatures%252BTo%252BEnhance%252BStructure%252BBased%252BDrug%252BDesign%252Bof%252Ba%252BMcl-1%252BInhibitor%252B%252528AZD5991%252529%252Band%252BOther%252BSynthetic%252BMacrocycles%26aulast%3DBalazs%26aufirst%3DAmber%2BY.%2BS.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D02052019%26date%3D19082019%26date%3D30072019%26volume%3D62%26issue%3D21%26spage%3D9418%26epage%3D9437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher
J. M. Brown, Michael P. Gotsbacher, Jason P. Holland, <span class="NLM_string-name hlFld-ContribAuthor">Rachel Codd</span>. </span><span class="cited-content_cbyCitation_article-title">endo-Hydroxamic Acid Monomers for the Assembly of a Suite of Non-native Dimeric Macrocyclic Siderophores Using Metal-Templated Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (20)
                                     , 13591-13603. <a href="https://doi.org/10.1021/acs.inorgchem.9b00878" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.9b00878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.9b00878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.9b00878%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3Dendo-Hydroxamic%252BAcid%252BMonomers%252Bfor%252Bthe%252BAssembly%252Bof%252Ba%252BSuite%252Bof%252BNon-native%252BDimeric%252BMacrocyclic%252BSiderophores%252BUsing%252BMetal-Templated%252BSynthesis%26aulast%3DBrown%26aufirst%3DChristopher%2BJ.%2BM.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27032019%26date%3D05062019%26volume%3D58%26issue%3D20%26spage%3D13591%26epage%3D13603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiping  Hao</span>, <span class="hlFld-ContribAuthor ">Xueying  Guo</span>, <span class="hlFld-ContribAuthor ">Shijun  He</span>, <span class="hlFld-ContribAuthor ">Zhongliang  Xu</span>, <span class="hlFld-ContribAuthor ">Lu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhongyu  Li</span>, <span class="hlFld-ContribAuthor ">Bichao  Song</span>, <span class="hlFld-ContribAuthor ">Jianping  Zuo</span>, <span class="hlFld-ContribAuthor ">Zhenyang  Lin</span>, <span class="hlFld-ContribAuthor ">Weibo  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Marine furanocembranoids-inspired macrocycles enabled by Pd-catalyzed unactivated C(sp3)-H olefination mediated by donor/donor carbenes. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-021-21484-x" title="DOI URL">https://doi.org/10.1038/s41467-021-21484-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-021-21484-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-021-21484-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DMarine%252Bfuranocembranoids-inspired%252Bmacrocycles%252Benabled%252Bby%252BPd-catalyzed%252Bunactivated%252BC%252528sp3%252529-H%252Bolefination%252Bmediated%252Bby%252Bdonor%25252Fdonor%252Bcarbenes%26aulast%3DHao%26aufirst%3DJiping%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenting  Li</span>, <span class="hlFld-ContribAuthor ">Lun  Tan</span>, <span class="hlFld-ContribAuthor ">Zhixiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiuqi  Xia</span>, <span class="hlFld-ContribAuthor ">Dongsheng  Lei</span>, <span class="hlFld-ContribAuthor ">Yuyan  Li</span>, <span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Shaoxue  Zeng</span>, <span class="hlFld-ContribAuthor ">Xiutian  Sima</span>, <span class="hlFld-ContribAuthor ">Yanyan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The X-ray structure of tubulysin analogue TGL in complex with tubulin and three possible routes for the development of next-generation tubulysin analogues. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2021,</strong> <em>565 </em>, 29-35. <a href="https://doi.org/10.1016/j.bbrc.2021.05.086" title="DOI URL">https://doi.org/10.1016/j.bbrc.2021.05.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2021.05.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2021.05.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DThe%252BX-ray%252Bstructure%252Bof%252Btubulysin%252Banalogue%252BTGL%252Bin%252Bcomplex%252Bwith%252Btubulin%252Band%252Bthree%252Bpossible%252Broutes%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnext-generation%252Btubulysin%252Banalogues%26aulast%3DLi%26aufirst%3DWenting%26date%3D2021%26volume%3D565%26spage%3D29%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Sun</span>, <span class="hlFld-ContribAuthor ">Shijun  He</span>, <span class="hlFld-ContribAuthor ">Zhongliang  Xu</span>, <span class="hlFld-ContribAuthor ">Jianping  Zuo</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Weibo  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Rh-Catalyzed C–H alkylation enabling modular synthesis of CF
              3
              -substituted benzannulated macrocyclic inhibitors of B cell responses. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (16)
                                     , 3589-3594. <a href="https://doi.org/10.1039/D1OB00296A" title="DOI URL">https://doi.org/10.1039/D1OB00296A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00296A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00296A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRh-Catalyzed%252BC%2525E2%252580%252593H%252Balkylation%252Benabling%252Bmodular%252Bsynthesis%252Bof%252BCF%252B3%252B-substituted%252Bbenzannulated%252Bmacrocyclic%252Binhibitors%252Bof%252BB%252Bcell%252Bresponses%26aulast%3DSun%26aufirst%3DTao%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D16%26spage%3D3589%26epage%3D3594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Durgesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Kamlesh  Kumari</span>, <span class="hlFld-ContribAuthor ">Ramesh  Chandra</span>, <span class="hlFld-ContribAuthor ">Pallavi  Jain</span>, <span class="hlFld-ContribAuthor ">Lata  Vodwal</span>, <span class="hlFld-ContribAuthor ">Geetu  Gambhir</span>, <span class="hlFld-ContribAuthor ">Prashant  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">A review targeting the infection by CHIKV using computational and experimental approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>24 </em>, 1-15. <a href="https://doi.org/10.1080/07391102.2021.1904004" title="DOI URL">https://doi.org/10.1080/07391102.2021.1904004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1904004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1904004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DA%252Breview%252Btargeting%252Bthe%252Binfection%252Bby%252BCHIKV%252Busing%252Bcomputational%252Band%252Bexperimental%252Bapproaches%26aulast%3DKumar%26aufirst%3DDurgesh%26date%3D2021%26date%3D2021%26volume%3D24%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa M.  Álvarez</span>, <span class="hlFld-ContribAuthor ">Ana Belén  García</span>, <span class="hlFld-ContribAuthor ">Concepción  Riesco-Fagundo</span>, <span class="hlFld-ContribAuthor ">José I.  Martín</span>, <span class="hlFld-ContribAuthor ">Carmen  Varela</span>, <span class="hlFld-ContribAuthor ">Antonio  Rodríguez Hergueta</span>, <span class="hlFld-ContribAuthor ">Esther  González Cantalapiedra</span>, <span class="hlFld-ContribAuthor ">Julen  Oyarzabal</span>, <span class="hlFld-ContribAuthor ">Bruno  Di Geronimo</span>, <span class="hlFld-ContribAuthor ">Milagros  Lorenzo</span>, <span class="hlFld-ContribAuthor ">M Isabel  Albarrán</span>, <span class="hlFld-ContribAuthor ">Antonio  Cebriá</span>, <span class="hlFld-ContribAuthor ">David  Cebrián</span>, <span class="hlFld-ContribAuthor ">Sonia  Martínez-González</span>, <span class="hlFld-ContribAuthor ">Carmen  Blanco-Aparicio</span>, <span class="hlFld-ContribAuthor ">Joaquín  Pastor</span>. </span><span class="cited-content_cbyCitation_article-title">Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113109. <a href="https://doi.org/10.1016/j.ejmech.2020.113109" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113109%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOmipalisib%252Binspired%252Bmacrocycles%252Bas%252Bdual%252BPI3K%25252FmTOR%252Binhibitors%26aulast%3D%25C3%2581lvarez%26aufirst%3DRosa%2BM.%26date%3D2021%26volume%3D211%26spage%3D113109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  Bogaerts</span>, <span class="hlFld-ContribAuthor ">Yoseph  Atilaw</span>, <span class="hlFld-ContribAuthor ">Stefan  Peintner</span>, <span class="hlFld-ContribAuthor ">Roy  Aerts</span>, <span class="hlFld-ContribAuthor ">Jan  Kihlberg</span>, <span class="hlFld-ContribAuthor ">Christian  Johannessen</span>, <span class="hlFld-ContribAuthor ">Máté  Erdélyi</span>. </span><span class="cited-content_cbyCitation_article-title">Employing complementary spectroscopies to study the conformations of an epimeric pair of side-chain stapled peptides in aqueous solution. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (7)
                                     , 4200-4208. <a href="https://doi.org/10.1039/D0RA10167B" title="DOI URL">https://doi.org/10.1039/D0RA10167B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA10167B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA10167B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DEmploying%252Bcomplementary%252Bspectroscopies%252Bto%252Bstudy%252Bthe%252Bconformations%252Bof%252Ban%252Bepimeric%252Bpair%252Bof%252Bside-chain%252Bstapled%252Bpeptides%252Bin%252Baqueous%252Bsolution%26aulast%3DBogaerts%26aufirst%3DJonathan%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D7%26spage%3D4200%26epage%3D4208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lu  Chen</span>, <span class="hlFld-ContribAuthor ">Haitian  Quan</span>, <span class="hlFld-ContribAuthor ">Zhongliang  Xu</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Yuanzhi  Xia</span>, <span class="hlFld-ContribAuthor ">Liguang  Lou</span>, <span class="hlFld-ContribAuthor ">Weibo  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A modular biomimetic strategy for the synthesis of macrolide P-glycoprotein inhibitors via Rh-catalyzed C-H activation. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-16084-0" title="DOI URL">https://doi.org/10.1038/s41467-020-16084-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-16084-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-16084-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DA%252Bmodular%252Bbiomimetic%252Bstrategy%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bmacrolide%252BP-glycoprotein%252Binhibitors%252Bvia%252BRh-catalyzed%252BC-H%252Bactivation%26aulast%3DChen%26aufirst%3DLu%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maximilian J.  Hochmair</span>, <span class="hlFld-ContribAuthor ">Hannah  Fabikan</span>, <span class="hlFld-ContribAuthor ">Oliver  Illini</span>, <span class="hlFld-ContribAuthor ">Christoph  Weinlinger</span>, <span class="hlFld-ContribAuthor ">Ulrike  Setinek</span>, <span class="hlFld-ContribAuthor ">Dagmar  Krenbek</span>, <span class="hlFld-ContribAuthor ">Helmut  Prosch</span>, <span class="hlFld-ContribAuthor ">Markus  Rauter</span>, <span class="hlFld-ContribAuthor ">Michael  Schumacher</span>, <span class="hlFld-ContribAuthor ">Ewald  Wöll</span>, <span class="hlFld-ContribAuthor ">Romana  Wass</span>, <span class="hlFld-ContribAuthor ">Elmar  Brehm</span>, <span class="hlFld-ContribAuthor ">Gudrun  Absenger</span>, <span class="hlFld-ContribAuthor ">Tatjana  Bundalo</span>, <span class="hlFld-ContribAuthor ">Peter  Errhalt</span>, <span class="hlFld-ContribAuthor ">Matthias  Urban</span>, <span class="hlFld-ContribAuthor ">Arschang  Valipour</span>. </span><span class="cited-content_cbyCitation_article-title">Later-Line Treatment with Lorlatinib in ALK- and ROS1-Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (11)
                                     , 371. <a href="https://doi.org/10.3390/ph13110371" title="DOI URL">https://doi.org/10.3390/ph13110371</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13110371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13110371%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DLater-Line%252BTreatment%252Bwith%252BLorlatinib%252Bin%252BALK-%252Band%252BROS1-Rearrangement-Positive%252BNSCLC%25253A%252BA%252BRetrospective%25252C%252BMulticenter%252BAnalysis%26aulast%3DHochmair%26aufirst%3DMaximilian%2BJ.%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D11%26spage%3D371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyed Abolfazl  Hosseini–Yazdi</span>, <span class="hlFld-ContribAuthor ">Leila  Noohinejad</span>, <span class="hlFld-ContribAuthor ">Hena  Kalantari</span>, <span class="hlFld-ContribAuthor ">Azadeh  Mirzaahmadi</span>. </span><span class="cited-content_cbyCitation_article-title">Anion-directed assemblies of Cu(II) mono, di, and poly-nuclear coordination compounds with a 32-membered azacrown ligand: Synthesis, characterisation and crystal structures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1215 </em>, 128200. <a href="https://doi.org/10.1016/j.molstruc.2020.128200" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.128200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.128200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.128200%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DAnion-directed%252Bassemblies%252Bof%252BCu%252528II%252529%252Bmono%25252C%252Bdi%25252C%252Band%252Bpoly-nuclear%252Bcoordination%252Bcompounds%252Bwith%252Ba%252B32-membered%252Bazacrown%252Bligand%25253A%252BSynthesis%25252C%252Bcharacterisation%252Band%252Bcrystal%252Bstructures%26aulast%3DHosseini%25E2%2580%2593Yazdi%26aufirst%3DSeyed%2BAbolfazl%26date%3D2020%26volume%3D1215%26spage%3D128200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruixiang  Cheng</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xiong</span>, <span class="hlFld-ContribAuthor ">Chaorong  Qi</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Yanwei  Ren</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclization of 3-triflyloxybenzynes with tetrahydrofuran
              via
              an anionic thia-Fries rearrangement. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (48)
                                     , 6495-6498. <a href="https://doi.org/10.1039/D0CC00135J" title="DOI URL">https://doi.org/10.1039/D0CC00135J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC00135J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC00135J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DMacrocyclization%252Bof%252B3-triflyloxybenzynes%252Bwith%252Btetrahydrofuran%252Bvia%252Ban%252Banionic%252Bthia-Fries%252Brearrangement%26aulast%3DCheng%26aufirst%3DRuixiang%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D48%26spage%3D6495%26epage%3D6498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Feng  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 275-286. <a href="https://doi.org/10.1080/13543776.2020.1729354" title="DOI URL">https://doi.org/10.1080/13543776.2020.1729354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1729354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1729354%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DLeucine-rich%252Brepeat%252Bkinase%252B2%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282014-present%252529%26aulast%3DDing%26aufirst%3DXiao%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aimee K.  Clarke</span>, <span class="hlFld-ContribAuthor ">William P.  Unsworth</span>. </span><span class="cited-content_cbyCitation_article-title">A happy medium: the synthesis of medicinally important medium-sized rings
              via
              ring expansion. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2020,</strong> <em>11 </em>
                                    (11)
                                     , 2876-2881. <a href="https://doi.org/10.1039/D0SC00568A" title="DOI URL">https://doi.org/10.1039/D0SC00568A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC00568A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC00568A%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DA%252Bhappy%252Bmedium%25253A%252Bthe%252Bsynthesis%252Bof%252Bmedicinally%252Bimportant%252Bmedium-sized%252Brings%252Bvia%252Bring%252Bexpansion%26aulast%3DClarke%26aufirst%3DAimee%2BK.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D11%26spage%3D2876%26epage%3D2881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saumitra  Sengupta</span>, <span class="hlFld-ContribAuthor ">Goverdhan  Mehta</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclization
              via
              C–H functionalization: a new paradigm in macrocycle synthesis. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (10)
                                     , 1851-1876. <a href="https://doi.org/10.1039/C9OB02765C" title="DOI URL">https://doi.org/10.1039/C9OB02765C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02765C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02765C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMacrocyclization%252Bvia%252BC%2525E2%252580%252593H%252Bfunctionalization%25253A%252Ba%252Bnew%252Bparadigm%252Bin%252Bmacrocycle%252Bsynthesis%26aulast%3DSengupta%26aufirst%3DSaumitra%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D10%26spage%3D1851%26epage%3D1876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>. </span><span class="cited-content_cbyCitation_article-title">Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (1)
                                     , 39-55. <a href="https://doi.org/10.1080/13543776.2020.1705783" title="DOI URL">https://doi.org/10.1080/13543776.2020.1705783</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1705783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1705783%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DFactor%252BXI%252528a%252529%252Binhibitors%252Bfor%252Bthrombosis%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252B%2525282016-present%252529%26aulast%3DAl-Horani%26aufirst%3DRami%2BA.%26date%3D2020%26date%3D2019%26volume%3D30%26issue%3D1%26spage%3D39%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Madsen</span>, <span class="hlFld-ContribAuthor ">Carlos  Azevedo</span>, <span class="hlFld-ContribAuthor ">Iolanda  Micco</span>, <span class="hlFld-ContribAuthor ">Lars Kolster  Petersen</span>, <span class="hlFld-ContribAuthor ">Nils Jakob Vest  Hansen</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of DNA-encoded libraries: A versatile tool for drug discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 181-249. <a href="https://doi.org/10.1016/bs.pmch.2020.03.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2020.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2020.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2020.03.001%26sid%3Dliteratum%253Aachs%26atitle%3DAn%252Boverview%252Bof%252BDNA-encoded%252Blibraries%25253A%252BA%252Bversatile%252Btool%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DMadsen%26aufirst%3DDaniel%26date%3D2020%26spage%3D181%26epage%3D249%26pub%3DElsevier%26date%3D2020%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah J.  Martin</span>, <span class="hlFld-ContribAuthor ">I-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">A.W. Edith  Chan</span>, <span class="hlFld-ContribAuthor ">Nicolas  Foloppe</span>. </span><span class="cited-content_cbyCitation_article-title">Modelling the binding mode of macrocycles: Docking and conformational sampling. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (1)
                                     , 115143. <a href="https://doi.org/10.1016/j.bmc.2019.115143" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115143%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DModelling%252Bthe%252Bbinding%252Bmode%252Bof%252Bmacrocycles%25253A%252BDocking%252Band%252Bconformational%252Bsampling%26aulast%3DMartin%26aufirst%3DSarah%2BJ.%26date%3D2020%26volume%3D28%26issue%3D1%26spage%3D115143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanling  Wang</span>, <span class="hlFld-ContribAuthor ">Huan  Ge</span>, <span class="hlFld-ContribAuthor ">Disha  Wang</span>, <span class="hlFld-ContribAuthor ">Huan  He</span>, <span class="hlFld-ContribAuthor ">Lu  Li</span>, <span class="hlFld-ContribAuthor ">Yanyan  Diao</span>, <span class="hlFld-ContribAuthor ">Zihao  Shen</span>, <span class="hlFld-ContribAuthor ">Lili  Zhu</span>, <span class="hlFld-ContribAuthor ">Shiliang  Li</span>, <span class="hlFld-ContribAuthor ">Zhenjiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of a Series of Novel Macrocycle Janus Kinase 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2019,</strong> <em>37 </em>
                                    (12)
                                     , 1259-1263. <a href="https://doi.org/10.1002/cjoc.201900316" title="DOI URL">https://doi.org/10.1002/cjoc.201900316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201900316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201900316%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252Ba%252BSeries%252Bof%252BNovel%252BMacrocycle%252BJanus%252BKinase%252B2%252BInhibitors%26aulast%3DWang%26aufirst%3DYanling%26date%3D2019%26date%3D2019%26volume%3D37%26issue%3D12%26spage%3D1259%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna V.  Vologzhanina</span>. </span><span class="cited-content_cbyCitation_article-title">Intermolecular Interactions in Functional Crystalline Materials: From Data to Knowledge. </span><span class="cited-content_cbyCitation_journal-name">Crystals</span><span> <strong>2019,</strong> <em>9 </em>
                                    (9)
                                     , 478. <a href="https://doi.org/10.3390/cryst9090478" title="DOI URL">https://doi.org/10.3390/cryst9090478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cryst9090478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcryst9090478%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystals%26atitle%3DIntermolecular%252BInteractions%252Bin%252BFunctional%252BCrystalline%252BMaterials%25253A%252BFrom%252BData%252Bto%252BKnowledge%26aulast%3DVologzhanina%26aufirst%3DAnna%2BV.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D9%26spage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of HCV NS3 protease-bound inhibitors shows the alkyl macrocycle linker of simeprevir (orange color by atom) occupying the region between the two alkyl side chain moieties of boceprevir (green color by atom), similar to the original observation<a onclick="showRef(event, 'ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42">(40−42)</a> that initiated research into macrocyclic inhibitors of NS3 protease (see text for discussion); overlay based solely on protein atoms (not shown) from the complex structures (simeprevir PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KEE">3KEE</a>;<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> boceprevir PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LOX">3LOX</a><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Overall macrocycle design strategy that led to the discovery of pacritinib. A modification of the table-of-contents figure and Figure 1 from ref <a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a>. Reproduced with permission from <i>Journal of Medicinal Chemistry</i>.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Copyright 2011 American Chemical Society.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure-based design of a macrocyclic HCV NS5B polymerase inhibitor. Overlay of public structures 2BRK<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> (green color by atom), 2BRL<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> (cyan color by atom) and 2DXS<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> (purple color by atom); likely regions for macrocyclization highlighted with shaded background spheres; designed macrocycle from 4DRU<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> shown in orange color by atom; protein surfaces from the respective complexes shown in gray; superpositions based strictly on protein backbone atoms.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/medium/jm-2018-01985a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Examples of bound ligands showing a conformational predisposition to macrocyclization. C-shaped or folded conformations of protein-bound small-molecule ligands showing one or more atom–atom pairs with relatively short atom–atom through-space distances for the corresponding through-bond paths (see text; distances in Å). PDB codes are the following (left to right): <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4P38">4P38</a>,<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KJS">3KJS</a>,<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU4">2XU4</a>,<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FZ7">4FZ7</a>.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-15/acs.jmedchem.8b01985/20190801/images/large/jm-2018-01985a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01985&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i16">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 97 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Driggers, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terrett, N. K.</span></span> <span> </span><span class="NLM_article-title">The exploration of macrocycles for drug discovery--an underexploited structural class</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1038/nrd2590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=18591981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFShsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=608-624&author=E.+M.+Driggersauthor=S.+P.+Haleauthor=J.+Leeauthor=N.+K.+Terrett&title=The+exploration+of+macrocycles+for+drug+discovery%2D%2Dan+underexploited+structural+class&doi=10.1038%2Fnrd2590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The exploration of macrocycles for drug discovery - an underexploited structural class</span></div><div class="casAuthors">Driggers, Edward M.; Hale, Stephen P.; Lee, Jinbo; Terrett, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">608-624</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products comprised of a macrocycle ring structure have proven their therapeutic applications as antibiotics, immunosuppressants as well as anticancer agents.  Despite this, macrocyclic compds. remain under-explored.  Terrett and colleagues review the properties and features of current macrocycle drugs, emphasizing the vast potential of synthetic macrocycles in drug discovery.  Macrocyclic natural products have evolved to fulfil numerous biochem. functions, and their profound pharmacol. properties have led to their development as drugs.  A macrocycle provides diverse functionality and stereochem. complexity in a conformationally pre-organized ring structure.  This can result in high affinity and selectivity for protein targets, while preserving sufficient bioavailability to reach intracellular locations.  Despite these valuable characteristics, and the proven success of more than 100 marketed macrocycle drugs derived from natural products, this structural class has been poorly explored within drug discovery.  This is in part due to concerns about synthetic intractability and non-drug-like properties.  This Review describes the growing body of data in favor of macrocyclic therapeutics, and demonstrates that this class of compds. can be both fully drug-like in its properties and readily prepd. owing to recent advances in synthetic medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDtW8LpE4ru7Vg90H21EOLACvtfcHk0ljzMtKOXHeGyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFShsbc%253D&md5=16e091818053e5b163b81078a8d03094</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2590%26sid%3Dliteratum%253Aachs%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DHale%26aufirst%3DS.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26atitle%3DThe%2520exploration%2520of%2520macrocycles%2520for%2520drug%2520discovery--an%2520underexploited%2520structural%2520class%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D608%26epage%3D624%26doi%3D10.1038%2Fnrd2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic drugs and clinical candidates: what can medicinal chemists learn from their properties?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">278</span>– <span class="NLM_lpage">295</span>, <span class="refDoi"> DOI: 10.1021/jm400887j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400887j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGnurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=278-295&author=F.+Giordanettoauthor=J.+Kihlberg&title=Macrocyclic+drugs+and+clinical+candidates%3A+what+can+medicinal+chemists+learn+from+their+properties%3F&doi=10.1021%2Fjm400887j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?</span></div><div class="casAuthors">Giordanetto, Fabrizio; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">278-295</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles are ideal in efforts to tackle difficult targets, but our understanding of what makes them cell permeable and orally bioavailable is limited.  Anal. of approx. 100 macrocyclic drugs and clin. candidates revealed that macrocycles are predominantly used for infectious disease and in oncol. and that most belong to the macrolide or cyclic peptide class.  A significant no. (N = 34) of these macrocycles are administered orally, revealing that oral bioavailability can be obtained at mol. wts. up to and above 1 kDa and polar surface areas ranging toward 250 Å2.  Moreover, insight from a group of de novo designed oral macrocycles in clin. studies and understanding of how cyclosporin A and model cyclic hexapeptides cross cell membranes may unlock wider opportunities in drug discovery.  However, the no. of oral macrocycles is still low and it remains to be seen if they are outliers or if macrocycles will open up novel oral druggable space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaeM2DXwvmiLVg90H21EOLACvtfcHk0lgVfAUM3mtppA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGnurjI&md5=a3e1743bd5ba34f73d8e78f8cb1bee5f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm400887j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400887j%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DMacrocyclic%2520drugs%2520and%2520clinical%2520candidates%253A%2520what%2520can%2520medicinal%2520chemists%2520learn%2520from%2520their%2520properties%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D278%26epage%3D295%26doi%3D10.1021%2Fjm400887j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mallinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Macrocycles in new drug discovery</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1438</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.93</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.4155%2Ffmc.12.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=22857532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCht7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1409-1438&author=J.+Mallinsonauthor=I.+Collins&title=Macrocycles+in+new+drug+discovery&doi=10.4155%2Ffmc.12.93"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles in new drug discovery</span></div><div class="casAuthors">Mallinson, Jamie; Collins, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1409-1438</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The use of drug-like macrocycles is emerging as an exciting area of medicinal chem., with several recent examples highlighting the favorable changes in biol. and physicochem. properties that macrocyclization can afford.  Natural product macrocycles and their synthetic derivs. have long been clin. useful and attention is now being focused on the wider use of macrocyclic scaffolds in medicinal chem. in the search for new drugs for increasingly challenging targets.  With the increasing awareness of concepts of drug-likeness and the dangers of mol. obesity', functionalized macrocyclic scaffolds could provide a way to generate ligand-efficient mols. with enhanced properties.  In this review we will sep. discuss the effects of macrocyclization upon potency, selectivity and physicochem. properties, concg. on recent case histories in oncol. drug discovery.  Addnl., we will highlight selected advances in the synthesis of macrocycles and provide an outlook on the future use of macrocyclic scaffolds in medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSrzcbKW7Tc7Vg90H21EOLACvtfcHk0lgVfAUM3mtppA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCht7rO&md5=63ad275af92ac89ae6b36c5071b578f8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.93%26sid%3Dliteratum%253Aachs%26aulast%3DMallinson%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMacrocycles%2520in%2520new%2520drug%2520discovery%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1409%26epage%3D1438%26doi%3D10.4155%2Ffmc.12.93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marsault, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, M. L.</span></span> <span> </span><span class="NLM_article-title">Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1961</span>– <span class="NLM_lpage">2004</span>, <span class="refDoi"> DOI: 10.1021/jm1012374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+are+great+cycles%3A+applications%2C+opportunities%2C+and+challenges+of+synthetic+macrocycles+in+drug+discovery&doi=10.1021%2Fjm1012374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0lgVfAUM3mtppA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520are%2520great%2520cycles%253A%2520applications%252C%2520opportunities%252C%2520and%2520challenges%2520of%2520synthetic%2520macrocycles%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1961%26epage%3D2004%26doi%3D10.1021%2Fjm1012374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wessjohann, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruijter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Rivera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, W.</span></span> <span> </span><span class="NLM_article-title">What can a chemist learn from nature’s macrocycles?--a brief, conceptual view</span>. <i>Mol. Diversity</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">186</span>, <span class="refDoi"> DOI: 10.1007/s11030-005-1314-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1007%2Fs11030-005-1314-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15789564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslels7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=171-186&author=L.+A.+Wessjohannauthor=E.+Ruijterauthor=D.+Garcia-Riveraauthor=W.+Brandt&title=What+can+a+chemist+learn+from+nature%E2%80%99s+macrocycles%3F%2D%2Da+brief%2C+conceptual+view&doi=10.1007%2Fs11030-005-1314-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">What can a chemist learn from nature's macrocycles? - A brief, conceptual view</span></div><div class="casAuthors">Wessjohann, Ludger A.; Ruijter, Eelco; Garcia-Rivera, Daniel; Brandt, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Diversity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">171-186</span>CODEN:
                <span class="NLM_cas:coden">MODIF4</span>;
        ISSN:<span class="NLM_cas:issn">1381-1991</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Macrocyclic natural products often display remarkable biol. activities, and many of these compds. (or their derivs.) are used as drugs.  The chem. diversity of these compds. is immense and may provide inspiration for innovative drug design.  Therefore, a database of naturally occurring macrocycles was analyzed for ring size, mol. wt. distribution, and the frequency of some common substructural motifs.  The underlying principles of the chem. diversity are reviewed in terms of biosynthetic origin and nature's strategies for diversity and complexity generation in relation to the structural diversity and similarities found in the macrocycle database.  Finally, it is suggested that synthetic chemists should use not only nature's mols., but also nature's strategies as a source of inspiration.  To illustrate this, the biosynthesis of macrocycles by non-ribosomal peptide synthetases and terpene and polyketide cyclases, as well as recent advances of these strategies in an integrated synthesis/biotechnol. approach are briefly reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVB4g1QplcWLVg90H21EOLACvtfcHk0ljdIXxNgIbRWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslels7w%253D&md5=88df3ca095b446e3781369708ccddfd2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs11030-005-1314-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11030-005-1314-x%26sid%3Dliteratum%253Aachs%26aulast%3DWessjohann%26aufirst%3DL.%2BA.%26aulast%3DRuijter%26aufirst%3DE.%26aulast%3DGarcia-Rivera%26aufirst%3DD.%26aulast%3DBrandt%26aufirst%3DW.%26atitle%3DWhat%2520can%2520a%2520chemist%2520learn%2520from%2520nature%25E2%2580%2599s%2520macrocycles%253F--a%2520brief%252C%2520conceptual%2520view%26jtitle%3DMol.%2520Diversity%26date%3D2005%26volume%3D9%26spage%3D171%26epage%3D186%26doi%3D10.1007%2Fs11030-005-1314-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominy, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feeney, P. J.</span></span> <span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(00)00129-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings&doi=10.1016%2FS0169-409X%2800%2900129-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0ljdIXxNgIbRWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26%26doi%3D10.1016%2FS0169-409X%2800%2900129-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobritzsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">How beyond rule of 5 drugs and clinical candidates bind to their targets</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2312</span>– <span class="NLM_lpage">2327</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01286</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2312-2327&author=B.+C.+Doakauthor=J.+Zhengauthor=D.+Dobritzschauthor=J.+Kihlberg&title=How+beyond+rule+of+5+drugs+and+clinical+candidates+bind+to+their+targets&doi=10.1021%2Facs.jmedchem.5b01286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">How Beyond Rule of 5 Drugs and Clinical Candidates Bind to Their Targets</span></div><div class="casAuthors">Doak, Bradley C.; Zheng, Jie; Dobritzsch, Doreen; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2312-2327</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To improve discovery of drugs for difficult targets, the opportunities of chem. space beyond the rule of 5 (bRo5) were examd. by retrospective anal. of a comprehensive set of structures for complexes between drugs and clin. candidates and their targets.  The anal. illustrates the potential of compds. far beyond rule of 5 space to modulate novel and difficult target classes that have large, flat, and groove-shaped binding sites.  However, ligand efficiencies are significantly reduced for flat- and groove-shape binding sites, suggesting that adjustments of how to use such metrics are required.  Ligands bRo5 appear to benefit from an appropriate balance between rigidity and flexibility to bind with sufficient affinity to their targets, with macrocycles and nonmacrocycles being found to have similar flexibility.  However, macrocycles were more disk- and spherelike, which may contribute to their superior binding to flat sites, while rigidification of nonmacrocycles lead to rodlike ligands that bind well to groove-shaped binding sites.  These insights should contribute to altering perceptions of what targets are considered "druggable" and provide support for drug design in beyond rule of 5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZD-h9VodiPLVg90H21EOLACvtfcHk0ljdIXxNgIbRWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Cgu77F&md5=a417b605d1a3ffbc7ee84706401f01f4</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01286%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DZheng%26aufirst%3DJ.%26aulast%3DDobritzsch%26aufirst%3DD.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DHow%2520beyond%2520rule%2520of%25205%2520drugs%2520and%2520clinical%2520candidates%2520bind%2520to%2520their%2520targets%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2312%26epage%3D2327%26doi%3D10.1021%2Facs.jmedchem.5b01286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kussie, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorina, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marechal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elenbaas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">948</span>– <span class="NLM_lpage">953</span>, <span class="refDoi"> DOI: 10.1126/science.274.5289.948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1126%2Fscience.274.5289.948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=8875929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1996&pages=948-953&author=P.+H.+Kussieauthor=S.+Gorinaauthor=V.+Marechalauthor=B.+Elenbaasauthor=J.+Moreauauthor=A.+J.+Levineauthor=N.+P.+Pavletich&title=Structure+of+the+MDM2+oncoprotein+bound+to+the+p53+tumor+suppressor+transactivation+domain&doi=10.1126%2Fscience.274.5289.948"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain</span></div><div class="casAuthors">Kussie, Paul H.; Gorina, Svetlana; Marechal, Vincent; Elenbaas, Brian; Moreau, Jacque; Levine, Arnold J.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">5289</span>),
    <span class="NLM_cas:pages">948-953</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The MDM2 oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.  In certain cancers, MDM2 amplification is a common event and contributes to the inactivation of p53.  The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic α helix.  The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 α helix and, in particular, on a triad of p53 amino acids - Phe19, Trp23, and Leu26 - which insert deep into the MDM2 cleft.  These same p53 residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates p53 by concealing its transactivation domain.  The structure also suggests that the amphipathic α helix may be a common structural motif in the binding of a diverse family of transactivation factors to the TATA-binding protein-assocd. factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotkRIRDnQnX7Vg90H21EOLACvtfcHk0lh1z8KW0m9ozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmslKnt7k%253D&md5=3702422b0a761617cff1498f47f30eeb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.274.5289.948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.274.5289.948%26sid%3Dliteratum%253Aachs%26aulast%3DKussie%26aufirst%3DP.%2BH.%26aulast%3DGorina%26aufirst%3DS.%26aulast%3DMarechal%26aufirst%3DV.%26aulast%3DElenbaas%26aufirst%3DB.%26aulast%3DMoreau%26aufirst%3DJ.%26aulast%3DLevine%26aufirst%3DA.%2BJ.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520the%2520MDM2%2520oncoprotein%2520bound%2520to%2520the%2520p53%2520tumor%2520suppressor%2520transactivation%2520domain%26jtitle%3DScience%26date%3D1996%26volume%3D274%26spage%3D948%26epage%3D953%26doi%3D10.1126%2Fscience.274.5289.948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurst, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. S.</span></span> <span> </span><span class="NLM_article-title">Expanding the range of “druggable” targets with natural product-based libraries: an academic perspective</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2010.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.cbpa.2010.02.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=20202892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2010&pages=308-314&author=R.+A.+Bauerauthor=J.+M.+Wurstauthor=D.+S.+Tan&title=Expanding+the+range+of+%E2%80%9Cdruggable%E2%80%9D+targets+with+natural+product-based+libraries%3A+an+academic+perspective&doi=10.1016%2Fj.cbpa.2010.02.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the range of druggable' targets with natural product-based libraries: an academic perspective</span></div><div class="casAuthors">Bauer, Renato A.; Wurst, Jacqueline M.; Tan, Derek S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-314</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Existing drugs address a relatively narrow range of biol. targets.  As a result, libraries of drug-like mols. have proven ineffective against a variety of challenging targets, such as protein-protein interactions, nucleic acid complexes, and antibacterial modalities.  In contrast, natural products are known to be effective at modulating such targets, and new libraries are being developed based on underrepresented scaffolds and regions of chem. space assocd. with natural products.  This has led to several recent successes in identifying new chem. probes that address these challenging targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpegWvUnIjr37Vg90H21EOLACvtfcHk0lh1z8KW0m9ozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWqsL4%253D&md5=0d2e6076ede53bf3a61c95bd3c08d05c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2010.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2010.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DR.%2BA.%26aulast%3DWurst%26aufirst%3DJ.%2BM.%26aulast%3DTan%26aufirst%3DD.%2BS.%26atitle%3DExpanding%2520the%2520range%2520of%2520%25E2%2580%259Cdruggable%25E2%2580%259D%2520targets%2520with%2520natural%2520product-based%2520libraries%253A%2520an%2520academic%2520perspective%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D14%26spage%3D308%26epage%3D314%26doi%3D10.1016%2Fj.cbpa.2010.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makley, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gestwicki, J. E.</span></span> <span> </span><span class="NLM_article-title">Expanding the number of “druggable” targets: non-enzymes and protein-protein interactions</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1111%2Fcbdd.12066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=23253128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1ymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=22-32&author=L.+N.+Makleyauthor=J.+E.+Gestwicki&title=Expanding+the+number+of+%E2%80%9Cdruggable%E2%80%9D+targets%3A+non-enzymes+and+protein-protein+interactions&doi=10.1111%2Fcbdd.12066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the number of "druggable" targets: non-enzymes and protein-protein interactions</span></div><div class="casAuthors">Makley, Leah N.; Gestwicki, Jason E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">22-32</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Following sequencing and assembly of the human genome, the preferred methods for identification of new drug targets have changed dramatically.  Modern tactics such as genome-wide assocn. studies (GWAS) and deep sequencing are fundamentally different from the pharmacol.-guided approaches used previously, in which knowledge of small mol. ligands acting at their cellular targets was the primary discovery engine.  A consequence of the "target-first, pharmacol.-second" strategy is that many predicted drug targets are non-enzymes, such as scaffolding, regulatory or structural proteins, and their activities are often dependent on protein-protein interactions (PPIs).  These types of targets create unique challenges to drug discovery efforts because enzymic turnover cannot be used as a convenient surrogate for compd. potency.  Moreover, it is often challenging to predict how ligand binding to non-enzymes might affect changes in protein function and/or pathobiol.  Thus, in the postgenomic era, targets might be strongly implicated by mol. biol.-based methods, yet they often later earn the designation of "undruggable".  Can the scope of available targets be widened to include these promising, but challenging, non-enzymes.  In this review, we discuss advances in high-throughput screening (HTS) technol. and chem. library design that are emerging to deal with these challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMtMz2zhY_vLVg90H21EOLACvtfcHk0lh1z8KW0m9ozg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1ymtQ%253D%253D&md5=9e8a15432b02550dca5c9e4668d99038</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12066%26sid%3Dliteratum%253Aachs%26aulast%3DMakley%26aufirst%3DL.%2BN.%26aulast%3DGestwicki%26aufirst%3DJ.%2BE.%26atitle%3DExpanding%2520the%2520number%2520of%2520%25E2%2580%259Cdruggable%25E2%2580%259D%2520targets%253A%2520non-enzymes%2520and%2520protein-protein%2520interactions%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D22%26epage%3D32%26doi%3D10.1111%2Fcbdd.12066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClendon, C. L.</span></span> <span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein-protein interfaces</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>450</i></span>,  <span class="NLM_fpage">1001</span>– <span class="NLM_lpage">1009</span>, <span class="refDoi"> DOI: 10.1038/nature06526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnature06526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=18075579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVaqtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein-protein+interfaces&doi=10.1038%2Fnature06526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Reaching for high-hanging fruit in drug discovery at protein-protein interfaces</span></div><div class="casAuthors">Wells, James A.; McClendon, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7172</span>),
    <span class="NLM_cas:pages">1001-1009</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting the interfaces between proteins has huge therapeutic potential, but discovering small-mol. drugs that disrupt protein-protein interactions is an enormous challenge.  Several recent success stories, however, indicate that protein-protein interfaces might be more tractable than has been thought.  These studies discovered small mols. that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein-protein interactions.  Remarkably, these small mols. bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner.  Some of these small mols. are now making their way through clin. trials, so this high-hanging fruit might not be far out of reach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-nGR3BqqkrVg90H21EOLACvtfcHk0liGkYkOqFUSzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVaqtr7F&md5=e7ed69fd8c362a71c4b99f029c16a6fc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature06526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06526%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein-protein%2520interfaces%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D1001%26epage%3D1009%26doi%3D10.1038%2Fnature06526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayly, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidmore, J.</span></span> <span> </span><span class="NLM_article-title">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">550</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd.2016.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27050677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=533-550&author=D.+E.+Scottauthor=A.+R.+Baylyauthor=C.+Abellauthor=J.+Skidmore&title=Small+molecules%2C+big+targets%3A+drug+discovery+faces+the+protein-protein+interaction+challenge&doi=10.1038%2Fnrd.2016.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules, big targets: drug discovery faces the protein-protein interaction challenge</span></div><div class="casAuthors">Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris; Skidmore, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">533-550</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) are of pivotal importance in the regulation of biol. systems and are consequently implicated in the development of disease states.  Recent work has begun to show that, with the right tools, certain classes of PPI can yield to the efforts of medicinal chemists to develop inhibitors, and the first PPI inhibitors have reached clin. development.  In this Review, we describe the research leading to these breakthroughs and highlight the existence of groups of structurally related PPIs within the PPI target class.  For each of these groups, we use examples of successful discovery efforts to illustrate the research strategies that have proved most useful.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK-aGzHa9mP7Vg90H21EOLACvtfcHk0liGkYkOqFUSzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFOgur4%253D&md5=9f0953567ae9338b8b36aa78b8160655</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.29%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DD.%2BE.%26aulast%3DBayly%26aufirst%3DA.%2BR.%26aulast%3DAbell%26aufirst%3DC.%26aulast%3DSkidmore%26aufirst%3DJ.%26atitle%3DSmall%2520molecules%252C%2520big%2520targets%253A%2520drug%2520discovery%2520faces%2520the%2520protein-protein%2520interaction%2520challenge%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D533%26epage%3D550%26doi%3D10.1038%2Fnrd.2016.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuenemann, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbe, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerdan, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, O.</span></span> <span> </span><span class="NLM_article-title">Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">23815</span>, <span class="refDoi"> DOI: 10.1038/srep23815</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fsrep23815" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27034268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1KktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=23815&author=M.+A.+Kuenemannauthor=C.+M.+Labbeauthor=A.+H.+Cerdanauthor=O.+Sperandio&title=Imbalance+in+chemical+space%3A+How+to+facilitate+the+identification+of+protein-protein+interaction+inhibitors&doi=10.1038%2Fsrep23815"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Imbalance in chemical space: How to facilitate the identification of protein-protein interaction inhibitors</span></div><div class="casAuthors">Kuenemann, Melaine A.; Labbe, Celine M.; Cerdan, Adrien H.; Sperandio, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23815</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein-protein interactions (PPIs) play vital roles in life and provide new opportunities for therapeutic interventions.  In this large data anal., 3,300 inhibitors of PPIs (iPPIs) were compared to 17 ref. datasets of collectively ∼566,000 compds. (including natural compds., existing drugs, active compds. on conventional targets, etc.) using a chemoinformatics approach.  Using this procedure, we showed that comparable classes of PPI targets can be formed using either the similarity of their ligands or the shared properties of their binding cavities, constituting a proof-of-concept that not only can binding pockets be used to group PPI targets, but that these pockets certainly condition the properties of their corresponding ligands.  These results demonstrate that matching regions in both chem. space and target space can be found.  Such identified classes of targets could lead to the design of PPI-class-specific chem. libraries and therefore facilitate the development of iPPIs to the stage of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB7AWb8BfwxrVg90H21EOLACvtfcHk0liGkYkOqFUSzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1KktLg%253D&md5=e08f767f9408cd68b2010d5a831a73cf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsrep23815&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep23815%26sid%3Dliteratum%253Aachs%26aulast%3DKuenemann%26aufirst%3DM.%2BA.%26aulast%3DLabbe%26aufirst%3DC.%2BM.%26aulast%3DCerdan%26aufirst%3DA.%2BH.%26aulast%3DSperandio%26aufirst%3DO.%26atitle%3DImbalance%2520in%2520chemical%2520space%253A%2520How%2520to%2520facilitate%2520the%2520identification%2520of%2520protein-protein%2520interaction%2520inhibitors%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D23815%26doi%3D10.1038%2Fsrep23815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashkenazi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairbrother, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leverson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souers, A. J.</span></span> <span> </span><span class="NLM_article-title">From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd.2016.253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=28209992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislynu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=273-284&author=A.+Ashkenaziauthor=W.+J.+Fairbrotherauthor=J.+D.+Leversonauthor=A.+J.+Souers&title=From+basic+apoptosis+discoveries+to+advanced+selective+BCL-2+family+inhibitors&doi=10.1038%2Fnrd.2016.253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors</span></div><div class="casAuthors">Ashkenazi, Avi; Fairbrother, Wayne J.; Leverson, Joel D.; Souers, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the B cell lymphoma 2 (BCL-2) gene family have a central role in regulating programmed cell death by controlling pro-apoptotic and anti-apoptotic intracellular signals.  In cancer, apoptosis evasion through dysregulation of specific BCL-2 family genes is a recurring event; accordingly, selective inhibition of specific anti-apoptotic BCL-2 family proteins represents an exciting therapeutic opportunity.  A combination of NMR (NMR)-based screening and structure-based drug design has yielded the first bona fide BCL-2 homol. 3 (BH3) mimetics, including the BCL-2 and BCL-XL dual antagonist navitoclax, which is the first BCL-2 family inhibitor to show efficacy in patients with cancer.  Clin. experience with navitoclax prompted the generation of the highly selective BCL-2 inhibitor venetoclax, which is now approved in the United States for the treatment of patients with chronic lymphocytic leukemia with 17p deletion who have received at least one prior therapy.  Recent advances have also been made in the development of potent and selective inhibitors of BCL-XL and myeloid cell leukemia 1 (MCL1), which are addnl. BCL-2 family members with established anti-apoptotic roles in cancer.  Here we review the latest progress in direct and selective targeting of BCL-2 family proteins for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXzAZwyiZQ9LVg90H21EOLACvtfcHk0ljNyEFXBzWaRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislynu7g%253D&md5=ac65b9fbff59988cafb9e381dc0de405</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.253%26sid%3Dliteratum%253Aachs%26aulast%3DAshkenazi%26aufirst%3DA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26atitle%3DFrom%2520basic%2520apoptosis%2520discoveries%2520to%2520advanced%2520selective%2520BCL-2%2520family%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D273%26epage%3D284%26doi%3D10.1038%2Fnrd.2016.253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vierling, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greiner, J.</span></span> <span> </span><span class="NLM_article-title">Prodrugs of HIV protease inhibitors</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1755</span>– <span class="NLM_lpage">1770</span>, <span class="refDoi"> DOI: 10.2174/1381612033454441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.2174%2F1381612033454441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=12871195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmt1GgtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=1755-1770&author=P.+Vierlingauthor=J.+Greiner&title=Prodrugs+of+HIV+protease+inhibitors&doi=10.2174%2F1381612033454441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of HIV protease inhibitors</span></div><div class="casAuthors">Vierling, Pierre; Greiner, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1755-1770</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite the efficiency of the present polytherapies against AIDS, HIV replication continues indicating difficulties in drug adherence, drug-drug interactions, resistance issues, and the existence of reservoirs or sanctuaries for the virus.  Moreover, most of the current FDA-approved HIV protease inhibitors (PIs) display disadvantageous physicochem. and pharmacol. properties such as low water soly., low oral bioavailability and/or low level of penetration into the HIV sanctuaries resulting from their in vivo binding to the plasma proteins and to the Multi-Drug-Resistant P-glycoprotein, their rapid metabolization and inactivation by the liver cytochrome P 450 enzymes.  To overcome these suboptimal pharmacokinetics, high daily doses must be ingested, which complicate patient adherence to the prescribed regimen and contribute to the appearance of serious long-term metabolic complications and to the decrease of the viral treatment outcome.  Another attractive alternative aimed at improving the safety, pharmacokinetics, and therapeutic potency of the current PIs is to modify these PIs into pharmacol. inactive prodrugs which are converted in vivo into their parent active drug.  The present review is dedicated to the different prodrug approaches, including the "lipophilic", "hydrophilic", "active transport" and "double-drug" prodrug strategies, which have been applied more particularly to the current HIV PIs used in clinic.  Among the strategies explored up to now, the most successful one was the "hydrophilic" prodrug approach which has led to the discovery of fosamprenavir, a phosphate ester prodrug of amprenavir, which has reached phase III clin. trials.  This success gives strong support for the search of PI prodrugs as a therapeutic alternative in addn. to the development of new and well-tolerated PIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppWLr-UkVzlLVg90H21EOLACvtfcHk0ljNyEFXBzWaRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmt1GgtLY%253D&md5=8a365aa7f60e6d29d673fe8546bf1cf1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1381612033454441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612033454441%26sid%3Dliteratum%253Aachs%26aulast%3DVierling%26aufirst%3DP.%26aulast%3DGreiner%26aufirst%3DJ.%26atitle%3DProdrugs%2520of%2520HIV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2003%26volume%3D9%26spage%3D1755%26epage%3D1770%26doi%3D10.2174%2F1381612033454441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walters, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M. A.</span></span> <span> </span><span class="NLM_article-title">What do medicinal chemists actually make? A 50-year retrospective</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">6405</span>– <span class="NLM_lpage">6416</span>, <span class="refDoi"> DOI: 10.1021/jm200504p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200504p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFWjsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6405-6416&author=W.+P.+Waltersauthor=J.+Greenauthor=J.+R.+Weissauthor=M.+A.+Murcko&title=What+do+medicinal+chemists+actually+make%3F+A+50-year+retrospective&doi=10.1021%2Fjm200504p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">What Do Medicinal Chemists Actually Make? A 50-Year Retrospective</span></div><div class="casAuthors">Walters, W. Patrick; Green, Jeremy; Weiss, Jonathan R.; Murcko, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6405-6416</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite the dramatically increasing costs of pharmaceutical R&D productivity, as measured by the no. of new drugs approved each year, has languished during the past decade.  Many different explanations have been proposed to account for this decline, such as increasing regulatory scrutiny, the inherent inefficiency of very large organizations, the pursuit of highly speculative targets identified from genomics, and more objective decision-making about advancing marginal compds. into latest age clin. trials.  Another factor often cited to help explain low pharmaceutical productivity is that, paradoxically, many compds. synthesized by medicinal chemists are not "druglike", at least as measured by various criteria.  The authors discuss the past, present and perspectives in the development of medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg5xuF4wHqKrVg90H21EOLACvtfcHk0ljNyEFXBzWaRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFWjsr7O&md5=33109f9d55967be0d34f377f433621e4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm200504p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200504p%26sid%3Dliteratum%253Aachs%26aulast%3DWalters%26aufirst%3DW.%2BP.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DJ.%2BR.%26aulast%3DMurcko%26aufirst%3DM.%2BA.%26atitle%3DWhat%2520do%2520medicinal%2520chemists%2520actually%2520make%253F%2520A%252050-year%2520retrospective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6405%26epage%3D6416%26doi%3D10.1021%2Fjm200504p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalyanaraman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span> <span> </span><span class="NLM_article-title">Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">14073</span>– <span class="NLM_lpage">14080</span>, <span class="refDoi"> DOI: 10.1021/ja063076p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja063076p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=14073-14080&author=T.+Rezaiauthor=J.+E.+Bockauthor=M.+V.+Zhouauthor=C.+Kalyanaramanauthor=R.+S.+Lokeyauthor=M.+P.+Jacobson&title=Conformational+flexibility%2C+internal+hydrogen+bonding%2C+and+passive+membrane+permeability%3A+successful+in+silico+prediction+of+the+relative+permeabilities+of+cyclic+peptides&doi=10.1021%2Fja063076p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Flexibility, Internal Hydrogen Bonding, and Passive Membrane Permeability: Successful in Silico Prediction of the Relative Permeabilities of Cyclic Peptides</span></div><div class="casAuthors">Rezai, Taha; Bock, Jonathan E.; Zhou, Mai V.; Kalyanaraman, Chakrapani; Lokey, R. Scott; Jacobson, Matthew P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">14073-14080</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report an atomistic phys. model for the passive membrane permeability of cyclic peptides.  The computational modeling was performed in advance of the expts. and did not involve the use of "training data".  The model explicitly treats the conformational flexibility of the peptides by extensive conformational sampling in low (membrane) and high (water) dielec. environments.  The passive membrane permeabilities of 11 cyclic peptides were obtained exptl. using a parallel artificial membrane permeability assay (PAMPA) and showed a linear correlation with the computational results with R2 = 0.96.  In general, the results support the hypothesis, already well established in the literature, that the ability to form internal hydrogen bonds is crit. for passive membrane permeability and can be the distinguishing factor among closely related compds., such as those studied here.  However, we have found that the no. of internal hydrogen bonds that can form in the membrane and the solvent-exposed polar surface area correlate more poorly with PAMPA permeability than our model, which quant. ests. the solvation free energy losses upon moving from high-dielec. water to the low-dielec. interior of a membrane.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofxfL018o86rVg90H21EOLACvtfcHk0ljg_X7iZscImA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCmur3I&md5=78d4b4082e6a72b288d4b6dac933ca35</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fja063076p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja063076p%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DBock%26aufirst%3DJ.%2BE.%26aulast%3DZhou%26aufirst%3DM.%2BV.%26aulast%3DKalyanaraman%26aufirst%3DC.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26atitle%3DConformational%2520flexibility%252C%2520internal%2520hydrogen%2520bonding%252C%2520and%2520passive%2520membrane%2520permeability%253A%2520successful%2520in%2520silico%2520prediction%2520of%2520the%2520relative%2520permeabilities%2520of%2520cyclic%2520peptides%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D14073%26epage%3D14080%26doi%3D10.1021%2Fja063076p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rezai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millhauser, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span> <span> </span><span class="NLM_article-title">Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2510</span>– <span class="NLM_lpage">2511</span>, <span class="refDoi"> DOI: 10.1021/ja0563455</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0563455" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGqu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=2510-2511&author=T.+Rezaiauthor=B.+Yuauthor=G.+L.+Millhauserauthor=M.+P.+Jacobsonauthor=R.+S.+Lokey&title=Testing+the+conformational+hypothesis+of+passive+membrane+permeability+using+synthetic+cyclic+peptide+diastereomers&doi=10.1021%2Fja0563455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers</span></div><div class="casAuthors">Rezai, Taha; Yu, Bin; Millhauser, Glenn L.; Jacobson, Matthew P.; Lokey, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2510-2511</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Little is known about the effect of conformation on passive membrane diffusion rates in small mols.  Evidence suggests that intramol. hydrogen bonding may play a role by reducing the energetic cost of desolvating hydrogen bond donors, esp. amide N-H groups.  We set out to test this hypothesis by investigating the passive membrane diffusion characteristics of a series of cyclic peptide diastereomers based on the sequence cyclo[Leu-Leu-Leu-Leu-Pro-Tyr].  We identified two cyclic hexapeptide diastereomers based on this sequence, whose membrane diffusion rates differed by nearly two log units.  Results of soln. NMR studies and hydrogen/deuterium (H/D) exchange expts. showed that membrane diffusion rates correlated with the degree of intramol. hydrogen bonding and H/D exchange rates.  The most permeable diastereomer, cyclo[D-Leu-D-Leu-Leu-D-Leu-Pro-Tyr], exhibited a passive membrane diffusion rate comparable to that of the orally available drug cyclosporine A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqooDObTy1BXrVg90H21EOLACvtfcHk0ljg_X7iZscImA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGqu7k%253D&md5=52e5cac6648efb70e743f294e3f8c4ec</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fja0563455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0563455%26sid%3Dliteratum%253Aachs%26aulast%3DRezai%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DMillhauser%26aufirst%3DG.%2BL.%26aulast%3DJacobson%26aufirst%3DM.%2BP.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26atitle%3DTesting%2520the%2520conformational%2520hypothesis%2520of%2520passive%2520membrane%2520permeability%2520using%2520synthetic%2520cyclic%2520peptide%2520diastereomers%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D2510%26epage%3D2511%26doi%3D10.1021%2Fja0563455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2601</span>– <span class="NLM_lpage">2611</span>, <span class="refDoi"> DOI: 10.1021/jm100087s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100087s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2601-2611&author=B.+Kuhnauthor=P.+Mohrauthor=M.+Stahl&title=Intramolecular+hydrogen+bonding+in+medicinal+chemistry&doi=10.1021%2Fjm100087s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular Hydrogen Bonding in Medicinal Chemistry</span></div><div class="casAuthors">Kuhn, Bernd; Mohr, Peter; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2601-2611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The formation of intramol. hydrogen bonds has a very pronounced effect on mol. structure and properties.  We study both aspects in detail with the aim of enabling a more rational use of this class of interactions in medicinal chem.  On the basis of exhaustive searches in crystal structure databases, we derive propensities for intramol. hydrogen bond formation of five- to eight-membered ring systems of relevance in drug discovery.  A no. of motifs, several of which are clearly underutilized in drug discovery, are analyzed in more detail by comparing small mol. and protein-ligand X-ray structures.  To investigate effects on physicochem. properties, sets of closely related structures with and without the ability to form intramol. hydrogen bonds were designed, synthesized, and characterized with respect to membrane permeability, water soly., and lipophilicity.  We find that changes in these properties depend on a subtle balance between the strength of the hydrogen bond interaction, geometry of the newly formed ring system, and the relative energies of the open and closed conformations in polar and unpolar environments.  A no. of general guidelines for medicinal chemists emerge from this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaV7tFRU4k7Vg90H21EOLACvtfcHk0ljTZFFf2QIbWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Clur8%253D&md5=b9b6865dfcc9bdf7796d15218f6e8ff2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm100087s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100087s%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2601%26epage%3D2611%26doi%3D10.1021%2Fjm100087s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alex, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span> <span> </span><span class="NLM_article-title">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">669</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1039/c1md00093d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1039%2Fc1md00093d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=669-674&author=A.+Alexauthor=D.+S.+Millanauthor=M.+Perezauthor=F.+Wakenhutauthor=G.+A.+Whitlock&title=Intramolecular+hydrogen+bonding+to+improve+membrane+permeability+and+absorption+in+beyond+rule+of+five+chemical+space&doi=10.1039%2Fc1md00093d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space</span></div><div class="casAuthors">Alex, Alexander; Millan, David S.; Perez, Manuel; Wakenhut, Florian; Whitlock, Gavin A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">669-674</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Utilizing 'beyond rule of five' chem. space is becoming increasingly important in drug design, but is usually at odds with good oral absorption.  The formation of intramol. hydrogen bonds in drug mols. is hypothesised to shield polarity facilitating improved membrane permeability and intestinal absorption.  NMR based evidence for intramol. hydrogen bonding in several 'beyond rule of five' oral drugs is described.  Furthermore, the propensity for these drugs to form intramol. hydrogen bonds could be predicted for through modeling the lowest energy conformation in the gas phase.  The modulation of apparent lipophilicity through intramol. hydrogen bonding in these mols. is supported by intrinsic cell permeability and intestinal absorption data in rat and human.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp93l2KJMdB2bVg90H21EOLACvtfcHk0ljTZFFf2QIbWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotl2gt7o%253D&md5=3effbdd29832ac7b57eabbc26c66217b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fc1md00093d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00093d%26sid%3Dliteratum%253Aachs%26aulast%3DAlex%26aufirst%3DA.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DPerez%26aufirst%3DM.%26aulast%3DWakenhut%26aufirst%3DF.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26atitle%3DIntramolecular%2520hydrogen%2520bonding%2520to%2520improve%2520membrane%2520permeability%2520and%2520absorption%2520in%2520beyond%2520rule%2520of%2520five%2520chemical%2520space%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26spage%3D669%26epage%3D674%26doi%3D10.1039%2Fc1md00093d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whitty, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viarengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beglov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajda, S.</span></span> <span> </span><span class="NLM_article-title">Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">712</span>– <span class="NLM_lpage">717</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2016.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.drudis.2016.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=26891978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVKrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=712-717&author=A.+Whittyauthor=M.+Zhongauthor=L.+Viarengoauthor=D.+Beglovauthor=D.+R.+Hallauthor=S.+Vajda&title=Quantifying+the+chameleonic+properties+of+macrocycles+and+other+high-molecular-weight+drugs&doi=10.1016%2Fj.drudis.2016.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Quantifying the chameleonic properties of macrocycles and other high-molecular-weight drugs</span></div><div class="casAuthors">Whitty, Adrian; Zhong, Mengqi; Viarengo, Lauren; Beglov, Dmitri; Hall, David R.; Vajda, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">712-717</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Key to the pharmaceutical utility of certain macrocyclic drugs is a 'chameleonic' ability to change their conformation to expose polar groups in aq. soln., but bury them when traversing lipid membranes.  Based on anal. of the structures of 20 macrocyclic compds. that are approved oral drugs, we propose that good soly. requires a topol. polar surface area (TPSA, in Å2) of ≥0.2 × mol. wt. (MW).  Meanwhile, good passive membrane permeability requires a mol. (i.e., 3D) PSA in nonpolar environments of ≤140 Å2.  We show that one or other of these limits is almost invariably violated for compds. with MW > 600 Da, suggesting that some degree of chameleonic behavior is required for most high MW oral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlN7rCqts5wLVg90H21EOLACvtfcHk0ljTZFFf2QIbWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVKrurs%253D&md5=024476298f7b72efa3f0a9303bed5900</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2016.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DWhitty%26aufirst%3DA.%26aulast%3DZhong%26aufirst%3DM.%26aulast%3DViarengo%26aufirst%3DL.%26aulast%3DBeglov%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DD.%2BR.%26aulast%3DVajda%26aufirst%3DS.%26atitle%3DQuantifying%2520the%2520chameleonic%2520properties%2520of%2520macrocycles%2520and%2520other%2520high-molecular-weight%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D712%26epage%3D717%26doi%3D10.1016%2Fj.drudis.2016.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doak, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Drug discovery beyond the rule of 5 - Opportunities and challenges</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1080/17460441.2017.1264385</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1080%2F17460441.2017.1264385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27883294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A280%3ADC%252BC2sjgtVejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=115-119&author=B.+C.+Doakauthor=J.+Kihlberg&title=Drug+discovery+beyond+the+rule+of+5+-+Opportunities+and+challenges&doi=10.1080%2F17460441.2017.1264385"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery beyond the rule of 5 - Opportunities and challenges</span></div><div class="casAuthors">Doak Bradley C; Kihlberg Jan</div><div class="citationInfo"><span class="NLM_cas:title">Expert opinion on drug discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">115-119</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRw3tmClaGOihOk4JA3soTqfW6udTcc2ea60K-Q4fDA9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sjgtVejtw%253D%253D&md5=bccc3e6cb938479044d18a2b25df9c1f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F17460441.2017.1264385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2017.1264385%26sid%3Dliteratum%253Aachs%26aulast%3DDoak%26aufirst%3DB.%2BC.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DDrug%2520discovery%2520beyond%2520the%2520rule%2520of%25205%2520-%2520Opportunities%2520and%2520challenges%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2017%26volume%3D12%26spage%3D115%26epage%3D119%26doi%3D10.1080%2F17460441.2017.1264385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poongavanam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danelius, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peintner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaraz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wlodek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdelyi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermondi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kihlberg, J.</span></span> <span> </span><span class="NLM_article-title">Conformational sampling of macrocyclic drugs in different environments: can we find the relevant conformations?</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">11742</span>– <span class="NLM_lpage">11757</span>, <span class="refDoi"> DOI: 10.1021/acsomega.8b01379</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.8b01379" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslKhtrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=11742-11757&author=V.+Poongavanamauthor=E.+Daneliusauthor=S.+Peintnerauthor=L.+Alcarazauthor=G.+Caronauthor=M.+D.+Cummingsauthor=S.+Wlodekauthor=M.+Erdelyiauthor=P.+C.+D.+Hawkinsauthor=G.+Ermondiauthor=J.+Kihlberg&title=Conformational+sampling+of+macrocyclic+drugs+in+different+environments%3A+can+we+find+the+relevant+conformations%3F&doi=10.1021%2Facsomega.8b01379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Sampling of Macrocyclic Drugs in Different Environments: Can We Find the Relevant Conformations?</span></div><div class="casAuthors">Poongavanam, Vasanthanathan; Danelius, Emma; Peintner, Stefan; Alcaraz, Lilian; Caron, Giulia; Cummings, Maxwell D.; Wlodek, Stanislaw; Erdelyi, Mate; Hawkins, Paul C. D.; Ermondi, Giuseppe; Kihlberg, Jan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">11742-11757</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conformational flexibility is a major determinant of the properties of macrocycles and other drugs in beyond rule of 5 (bRo5) space.  Prediction of conformations is essential for design of drugs in this space and the authors have evaluated three tools for conformational sampling of a set of ten bRo5 drugs and clin. candidates in polar and apolar environments.  The distance-geometry based OMEGA was found to yield ensembles spanning larger structure and property spaces than the two MD based methods, MOE-LowMode MD (MOE) and MacroModel-Macrocycle Conformational Sampling (MC).  Both MC and OMEGA, but not MOE, generated different ensembles for polar and apolar environments.  All three conformational search methods generated conformers similar to the crystal structure conformers for nine of the ten compds., with OMEGA performing somewhat better than MOE and MC.  MOE and OMEGA found all six conformers of roxithromycin that were identified by NMR in aq. solns., while only OMEGA sampled the three conformers obsd. in chloroform.  The authors suggest that characterization of conformers using mol. descriptors, e.g. the radius of gyration (Rgyr) and polar surface area (PSA), is preferred to energy- or RMSD-based methods for selection of biol. relevant conformers in drug discovery in bRo5 space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoetOG-yDeciLVg90H21EOLACvtfcHk0li8Cy-prpsZbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslKhtrnI&md5=a8722551b161e907daf55146f22b6d57</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facsomega.8b01379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.8b01379%26sid%3Dliteratum%253Aachs%26aulast%3DPoongavanam%26aufirst%3DV.%26aulast%3DDanelius%26aufirst%3DE.%26aulast%3DPeintner%26aufirst%3DS.%26aulast%3DAlcaraz%26aufirst%3DL.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DWlodek%26aufirst%3DS.%26aulast%3DErdelyi%26aufirst%3DM.%26aulast%3DHawkins%26aufirst%3DP.%2BC.%2BD.%26aulast%3DErmondi%26aufirst%3DG.%26aulast%3DKihlberg%26aufirst%3DJ.%26atitle%3DConformational%2520sampling%2520of%2520macrocyclic%2520drugs%2520in%2520different%2520environments%253A%2520can%2520we%2520find%2520the%2520relevant%2520conformations%253F%26jtitle%3DACS%2520Omega%26date%3D2018%26volume%3D3%26spage%3D11742%26epage%3D11757%26doi%3D10.1021%2Facsomega.8b01379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otvos, L.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wade, J. D.</span></span> <span> </span><span class="NLM_article-title">Current challenges in peptide-based drug discovery</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">62</span>, <span class="refDoi"> DOI: 10.3389/fchem.2014.00062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.3389%2Ffchem.2014.00062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=25152873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FkvVWquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=62&author=L.+Otvosauthor=J.+D.+Wade&title=Current+challenges+in+peptide-based+drug+discovery&doi=10.3389%2Ffchem.2014.00062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Current challenges in peptide-based drug discovery</span></div><div class="casAuthors">Otvos Laszlo Jr; Wade John D</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">62</span>
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdBTaiObNX6fIW7hznt0zpfW6udTcc2ebWwRDa5mcIdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FkvVWquw%253D%253D&md5=02484893d0ab296edf6190171cf1c88d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2014.00062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2014.00062%26sid%3Dliteratum%253Aachs%26aulast%3DOtvos%26aufirst%3DL.%26aulast%3DWade%26aufirst%3DJ.%2BD.%26atitle%3DCurrent%2520challenges%2520in%2520peptide-based%2520drug%2520discovery%26jtitle%3DFront.%2520Chem.%26date%3D2014%26volume%3D2%26spage%3D62%26doi%3D10.3389%2Ffchem.2014.00062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudin, A. K.</span></span> <span> </span><span class="NLM_article-title">Contemporary strategies for peptide macrocyclization</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1038/nchem.1062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnchem.1062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=21697871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFWjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=509-524&author=C.+J.+Whiteauthor=A.+K.+Yudin&title=Contemporary+strategies+for+peptide+macrocyclization&doi=10.1038%2Fnchem.1062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Contemporary strategies for peptide macrocyclization</span></div><div class="casAuthors">White, Christopher J.; Yudin, Andrei K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">509-524</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Peptide macrocycles have found applications that range from drug discovery to nanomaterials.  These ring-shaped mols. have shown remarkable capacity for functional fine-tuning.  Such capacity is enabled by the possibility of adjusting the peptide conformation using the techniques of chem. synthesis.  Cyclic peptides have been difficult, and often impossible, to prep. using traditional synthetic methods.  For macrocyclization to occur, the activated peptide must adopt an entropically disfavored pre-cyclization conformation before forming the desired product.  Here, recent solns. to some of the major challenges in this important area of contemporary synthesis were reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUTda6OkfQprVg90H21EOLACvtfcHk0li8Cy-prpsZbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFWjtrc%253D&md5=32dfd94692ca20901dc8828bcd27ae8c</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1062%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DC.%2BJ.%26aulast%3DYudin%26aufirst%3DA.%2BK.%26atitle%3DContemporary%2520strategies%2520for%2520peptide%2520macrocyclization%26jtitle%3DNat.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D509%26epage%3D524%26doi%3D10.1038%2Fnchem.1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepherd, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucke, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoermer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Orally absorbed cyclic peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">8094</span>– <span class="NLM_lpage">8128</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.6b00838</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.6b00838" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXot12lurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2017&pages=8094-8128&author=D.+S.+Nielsenauthor=N.+E.+Shepherdauthor=W.+Xuauthor=A.+J.+Luckeauthor=M.+J.+Stoermerauthor=D.+P.+Fairlie&title=Orally+absorbed+cyclic+peptides&doi=10.1021%2Facs.chemrev.6b00838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Absorbed Cyclic Peptides</span></div><div class="casAuthors">Nielsen, Daniel S.; Shepherd, Nicholas E.; Xu, Weijun; Lucke, Andrew J.; Stoermer, Martin J.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8094-8128</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Peptides and proteins are not orally bioavailable in mammals, although a few peptides are intestinally absorbed in small amts.  Polypeptides are generally too large and polar to passively diffuse through lipid membranes, while most known active transport mechanisms facilitate cell uptake of only very small peptides.  Systematic evaluations of peptides with mol. wts. above 500 Da are needed to identify parameters that influence oral bioavailability.  Here we describe 125 cyclic peptides contg. four to thirty-seven amino acids that are orally absorbed by mammals.  Cyclization minimizes degrdn. in the gut, blood and tissues by removing cleavable N- and C-termini and by shielding components from metabolic enzymes.  Cyclization also folds peptides into bioactive conformations that det. exposure of polar atoms to solvation by water and lipids, and therefore should influence oral bioavailability.  Key chem. properties thought to influence oral absorption and bioavailability are analyzed, including mol. wt., octanol-water partitioning, hydrogen bond donors/acceptors, rotatable bonds and polar surface area.  The cyclic peptides violated to different degrees all of the limits traditionally considered to be important for oral bioavailability of drug-like small mols., although fewer hydrogen bond donors and reduced flexibility generally favored oral absorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprHf1YVkf7ErVg90H21EOLACvtfcHk0ljYCi9lE9hfFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXot12lurY%253D&md5=38af1945471e5ddffd3ae630ebbe129b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.6b00838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.6b00838%26sid%3Dliteratum%253Aachs%26aulast%3DNielsen%26aufirst%3DD.%2BS.%26aulast%3DShepherd%26aufirst%3DN.%2BE.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLucke%26aufirst%3DA.%2BJ.%26aulast%3DStoermer%26aufirst%3DM.%2BJ.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DOrally%2520absorbed%2520cyclic%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2017%26volume%3D117%26spage%3D8094%26epage%3D8128%26doi%3D10.1021%2Facs.chemrev.6b00838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ene, D.</span></span> <span> </span><span class="NLM_article-title">Olefin metathesis in drug discovery and development - examples from recent patent literature</span>. <i>Org. Process Res. Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1938</span>– <span class="NLM_lpage">1962</span>, <span class="refDoi"> DOI: 10.1021/acs.oprd.7b00319</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.oprd.7b00319" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2gsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=1938-1962&author=D.+Hughesauthor=P.+Wheelerauthor=D.+Ene&title=Olefin+metathesis+in+drug+discovery+and+development+-+examples+from+recent+patent+literature&doi=10.1021%2Facs.oprd.7b00319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Olefin Metathesis in Drug Discovery and Development-Examples from Recent Patent Literature</span></div><div class="casAuthors">Hughes, David; Wheeler, Philip; Ene, Doina</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1938-1962</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review that summarizes applications of the metathesis reactions in drug discovery and development in the pharmaceutical industry disclosed in the patent literature from Jan. 2016 to August 2017.  The olefin metathesis reaction is finding increasing use in drug discovery and process chem., with a no. of applications now implemented at com. manufg. scale.  Catalyst improvements over the past decade have allowed use of the metathesis reaction with highly functionalized substrates, allowing chemists to access increasingly diverse chem. space, including most notably macrocycles, constrained small ring spirocycles, and fused-ring systems.  For scientists employed in the pharmaceutical industry, the patent literature is the primary avenue for communication of synthetic routes to drug candidates.  While most examples of the metathesis reaction in the patent literature offer only sketchy exptl. details and provide little context on reaction development, the wide scope of substrates within the pharmaceutical patent literature provides a true indication of reaction scope and functional group compatibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwS-l_9Wgak7Vg90H21EOLACvtfcHk0ljYCi9lE9hfFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2gsrbP&md5=8fcebbc4105e77751d56724d758535ac</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.oprd.7b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.oprd.7b00319%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DD.%26aulast%3DWheeler%26aufirst%3DP.%26aulast%3DEne%26aufirst%3DD.%26atitle%3DOlefin%2520metathesis%2520in%2520drug%2520discovery%2520and%2520development%2520-%2520examples%2520from%2520recent%2520patent%2520literature%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2017%26volume%3D21%26spage%3D1938%26epage%3D1962%26doi%3D10.1021%2Facs.oprd.7b00319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogba, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Leary, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grubbs, R. H.</span></span> <span> </span><span class="NLM_article-title">Recent advances in ruthenium-based olefin metathesis</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">4510</span>– <span class="NLM_lpage">4544</span>, <span class="refDoi"> DOI: 10.1039/C8CS00027A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1039%2FC8CS00027A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=29714397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFyqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=4510-4544&author=O.+M.+Ogbaauthor=N.+C.+Warnerauthor=D.+J.+O%E2%80%99Learyauthor=R.+H.+Grubbs&title=Recent+advances+in+ruthenium-based+olefin+metathesis&doi=10.1039%2FC8CS00027A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in ruthenium-based olefin metathesis</span></div><div class="casAuthors">Ogba, O. M.; Warner, N. C.; O'Leary, D. J.; Grubbs, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4510-4544</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ruthenium-based olefin metathesis catalysts, known for their functional group tolerance and broad applicability in org. synthesis and polymer science, continue to evolve as an enabling technol. in these areas.  A discussion of recent mechanistic investigations is followed by an overview of selected applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-0jCz26VHJ7Vg90H21EOLACvtfcHk0ljYCi9lE9hfFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFyqs7c%253D&md5=c7b8d582c3b5eb57b430825a2288f1d2</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1039%2FC8CS00027A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CS00027A%26sid%3Dliteratum%253Aachs%26aulast%3DOgba%26aufirst%3DO.%2BM.%26aulast%3DWarner%26aufirst%3DN.%2BC.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DD.%2BJ.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DRecent%2520advances%2520in%2520ruthenium-based%2520olefin%2520metathesis%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2018%26volume%3D47%26spage%3D4510%26epage%3D4544%26doi%3D10.1039%2FC8CS00027A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dias, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urban, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roessner, U.</span></span> <span> </span><span class="NLM_article-title">A historical overview of natural products in drug discovery</span>. <i>Metabolites</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.3390/metabo2020303</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.3390%2Fmetabo2020303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=24957513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1SltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=303-336&author=D.+A.+Diasauthor=S.+Urbanauthor=U.+Roessner&title=A+historical+overview+of+natural+products+in+drug+discovery&doi=10.3390%2Fmetabo2020303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">A historical overview of natural products in drug discovery</span></div><div class="casAuthors">Dias, Daniel A.; Urban, Sylvia; Roessner, Ute</div><div class="citationInfo"><span class="NLM_cas:title">Metabolites</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">303-336</span>CODEN:
                <span class="NLM_cas:coden">METALU</span>;
        ISSN:<span class="NLM_cas:issn">2218-1989</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Historically, natural products have been used since ancient times and in folklore for the treatment of many diseases and illnesses.  Classical natural product chem. methodologies enabled a vast array of bioactive secondary metabolites from terrestrial and marine sources to be discovered.  Many of these natural products have gone on to become current drug candidates.  This brief review aims to highlight historically significant bioactive marine and terrestrial natural products, their use in folklore and dereplication techniques to rapidly facilitate their discovery.  Furthermore a discussion of how natural product chem. has resulted in the identification of many drug candidates; the application of advanced hyphenated spectroscopic techniques to aid in their discovery, the future of natural product chem. and finally adopting metabolomic profiling and dereplication approaches for the comprehensive study of natural product exts. will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsKveZ4J9wU7Vg90H21EOLACvtfcHk0ljYCi9lE9hfFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1SltLs%253D&md5=d02ea918e56b6cc7de17053adaf47650</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3390%2Fmetabo2020303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmetabo2020303%26sid%3Dliteratum%253Aachs%26aulast%3DDias%26aufirst%3DD.%2BA.%26aulast%3DUrban%26aufirst%3DS.%26aulast%3DRoessner%26aufirst%3DU.%26atitle%3DA%2520historical%2520overview%2520of%2520natural%2520products%2520in%2520drug%2520discovery%26jtitle%3DMetabolites%26date%3D2012%26volume%3D2%26spage%3D303%26epage%3D336%26doi%3D10.3390%2Fmetabo2020303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koehn, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">The evolving role of natural products in drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">206</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nrd1657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd1657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15729362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslSnsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=206-220&author=F.+E.+Koehnauthor=G.+T.+Carter&title=The+evolving+role+of+natural+products+in+drug+discovery&doi=10.1038%2Fnrd1657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The evolving role of natural products in drug discovery</span></div><div class="casAuthors">Koehn, Frank E.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-220</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their derivs. have historically been invaluable as a source of therapeutic agents.  However, in the past decade, research into natural products in the pharmaceutical industry has declined, owing to issues such as the lack of compatibility of traditional natural-product ext. libraries with high-throughput screening.  However, as discussed in this review, recent technol. advances that help to address these issues, coupled with unrealized expectations from current lead-generation strategies, have led to a renewed interest in natural products in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRGIXVxX38LVg90H21EOLACvtfcHk0lisPunI6K3IuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslSnsrg%253D&md5=ce80052abaa76430220ee5981138053e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnrd1657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1657%26sid%3Dliteratum%253Aachs%26aulast%3DKoehn%26aufirst%3DF.%2BE.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DThe%2520evolving%2520role%2520of%2520natural%2520products%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D206%26epage%3D220%26doi%3D10.1038%2Fnrd1657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhaus, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">From complex natural products to simple synthetic mimetics by computational de novo design</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6789</span>– <span class="NLM_lpage">6792</span>, <span class="refDoi"> DOI: 10.1002/anie.201601941</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.201601941" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28Xms1OisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=6789-6792&author=L.+Friedrichauthor=T.+Rodriguesauthor=C.+S.+Neuhausauthor=P.+Schneiderauthor=G.+Schneider&title=From+complex+natural+products+to+simple+synthetic+mimetics+by+computational+de+novo+design&doi=10.1002%2Fanie.201601941"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">From Complex Natural Products to Simple Synthetic Mimetics by Computational De Novo Design</span></div><div class="casAuthors">Friedrich, Lukas; Rodrigues, Tiago; Neuhaus, Claudia S.; Schneider, Petra; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6789-6792</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The authors present the computational de novo design of synthetically accessible chem. entities that mimic the complex sesquiterpene natural product (-)-Englerin A.  The authors synthesized lead-like probes from com. available building blocks and profiled them for activity against a computationally predicted panel of macromol. targets.  Both the design template (-)-Englerin A and its low-mol. wt. mimetics presented nanomolar binding affinities and antagonized the transient receptor potential calcium channel TRPM8 in a cell-based assay, without showing target promiscuity or frequent-hitter properties.  This proof-of-concept study outlines an expeditious soln. to obtaining natural-product-inspired chem. matter with desirable properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBDJqrkHVbAbVg90H21EOLACvtfcHk0lisPunI6K3IuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xms1OisL4%253D&md5=7c1af0c6a47b8dc7241737e41a9e5e3b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fanie.201601941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201601941%26sid%3Dliteratum%253Aachs%26aulast%3DFriedrich%26aufirst%3DL.%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DNeuhaus%26aufirst%3DC.%2BS.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DFrom%2520complex%2520natural%2520products%2520to%2520simple%2520synthetic%2520mimetics%2520by%2520computational%2520de%2520novo%2520design%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2016%26volume%3D55%26spage%3D6789%26epage%3D6792%26doi%3D10.1002%2Fanie.201601941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, A.</span></span> <span> </span><span class="NLM_article-title">The impact of natural products upon modern drug discovery</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2008.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.cbpa.2008.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=18423384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1ersrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=306-317&author=A.+Ganesan&title=The+impact+of+natural+products+upon+modern+drug+discovery&doi=10.1016%2Fj.cbpa.2008.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The impact of natural products upon modern drug discovery</span></div><div class="casAuthors">Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-317</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the period 1970-2006, a total of 24 unique natural products were discovered that led to an approved drug.  We analyze these successful leads in terms of drug-like properties, and show that they can be divided into two equal subsets.  The first falls in the Lipinski universe' and complies with the Rule of Five.  The second is a parallel universe' that violates the rules.  Nevertheless, the latter compds. remain largely compliant in terms of log P and H-bond donors, highlighting the importance of these two metrics in predicting bioavailability.  Natural products are often cited as an exception to Lipinski's rules.  We believe this is because nature has learned to maintain low hydrophobicity and intermol. H-bond donating potential when it needs to make biol. active compds. with high mol. wt. and large nos. of rotatable bonds.  In addn., natural products are more likely than purely synthetic compds. to resemble biosynthetic intermediates or endogenous metabolites, and hence take advantage of active transport mechanisms.  Interestingly, the natural product leads in the Lipinski and parallel universe had an identical success rate (50%) in delivering an oral drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXd8x0Vy0yerVg90H21EOLACvtfcHk0lisPunI6K3IuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1ersrk%253D&md5=8cdde276c59d84071ea2d6f572d10088</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DThe%2520impact%2520of%2520natural%2520products%2520upon%2520modern%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D306%26epage%3D317%26doi%3D10.1016%2Fj.cbpa.2008.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vederas, J. C.</span></span> <span> </span><span class="NLM_article-title">Drug discovery and natural products: end of an era or an endless frontier?</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1126/science.1168243</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1126%2Fscience.1168243" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=19589993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVGmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2009&pages=161-165&author=J.+W.+Liauthor=J.+C.+Vederas&title=Drug+discovery+and+natural+products%3A+end+of+an+era+or+an+endless+frontier%3F&doi=10.1126%2Fscience.1168243"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Drug discovery and natural products end of an era or an endless frontier?</span></div><div class="casAuthors">Li, Jess W.-H.; Vederas, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">5937</span>),
    <span class="NLM_cas:pages">161-165</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr90S_IHvC-8bVg90H21EOLACvtfcHk0lisPunI6K3IuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVGmsrc%253D&md5=92cbb0ae2947501b031a99b774d2adfb</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.1168243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1168243%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BW.%26aulast%3DVederas%26aufirst%3DJ.%2BC.%26atitle%3DDrug%2520discovery%2520and%2520natural%2520products%253A%2520end%2520of%2520an%2520era%2520or%2520an%2520endless%2520frontier%253F%26jtitle%3DScience%26date%3D2009%26volume%3D325%26spage%3D161%26epage%3D165%26doi%3D10.1126%2Fscience.1168243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the 30 years from 1981 to 2010</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1021/np200906s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200906s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVeku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=311-335&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+30+years+from+1981+to+2010&doi=10.1021%2Fnp200906s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">311-335</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">This review is an updated and expanded version of the three prior reviews that were published in this journal in 1997, 2003, and 2007.  In the case of all approved therapeutic agents, the time frame has been extended to cover the 30 years from Jan. 1, 1981, to Dec. 31, 2010, for all diseases worldwide, and from 1950 (earliest so far identified) to Dec. 2010 for all approved antitumor drugs worldwide.  We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions and have added a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixts." that have now been recognized as drug entities by the FDA and similar organizations.  From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well.  Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 175 small mols., 131, or 74.8%, are other than "S" (synthetic), with 85, or 48.6%, actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compd. approved as a drug in this 30-yr time frame.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5OzO0oiD5sLVg90H21EOLACvtfcHk0li_WE8IWkSffQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVeku78%253D&md5=395ac7378f07d122a5789d7b440f858d</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fnp200906s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200906s%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%252030%2520years%2520from%25201981%2520to%25202010%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D311%26epage%3D335%26doi%3D10.1021%2Fnp200906s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, G.</span></span> <span> </span><span class="NLM_article-title">Counting on natural products for drug design</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchem.2479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnchem.2479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27219696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=531-541&author=T.+Rodriguesauthor=D.+Rekerauthor=P.+Schneiderauthor=G.+Schneider&title=Counting+on+natural+products+for+drug+design&doi=10.1038%2Fnchem.2479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Counting on natural products for drug design</span></div><div class="casAuthors">Rodrigues, Tiago; Reker, Daniel; Schneider, Petra; Schneider, Gisbert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">531-541</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their mol. frameworks have a long tradition as valuable starting points for medicinal chem. and drug discovery.  Recently, there has been a revitalization of interest in the inclusion of these chemotypes in compd. collections for screening and achieving selective target modulation.  Here the authors discuss natural-product-inspired drug discovery with a focus on recent advances in the design of synthetically tractable small mols. that mimic nature's chem.  The authors highlight the potential of innovative computational tools in processing structurally complex natural products to predict their macromol. targets and attempt to forecast the role that natural-product-derived fragments and fragment-like natural products will play in next-generation drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNR16z66-NgLVg90H21EOLACvtfcHk0li_WE8IWkSffQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmslSrsbk%253D&md5=3f6391192d648de2a54524afafd6203a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2479%26sid%3Dliteratum%253Aachs%26aulast%3DRodrigues%26aufirst%3DT.%26aulast%3DReker%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DG.%26atitle%3DCounting%2520on%2520natural%2520products%2520for%2520drug%2520design%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D531%26epage%3D541%26doi%3D10.1038%2Fnchem.2479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, D. S.</span></span> <span> </span><span class="NLM_article-title">Cheminformatic comparison of approved drugs from natural product versus synthetic origins</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4802</span>– <span class="NLM_lpage">4807</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.bmcl.2015.07.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=26254944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOmur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4802-4807&author=C.+F.+Strattonauthor=D.+J.+Newmanauthor=D.+S.+Tan&title=Cheminformatic+comparison+of+approved+drugs+from+natural+product+versus+synthetic+origins&doi=10.1016%2Fj.bmcl.2015.07.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cheminformatic comparison of approved drugs from natural product versus synthetic origins</span></div><div class="casAuthors">Stratton, Christopher F.; Newman, David J.; Tan, Derek S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4802-4807</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite the recent decline of natural product discovery programs in the pharmaceutical industry, approx. half of all new drug approvals still trace their structural origins to a natural product.  Herein, we use principal component anal. to compare the structural and physicochem. features of drugs from natural product-based vs. completely synthetic origins that were approved between 1981 and 2010.  Drugs based on natural product structures display greater chem. diversity and occupy larger regions of chem. space than drugs from completely synthetic origins.  Notably, synthetic drugs based on natural product pharmacophores also exhibit lower hydrophobicity and greater stereochem. content than drugs from completely synthetic origins.  These results illustrate that structural features found in natural products can be successfully incorporated into synthetic drugs, thereby increasing the chem. diversity available for small-mol. drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc6Ar3gQVrDrVg90H21EOLACvtfcHk0li_WE8IWkSffQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOmur3I&md5=9fe156eef0e6c57aabe2bfe65aae948c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.014%26sid%3Dliteratum%253Aachs%26aulast%3DStratton%26aufirst%3DC.%2BF.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DTan%26aufirst%3DD.%2BS.%26atitle%3DCheminformatic%2520comparison%2520of%2520approved%2520drugs%2520from%2520natural%2520product%2520versus%2520synthetic%2520origins%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4802%26epage%3D4807%26doi%3D10.1016%2Fj.bmcl.2015.07.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ertl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roggo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuffenhauer, A.</span></span> <span> </span><span class="NLM_article-title">Natural product-likeness score and its application for prioritization of compound libraries</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1021/ci700286x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci700286x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=68-74&author=P.+Ertlauthor=S.+Roggoauthor=A.+Schuffenhauer&title=Natural+product-likeness+score+and+its+application+for+prioritization+of+compound+libraries&doi=10.1021%2Fci700286x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Product-likeness Score and Its Application for Prioritization of Compound Libraries</span></div><div class="casAuthors">Ertl, Peter; Roggo, Silvio; Schuffenhauer, Ansgar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-74</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Natural products (NPs) have been optimized in a very long natural selection process for optimal interactions with biol. macromols.  NPs are therefore an excellent source of validated substructures for the design of novel bioactive mols.  Various cheminformatics techniques can provide useful help in analyzing NPs, and the results of such studies may be used with advantage in the drug discovery process.  In the present study we describe a method to calc. the natural product-likeness score-a Bayesian measure which allows for the detn. of how mols. are similar to the structural space covered by natural products.  This score is shown to efficiently sep. NPs from synthetic mols. in a cross-validation expt.  Possible applications of the NP-likeness score are discussed and illustrated on several examples including virtual screening, prioritization of compd. libraries toward NP-likeness, and design of building blocks for the synthesis of NP-like libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGre4QzdpRURjbVg90H21EOLACvtfcHk0lhKOw6oEffoXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCqtLfP&md5=0ecfc66d9cd731fcd5c131cd246d7dcf</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fci700286x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700286x%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRoggo%26aufirst%3DS.%26aulast%3DSchuffenhauer%26aufirst%3DA.%26atitle%3DNatural%2520product-likeness%2520score%2520and%2520its%2520application%2520for%2520prioritization%2520of%2520compound%2520libraries%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2008%26volume%3D48%26spage%3D68%26epage%3D74%26doi%3D10.1021%2Fci700286x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J. M.</span></span> <span> </span><span class="NLM_article-title">Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry</span>. <i>J. Chem. Inf. Comput. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">227</span>, <span class="refDoi"> DOI: 10.1021/ci0200467</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci0200467" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlOksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=218-227&author=M.+Feherauthor=J.+M.+Schmidt&title=Property+distributions%3A+differences+between+drugs%2C+natural+products%2C+and+molecules+from+combinatorial+chemistry&doi=10.1021%2Fci0200467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry</span></div><div class="casAuthors">Feher, Miklos; Schmidt, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">218-227</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The differences between three different compd. classes, natural products, mols. from combinatorial synthesis, and drug mols., were investigated.  The major structural differences between natural and combinatorial compds. originate mainly from properties introduced to make combinatorial synthesis more efficient.  These include the no. of chiral centers, the prevalence of arom. rings, the introduction of complex ring systems, and the degree of the satn. of the mol. as well as the no. and ratios of different heteroatoms.  As drug mols. derive from both natural and synthetic sources, they cover a joint area in property space of natural and combinatorial compds.  A PCA-based scheme is presented that differentiates the three classes of compds.  It is suggested that by mimicking certain distribution properties of natural compds., combinatorial products might be made that are substantially more diverse and have greater biol. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpma3fkS14voLVg90H21EOLACvtfcHk0lhKOw6oEffoXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlOksLg%253D&md5=eb86ed83699fc487dfb7f2cb55296e69</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fci0200467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci0200467%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%2BM.%26atitle%3DProperty%2520distributions%253A%2520differences%2520between%2520drugs%252C%2520natural%2520products%252C%2520and%2520molecules%2520from%2520combinatorial%2520chemistry%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2003%26volume%3D43%26spage%3D218%26epage%3D227%26doi%3D10.1021%2Fci0200467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edrada-Ebel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, R. J.</span></span> <span> </span><span class="NLM_article-title">The re-emergence of natural products for drug discovery in the genomics era</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1038/nrd4510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrd4510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=25614221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVarsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=111-129&author=A.+L.+Harveyauthor=R.+Edrada-Ebelauthor=R.+J.+Quinn&title=The+re-emergence+of+natural+products+for+drug+discovery+in+the+genomics+era&doi=10.1038%2Fnrd4510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The re-emergence of natural products for drug discovery in the genomics era</span></div><div class="casAuthors">Harvey, Alan L.; Edrada-Ebel, RuAngelie; Quinn, Ronald J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">111-129</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Natural products have been a rich source of compds. for drug discovery.  However, their use has diminished in the past two decades, in part because of tech. barriers to screening natural products in high-throughput assays against mol. targets.  Here, we review strategies for natural product screening that harness the recent tech. advances that have reduced these barriers.  We also assess the use of genomic and metabolomic approaches to augment traditional methods of studying natural products, and highlight recent examples of natural products in antimicrobial drug discovery and as inhibitors of protein-protein interactions.  The growing appreciation of functional assays and phenotypic screens may further contribute to a revival of interest in natural products for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkQ8QarpZ6orVg90H21EOLACvtfcHk0lhKOw6oEffoXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVarsbg%253D&md5=b871148315dc0623683498fa15205b14</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnrd4510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4510%26sid%3Dliteratum%253Aachs%26aulast%3DHarvey%26aufirst%3DA.%2BL.%26aulast%3DEdrada-Ebel%26aufirst%3DR.%26aulast%3DQuinn%26aufirst%3DR.%2BJ.%26atitle%3DThe%2520re-emergence%2520of%2520natural%2520products%2520for%2520drug%2520discovery%2520in%2520the%2520genomics%2520era%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D111%26epage%3D129%26doi%3D10.1038%2Fnrd4510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamarre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordingley, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudreau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukolj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagace, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poupart, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rancourt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sentjens, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St George, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibeault, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weldon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas-Brunet, M.</span></span> <span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>426</i></span>,  <span class="NLM_fpage">186</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1038/nature02099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+Bosauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.+M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagaceauthor=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.+A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.+L.+Yongauthor=M.+Llinas-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus&doi=10.1038%2Fnature02099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lgKC0olz9p_1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189%26doi%3D10.1038%2Fnature02099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span> <span> </span><span class="NLM_article-title">The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1002/bip.20127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fbip.20127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15386268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVSnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2004&pages=309-323&author=Y.+S.+Tsantrizos&title=The+design+of+a+potent+inhibitor+of+the+hepatitis+C+virus+NS3+protease%3A+BILN+2061%2D%2Dfrom+the+NMR+tube+to+the+clinic&doi=10.1002%2Fbip.20127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061 - From the NMR tube to the clinic</span></div><div class="casAuthors">Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-323</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The virally encoded serine protease NS3/NS4A is essential to the life cycle of the hepatitis C virus (HCV), an important human pathogen causing chronic hepatitis, cirrhosis of the liver, and hepatocellular carcinoma.  Until very recently, the design of inhibitors for the HCV NS3 protease was limited to large peptidomimetic compds. with poor pharmacokinetic properties, making drug discovery an extremely challenging endeavor.  In our quest for the discovery of a small-mol. lead that could block replication of the hepatitis C virus by binding to the HCV NS3 protease, the crit. protein-polypeptide interactions between the virally encoded NS3 serine protease and its polyprotein substrate were investigated.  Lead optimization of a substrate-based hexapeptide, guided by structural data, led to the understanding of the mol. dynamics and electronic effects that modulate the affinity of peptidomimetic ligands for the active site of this enzyme.  Macrocyclic β-strand scaffolds were designed that allowed the discovery of potent, highly selective, and orally bioavailable compds.  These mols. were the first HCV NS3 protease inhibitors reported that inhibit replication of HCV subgenomic RNA in a cell-based replicon assay at low nanomolar concns.  Optimization of their biopharmaceutical properties led to the discovery of the clin. candidate BILN 2061.  Oral administration of BILN 2061 to patients infected with the hepatitis C genotype 1 virus resulted in an impressive redn. of viral RNA levels, establishing proof-of-concept for HCV NS3 protease inhibitors as therapeutic agents in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxxZEqYR5XlrVg90H21EOLACvtfcHk0lgKC0olz9p_1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVSnsLk%253D&md5=94dc1ba22bec28da890d081c2cd9efee</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1002%2Fbip.20127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.20127%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DThe%2520design%2520of%2520a%2520potent%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520BILN%25202061--from%2520the%2520NMR%2520tube%2520to%2520the%2520clinic%26jtitle%3DBiopolymers%26date%3D2004%26volume%3D76%26spage%3D309%26epage%3D323%26doi%3D10.1002%2Fbip.20127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goudreau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukolj, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinas-Brunet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamarre, D.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">1356</span>– <span class="NLM_lpage">1360</span>, <span class="refDoi"> DOI: 10.1002/anie.200390347</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.200390347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1356-1360&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+inhibitors+of+the+NS3+protease+as+potential+therapeutic+agents+of+hepatitis+C+virus+infection&doi=10.1002%2Fanie.200390347"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span></div><div class="casAuthors">Tsantrizos, Youla S.; Bolger, Gordon; Bonneau, Pierre; Cameron, Dale R.; Goudreau, Nathalie; Kukolj, George; LaPlante, Steven R.; Llinas-Brunet, Montse; Nar, Herbert; Lamarre, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1356-1360</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel class of selective inhibitors of the hepatitis C virus NS3 protease, an enzyme which is essential for viral replication in vivo, was developed.  The inhibitors are based on the structure-activity relationship between a substrate-based peptidomimetic ligand and the HCV NS3 serine protease.  The designed HCV inhibitor and its satd. analogs are the first inhibitors of the NS3 protease which inhibit HCV RNA replication in the cell-based replicon assay.  In addn., they are orally absorbed and stable to metabolic breakdown.  Thus, these compds. show many of the desirable properties of a druglike archetype and could lead t a clin. useful antiviral agent for the treatment of hepatitis C viral infections in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCij3shP5tmLVg90H21EOLACvtfcHk0lgKC0olz9p_1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D&md5=e0a3c98ee0096bfc3d058bf0b92b81c3</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.200390347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200390347%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520the%2520NS3%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1356%26epage%3D1360%26doi%3D10.1002%2Fanie.200390347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tyndall, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">907</span>, <span class="refDoi"> DOI: 10.2174/0929867013372715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.2174%2F0929867013372715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=11375757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVeiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2001&pages=893-907&author=J.+D.+Tyndallauthor=D.+P.+Fairlie&title=Macrocycles+mimic+the+extended+peptide+conformation+recognized+by+aspartic%2C+serine%2C+cysteine+and+metallo+proteases&doi=10.2174%2F0929867013372715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteases</span></div><div class="casAuthors">Tyndall, Joel D. A.; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">893-907</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers</span>)
        </div><div class="casAbstract">A review with refs.  It has been previously demonstrated that aspartic, serine, metallo and cysteine proteases bind to their inhibitors and substrate analogs in a single conformation, the saw-tooth or extended beta-strand.  Consequently a generic approach to the development of protease inhibitors is the use of constraints that conformationally restrict putative inhibitor mols. to an extended form.  In this way the inhibitor is pre-organized for binding to a protease and does not need to rearrange its structure.  One constraining device that has proven to be effective for such pre-organization is macrocyclization.  This article illustrates the general principle that macrocycles, esp. those composed of 3-4 amino acids and usually 13-17 ring atoms, can effectively mimic the extended conformation of short peptide sequences.  Such structure-stabilizing macrocycles are stable to degrdn. by proteases, valuable components of potent protease inhibitors, and in many cases they are also bioavailable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyuoMyDlMrlbVg90H21EOLACvtfcHk0lgKC0olz9p_1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVeiur4%253D&md5=2525f64466090d8f371452ed9f0d676c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2174%2F0929867013372715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867013372715%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DMacrocycles%2520mimic%2520the%2520extended%2520peptide%2520conformation%2520recognized%2520by%2520aspartic%252C%2520serine%252C%2520cysteine%2520and%2520metallo%2520proteases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2001%26volume%3D8%26spage%3D893%26epage%3D907%26doi%3D10.2174%2F0929867013372715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amssoms, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Last, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devogelaere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijgen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berke, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehertogh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleiren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der Helm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Emelen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyanguile, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based macrocyclization yields hepatitis C virus NS5B inhibitors with improved binding affinities and pharmacokinetic properties</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4637</span>– <span class="NLM_lpage">4640</span>, <span class="refDoi"> DOI: 10.1002/anie.201200110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.201200110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvVGltLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=4637-4640&author=M.+D.+Cummingsauthor=T.+I.+Linauthor=L.+Huauthor=A.+Tahriauthor=D.+McGowanauthor=K.+Amssomsauthor=S.+Lastauthor=B.+Devogelaereauthor=M.+C.+Rouanauthor=L.+Vijgenauthor=J.+M.+Berkeauthor=P.+Dehertoghauthor=E.+Fransenauthor=E.+Cleirenauthor=L.+Van+Der+Helmauthor=G.+Fanningauthor=K.+Van+Emelenauthor=O.+Nyanguileauthor=K.+Simmenauthor=P.+Raboissonauthor=S.+Vendeville&title=Structure-based+macrocyclization+yields+hepatitis+C+virus+NS5B+inhibitors+with+improved+binding+affinities+and+pharmacokinetic+properties&doi=10.1002%2Fanie.201200110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties</span></div><div class="casAuthors">Cummings, Maxwell D.; Lin, Tse-I.; Hu, Lili; Tahri, Abdellah; McGowan, David; Amssoms, Katie; Last, Stefaan; Devogelaere, Benoit; Rouan, Marie-Claude; Vijgen, Leen; Berke, Jan Martin; Dehertogh, Pascale; Fransen, Els; Cleiren, Erna; van der Helm, Liesbet; Fanning, Gregory; Van Emelen, Kristof; Nyanguile, Origene; Simmen, Kenny; Raboisson, Pierre; Vendeville, Sandrine</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4637-4640, S4637/1-S4637/20</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Macrocyclization is one mol. design strategy that can be used to improve the drug-related characteristics of small mols. and peptides,'1"4' and thus may provide a route to a less restrictive "drug-likeness space".  Structure-based design is typically focused on the optimization of a chem. series to increase affinity toward a target protein: modification to gain addnl. binding contacts and rigidification to favor a bio-active conformation are two common strategies.  In addn. to affinity for the primary target, a 3D structure of a relevant protein-small mol. complex can be used to guide the optimization of other pharmaceutical properties.  Substituent positions that project away from the binding site may be chem. exploited to alter one or more PK- or ADME-related properties (e.g. "solubilizing groups") while having minimal effect on the therapeutically relevant binding interaction (PK = pharmacokinetics; ADME = absorption, distribution, metab., and excretion).  Pursuing a design strategy based on publicly available 3D structures, we combined rigidification and the introduction of a PK-enhancing group in a single modification by forming a macrocycle between two solvent-exposed substituent positions of a small-mol. inhibitor of an essential viral enzyme.  In the present work we have used structure-based design to guide macrocyclization, leading to the discovery of new inhibitors that maintain potency while showing substantially improved pharmacokinetic behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr70QpVIVUDr7Vg90H21EOLACvtfcHk0lgwQKu-BaXwZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvVGltLc%253D&md5=1dc1c86dcc8f22d406256e4a779e9e6e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Fanie.201200110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201200110%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DAmssoms%26aufirst%3DK.%26aulast%3DLast%26aufirst%3DS.%26aulast%3DDevogelaere%26aufirst%3DB.%26aulast%3DRouan%26aufirst%3DM.%2BC.%26aulast%3DVijgen%26aufirst%3DL.%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26aulast%3DDehertogh%26aufirst%3DP.%26aulast%3DFransen%26aufirst%3DE.%26aulast%3DCleiren%26aufirst%3DE.%26aulast%3DVan%2BDer%2BHelm%26aufirst%3DL.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DVan%2BEmelen%26aufirst%3DK.%26aulast%3DNyanguile%26aufirst%3DO.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DVendeville%26aufirst%3DS.%26atitle%3DStructure-based%2520macrocyclization%2520yields%2520hepatitis%2520C%2520virus%2520NS5B%2520inhibitors%2520with%2520improved%2520binding%2520affinities%2520and%2520pharmacokinetic%2520properties%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D4637%26epage%3D4640%26doi%3D10.1002%2Fanie.201200110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosise, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taremi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarosh-Tomaine, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senior, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasappan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovey, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saksena, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2310</span>– <span class="NLM_lpage">2318</span>, <span class="refDoi"> DOI: 10.1021/jm060173k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060173k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlyjt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2310-2318&author=A.+J.+Prongayauthor=Z.+Guoauthor=N.+Yaoauthor=J.+Pichardoauthor=T.+Fischmannauthor=C.+Stricklandauthor=J.+Myersauthor=P.+C.+Weberauthor=B.+M.+Beyerauthor=R.+Ingramauthor=Z.+Hongauthor=W.+W.+Prosiseauthor=L.+Ramanathanauthor=S.+S.+Taremiauthor=T.+Yarosh-Tomaineauthor=R.+Zhangauthor=M.+Seniorauthor=R.+S.+Yangauthor=B.+Malcolmauthor=A.+Arasappanauthor=F.+Bennettauthor=S.+L.+Bogenauthor=K.+Chenauthor=E.+Jaoauthor=Y.+T.+Liuauthor=R.+G.+Loveyauthor=A.+K.+Saksenaauthor=S.+Venkatramanauthor=V.+Girijavallabhanauthor=F.+G.+Njorogeauthor=V.+Madison&title=Discovery+of+the+HCV+NS3%2F4A+protease+inhibitor+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-+%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-+6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28Sch+503034%29+II.+Key+steps+in+structure-based+optimization&doi=10.1021%2Fjm060173k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the HCV NS3/4A Protease Inhibitor (1R,5S)-N-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034). Key Steps in Structure-Based Optimization</span></div><div class="casAuthors">Prongay, Andrew J.; Guo, Zhuyan; Yao, Nanhua; Pichardo, John; Fischmann, Thierry; Strickland, Corey; Myers, Joseph, Jr.; Weber, Patricia C.; Beyer, Brian M.; Ingram, Richard; Hong, Zhi; Prosise, Winifred W.; Ramanathan, Lata; Taremi, S. Shane; Yarosh-Tomaine, Taisa; Zhang, Rumin; Senior, Mary; Yang, Rong-Sheng; Malcolm, Bruce; Arasappan, Ashok; Bennett, Frank; Bogen, Stephane L.; Chen, Kevin; Jao, Edwin; Liu, Yi-Tsung; Lovey, Raymond G.; Saksena, Anil K.; Venkatraman, Srikanth; Girijavallabhan, Viyyoor; Njoroge, F. George; Madison, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2310-2318</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The structures of both the native holo-HCV NS3/4A protease domain and the protease domain with a serine 139 to alanine (S139A) mutation were solved to high resoln.  Subsequently, structures were detd. for a series of ketoamide inhibitors in complex with the protease.  The changes in the inhibitor potency were correlated with changes in the buried surface area upon binding the inhibitor to the active site.  The largest contribution to the binding energy arises from the hydrophobic interactions of the P1 and P2 groups as they bind to the S1 and S2 pockets [the numbering of the subsites is as defined in Berger, A.; Schechter, I. Philos. Trans. R. Soc. London, Ser. B 1970, 257, 249-264].  This correlation of the changes in potency with increased buried surface area contributed directly to the design of a potent tripeptide inhibitor of the HCV NS3/4A protease that is currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjU_OrFFP_JrVg90H21EOLACvtfcHk0lgwQKu-BaXwZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlyjt7c%253D&md5=9df7e3bc9b4973c82daf88d8fcf16b35</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm060173k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060173k%26sid%3Dliteratum%253Aachs%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DYarosh-Tomaine%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSenior%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.%2BS.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%2BT.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520the%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%2520%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-%25206%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528Sch%2520503034%2529%2520II.%2520Key%2520steps%2520in%2520structure-based%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2310%26epage%3D2318%26doi%3D10.1021%2Fjm060173k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span> <span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">4607</span>– <span class="NLM_lpage">4609</span>, <span class="refDoi"> DOI: 10.1021/ja711120r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFygur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.+S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.+L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease&doi=10.1021%2Fja711120r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease</span></div><div class="casAuthors">Liverton, Nigel J.; Holloway, M. Katharine; McCauley, John A.; Rudd, Michael T.; Butcher, John W.; Carroll, Steven S.; DiMuzio, Jillian; Fandozzi, Christine; Gilbert, Kevin F.; Mao, Shi-Shan; McIntyre, Charles J.; Nguyen, Kevin T.; Romano, Joseph J.; Stahlhut, Mark; Wan, Bang-Lin; Olsen, David B.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4607-4609</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. modeling of inhibitor bound full length HCV NS3/4A protease structures proved to be a valuable tool in the design of a new series of potent NS3 protease inhibitors.  Optimization of initial compds. provided 25a.  The in vitro activity and selectivity as well as the rat pharmacokinetic profile of 25a compare favorably with the data for other NS3/4A protease inhibitors currently in clin. development for the treatment of HCV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppYenMBNqdeLVg90H21EOLACvtfcHk0ljkhKIAALyVFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFygur8%253D&md5=5e7bb98bdb19c30bebb30f03a702838d</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.%2BS.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609%26doi%3D10.1021%2Fja711120r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arasappan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vibulbhan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parekh, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span> <span> </span><span class="NLM_article-title">Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1021/jm050820s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050820s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XitV2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=995-1005&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=A.+Arasappanauthor=S.+Venkatramanauthor=B.+Vibulbhanauthor=W.+Yangauthor=T.+N.+Parekhauthor=J.+Pichardoauthor=A.+Prongayauthor=K.+C.+Chengauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Novel+potent+hepatitis+C+virus+NS3+serine+protease+inhibitors+derived+from+proline-based+macrocycles&doi=10.1021%2Fjm050820s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Potent Hepatitis C Virus NS3 Serine Protease Inhibitors Derived from Proline-Based Macrocycles</span></div><div class="casAuthors">Chen, Kevin X.; Njoroge, F. George; Arasappan, Ashok; Venkatraman, Srikanth; Vibulbhan, Bancha; Yang, Weiying; Parekh, Tejal N.; Pichardo, John; Prongay, Andrew; Cheng, Kuo-Chi; Butkiewicz, Nancy; Yao, Nanhua; Madison, Vincent; Girijavallabhan, Viyyoor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">995-1005</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS3 protease is essential for viral replication.  It has been a target of choice for intensive drug discovery research.  On the basis of an active pentapeptide inhibitor, I, we envisioned that macrocyclization from the P2 proline to P3 capping could enhance binding to the backbone Ala156 residue and the S4 pocket.  Thus, a no. of P2 proline-based macrocyclic α-ketoamide inhibitors were prepd. and investigated in an HCV NS3 serine protease continuous assay (Ki*).  The biol. activity varied substantially depending on factors such as the ring size, no. of amino acid residues, no. of Me substituents, type of heteroatom in the linker, P3 residue, and configuration at the proline C-4 center.  The pentapeptide inhibitors were very potent, with the C-terminal acids and amides being the most active ones [II; R = H, R1 = cyclohexyl, R2 = NH-Gly-Phg-NMe2 (24), Ki* = 8 nM].  The tetrapeptides and tripeptides were less potent.  Sixteen- and seventeen-membered macrocyclic compds. were equally potent, while fifteen-membered analogs were slightly less active.  Gem-Di-Me substituents at the linker improved the potency of all inhibitors [the best compd. was II (R = Me, R1 = cyclohexyl, R2 = NH-Gly-Phg-NMe2) (45), Ki* = 6 nM].  The combination of tert-leucine at P3 and di-Me substituents at the linker in compd. II (R = Me, R1 = t-Bu, R2 = NH-Gly-Phg-NMe2) realized a selectivity of 307 against human neutrophil elastase.  Compd. 45 had an IC50 of 130 nM in a cellular replicon assay, while IC50 for 24 was 400 nM.  Several compds. had excellent s.c. AUC and bioavailability in rats.  Although tripeptide compd. II (R = Me, R1 = cyclohexyl, R2 = NH-allyl) was 97% orally bioavailable, larger pentapeptides generally had low oral bioavailability.  The X-ray crystal structure of compds. 24 and 45 bound to the protease demonstrated the close interaction of the macrocycle with the Ala156 Me group and S4 pocket.  The strategy of macrocyclization has been proved to be successful in improving potency (>20-fold greater than that of I) and in structural depeptization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdS3he5kAl_bVg90H21EOLACvtfcHk0ljkhKIAALyVFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitV2mtQ%253D%253D&md5=113c44a06c8018697ee83ae8614b6a95</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjm050820s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050820s%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%2BN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DNovel%2520potent%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%2520inhibitors%2520derived%2520from%2520proline-based%2520macrocycles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D995%26epage%3D1005%26doi%3D10.1021%2Fjm050820s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6229</span>– <span class="NLM_lpage">6235</span>, <span class="refDoi"> DOI: 10.1021/jm050323b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVGhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6229-6235&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Design%2C+synthesis%2C+and+biological+activity+of+m-tyrosine-based+16-+and+17-membered+macrocyclic+inhibitors+of+hepatitis+C+virus+NS3+serine+protease&doi=10.1021%2Fjm050323b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Activity of m-Tyrosine-Based 16- and 17-Membered Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease</span></div><div class="casAuthors">Chen, Kevin X.; Njoroge, F. George; Pichardo, John; Prongay, Andrew; Butkiewicz, Nancy; Yao, Nanhua; Madison, Vincent; Girijavallabhan, Viyyoor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6229-6235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The limited efficacy and considerable side effects of currently available therapies for the treatment of hepatitis C virus (HCV) infection have prompted significant efforts toward the development of safe and effective new therapeutics.  Towards that goal, m-tyrosine-based 17-membered macrocycles I (R = OBu-t, OH, NHMe, NMe2) and 16-membered macrocycles II (R = OBu-t, OH) were prepd. from m-tyrosine Me ester as HCV inhibitors.  I and II were tested in an HCV protease continuous assay.  The binding consts. indicated that II were less potent than I.  It was also evident that C-terminal acids and amides (binding const. range: 0.16-0.31 μM) were much better inhibitors than tert-Bu esters.  The x-ray crystal structure of I (R = OH) bound to the enzyme revealed that the macrocycle formed a "donut"-shaped ring around the Me group of Ala156; P2' Ph and P1 Pr groups wrapped around the Lys136 side chain, forming a "C"-shaped clamp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsFwPDh8XiLrVg90H21EOLACvtfcHk0ljuhwTLE_2EoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVGhtL0%253D&md5=a39ea79e72e9066c0f8e7891fe6733ea</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm050323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050323b%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520m-tyrosine-based%252016-%2520and%252017-membered%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6229%26epage%3D6235%26doi%3D10.1021%2Fjm050323b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butkiewicz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span> <span> </span><span class="NLM_article-title">Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 protease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">567</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1021/jm050520a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050520a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=567-574&author=K.+X.+Chenauthor=F.+G.+Njorogeauthor=J.+Pichardoauthor=A.+Prongayauthor=N.+Butkiewiczauthor=N.+Yaoauthor=V.+Madisonauthor=V.+Girijavallabhan&title=Potent+7-hydroxy-1%2C2%2C3%2C4-tetrahydroisoquinoline-3-carboxylic+acid-based+macrocyclic+inhibitors+of+hepatitis+C+virus+NS3+protease&doi=10.1021%2Fjm050520a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 protease</span></div><div class="casAuthors">Chen, Kevin X.; Njoroge, F. George; Pichardo, John; Prongay, Andrew; Butkiewicz, Nancy; Yao, Nanhua; Madison, Vincent; Girijavallabhan, Viyyoor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">567-574</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The NS3 protease of hepatitis C virus (HCV) has emerged as one of the best characterized targets for next-generation HCV therapy.  The tetrapeptide and pentapeptide contg. Tic moiety (Tic = 1,2,3,4-tetrahydroisoquinoline-3-carboxylamide) are α-ketoamide-type HCV serine protease inhibitors with modest potency.  We envisioned that the Tic moiety could be cyclized to the P3 capping group.  The resulting macrocycle could enhance the binding through its extra contact with the Ala156 Me group.  The precursor of the macrocycle was prepd. by capping obtained by amino acids coupling dipeptide I (Boc = tert-butoxycarbonyl) as hept-6-enoylamid, following by hydrogenation of the double bond.  The macrocyclization was achieved under Mitsunobu conditions (PPh3, ADDP).  The macrocyclic acid was then combined with appropriate right-hand fragments, which were prepd. from common intermediate BocNHCH(n-Pr)CH(OH)CO2H.  Finally, oxidn., deprotection, and amidation of α-hydroxyamide provided target inhibitors, e. g. II (R2 = Ot-Bu, OH, NMe2), which were tested in HCV NS3 protease continuous assay and showed a very good inhibitory activity against HCV NS3 protease.  The X-ray crystal structure of compd. II (R2 = NMe2) bound to the protease revealed that the macrocycle adopted a donut-like conformation and had close contact with the Ala156 Me group.  The ketone carbonyl formed a reversible covalent bond with Ser139.  The n-Pr of P1 norvaline and the arom. ring of P2' phenylglycine formed a C-shaped clamp around the Lys136 side chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiekDRG7PAMLVg90H21EOLACvtfcHk0ljuhwTLE_2EoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant73P&md5=3cec0c957614ed76433764467dfac1ae</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm050520a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050520a%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26atitle%3DPotent%25207-hydroxy-1%252C2%252C3%252C4-tetrahydroisoquinoline-3-carboxylic%2520acid-based%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D567%26epage%3D574%26doi%3D10.1021%2Fjm050520a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Francesco, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessole, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pace, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiore, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesci, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Muzio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteagudo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span> <span> </span><span class="NLM_article-title">Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1,3-thiazole as a P4 carbamate replacement</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7014</span>– <span class="NLM_lpage">7028</span>, <span class="refDoi"> DOI: 10.1021/jm900524b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900524b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7014-7028&author=M.+E.+Di%0AFrancescoauthor=G.+Dessoleauthor=E.+Niziauthor=P.+Paceauthor=U.+Kochauthor=F.+Fioreauthor=S.+Pesciauthor=J.+Di+Muzioauthor=E.+Monteagudoauthor=M.+Rowleyauthor=V.+Summa&title=Novel+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4A+protease+featuring+a+2-amino-1%2C3-thiazole+as+a+P4+carbamate+replacement&doi=10.1021%2Fjm900524b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement</span></div><div class="casAuthors">Di Francesco, M. Emilia; Dessole, Gabriella; Nizi, Emanuela; Pace, Paola; Koch, Uwe; Fiore, Fabrizio; Pesci, Silvia; Di Muzio, Jillian; Monteagudo, Edith; Rowley, Michael; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7014-7028</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of P2-P4 macrocyclic inhibitors of HCV NS3/4A protease characterized by high levels of potency and liver exposure was recently reported.  Within this novel class of inhibitors, a structurally diverse series of compds. I [X = isoquinoline-1,7-diyl, 2-phenylquinoline-4,6-diyl, 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)2, (CH2)3, CH2CMe2; Z = thiazol-2,4-diyl, 1,3,4-oxadiazol-2,5-diyl; R1 = i-Pr, t-Bu, cyclohexyl, (S)-EtCHMe, cyclopentyl; R2 = H2C:CH, Et] featuring a 2-amino-1,3-thiazole as replacement of the carbamate in P4 was identified.  Optimization studies focused on structural modifications in the P3, P2, and P1 regions of the macrocycle as well as on the linker chain and resulted in the discovery of several analogs characterized by excellent levels of enzyme and cellular activity.  Among these, I [double bond; X = 2-carbonyl-1,3-dihydroisoindolyl; Y = (CH2)3; Z = thiazol-2,4-diyl; R1 = (S)-EtCHMe; R2 = H2C:CH] displayed an attractive pharmacokinetic profile in preclin. species and showed sustained liver levels following oral administration in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIFtigQW8FUrVg90H21EOLACvtfcHk0ljuhwTLE_2EoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWgt7fN&md5=76e409fa1d0e9812ee78c4eeabca21ce</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm900524b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900524b%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DDessole%26aufirst%3DG.%26aulast%3DNizi%26aufirst%3DE.%26aulast%3DPace%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DPesci%26aufirst%3DS.%26aulast%3DDi%2BMuzio%26aufirst%3DJ.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DNovel%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4A%2520protease%2520featuring%2520a%25202-amino-1%252C3-thiazole%2520as%2520a%2520P4%2520carbamate%2520replacement%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7014%26epage%3D7028%26doi%3D10.1021%2Fjm900524b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Condroski, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serebryany, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenglowsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madduru, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodard, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemieux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geck Do, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandhuber, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beigelman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blatt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiwert, S. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of danoprevir (ITMN-191/R7227), a highly selective and potent inhibitor of hepatitis C virus (HCV) NS3/4A protease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1753</span>– <span class="NLM_lpage">1769</span>, <span class="refDoi"> DOI: 10.1021/jm400164c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400164c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFaku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1753-1769&author=Y.+Jiangauthor=S.+W.+Andrewsauthor=K.+R.+Condroskiauthor=B.+Buckmanauthor=V.+Serebryanyauthor=S.+Wenglowskyauthor=A.+L.+Kennedyauthor=M.+R.+Madduruauthor=B.+Wangauthor=M.+Lyonauthor=G.+A.+Dohertyauthor=B.+T.+Woodardauthor=C.+Lemieuxauthor=M.+Geck+Doauthor=H.+Zhangauthor=J.+Ballardauthor=G.+Vigersauthor=B.+J.+Brandhuberauthor=P.+Stengelauthor=J.+A.+Joseyauthor=L.+Beigelmanauthor=L.+Blattauthor=S.+D.+Seiwert&title=Discovery+of+danoprevir+%28ITMN-191%2FR7227%29%2C+a+highly+selective+and+potent+inhibitor+of+hepatitis+C+virus+%28HCV%29+NS3%2F4A+protease&doi=10.1021%2Fjm400164c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease</span></div><div class="casAuthors">Jiang, Yutong; Andrews, Steven W.; Condroski, Kevin R.; Buckman, Brad; Serebryany, Vlad; Wenglowsky, Steve; Kennedy, April L.; Madduru, Machender R.; Wang, Bin; Lyon, Michael; Doherty, George A.; Woodard, Benjamin T.; Lemieux, Christine; Do, Mary Geck; Zhang, Hailong; Ballard, Joshua; Vigers, Guy; Brandhuber, Barbra J.; Stengel, Peter; Josey, John A.; Beigelman, Leonid; Blatt, Lawrence; Seiwert, Scott D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1753-1769</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HCV serine protease NS3 represents an attractive drug target because it is not only essential for viral replication but also implicated in the viral evasion of the host immune response pathway through direct cleavage of key proteins in the human innate immune system.  Through structure-based drug design and optimization, macrocyclic peptidomimetic mols. bearing both a lipophilic P2 isoindoline carbamate and a P1/P1' acylsulfonamide/acylsulfamide carboxylic acid bioisostere were prepd. that possessed subnanomolar potency against the NS3 protease in a subgenomic replicon-based cellular assay (Huh-7).  Danoprevir (compd. 49) was selected as the clin. development candidate for its favorable potency profile across multiple HCV genotypes and key mutant strains and for its good in vitro ADME profiles and in vivo target tissue (liver) exposures across multiple animal species.  X-ray crystallog. studies elucidated several key features in the binding of danoprevir to HCV NS3 protease and proved invaluable to the iterative structure-based design strategy of the authors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplS3sgoIBu_7Vg90H21EOLACvtfcHk0lguIDdazQGHiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFaku7w%253D&md5=2a979cd1202b9360bcef316dddd8382f</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm400164c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400164c%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DBuckman%26aufirst%3DB.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DWenglowsky%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DA.%2BL.%26aulast%3DMadduru%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DLyon%26aufirst%3DM.%26aulast%3DDoherty%26aufirst%3DG.%2BA.%26aulast%3DWoodard%26aufirst%3DB.%2BT.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DGeck%2BDo%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26atitle%3DDiscovery%2520of%2520danoprevir%2520%2528ITMN-191%252FR7227%2529%252C%2520a%2520highly%2520selective%2520and%2520potent%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520%2528HCV%2529%2520NS3%252F4A%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1753%26epage%3D1769%26doi%3D10.1021%2Fjm400164c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudd, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romano, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swestock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMuzio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahlhut, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trainor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of vaniprevir (MK-7009), a macrocyclic hepatitis C virus NS3/4a protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2443</span>– <span class="NLM_lpage">2463</span>, <span class="refDoi"> DOI: 10.1021/jm9015526</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9015526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2443-2463&author=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=M.+T.+Ruddauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=J.+W.+Butcherauthor=K.+F.+Gilbertauthor=K.+J.+Bushauthor=M.+K.+Hollowayauthor=J.+Swestockauthor=B.+L.+Wanauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=D.+J.+Grahamauthor=S.+W.+Ludmererauthor=S.+S.+Maoauthor=M.+W.+Stahlhutauthor=C.+M.+Fandozziauthor=N.+Trainorauthor=D.+B.+Olsenauthor=J.+P.+Vaccaauthor=N.+J.+Liverton&title=Discovery+of+vaniprevir+%28MK-7009%29%2C+a+macrocyclic+hepatitis+C+virus+NS3%2F4a+protease+inhibitor&doi=10.1021%2Fjm9015526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></div><div class="casAuthors">McCauley, John A.; McIntyre, Charles J.; Rudd, Michael T.; Nguyen, Kevin T.; Romano, Joseph J.; Butcher, John W.; Gilbert, Kevin F.; Bush, Kimberly J.; Holloway, M. Katharine; Swestock, John; Wan, Bang-Lin; Carroll, Steven S.; DiMuzio, Jillian M.; Graham, Donald J.; Ludmerer, Steven W.; Mao, Shi-Shan; Stahlhut, Mark W.; Fandozzi, Christine M.; Trainor, Nicole; Olsen, David B.; Vacca, Joseph P.; Liverton, Nigel J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2443-2463</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a mol.-modeling derived strategy.  Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compds. via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing.  These studies led to the identification of clin. candidate vaniprevir, MK-7009, which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_2CVs9I1H_7Vg90H21EOLACvtfcHk0lguIDdazQGHiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2gsr8%253D&md5=dc820c588d5482f6913091a87eaf9af1</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DBush%26aufirst%3DK.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSwestock%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DB.%2BL.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMao%26aufirst%3DS.%2BS.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DTrainor%26aufirst%3DN.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26atitle%3DDiscovery%2520of%2520vaniprevir%2520%2528MK-7009%2529%252C%2520a%2520macrocyclic%2520hepatitis%2520C%2520virus%2520NS3%252F4a%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2443%26epage%3D2463%26doi%3D10.1021%2Fjm9015526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatraman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velazquez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pichardo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prongay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girijavallabhan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwinski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njoroge, F. G.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1021/jm800940u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800940u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFals7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=336-346&author=S.+Venkatramanauthor=F.+Velazquezauthor=W.+Wuauthor=M.+Blackmanauthor=K.+X.+Chenauthor=S.+Bogenauthor=L.+Nairauthor=X.+Tongauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=J.+Pichardoauthor=A.+Prongayauthor=K.+C.+Chengauthor=V.+Girijavallabhanauthor=J.+Piwinskiauthor=N.+Y.+Shihauthor=F.+G.+Njoroge&title=Discovery+and+structure-activity+relationship+of+P1-P3+ketoamide+derived+macrocyclic+inhibitors+of+hepatitis+C+virus+NS3+protease&doi=10.1021%2Fjm800940u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity Relationship of P1-P3 Ketoamide Derived Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease</span></div><div class="casAuthors">Venkatraman, Srikanth; Velazquez, Francisco; Wu, Wanli; Blackman, Melissa; Chen, Kevin X.; Bogen, Stephane; Nair, Latha; Tong, Xiao; Chase, Robert; Hart, Andrea; Agrawal, Sony; Pichardo, John; Prongay, Andrew; Cheng, Kuo-Chi; Girijavallabhan, Viyyoor; Piwinski, John; Shih, Neng-Yang; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">336-346</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is the major cause of chronic liver disease, leading to cirrhosis and hepatocellular carcinoma, and affects more than 200 million people worldwide.  Although combination therapy of interferon-α and ribavirin is reasonably successful in treating majority of genotypes, its efficacy against the predominant genotype (genotype 1) is moderate at best, with only about 40% of the patients showing sustained virol. response.  Herein, the SAR leading to the discovery of a series of ketoamide derived P1-P3 macrocyclic inhibitors that are more potent than the first generation clin. candidate, boceprevir (Sch 503034), is discussed.  The optimization of these macrocyclic inhibitors identified a P3 imide capped analog (I) that was 20 times more potent than boceprevir and demonstrated good oral pharmacokinetics in rats.  X-ray structure of I bound to NS3 protease and biol. data are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJWmH7aKVi7bVg90H21EOLACvtfcHk0lguIDdazQGHiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFals7fF&md5=377bc2c7a1635fe7e1df893692f84bf5</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm800940u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800940u%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DVelazquez%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DBlackman%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DBogen%26aufirst%3DS.%26aulast%3DNair%26aufirst%3DL.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DShih%26aufirst%3DN.%2BY.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationship%2520of%2520P1-P3%2520ketoamide%2520derived%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D336%26epage%3D346%26doi%3D10.1021%2Fjm800940u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilja, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fellander, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baraznenok, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nystrom, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span> <span> </span><span class="NLM_article-title">Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease target</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1652</span>– <span class="NLM_lpage">1655</span>, <span class="refDoi"> DOI: 10.1002/anie.200906696</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.200906696" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1652-1655&author=M.+D.+Cummingsauthor=J.+Lindbergauthor=T.+I.+Linauthor=H.+De+Kockauthor=O.+Lenzauthor=E.+Liljaauthor=S.+Fellanderauthor=V.+Baraznenokauthor=S.+Nystromauthor=M.+Nilssonauthor=L.+Vrangauthor=M.+Edlundauthor=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+Raboissonauthor=K.+Simmen&title=Induced-fit+binding+of+the+macrocyclic+noncovalent+inhibitor+TMC435+to+its+HCV+NS3%2FNS4A+protease+target&doi=10.1002%2Fanie.200906696"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Induced-Fit Binding of the Macrocyclic Noncovalent Inhibitor TMC435 to its HCV NS3/NS4A Protease Target</span></div><div class="casAuthors">Cummings, Maxwell D.; Lindberg, Jimmy; Lin, Tse-I.; de Kock, Herman; Lenz, Oliver; Lilja, Elisabet; Fellander, Sara; Baraznenok, Vera; Nystrom, Susanne; Nilsson, Magnus; Vrang, Lotta; Edlund, Michael; Rosenquist, Asa; Samuelsson, Bertil; Raboisson, Pierre; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1652-1655, S1652/1-S1652/11</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We have detd. the crystal structure of the macrocyclic inhibitor TMC435 bound to its HCV NS3/4A protease target at a resoln. of 2.4 Å, providing at. detail of induced fit to an extended S2 subsite.  The complex structure helps to rationalize the impact of key modifications in the optimization path that led to 1, and is guiding our understanding of resistance patterns.  Future modeling and structure-based design efforts aimed at NS3/NS4A protease should benefit from the new structure, which represents the first example of a noncovalent NS3/NS4A protease-inhibitor complex deposited in the PDB and details the induced fit involved in accommodating a large P2 substituent.  Inhibitors with large P2 groups that occupy the extended S2 subsite probe the crystallog. obsd. helicase-protease interface, and it is hoped that future studies will clarify the relevance of interfacial contacts to protease activity and protease inhibitor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAEYqCPA57hLVg90H21EOLACvtfcHk0ljMSFnqWoPCVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVaktbs%253D&md5=535b340784d1af62df32e8cf3bd3fe87</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fanie.200906696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200906696%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLindberg%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DDe%2BKock%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DLilja%26aufirst%3DE.%26aulast%3DFellander%26aufirst%3DS.%26aulast%3DBaraznenok%26aufirst%3DV.%26aulast%3DNystrom%26aufirst%3DS.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DInduced-fit%2520binding%2520of%2520the%2520macrocyclic%2520noncovalent%2520inhibitor%2520TMC435%2520to%2520its%2520HCV%2520NS3%252FNS4A%2520protease%2520target%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D1652%26epage%3D1655%26doi%3D10.1002%2Fanie.200906696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvador-Oden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahling, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickstrom, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamelink, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Vreken, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delouvroy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pille, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surleraux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigerinck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4853</span>– <span class="NLM_lpage">4858</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.bmcl.2008.07.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=18678486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+De+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.+I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+Wahlingauthor=K.+Wickstromauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure-activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350&doi=10.1016%2Fj.bmcl.2008.07.088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span></div><div class="casAuthors">Raboisson, Pierre; de Kock, Herman; Rosenquist, Asa; Nilsson, Magnus; Salvador-Oden, Lourdes; Lin, Tse-I.; Roue, Natalie; Ivanov, Vladimir; Wahling, Horst; Wickstrom, Kristina; Hamelink, Elizabeth; Edlund, Michael; Vrang, Lotta; Vendeville, Sandrine; Van de Vreken, Wim; McGowan, David; Tahri, Abdellah; Hu, Lili; Boutton, Carlo; Lenz, Oliver; Delouvroy, Frederic; Pille, Geert; Surleraux, Dominique; Wigerinck, Piet; Samuelsson, Bertil; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4853-4858</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">SAR anal. performed with a limited set of cyclopentane-contg. macrocycles led to the identification of TMC435350 (I) as a potent inhibitor of HCV NS3/4A protease (Ki = 0.36 nM) and viral replication (replicon EC50 = 7.8 nM).  TMC435350 also displayed low in vitro clearance and high permeability, which were confirmed by in vivo pharmacokinetic studies.  TMC435350 is currently being evaluated in the clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbRb8GhLBkJ7Vg90H21EOLACvtfcHk0ljMSFnqWoPCVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbvE&md5=001abd8307658a926479ff77496b6ff9</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.088%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DDe%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DWahling%26aufirst%3DH.%26aulast%3DWickstrom%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure-activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858%26doi%3D10.1016%2Fj.bmcl.2008.07.088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Kock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horvath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalmeijer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De La Rosa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beumont-Mauviel, M.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1673</span>– <span class="NLM_lpage">1693</span>, <span class="refDoi"> DOI: 10.1021/jm401507s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401507s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpslekuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1673-1693&author=A.+Rosenquistauthor=B.+Samuelssonauthor=P.+O.+Johanssonauthor=M.+D.+Cummingsauthor=O.+Lenzauthor=P.+Raboissonauthor=K.+Simmenauthor=S.+Vendevilleauthor=H.+De+Kockauthor=M.+Nilssonauthor=A.+Horvathauthor=R.+Kalmeijerauthor=G.+De+La+Rosaauthor=M.+Beumont-Mauviel&title=Discovery+and+development+of+simeprevir+%28TMC435%29%2C+a+HCV+NS3%2F4A+protease+inhibitor&doi=10.1021%2Fjm401507s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor</span></div><div class="casAuthors">Rosenquist, Aasa; Samuelsson, Bertil; Johansson, Per-Ola; Cummings, Maxwell D.; Lenz, Oliver; Raboisson, Pierre; Simmen, Kenny; Vendeville, Sandrine; de Kock, Herman; Nilsson, Magnus; Horvath, Andras; Kalmeijer, Ronald; de la Rosa, Guy; Beumont-Mauviel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1673-1693</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus is a blood-borne infection and the leading cause of chronic liver disease (including cirrhosis and cancer) and liver transplantation.  Since the identification of HCV in 1989, there has been an extensive effort to identify and improve treatment options.  An important milestone was reached in 2011 with the approval of the first-generation HCV NS3/4A protease inhibitors.  However, new therapies are needed to improve cure rates, shorten treatment duration, and improve tolerability.  Here we summarize the extensive medicinal chem. effort to develop novel P2 cyclopentane macrocyclic inhibitors guided by HCV NS3 protease assays, the cellular replicon system, structure-based design, and a panel of DMPK assays.  The selection of compd. 29 (simeprevir, TMC435) as clin. candidate was based on its excellent biol., PK, and safety pharmacol. profile.  Compd. 29 has recently been approved for treatment of chronic HCV infection in combination with pegylated interferon-α and ribavirin in Japan, Canada, and USA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryCRg3NRRjzrVg90H21EOLACvtfcHk0lja_XMa9nmz_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpslekuw%253D%253D&md5=fd9c1df095e47a111d9680af4c40ccc6</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm401507s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401507s%26sid%3Dliteratum%253Aachs%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DJohansson%26aufirst%3DP.%2BO.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DDe%2BKock%26aufirst%3DH.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DHorvath%26aufirst%3DA.%26aulast%3DKalmeijer%26aufirst%3DR.%26aulast%3DDe%2BLa%2BRosa%26aufirst%3DG.%26aulast%3DBeumont-Mauviel%26aufirst%3DM.%26atitle%3DDiscovery%2520and%2520development%2520of%2520simeprevir%2520%2528TMC435%2529%252C%2520a%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1673%26epage%3D1693%26doi%3D10.1021%2Fjm401507s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, M.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, M. N.</span></span> <span> </span><span class="NLM_article-title">Overcoming the unfavourable entropic contribution of ligand binding with a macrocyclic inhibitor bound to penicillopepsin</span>. <i>Adv. Exp. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>436</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1007/978-1-4615-5373-1_50</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1007%2F978-1-4615-5373-1_50" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=9561242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFKnsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=1998&pages=355-359&author=M.%0AE.+Fraserauthor=J.+H.+Meyerauthor=P.+A.+Bartlettauthor=M.+N.+James&title=Overcoming+the+unfavourable+entropic+contribution+of+ligand+binding+with+a+macrocyclic+inhibitor+bound+to+penicillopepsin&doi=10.1007%2F978-1-4615-5373-1_50"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming the unfavorable entropic contribution of ligand binding with a macrocyclic inhibitor bound to penicillopepsin</span></div><div class="casAuthors">Fraser, Marie F.; Meyer, J. Hoyt; Bartlett, Paul A.; James, Michael N. G.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">Aspartic Proteinases</span>),
    <span class="NLM_cas:pages">355-359</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Plenum Publishing Corp.</span>)
        </div><div class="casAbstract">One way to improve the binding of a ligand to its protein receptor is by forcing the unbound ligand to adopt the same conformation as it has when bound to the receptor.  The conformational constraint then reduces the entropic disadvantage of ordered binding to the protein.  The constraint should change the structure of the ligand as little as possible, so as to retain the favorable enthalpic interactions of the ligand with the receptor.  Including a ring structure in the design of a ligand can reduce its conformational flexibility and it may be possible to introduce the ring without changing how the ligand binds to the receptor.  A macrocyclic inhibitor of penicillopepsin, as well as two acyclic analogs, were synthesized.  Availability of the macrocyclic inhibitor and the acyclic analogs make it possible to evaluate the entropic effect of the cyclization, provided that they bind to penicillopepsin in the same manner.  Enzyme inhibition by the various inhibitors was evaluated, and the crystal structure of the macrocyclic inhibitor co-crystd. with penicillopepsin was detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqywUc6QyslELVg90H21EOLACvtfcHk0lja_XMa9nmz_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFKnsrY%253D&md5=7d64b9744103afdb02bb131109050bfe</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1007%2F978-1-4615-5373-1_50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4615-5373-1_50%26sid%3Dliteratum%253Aachs%26aulast%3DFraser%26aufirst%3DM.%2BE.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DBartlett%26aufirst%3DP.%2BA.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DOvercoming%2520the%2520unfavourable%2520entropic%2520contribution%2520of%2520ligand%2520binding%2520with%2520a%2520macrocyclic%2520inhibitor%2520bound%2520to%2520penicillopepsin%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1998%26volume%3D436%26spage%3D355%26epage%3D359%26doi%3D10.1007%2F978-1-4615-5373-1_50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tyndall, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nall, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlie, D. P.</span></span> <span> </span><span class="NLM_article-title">Proteases universally recognize beta strands in their active sites</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">973</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1021/cr040669e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr040669e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=973-999&author=J.+D.+Tyndallauthor=T.+Nallauthor=D.+P.+Fairlie&title=Proteases+universally+recognize+beta+strands+in+their+active+sites&doi=10.1021%2Fcr040669e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases universally recognize beta strands in their active sites</span></div><div class="casAuthors">Tyndall, Joel D. A.; Nall, Tessa; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">973-999</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Proteases account for a significant proportion (∼2%) of the human genome with >550 defined members and a further ∼100 predicted human proteases.  Proteases also represent 1-5% of the genomes of infectious organisms such as bacteria, parasites, and viruses.  They are categorized by the nature of their active site catalytic residue(s) as metallo (34%), serine (30%), cysteine (26%), aspartic (4%), and the less characterized threonine (5%).  Mammalian proteases, of which ∼20% are membrane-bound, are aberrantly expressed or underregulated during many disease conditions, suggesting that inhibitors of specific proteases might be able to control irregular mammalian physiol.  Alternatively, since there are now >50 human proteases where one or more genetic mutations have been found to lead to hereditary diseases, gene therapy may be a useful approach when it eventually becomes technol. feasible.  The goal of protease inhibitor design is to develop potent inhibitors of the offending or mammalian protease but with accompanying selectivity to avoid inhibiting very similar host proteases required for normal host physiol.  This review summarizes an anal. of >1500 3-dimensional crystal (x-ray) and soln. (NMR) structures from the Protein Data Bank of substrates, products, and inhibitors bound in the active sites of all 5 protease classes.  Most of the active sites, with few exceptions, have been found to recognize peptidic and non-peptidic ligands in an extended β-strand conformation.  Such conformational selection of ligands explains the resistance of folded/structured regions of proteins to proteolytic degrdn., the susceptibility of denatured proteins to processing, and the higher affinity of conformationally constrained 'extended' inhibitors/substrates for proteases.  On the basis of the results presented by the authors, one would predict that the use of various approaches to fix an extended β-strand ligand conformation should produce high-affinity inhibitors even for proteases of unknown structure, provided that the substrate specificity and protease type is known.  This inference should be extremely valuable, particularly when the structure of a protease is not known and inhibitor design has to be based solely on substrate preferences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uFIrmHewBrVg90H21EOLACvtfcHk0lja_XMa9nmz_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D&md5=67da540a9c260f7c80d9a2f7128dfc15</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fcr040669e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040669e%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%26aulast%3DNall%26aufirst%3DT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DProteases%2520universally%2520recognize%2520beta%2520strands%2520in%2520their%2520active%2520sites%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D973%26epage%3D999%26doi%3D10.1021%2Fcr040669e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, M. H.</span></span> <span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2015.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.drudis.2015.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=26210956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=5-10&author=P.+Wuauthor=T.+E.+Nielsenauthor=M.+H.+Clausen&title=Small-molecule+kinase+inhibitors%3A+an+analysis+of+FDA-approved+drugs&doi=10.1016%2Fj.drudis.2015.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors: an analysis of FDA-approved drugs</span></div><div class="casAuthors">Wu, Peng; Nielsen, Thomas E.; Clausen, Mads H.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-10</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Small-mol. kinase inhibitors (SMKIs), 28 of which are approved by the US Food and Drug Administration (FDA), have been actively pursued as promising targeted therapeutics.  Here, we assess the key structural and physicochem. properties, target selectivity and mechanism of function, and therapeutic indications of these approved inhibitors.  Our anal. showed that >30% of approved SMKIs have a mol. wt. (MW) exceeding 500 and all have a total ring count of between three and five.  The assumption that type II inhibitors tend to be more selective than type I inhibitors has been proved to be unreliable.  Although previous SMKI research was concd. on tyrosine kinase inhibitors for cancer treatment, recent progress indicates diversification of SMKI research in terms of new targets, mechanistic types, and therapeutic indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZrY68ZOI2xLVg90H21EOLACvtfcHk0lijWt-wme2-Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Gru73P&md5=228524fa464393053ecbfac19e994929</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2015.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2015.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DT.%2BE.%26aulast%3DClausen%26aufirst%3DM.%2BH.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%253A%2520an%2520analysis%2520of%2520FDA-approved%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2016%26volume%3D21%26spage%3D5%26epage%3D10%26doi%3D10.1016%2Fj.drudis.2015.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanks, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span> <span> </span><span class="NLM_article-title">Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1096/fasebj.9.8.7768349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1096%2Ffasebj.9.8.7768349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=7768349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1ajsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1995&pages=576-596&author=S.+K.+Hanksauthor=T.+Hunter&title=Protein+kinases+6.+The+eukaryotic+protein+kinase+superfamily%3A+kinase+%28catalytic%29+domain+structure+and+classification&doi=10.1096%2Ffasebj.9.8.7768349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Protein kinases. 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification</span></div><div class="casAuthors">Hanks, Steven K.; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">576-96</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A review with 48 refs.  The eukaryotic protein kinases make up a large superfamily of homologous proteins.  They are related by virtue of their kinase domains (also known as catalytic domains), which consist of ∼250-300 amino acid residues.  The kinase domains that define this group of enzymes contain 12 conserved subdomains that fold into a common catalytic core structure, as revealed by the 3-dimensional structures of several protein-serine kinases.  There are 2 main subdivisions within the superfamily: the protein-serine/threonine kinases and the protein-tyrosine kinases.  A classification scheme can be founded on a kinase domain phylogeny, which reveals families of enzymes that have related substrate specificities and modes of regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxv30nsEyVU7Vg90H21EOLACvtfcHk0lijWt-wme2-Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1ajsbc%253D&md5=869a3926ba04f288947f80616bdcfb98</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.9.8.7768349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.9.8.7768349%26sid%3Dliteratum%253Aachs%26aulast%3DHanks%26aufirst%3DS.%2BK.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DProtein%2520kinases%25206.%2520The%2520eukaryotic%2520protein%2520kinase%2520superfamily%253A%2520kinase%2520%2528catalytic%2529%2520domain%2520structure%2520and%2520classification%26jtitle%3DFASEB%2520J.%26date%3D1995%26volume%3D9%26spage%3D576%26epage%3D596%26doi%3D10.1096%2Ffasebj.9.8.7768349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Noble, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endicott, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, L. N.</span></span> <span> </span><span class="NLM_article-title">Protein kinase inhibitors: insights into drug design from structure</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>303</i></span>,  <span class="NLM_fpage">1800</span>– <span class="NLM_lpage">1805</span>, <span class="refDoi"> DOI: 10.1126/science.1095920</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1126%2Fscience.1095920" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15031492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFehurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2004&pages=1800-1805&author=M.+E.+Nobleauthor=J.+A.+Endicottauthor=L.+N.+Johnson&title=Protein+kinase+inhibitors%3A+insights+into+drug+design+from+structure&doi=10.1126%2Fscience.1095920"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Kinase Inhibitors: Insights into Drug Design from Structure</span></div><div class="casAuthors">Noble, Martin E. M.; Endicott, Jane A.; Johnson, Louise N.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">5665</span>),
    <span class="NLM_cas:pages">1800-1805</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Protein kinases are targets for treatment of a no. of diseases.  This review focuses on kinase inhibitors that are in the clinic or in clin. trials and for which structural information is available.  Structures have informed drug design and have illuminated the mechanism of inhibition.  We review progress with the receptor tyrosine kinases (growth factor receptors EGFR, VEGFR, and FGFR) and nonreceptor tyrosine kinases (Bcr-Abl), where advances have been made with cancer therapeutic agents such as Herceptin and Gleevec.  Among the serine-threonine kinases, p38, Rho-kinase, cyclin-dependent kinases, and Chk1 have been targeted with productive results for inflammation and cancer.  Structures have provided insights into targeting the inactive or active form of the kinase, for targeting the global constellation of residues at the ATP site or less conserved addnl. pockets or single residues, and into targeting noncatalytic domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWqtKz7cvN_rVg90H21EOLACvtfcHk0lijWt-wme2-Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFehurc%253D&md5=7fd3f60bee46e59307436eeed285d6ae</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1126%2Fscience.1095920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1095920%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26atitle%3DProtein%2520kinase%2520inhibitors%253A%2520insights%2520into%2520drug%2520design%2520from%2520structure%26jtitle%3DScience%26date%3D2004%26volume%3D303%26spage%3D1800%26epage%3D1805%26doi%3D10.1126%2Fscience.1095920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">39</span>, <span class="refDoi"> DOI: 10.1038/nrc2559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors&doi=10.1038%2Fnrc2559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lgzSPI-au-d7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39%26doi%3D10.1038%2Fnrc2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1241</span>, <span class="refDoi"> DOI: 10.1021/cb500129t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500129t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtV2nt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1230-1241&author=Z.+Zhaoauthor=H.+Wuauthor=L.+Wangauthor=Y.+Liuauthor=S.+Knappauthor=Q.+Liuauthor=N.+S.+Gray&title=Exploration+of+type+II+binding+mode%3A+A+privileged+approach+for+kinase+inhibitor+focused+drug+discovery%3F&doi=10.1021%2Fcb500129t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?</span></div><div class="casAuthors">Zhao, Zheng; Wu, Hong; Wang, Li; Liu, Yi; Knapp, Stefan; Liu, Qingsong; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1230-1241</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The ATP site of kinases displays remarkable conformational flexibility when accommodating chem. diverse small mol. inhibitors.  The so-called activation segment, whose conformation controls catalytic activity and access to the substrate binding pocket, can undergo a large conformational change with the active state assuming a 'DFG-in' and an inactive state assuming a 'DFG-out' conformation.  Compds. that preferentially bind to the DFG-out conformation are typically called 'type II' inhibitors in contrast to 'type I' inhibitors that bind to the DFG-in conformation.  This review surveys the large no. of type II inhibitors that have been developed and provides an anal. of their crystallog. detd. binding modes.  Using a small library of type II inhibitors, we demonstrate that more than 200 kinases can be targeted, suggesting that type II inhibitors may not be intrinsically more selective than type I inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jYt6Db3Ap7Vg90H21EOLACvtfcHk0lgzSPI-au-d7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtV2nt7s%253D&md5=95bf185ff7f973eda5a65f4096bfaa82</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fcb500129t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500129t%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DExploration%2520of%2520type%2520II%2520binding%2520mode%253A%2520A%2520privileged%2520approach%2520for%2520kinase%2520inhibitor%2520focused%2520drug%2520discovery%253F%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1230%26epage%3D1241%26doi%3D10.1021%2Fcb500129t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacoby, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wroblowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buyck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neefs, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vlijmen, H.</span></span> <span> </span><span class="NLM_article-title">Protocols for the design of kinase-focused compound libraries</span>. <i>Mol. Inf.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>37</i></span>, <span class="NLM_elocation-id">e1700119</span> <span class="refDoi"> DOI: 10.1002/minf.201700119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fminf.201700119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=29116686" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2018&author=E.+Jacobyauthor=B.+Wroblowskiauthor=C.+Buyckauthor=J.+M.+Neefsauthor=C.+Meyerauthor=M.+D.+Cummingsauthor=H.+Van+Vlijmen&title=Protocols+for+the+design+of+kinase-focused+compound+libraries&doi=10.1002%2Fminf.201700119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1002%2Fminf.201700119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fminf.201700119%26sid%3Dliteratum%253Aachs%26aulast%3DJacoby%26aufirst%3DE.%26aulast%3DWroblowski%26aufirst%3DB.%26aulast%3DBuyck%26aufirst%3DC.%26aulast%3DNeefs%26aufirst%3DJ.%2BM.%26aulast%3DMeyer%26aufirst%3DC.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DVan%2BVlijmen%26aufirst%3DH.%26atitle%3DProtocols%2520for%2520the%2520design%2520of%2520kinase-focused%2520compound%2520libraries%26jtitle%3DMol.%2520Inf.%26date%3D2018%26volume%3D37%26doi%3D10.1002%2Fminf.201700119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">William, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ong, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasha, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajulu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6). 1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4638</span>– <span class="NLM_lpage">4658</span>, <span class="refDoi"> DOI: 10.1021/jm200326p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200326p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1ent7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4638-4658&author=A.+D.+Williamauthor=A.+C.+Leeauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=E.+Tanauthor=D.+Chenauthor=M.+Williamsauthor=E.+T.+Sunauthor=K.+C.+Gohauthor=W.+C.+Ongauthor=S.+K.+Gohauthor=S.+Hartauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+macrocycle+11-%282-pyrrolidin-1-yl-ethoxy%29-14%2C19-dioxa-5%2C7%2C26-triaza-tetracyclo%5B19.3.1.1%282%2C6%29.+1%288%2C12%29%5Dheptacosa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2C10%2C12%2827%29%2C16%2C21%2C23-decaene+%28SB1518%29%2C+a+potent+Janus+kinase+2%2Ffms-like+tyrosine+kinase-3+%28JAK2%2FFLT3%29+inhibitor+for+the+treatment+of+myelofibrosis+and+lymphoma&doi=10.1021%2Fjm200326p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma</span></div><div class="casAuthors">William, Anthony D.; Lee, Angeline C.-H.; Blanchard, Stephanie; Poulsen, Anders; Teo, Ee Ling; Nagaraj, Harish; Tan, Evelyn; Chen, Dizhong; Williams, Meredith; Sun, Eric T.; Goh, Kee Chuan; Ong, Wai Chung; Goh, Siok Kun; Hart, Stefan; Jayaraman, Ramesh; Pasha, Mohammed Khalid; Ethirajulu, Kantharaj; Wood, Jeanette M.; Dymock, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4638-4658</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Discovery of the activating mutation V617F in Janus Kinase 2 (JAK2V617F), a tyrosine kinase critically involved in receptor signaling, recently ignited interest in JAK2 inhibitor therapy as a treatment for myelofibrosis (MF).  Herein, we describe the design and synthesis of a series of small mol. 4-aryl-2-aminopyrimidine macrocycles and their biol. evaluation against the JAK family of kinase enzymes and FLT3.  The most promising leads were assessed for their in vitro ADME properties culminating in the discovery of I, a potent JAK2 (IC50 = 23 and 19 nM for JAK2WT and JAK2V617F, resp.) and FLT3 (IC50 = 22 nM) inhibitor with selectivity against JAK1 and JAK3 (IC50 = 1280 and 520 nM, resp.).  Further profiling of I in preclin. species and mouse xenograft and allograft models is described.  Compd. I (SB1518) was selected as a development candidate and progressed into clin. trials where it is currently in phase 2 for MF and lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXtMiC4eaIMLVg90H21EOLACvtfcHk0lgzSPI-au-d7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1ent7c%253D&md5=1fa1a5250cae6ec8c59db67e593fb1f6</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm200326p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200326p%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%2BC.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DOng%26aufirst%3DW.%2BC.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520macrocycle%252011-%25282-pyrrolidin-1-yl-ethoxy%2529-14%252C19-dioxa-5%252C7%252C26-triaza-tetracyclo%255B19.3.1.1%25282%252C6%2529.%25201%25288%252C12%2529%255Dheptacosa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252C10%252C12%252827%2529%252C16%252C21%252C23-decaene%2520%2528SB1518%2529%252C%2520a%2520potent%2520Janus%2520kinase%25202%252Ffms-like%2520tyrosine%2520kinase-3%2520%2528JAK2%252FFLT3%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520myelofibrosis%2520and%2520lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4638%26epage%3D4658%26doi%3D10.1021%2Fjm200326p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">William, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanchard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaraj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaraman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasha, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajulu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptaco sa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a potent inhibitor of cyclin dependent kinases (CDKs), Janus kinase 2 (JAK2), and fms-like tyrosine kinase-3 (FLT3) for the treatment of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1021/jm201112g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201112g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=169-196&author=A.+D.+Williamauthor=A.+C.+Leeauthor=K.+C.+Gohauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=C.+P.+Leeauthor=H.+Wangauthor=M.+Williamsauthor=E.+T.+Sunauthor=C.+Huauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+kinase+spectrum+selective+macrocycle+%2816E%29-14-methyl-20-oxa-5%2C7%2C14%2C26-tetraazatetracyclo%5B19.3.1.1%282%2C6%29.1%288%2C12%29%5Dheptaco+sa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2827%29%2C9%2C11%2C16%2C21%2C23-decaene+%28SB1317%2FTG02%29%2C+a+potent+inhibitor+of+cyclin+dependent+kinases+%28CDKs%29%2C+Janus+kinase+2+%28JAK2%29%2C+and+fms-like+tyrosine+kinase-3+%28FLT3%29+for+the+treatment+of+cancer&doi=10.1021%2Fjm201112g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Kinase Spectrum Selective Macrocycle (16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a Potent Inhibitor of Cyclin Dependent Kinases (CDKs), Janus Kinase 2 (JAK2), and Fms-like Tyrosine Kinase-3 (FLT3) for the Treatment of Cancer</span></div><div class="casAuthors">William, Anthony D.; Lee, Angeline C.-H.; Goh, Kee Chuan; Blanchard, Stephanie; Poulsen, Anders; Teo, Ee Ling; Nagaraj, Harish; Lee, Chai Ping; Wang, Haishan; Williams, Meredith; Sun, Eric T.; Hu, Changyong; Jayaraman, Ramesh; Pasha, Mohammed Khalid; Ethirajulu, Kantharaj; Wood, Jeanette M.; Dymock, Brian W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we describe the design, synthesis, and SAR of a series of unique small mol. macrocycles that show spectrum selective kinase inhibition of CDKs, JAK2, and FLT3.  The most promising leads were assessed in vitro for their inhibition of cancer cell proliferation, soly., CYP450 inhibition, and microsomal stability.  This screening cascade revealed 26h (I) as a preferred compd. with target IC50 of 13, 73, and 56 nM for CDK2, JAK2 and FLT3, resp.  Pharmacokinetic (PK) studies of 26h in preclin. species showed good oral exposures.  Oral efficacy was obsd. in colon (HCT-116) and lymphoma (Ramos) xenograft studies, in line with the obsd. PK/PD correlation.  26H (SB1317/TG02) was progressed into development in 2010 and is currently undergoing phase 1 clin. trials in advanced leukemias and multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMvOv-_pFzbVg90H21EOLACvtfcHk0lhEXiDYhskASQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylur7P&md5=50affe14bd28594735131d6b5841502a</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm201112g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201112g%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%2BC.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DC.%2BP.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520kinase%2520spectrum%2520selective%2520macrocycle%2520%252816E%2529-14-methyl-20-oxa-5%252C7%252C14%252C26-tetraazatetracyclo%255B19.3.1.1%25282%252C6%2529.1%25288%252C12%2529%255Dheptaco%2520sa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252827%2529%252C9%252C11%252C16%252C21%252C23-decaene%2520%2528SB1317%252FTG02%2529%252C%2520a%2520potent%2520inhibitor%2520of%2520cyclin%2520dependent%2520kinases%2520%2528CDKs%2529%252C%2520Janus%2520kinase%25202%2520%2528JAK2%2529%252C%2520and%2520fms-like%2520tyrosine%2520kinase-3%2520%2528FLT3%2529%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D169%26epage%3D196%26doi%3D10.1021%2Fjm201112g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deal, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingardo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(m etheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain exposure and broad-spectrum potency against ALK-resistant mutations</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4720</span>– <span class="NLM_lpage">4744</span>, <span class="refDoi"> DOI: 10.1021/jm500261q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.+L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28m+etheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5D-benzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+macrocyclic+inhibitor+of+anaplastic+lymphoma+kinase+%28ALK%29+and+c-ros+oncogene+1+%28ROS1%29+with+preclinical+brain+exposure+and+broad-spectrum+potency+against+ALK-resistant+mutations&doi=10.1021%2Fjm500261q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations</span></div><div class="casAuthors">Johnson, Ted W.; Richardson, Paul F.; Bailey, Simon; Brooun, Alexei; Burke, Benjamin J.; Collins, Michael R.; Cui, J. Jean; Deal, Judith G.; Deng, Ya-Li; Dinh, Dac; Engstrom, Lars D.; He, Mingying; Hoffman, Jacqui; Hoffman, Robert L.; Huang, Qinhua; Kania, Robert S.; Kath, John C.; Lam, Hieu; Lam, Justine L.; Le, Phuong T.; Lingardo, Laura; Liu, Wei; McTigue, Michele; Palmer, Cynthia L.; Sach, Neal W.; Smeal, Tod; Smith, Graham L.; Stewart, Albert E.; Timofeevski, Sergei; Zhu, Huichun; Zhu, Jinjiang; Zou, Helen Y.; Edwards, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4720-4744</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Although crizotinib demonstrates robust efficacy in anaplastic lymphoma kinase (ALK)-pos. non-small-cell lung carcinoma patients, progression during treatment eventually develops.  Resistant patient samples revealed a variety of point mutations in the kinase domain of ALK, including the L1196M gatekeeper mutation.  In addn., some patients progress due to cancer metastasis in the brain.  Using structure-based drug design, lipophilic efficiency, and phys.-property-based optimization, highly potent macrocyclic ALK inhibitors were prepd. with good absorption, distribution, metab., and excretion (ADME), low propensity for p-glycoprotein 1-mediated efflux, and good passive permeability.  These structurally unusual macrocyclic inhibitors were potent against wild-type ALK and clin. reported ALK kinase domain mutations.  Significant synthetic challenges were overcome, utilizing novel transformations to enable the use of these macrocycles in drug discovery paradigms.  This work led to the discovery of 8k (PF-06463922), combining broad-spectrum potency, central nervous system ADME, and a high degree of kinase selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqXkb49ad31bVg90H21EOLACvtfcHk0lhEXiDYhskASQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSgtL4%253D&md5=db21844f8e9a2f9ca5953bca56ad7b1c</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528m%2520etheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255D-benzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520macrocyclic%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%2520and%2520c-ros%2520oncogene%25201%2520%2528ROS1%2529%2520with%2520preclinical%2520brain%2520exposure%2520and%2520broad-spectrum%2520potency%2520against%2520ALK-resistant%2520mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4720%26epage%3D4744%26doi%3D10.1021%2Fjm500261q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appleman, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McTigue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timofeevski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonnell, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappin, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affolter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smeal, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charest, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span> <span> </span><span class="NLM_article-title">PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">3493</span>– <span class="NLM_lpage">3498</span>, <span class="refDoi"> DOI: 10.1073/pnas.1420785112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1073%2Fpnas.1420785112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=25733882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1Grur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=3493-3498&author=H.+Y.+Zouauthor=Q.+Liauthor=L.+D.+Engstromauthor=M.+Westauthor=V.+Applemanauthor=K.+A.+Wongauthor=M.+McTigueauthor=Y.+L.+Dengauthor=W.+Liuauthor=A.+Broounauthor=S.+Timofeevskiauthor=S.+R.+McDonnellauthor=P.+Jiangauthor=M.+D.+Falkauthor=P.+B.+Lappinauthor=T.+Affolterauthor=T.+Nicholsauthor=W.+Huauthor=J.+Lamauthor=T.+W.+Johnsonauthor=T.+Smealauthor=A.+Charestauthor=V.+R.+Fantin&title=PF-06463922+is+a+potent+and+selective+next-generation+ROS1%2FALK+inhibitor+capable+of+blocking+crizotinib-resistant+ROS1+mutations&doi=10.1073%2Fpnas.1420785112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Engstrom, Lars D.; West, Melissa; Appleman, Vicky; Wong, Katy A.; McTigue, Michele; Deng, Ya-Li; Liu, Wei; Brooun, Alexei; Timofeevski, Sergei; McDonnell, Scott R. P.; Jiang, Ping; Falk, Matthew D.; Lappin, Patrick B.; Affolter, Timothy; Nichols, Tim; Hu, Wenyue; Lam, Justine; Johnson, Ted W.; Smeal, Tod; Charest, Al; Fantin, Valeria R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3493-3498</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Oncogenic c-ros oncogene 1 (ROS1) fusion kinases have been identified in a variety of human cancers and are attractive targets for cancer therapy.  The MET/ALK/ROS1 inhibitor crizotinib (Xalkori, PF-02341066) has demonstrated promising clin. activity in ROS1 fusion-pos. non-small cell lung cancer.  However, emerging clin. evidence has shown that patients can develop resistance by acquiring secondary point mutations in ROS1 kinase.  In this study the authors characterized the ROS1 activity of PF-06463922, a novel, orally available, CNS-penetrant, ATP-competitive small-mol. inhibitor of ALK/ROS1.  In vitro, PF-06463922 exhibited subnanomolar cellular potency against oncogenic ROS1 fusions and inhibited the crizotinib-refractory ROS1G2032R mutation and the ROS1G2026M gatekeeper mutation.  Compared with crizotinib and the second-generation ALK/ROS1 inhibitors ceritinib and alectinib, PF-06463922 showed significantly improved inhibitory activity against ROS1 kinase.  A crystal structure of the PF-06463922-ROS1 kinase complex revealed favorable interactions contributing to the high-affinity binding.  In vivo, PF-06463922 showed marked antitumor activity in tumor models expressing FIG-ROS1, CD74-ROS1, and the CD74-ROS1G2032R mutation.  Furthermore, PF-06463922 demonstrated antitumor activity in a genetically engineered mouse model of FIG-ROS1 glioblastoma.  Taken together, the authors' results indicate that PF-06463922 has potential for treating ROS1 fusion-pos. cancers, including those requiring agents with CNS-penetrating properties, as well as for overcoming crizotinib resistance driven by ROS1 mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5t2o5BKPhK7Vg90H21EOLACvtfcHk0liRmWU8EgmYwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1Grur8%253D&md5=8f549572dfac12c74b88705d57979c09</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1420785112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1420785112%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DWest%26aufirst%3DM.%26aulast%3DAppleman%26aufirst%3DV.%26aulast%3DWong%26aufirst%3DK.%2BA.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DFalk%26aufirst%3DM.%2BD.%26aulast%3DLappin%26aufirst%3DP.%2BB.%26aulast%3DAffolter%26aufirst%3DT.%26aulast%3DNichols%26aufirst%3DT.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DLam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DCharest%26aufirst%3DA.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26atitle%3DPF-06463922%2520is%2520a%2520potent%2520and%2520selective%2520next-generation%2520ROS1%252FALK%2520inhibitor%2520capable%2520of%2520blocking%2520crizotinib-resistant%2520ROS1%2520mutations%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2015%26volume%3D112%26spage%3D3493%26epage%3D3498%26doi%3D10.1073%2Fpnas.1420785112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><a href="https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm625027.htm" class="extLink">https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm625027.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fwww.fda.gov%2FDrugs%2FInformationOnDrugs%2FApprovedDrugs%2Fucm625027.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Atwell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feil, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froning, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keegan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leon, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller-Dieckmann, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nienaber, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noland, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajashankar, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burley, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, S. G.</span></span> <span> </span><span class="NLM_article-title">A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">55827</span>– <span class="NLM_lpage">55832</span>, <span class="refDoi"> DOI: 10.1074/jbc.M409792200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1074%2Fjbc.M409792200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15507431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeisL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=55827-55832&author=S.+Atwellauthor=J.+M.+Adamsauthor=J.+Badgerauthor=M.+D.+Buchananauthor=I.+K.+Feilauthor=K.+J.+Froningauthor=X.+Gaoauthor=J.+Hendleauthor=K.+Keeganauthor=B.+C.+Leonauthor=H.+J.+Muller-Dieckmannauthor=V.+L.+Nienaberauthor=B.+W.+Nolandauthor=K.+Postauthor=K.+R.+Rajashankarauthor=A.+Ramosauthor=M.+Russellauthor=S.+K.+Burleyauthor=S.+G.+Buchanan&title=A+novel+mode+of+Gleevec+binding+is+revealed+by+the+structure+of+spleen+tyrosine+kinase&doi=10.1074%2Fjbc.M409792200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase</span></div><div class="casAuthors">Atwell, Shane; Adams, Jason M.; Badger, John; Buchanan, Michelle D.; Feil, Ingeborg K.; Froning, Karen J.; Gao, Xia; Hendle, Joerg; Keegan, Kevin; Leon, Barbara C.; Mueller-Dieckmann, Hans J.; Nienaber, Vicki L.; Noland, Brian W.; Post, Kai; Rajashankar, K. R.; Ramos, Aurora; Russell, Marijane; Burley, Stephen K.; Buchanan, Sean G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">55827-55832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a non-receptor tyrosine kinase required for signaling from immunoreceptors in various hematopoietic cells.  Phosphorylation of two tyrosine residues in the activation loop of the Syk kinase catalytic domain is necessary for signaling, a phenomenon typical of tyrosine kinase family members.  Syk in vitro enzyme activity, however, does not depend on phosphorylation (activation loop tyrosine phenylalanine mutants retain catalytic activity).  We have detd. the x-ray structure of the unphosphorylated form of the kinase catalytic domain of Syk.  The enzyme adopts a conformation of the activation loop typically seen only in activated, phosphorylated tyrosine kinases, explaining why Syk does not require phosphorylation for activation.  We also demonstrate that Gleevec (STI-571, Imatinib) inhibits the isolated kinase domains of both unphosphorylated Syk and phosphorylated Abl with comparable potency.  Gleevec binds Syk in a novel, compact cis-conformation that differs dramatically from the binding mode obsd. with unphosphorylated Abl, the more Gleevec-sensitive form of Abl.  This finding suggests the existence of two distinct Gleevec binding modes: an extended, trans-conformation characteristic of tight binding to the inactive conformation of a protein kinase and a second compact, cis-conformation characteristic of weaker binding to the active conformation.  Finally, the Syk-bound cis-conformation of Gleevec bears a striking resemblance to the rigid structure of the nonspecific, natural product kinase inhibitor staurosporine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7D3dM-QQRHLVg90H21EOLACvtfcHk0liRmWU8EgmYwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeisL7N&md5=b55eefe8790607cb5c8ae7be8795a83b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409792200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409792200%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBadger%26aufirst%3DJ.%26aulast%3DBuchanan%26aufirst%3DM.%2BD.%26aulast%3DFeil%26aufirst%3DI.%2BK.%26aulast%3DFroning%26aufirst%3DK.%2BJ.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHendle%26aufirst%3DJ.%26aulast%3DKeegan%26aufirst%3DK.%26aulast%3DLeon%26aufirst%3DB.%2BC.%26aulast%3DMuller-Dieckmann%26aufirst%3DH.%2BJ.%26aulast%3DNienaber%26aufirst%3DV.%2BL.%26aulast%3DNoland%26aufirst%3DB.%2BW.%26aulast%3DPost%26aufirst%3DK.%26aulast%3DRajashankar%26aufirst%3DK.%2BR.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26atitle%3DA%2520novel%2520mode%2520of%2520Gleevec%2520binding%2520is%2520revealed%2520by%2520the%2520structure%2520of%2520spleen%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D55827%26epage%3D55832%26doi%3D10.1074%2Fjbc.M409792200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inesta-Vaquera, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niepel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficarro, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machleidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughlin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LoGrasso, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patricelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomanbhoy, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorger, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective covalent inhibitors of JNK</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.chembiol.2011.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=22284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=140-154&author=T.+Zhangauthor=F.+Inesta-Vaqueraauthor=M.+Niepelauthor=J.+Zhangauthor=S.+B.+Ficarroauthor=T.+Machleidtauthor=T.+Xieauthor=J.+A.+Martoauthor=N.+Kimauthor=T.+Simauthor=J.+D.+Laughlinauthor=H.+Parkauthor=P.+V.+LoGrassoauthor=M.+Patricelliauthor=T.+K.+Nomanbhoyauthor=P.+K.+Sorgerauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Discovery+of+potent+and+selective+covalent+inhibitors+of+JNK&doi=10.1016%2Fj.chembiol.2011.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Covalent Inhibitors of JNK</span></div><div class="casAuthors">Zhang, Tinghu; Inesta-Vaquera, Francisco; Niepel, Mario; Zhang, Jianming; Ficarro, Scott B.; Machleidt, Thomas; Xie, Ting; Marto, Jarrod A.; Kim, Nam Doo; Sim, Taebo; Laughlin, John D.; Park, Hajeung; LoGrasso, Philip V.; Patricelli, Matt; Nomanbhoy, Tyzoon K.; Sorger, Peter K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-154</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response.  Here, we report the discovery of irreversible inhibitors of JNK1/2/3.  We describe two JNK3 cocrystal structures at 2.60 and 2.97 Å resoln. that show the compds. form covalent bonds with a conserved cysteine residue.  JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue.  Extensive biochem., cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compd. will be broadly useful as a pharmacol. probe of JNK-dependent signal transduction.  Potential lead compds. have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXs0FY7FSmt7Vg90H21EOLACvtfcHk0lgovhL39eCSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D&md5=f7d9647fb2be162c637b1d31a778ceb4</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DInesta-Vaquera%26aufirst%3DF.%26aulast%3DNiepel%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DLaughlin%26aufirst%3DJ.%2BD.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DPatricelli%26aufirst%3DM.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520covalent%2520inhibitors%2520of%2520JNK%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D140%26epage%3D154%26doi%3D10.1016%2Fj.chembiol.2011.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGowan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amssoms, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Last, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devogelaere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vijgen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berke, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehertogh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fransen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleiren, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Der
Helm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyanguile, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Remoortere, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raboisson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vendeville, S.</span></span> <span> </span><span class="NLM_article-title">Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1880</span>– <span class="NLM_lpage">1892</span>, <span class="refDoi"> DOI: 10.1021/jm401396p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401396p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=1880-1892&author=M.+D.+Cummingsauthor=T.+I.+Linauthor=L.+Huauthor=A.+Tahriauthor=D.+McGowanauthor=K.+Amssomsauthor=S.+Lastauthor=B.+Devogelaereauthor=M.+C.+Rouanauthor=L.+Vijgenauthor=J.+M.+Berkeauthor=P.+Dehertoghauthor=E.+Fransenauthor=E.+Cleirenauthor=L.+Van+Der%0AHelmauthor=G.+Fanningauthor=O.+Nyanguileauthor=K.+Simmenauthor=P.+Van+Remoortereauthor=P.+Raboissonauthor=S.+Vendeville&title=Discovery+and+early+development+of+TMC647055%2C+a+non-nucleoside+inhibitor+of+the+hepatitis+C+virus+NS5B+polymerase&doi=10.1021%2Fjm401396p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Early Development of TMC647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase</span></div><div class="casAuthors">Cummings, Maxwell D.; Lin, Tse-I.; Hu, Lili; Tahri, Abdellah; McGowan, David; Amssoms, Katie; Last, Stefaan; Devogelaere, Benoit; Rouan, Marie-Claude; Vijgen, Leen; Berke, Jan Martin; Dehertogh, Pascale; Fransen, Els; Cleiren, Erna; van der Helm, Liesbet; Fanning, Gregory; Nyanguile, Origene; Simmen, Kenny; Van Remoortere, Pieter; Raboisson, Pierre; Vendeville, Sandrine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1880-1892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based macrocyclization of a 6-carboxylic acid indole chemotype has yielded potent and selective finger-loop inhibitors of the hepatitis C virus (HCV) NS5B polymerase.  Lead optimization in conjunction with in vivo evaluation in rats identified several compds. showing (i) nanomolar potency in HCV replicon cells, (ii) limited toxicity and off-target activities, and (iii) encouraging preclin. pharmacokinetic profiles characterized by high liver distribution.  This effort culminated in the identification of TMC647055 (I), a nonzwitterionic 17-membered-ring macrocycle characterized by high affinity, long polymerase residence time, and broad genotypic coverage.  In vitro results of the combination of I with the HCV protease inhibitor TMC435 (simeprevir) supported an evaluation of this combination in patients with regard to virus suppression and resistance emergence.  In a phase 1b trial with HCV genotype 1-infected patients, I was considered to be safe and well-tolerated and demonstrated potent antiviral activity, which was further enhanced in a combination study with TMC435.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFfQhbJ5iLObVg90H21EOLACvtfcHk0lgovhL39eCSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktLnJ&md5=2b41cdc2df2fde1d8462e2d3a97033ab</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm401396p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401396p%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DAmssoms%26aufirst%3DK.%26aulast%3DLast%26aufirst%3DS.%26aulast%3DDevogelaere%26aufirst%3DB.%26aulast%3DRouan%26aufirst%3DM.%2BC.%26aulast%3DVijgen%26aufirst%3DL.%26aulast%3DBerke%26aufirst%3DJ.%2BM.%26aulast%3DDehertogh%26aufirst%3DP.%26aulast%3DFransen%26aufirst%3DE.%26aulast%3DCleiren%26aufirst%3DE.%26aulast%3DVan%2BDer%2BHelm%26aufirst%3DL.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DNyanguile%26aufirst%3DO.%26aulast%3DSimmen%26aufirst%3DK.%26aulast%3DVan%2BRemoortere%26aufirst%3DP.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DVendeville%26aufirst%3DS.%26atitle%3DDiscovery%2520and%2520early%2520development%2520of%2520TMC647055%252C%2520a%2520non-nucleoside%2520inhibitor%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D1880%26epage%3D1892%26doi%3D10.1021%2Fjm401396p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="note"><p class="first last">Clinical development of this compound was suspended for business-related reasons.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Marco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Francesco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliaccio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carfi, A.</span></span> <span> </span><span class="NLM_article-title">Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">29765</span>– <span class="NLM_lpage">29770</span>, <span class="refDoi"> DOI: 10.1074/jbc.M505423200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1074%2Fjbc.M505423200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=15955819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1Sltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=29765-29770&author=S.+Di%0AMarcoauthor=C.+Volpariauthor=L.+Tomeiauthor=S.+Altamuraauthor=S.+Harperauthor=F.+Narjesauthor=U.+Kochauthor=M.+Rowleyauthor=R.+De+Francescoauthor=G.+Migliaccioauthor=A.+Carfi&title=Interdomain+communication+in+hepatitis+C+virus+polymerase+abolished+by+small+molecule+inhibitors+bound+to+a+novel+allosteric+site&doi=10.1074%2Fjbc.M505423200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site</span></div><div class="casAuthors">Di Marco, Stefania; Volpari, Cinzia; Tomei, Licia; Altamura, Sergio; Harper, Steven; Narjes, Frank; Koch, Uwe; Rowley, Michael; De Francesco, Raffaele; Migliaccio, Giovanni; Carfi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">29765-29770</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase is required for replication of the viral genome and is a key target for therapeutic intervention against HCV.  We have detd. the crystal structures of the HCV polymerase complexed with two indole-based allosteric inhibitors at 2.3- and 2.4-Å resoln.  The structures show that these inhibitors bind to a site on the surface of the thumb domain.  A cyclohexyl and Ph ring substituents, bridged by an indole moiety, fill two closely spaced pockets, whereas a carboxylate substituent forms a salt bridge with an exposed arginine side chain.  Interestingly, in the apoenzyme, the inhibitor binding site is occupied by a small α-helix at the tip of the N-terminal loop that connects the fingers and thumb domains.  Thus, these mols. inhibit the enzyme by preventing formation of intramol. contacts between these two domains and consequently precluding their coordinated movements during RNA synthesis.  Our structures identify a novel mechanism by which a new class of allosteric inhibitors inhibits the HCV polymerase and open the way to the development of novel antiviral agents against this clin. relevant human pathogen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWHS1-2Y1C8LVg90H21EOLACvtfcHk0lgovhL39eCSIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1Sltr0%253D&md5=1192532b3624ec0032d9dff24c19a704</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M505423200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M505423200%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BMarco%26aufirst%3DS.%26aulast%3DVolpari%26aufirst%3DC.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DHarper%26aufirst%3DS.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DCarfi%26aufirst%3DA.%26atitle%3DInterdomain%2520communication%2520in%2520hepatitis%2520C%2520virus%2520polymerase%2520abolished%2520by%2520small%2520molecule%2520inhibitors%2520bound%2520to%2520a%2520novel%2520allosteric%2520site%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D29765%26epage%3D29770%26doi%3D10.1074%2Fjbc.M505423200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ikegashira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuruha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ando, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6950</span>– <span class="NLM_lpage">6953</span>, <span class="refDoi"> DOI: 10.1021/jm0610245</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0610245" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6950-6953&author=K.+Ikegashiraauthor=T.+Okaauthor=S.+Hirashimaauthor=S.+Nojiauthor=H.+Yamanakaauthor=Y.+Haraauthor=T.+Adachiauthor=J.+Tsuruhaauthor=S.+Doiauthor=Y.+Haseauthor=T.+Noguchiauthor=I.+Andoauthor=N.+Oguraauthor=S.+Ikedaauthor=H.+Hashimoto&title=Discovery+of+conformationally+constrained+tetracyclic+compounds+as+potent+hepatitis+C+virus+NS5B+RNA+polymerase+inhibitors&doi=10.1021%2Fjm0610245"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Conformationally Constrained Tetracyclic Compounds as Potent Hepatitis C Virus NS5B RNA Polymerase Inhibitors</span></div><div class="casAuthors">Ikegashira, Kazutaka; Oka, Takahiro; Hirashima, Shintaro; Noji, Satoru; Yamanaka, Hiroshi; Hara, Yoshinori; Adachi, Tsuyoshi; Tsuruha, Jun-Ichiro; Doi, Satoki; Hase, Yasunori; Noguchi, Toru; Ando, Izuru; Ogura, Naoki; Ikeda, Satoru; Hashimoto, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6950-6953</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report a new series of hepatitis C virus NS5B RNA polymerase inhibitors contg. a conformationally constrained tetracyclic scaffold.  SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (I and II) bearing a basic pendent group with high biochem. and cellular potencies.  These compds. displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF0S142h4FZLVg90H21EOLACvtfcHk0li7hJu5W9WlIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKrs7rF&md5=18234c5535779cf60484899c6e63770f</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm0610245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610245%26sid%3Dliteratum%253Aachs%26aulast%3DIkegashira%26aufirst%3DK.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DNoji%26aufirst%3DS.%26aulast%3DYamanaka%26aufirst%3DH.%26aulast%3DHara%26aufirst%3DY.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DTsuruha%26aufirst%3DJ.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DAndo%26aufirst%3DI.%26aulast%3DOgura%26aufirst%3DN.%26aulast%3DIkeda%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520conformationally%2520constrained%2520tetracyclic%2520compounds%2520as%2520potent%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA%2520polymerase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6950%26epage%3D6953%26doi%3D10.1021%2Fjm0610245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="note"><p class="first last">The nature of the macrocycle linker was shown to have profound effects on oral bioavailability, clearance, liver microsomal stability, liver/plasma partitioning, and total liver accumulation. These results are discussed in detail in ref <a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and references therein.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="note"><p class="first last">TMC647055 progressed into phase 2 clinical trials. Development was discontinued for strategic reasons.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corte, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. E.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozarth, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiffert, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decicco, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, M. L.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of macrocyclic factor XIa inhibitors: discovery of the macrocyclic amide linker</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1075</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01460</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01460" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVKisrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1060-1075&author=J.+R.+Corteauthor=T.+Fangauthor=H.+Osunaauthor=D.+J.+Pintoauthor=K.+A.+Rossiauthor=J.+E.+Myersauthor=S.+Sheriffauthor=Z.+Louauthor=J.+J.+Zhengauthor=T.+W.+Harperauthor=J.+M.+Bozarthauthor=Y.+Wuauthor=J.+M.+Luettgenauthor=D.+A.+Seiffertauthor=C.+P.+Deciccoauthor=R.+R.+Wexlerauthor=M.+L.+Quan&title=Structure-based+design+of+macrocyclic+factor+XIa+inhibitors%3A+discovery+of+the+macrocyclic+amide+linker&doi=10.1021%2Facs.jmedchem.6b01460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Macrocyclic Factor XIa Inhibitors: Discovery of the Macrocyclic Amide Linker</span></div><div class="casAuthors">Corte, James R.; Fang, Tianan; Osuna, Honey; Pinto, Donald J. P.; Rossi, Karen A.; Myers, Joseph E.; Sheriff, Steven; Lou, Zhen; Zheng, Joanna J.; Harper, Timothy W.; Bozarth, Jeffrey M.; Wu, Yiming; Luettgen, Joseph M.; Seiffert, Dietmar A.; Decicco, Carl P.; Wexler, Ruth R.; Quan, Mimi L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1060-1075</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of macrocyclic FXIa inhibitors was designed based on our lead acyclic Ph imidazole chemotype.  Our initial macrocycles, which were double-digit nanomolar FXIa inhibitors, were further optimized with assistance from utilization of structure-based drug design and ligand bound X-ray crystal structures.  This effort resulted in the discovery of a macrocyclic amide linker which was found to form a key hydrogen bond with the carbonyl of Leu41 in the FXIa active site, resulting in potent FXIa inhibitors.  The macrocyclic FXIa series, exemplified by compd. 16, had a FXIa Ki = 0.16 nM with potent anticoagulant activity in an in vitro clotting assay (aPTT EC1.5x = 0.27 μM) and excellent selectivity against the relevant blood coagulation enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSUGpFskDtZLVg90H21EOLACvtfcHk0li7hJu5W9WlIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVKisrk%253D&md5=82f615b27494ac96c0ba3ce0e40f010b</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01460%26sid%3Dliteratum%253Aachs%26aulast%3DCorte%26aufirst%3DJ.%2BR.%26aulast%3DFang%26aufirst%3DT.%26aulast%3DOsuna%26aufirst%3DH.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DMyers%26aufirst%3DJ.%2BE.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26aulast%3DHarper%26aufirst%3DT.%2BW.%26aulast%3DBozarth%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DSeiffert%26aufirst%3DD.%2BA.%26aulast%3DDecicco%26aufirst%3DC.%2BP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26atitle%3DStructure-based%2520design%2520of%2520macrocyclic%2520factor%2520XIa%2520inhibitors%253A%2520discovery%2520of%2520the%2520macrocyclic%2520amide%2520linker%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1060%26epage%3D1075%26doi%3D10.1021%2Facs.jmedchem.6b01460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Priestley, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheney, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLucca, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of macrocyclic coagulation factor VIIa inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6225</span>– <span class="NLM_lpage">6236</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6225-6236&author=E.+S.+Priestleyauthor=D.+L.+Cheneyauthor=I.+DeLuccaauthor=A.+Weiauthor=J.+M.+Luettgenauthor=A.+R.+Rendinaauthor=P.+C.+Wongauthor=R.+R.+Wexler&title=Structure-based+design+of+macrocyclic+coagulation+factor+VIIa+inhibitors&doi=10.1021%2Facs.jmedchem.5b00788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Macrocyclic Coagulation Factor VIIa Inhibitors</span></div><div class="casAuthors">Priestley, E. Scott; Cheney, Daniel L.; DeLucca, Indawati; Wei, Anzhi; Luettgen, Joseph M.; Rendina, Alan R.; Wong, Pancras C.; Wexler, Ruth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6225-6236</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of a crystal structure of a phenylpyrrolidine lead and subsequent mol. modeling results, we designed and synthesized a novel series of macrocyclic FVIIa inhibitors.  The optimal 16-membered macrocycle was 60-fold more potent than an acyclic analog.  Further potency optimization by incorporation of P1' alkyl sulfone and P2 Me groups provided a macrocycle with TF/FVIIa Ki = 1.6 nM, excellent selectivity against a panel of seven serine proteases, and FVII-deficient prothrombin time EC2x = 1.2 μM.  Discovery of this potent, selective macrocyclic scaffold opens new possibilities for the development of orally bioavailable FVIIa inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIZvUgkobQ3bVg90H21EOLACvtfcHk0ljDRveCzwusKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFejtb%252FM&md5=881772bfb89d6097de1cfc14f6c7bb8b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00788%26sid%3Dliteratum%253Aachs%26aulast%3DPriestley%26aufirst%3DE.%2BS.%26aulast%3DCheney%26aufirst%3DD.%2BL.%26aulast%3DDeLucca%26aufirst%3DI.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DStructure-based%2520design%2520of%2520macrocyclic%2520coagulation%2520factor%2520VIIa%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6225%26epage%3D6236%26doi%3D10.1021%2Facs.jmedchem.5b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motwani, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenquist, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of P1′-functionalized macrocyclic transition-state mimicking HIV-1 protease inhibitors encompassing a tertiary alcohol</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6444</span>– <span class="NLM_lpage">6457</span>, <span class="refDoi"> DOI: 10.1021/jm500434q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500434q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtF2lsbnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6444-6457&author=M.+De%0ARosaauthor=J.+Ungeauthor=H.+V.+Motwaniauthor=A.+Rosenquistauthor=L.+Vrangauthor=H.+Wallbergauthor=M.+Larhed&title=Synthesis+of+P1%E2%80%B2-functionalized+macrocyclic+transition-state+mimicking+HIV-1+protease+inhibitors+encompassing+a+tertiary+alcohol&doi=10.1021%2Fjm500434q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of P1'-Functionalized Macrocyclic Transition-State Mimicking HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol</span></div><div class="casAuthors">De Rosa, Maria; Unge, Johan; Motwani, Hitesh V.; Rosenquist, Aasa; Vrang, Lotta; Wallberg, Hans; Larhed, Mats</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6444-6457</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Seven novel tertiary alc.-contg. linear HIV-1 protease inhibitors (PIs), decorated at the para position of the benzyl group in the P1' side with (hetero)arom. moieties, were synthesized and biol. evaluated.  To study the inhibition and antiviral activity effect of P1-P3 macrocyclization, 14- and 15-membered macrocyclic PIs were prepd. by ring-closing metathesis of the corresponding linear PIs.  The macrocycles were more active than the linear precursors and compd. 10f, with a 2-thiazolyl group in the P1' position, was the most potent PI of this new series (Ki = 2.2 nM, EC50 0.2 μM).  Co-crystd. complexes of both linear and macrocyclic PIs with the HIV-1 protease enzyme were prepd. and analyzed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxGfX47dsVkLVg90H21EOLACvtfcHk0ljDRveCzwusKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtF2lsbnM&md5=072cfae220ae6d3355a2c4bc74a4bf3a</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm500434q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500434q%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRosa%26aufirst%3DM.%26aulast%3DUnge%26aufirst%3DJ.%26aulast%3DMotwani%26aufirst%3DH.%2BV.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DWallberg%26aufirst%3DH.%26aulast%3DLarhed%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520P1%25E2%2580%25B2-functionalized%2520macrocyclic%2520transition-state%2520mimicking%2520HIV-1%2520protease%2520inhibitors%2520encompassing%2520a%2520tertiary%2520alcohol%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6444%26epage%3D6457%26doi%3D10.1021%2Fjm500434q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stachel, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sankaranarayanan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietrak, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espeseth, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazuda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span> <span> </span><span class="NLM_article-title">Macrocyclic inhibitors of beta-secretase: functional activity in an animal model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6147</span>– <span class="NLM_lpage">6150</span>, <span class="refDoi"> DOI: 10.1021/jm060884i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060884i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVymtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6147-6150&author=S.+J.+Stachelauthor=C.+A.+Coburnauthor=S.+Sankaranarayananauthor=E.+A.+Priceauthor=B.+L.+Pietrakauthor=Q.+Huangauthor=J.+Linebergerauthor=A.+S.+Espesethauthor=L.+Jinauthor=J.+Ellisauthor=M.+K.+Hollowayauthor=S.+Munshiauthor=T.+Allisonauthor=D.+Hazudaauthor=A.+J.+Simonauthor=S.+L.+Grahamauthor=J.+P.+Vacca&title=Macrocyclic+inhibitors+of+beta-secretase%3A+functional+activity+in+an+animal+model&doi=10.1021%2Fjm060884i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of β-secretase: functional activity in an animal model</span></div><div class="casAuthors">Stachel, Shawn J.; Coburn, Craig A.; Sankaranarayanan, Sethu; Price, Eric A.; Pietrak, Beth L.; Huang, Qian; Lineberger, Janet; Espeseth, Amy S.; Jin, Lixia; Ellis, Joan; Holloway, M. Katharine; Munshi, Sanjeev; Allison, Timothy; Hazuda, Daria; Simon, Adam J.; Graham, Samuel L.; Vacca, Joseph P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6147-6150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A macrocyclic inhibitor of β-secretase was designed by covalently crosslinking the P1 and P3 side chains of an isophthalamide-based inhibitor.  Macrocyclization resulted in significantly improved potency and phys. properties when compared to the initial lead structures.  More importantly, these macrocyclic inhibitors also displayed in vivo amyloid lowering when dosed in a murine model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMxrOyVlJE6bVg90H21EOLACvtfcHk0ljDRveCzwusKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVymtbw%253D&md5=68e93484eb2d6e3c1d00b917aac763d8</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm060884i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060884i%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DPietrak%26aufirst%3DB.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DLineberger%26aufirst%3DJ.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DAllison%26aufirst%3DT.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520beta-secretase%253A%2520functional%2520activity%2520in%2520an%2520animal%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6147%26epage%3D6150%26doi%3D10.1021%2Fjm060884i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoull, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abrams, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blades, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuaqui, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbajo, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Code, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuller, N. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gangl, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemmitt, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raubo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawlins, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of pyrazolo[1,5-a]pyrimidine B-cell lymphoma 6 (BCL6) binders and optimization to high affinity macrocyclic inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4386</span>– <span class="NLM_lpage">4402</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00359</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00359" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFOmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4386-4402&author=W.+McCoullauthor=R.+D.+Abramsauthor=E.+Andersonauthor=K.+Bladesauthor=P.+Bartonauthor=M.+Boxauthor=J.+Burgessauthor=K.+Bythauthor=Q.+Caoauthor=C.+Chuaquiauthor=R.+J.+Carbajoauthor=T.+Cheungauthor=E.+Codeauthor=A.+D.+Fergusonauthor=S.+Filleryauthor=N.+O.+Fullerauthor=E.+Ganglauthor=N.+Gaoauthor=M.+Gristauthor=D.+Hargreavesauthor=M.+R.+Howardauthor=J.+Huauthor=P.+D.+Kemmittauthor=J.+E.+Nelsonauthor=N.+O%E2%80%99Connellauthor=D.+B.+Princeauthor=P.+Rauboauthor=P.+B.+Rawlinsauthor=G.+R.+Robbauthor=J.+Shiauthor=M.+J.+Waringauthor=D.+Whittakerauthor=M.+Wylotauthor=X.+Zhu&title=Discovery+of+pyrazolo%5B1%2C5-a%5Dpyrimidine+B-cell+lymphoma+6+%28BCL6%29+binders+and+optimization+to+high+affinity+macrocyclic+inhibitors&doi=10.1021%2Facs.jmedchem.7b00359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors</span></div><div class="casAuthors">McCoull, William; Abrams, Roman D.; Anderson, Erica; Blades, Kevin; Barton, Peter; Box, Matthew; Burgess, Jonathan; Byth, Kate; Cao, Qing; Chuaqui, Claudio; Carbajo, Rodrigo J.; Cheung, Tony; Code, Erin; Ferguson, Andrew D.; Fillery, Shaun; Fuller, Nathan O.; Gangl, Eric; Gao, Ning; Grist, Matthew; Hargreaves, David; Howard, Martin R.; Hu, Jun; Kemmitt, Paul D.; Nelson, Jennifer E.; O'Connell, Nichole; Prince, D. Bryan; Raubo, Piotr; Rawlins, Philip B.; Robb, Graeme R.; Shi, Junjie; Waring, Michael J.; Whittaker, David; Wylot, Marta; Zhu, Xiahui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4386-4402</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of the protein-protein interaction between B-cell lymphoma 6 (BCL6) and corepressors has been implicated as a therapeutic target in diffuse large B-cell lymphoma (DLBCL) cancers and profiling of potent and selective BCL6 inhibitors are crit. to test this hypothesis.  We identified a pyrazolo[1,5-a]pyrimidine series of BCL6 binders from a fragment screen in parallel with a virtual screen.  Using structure-based drug design, binding affinity was increased 100000-fold.  This involved displacing crystallog. water, forming new ligand-protein interactions and a macrocyclization to favor the bioactive conformation of the ligands.  Optimization for slow off-rate const. kinetics was conducted as well as improving selectivity against an off-target kinase, CK2.  Potency in a cellular BCL6 assay was further optimized to afford highly selective probe mols.  Only weak antiproliferative effects were obsd. across a no. of DLBCL lines and a multiple myeloma cell line without a clear relationship to BCL6 potency.  As a result, we conclude that the BCL6 hypothesis in DLBCL cancer remains unproven.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWp2OlXAZDFLVg90H21EOLACvtfcHk0lhHQe7Do-t0JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFOmsbo%253D&md5=fc4142453a0580edbf04802e15d4d9aa</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00359%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DAbrams%26aufirst%3DR.%2BD.%26aulast%3DAnderson%26aufirst%3DE.%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DBarton%26aufirst%3DP.%26aulast%3DBox%26aufirst%3DM.%26aulast%3DBurgess%26aufirst%3DJ.%26aulast%3DByth%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DQ.%26aulast%3DChuaqui%26aufirst%3DC.%26aulast%3DCarbajo%26aufirst%3DR.%2BJ.%26aulast%3DCheung%26aufirst%3DT.%26aulast%3DCode%26aufirst%3DE.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DFillery%26aufirst%3DS.%26aulast%3DFuller%26aufirst%3DN.%2BO.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DN.%26aulast%3DGrist%26aufirst%3DM.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DHoward%26aufirst%3DM.%2BR.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DKemmitt%26aufirst%3DP.%2BD.%26aulast%3DNelson%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DN.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DRaubo%26aufirst%3DP.%26aulast%3DRawlins%26aufirst%3DP.%2BB.%26aulast%3DRobb%26aufirst%3DG.%2BR.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWylot%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520pyrazolo%255B1%252C5-a%255Dpyrimidine%2520B-cell%2520lymphoma%25206%2520%2528BCL6%2529%2520binders%2520and%2520optimization%2520to%2520high%2520affinity%2520macrocyclic%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4386%26epage%3D4402%26doi%3D10.1021%2Facs.jmedchem.7b00359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Estrada-Ortiz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neochoritis, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twarda-Clapa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musielak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holak, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domling, A.</span></span> <span> </span><span class="NLM_article-title">Artificial macrocycles as potent p53-MDM2 Inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00219</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00219" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1025-1030&author=N.+Estrada-Ortizauthor=C.+G.+Neochoritisauthor=A.+Twarda-Clapaauthor=B.+Musielakauthor=T.+A.+Holakauthor=A.+Domling&title=Artificial+macrocycles+as+potent+p53-MDM2+Inhibitors&doi=10.1021%2Facsmedchemlett.7b00219"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Artificial Macrocycles as Potent p53-MDM2 Inhibitors</span></div><div class="casAuthors">Estrada-Ortiz, Natalia; Neochoritis, Constantinos G.; Twarda-Clapa, Aleksandra; Musielak, Bogdan; Holak, Tad A.; Doemling, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Based on a combination of an Ugi four component reaction and a ring closing metathesis, a library of novel artificial macrocyclic inhibitors of the p53-MDM2 interaction was designed and synthesized.  These macrocycles, alternatively to stapled peptides, target for the first time the large hydrophobic surface area formed by Tyr67, Gln72, His73, Val93, and Lys94 yielding derivs. with affinity to MDM2 in the nanomolar range.  Their binding affinity with MDM2 was evaluated using fluorescence polarization (FP) assay and 1H-15N two-dimensional HSQC NMR expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWgHNqMYuVkrVg90H21EOLACvtfcHk0lhHQe7Do-t0JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeitbrO&md5=ff61cf19c704714d2175a1a760f2867b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00219%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada-Ortiz%26aufirst%3DN.%26aulast%3DNeochoritis%26aufirst%3DC.%2BG.%26aulast%3DTwarda-Clapa%26aufirst%3DA.%26aulast%3DMusielak%26aufirst%3DB.%26aulast%3DHolak%26aufirst%3DT.%2BA.%26aulast%3DDomling%26aufirst%3DA.%26atitle%3DArtificial%2520macrocycles%2520as%2520potent%2520p53-MDM2%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Facsmedchemlett.7b00219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Schoolmeester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgour, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayers, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhardt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogg, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selmi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swales, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittamore, P. R.</span></span> <span> </span><span class="NLM_article-title">Novel acidic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitor with reduced acyl glucuronide liability: the discovery of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid (AZD8329)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10136</span>– <span class="NLM_lpage">10147</span>, <span class="refDoi"> DOI: 10.1021/jm301252n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301252n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFChsrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10136-10147&author=J.+S.+Scottauthor=J.+De+Schoolmeesterauthor=E.+Kilgourauthor=R.+M.+Mayersauthor=M.+J.+Packerauthor=D.+Hargreavesauthor=S.+Gerhardtauthor=D.+J.+Oggauthor=A.+Reesauthor=N.+Selmiauthor=A.+Stockerauthor=J.+G.+Swalesauthor=P.+R.+Whittamore&title=Novel+acidic+11beta-hydroxysteroid+dehydrogenase+type+1+%2811beta-HSD1%29+inhibitor+with+reduced+acyl+glucuronide+liability%3A+the+discovery+of+4-%5B4-%282-adamantylcarbamoyl%29-5-tert-butyl-pyrazol-1-yl%5Dbenzoic+acid+%28AZD8329%29&doi=10.1021%2Fjm301252n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Acidic 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitor with Reduced Acyl Glucuronide Liability: The Discovery of 4-[4-(2-Adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic Acid (AZD8329)</span></div><div class="casAuthors">Scott, James S.; deSchoolmeester, Joanne; Kilgour, Elaine; Mayers, Rachel M.; Packer, Martin J.; Hargreaves, David; Gerhardt, Stefan; Ogg, Derek J.; Rees, Amanda; Selmi, Nidhal; Stocker, Andrew; Swales, John G.; Whittamore, Paul R. O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10136-10147</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of 11β-HSD1 is viewed as a potential target for the treatment of obesity and other elements of the metabolic syndrome.  We report here the optimization of a carboxylic acid class of inhibitors from AZD4017 (I) to the development candidate AZD8329 (II).  A structural change from pyridine to pyrazole together with structural optimization led to an improved tech. profile in terms of both soly. and pharmacokinetics.  The extent of acyl glucuronidation was reduced through structural optimization of both the carboxylic acid and amide substituents, coupled with a redn. in lipophilicity leading to an overall increase in metabolic stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKFfab5QO3Q7Vg90H21EOLACvtfcHk0lhHQe7Do-t0JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFChsrbF&md5=c48d951089cae3c4ad95c938ecaaf8e5</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm301252n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301252n%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BS.%26aulast%3DDe%2BSchoolmeester%26aufirst%3DJ.%26aulast%3DKilgour%26aufirst%3DE.%26aulast%3DMayers%26aufirst%3DR.%2BM.%26aulast%3DPacker%26aufirst%3DM.%2BJ.%26aulast%3DHargreaves%26aufirst%3DD.%26aulast%3DGerhardt%26aufirst%3DS.%26aulast%3DOgg%26aufirst%3DD.%2BJ.%26aulast%3DRees%26aufirst%3DA.%26aulast%3DSelmi%26aufirst%3DN.%26aulast%3DStocker%26aufirst%3DA.%26aulast%3DSwales%26aufirst%3DJ.%2BG.%26aulast%3DWhittamore%26aufirst%3DP.%2BR.%26atitle%3DNovel%2520acidic%252011beta-hydroxysteroid%2520dehydrogenase%2520type%25201%2520%252811beta-HSD1%2529%2520inhibitor%2520with%2520reduced%2520acyl%2520glucuronide%2520liability%253A%2520the%2520discovery%2520of%25204-%255B4-%25282-adamantylcarbamoyl%2529-5-tert-butyl-pyrazol-1-yl%255Dbenzoic%2520acid%2520%2528AZD8329%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10136%26epage%3D10147%26doi%3D10.1021%2Fjm301252n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schormann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velu, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senkovich, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chenna, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinkre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chattopadhyay, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4056</span>– <span class="NLM_lpage">4066</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1016%2Fj.bmc.2010.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=20452776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmslOisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=4056-4066&author=N.+Schormannauthor=S.+E.+Veluauthor=S.+Murugesanauthor=O.+Senkovichauthor=K.+Walkerauthor=B.+C.+Chennaauthor=B.+Shinkreauthor=A.+Desaiauthor=D.+Chattopadhyay&title=Synthesis+and+characterization+of+potent+inhibitors+of+Trypanosoma+cruzi+dihydrofolate+reductase&doi=10.1016%2Fj.bmc.2010.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of potent inhibitors of Trypanosoma cruzi dihydrofolate reductase</span></div><div class="casAuthors">Schormann, Norbert; Velu, Sadanandan E.; Murugesan, Srinivasan; Senkovich, Olga; Walker, Kiera; Chenna, Bala C.; Shinkre, Bidhan; Desai, Amar; Chattopadhyay, Debasish</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4056-4066</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dihydrofolate reductase (DHFR) of the parasite Trypanosoma cruzi (T. cruzi) is a potential target for developing drugs to treat Chagas' disease.  We have undertaken a detailed structure-activity study of this enzyme.  We report here synthesis and characterization of six potent inhibitors of the parasitic enzyme.  Inhibitory activity of each compd. was detd. against T. cruzi and human DHFR.  One of these compds., Et 4-(5-[(2,4-diamino-6-quinazolinyl)methyl]amino-2-methoxyphenoxy)butanoate (6b) was co-crystd. with the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of T. cruzi and the crystal structure of the ternary enzyme:cofactor:inhibitor complex was detd.  Mol. docking was used to analyze the potential interactions of all inhibitors with T. cruzi DHFR and human DHFR.  Inhibitory activities of these compds. are discussed in the light of enzyme-ligand interactions.  Binding affinities of each inhibitor for the resp. enzymes were calcd. based on the exptl. or docked binding mode.  An estd. 60-70% of the total binding energy is contributed by the 2,4-diaminoquinazoline scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsx5O48H5w7rVg90H21EOLACvtfcHk0lgD8HJkxhjtVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmslOisLY%253D&md5=9e468f0fd4674cfd0c6c37916c7106bb</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DSchormann%26aufirst%3DN.%26aulast%3DVelu%26aufirst%3DS.%2BE.%26aulast%3DMurugesan%26aufirst%3DS.%26aulast%3DSenkovich%26aufirst%3DO.%26aulast%3DWalker%26aufirst%3DK.%26aulast%3DChenna%26aufirst%3DB.%2BC.%26aulast%3DShinkre%26aufirst%3DB.%26aulast%3DDesai%26aufirst%3DA.%26aulast%3DChattopadhyay%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520potent%2520inhibitors%2520of%2520Trypanosoma%2520cruzi%2520dihydrofolate%2520reductase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D4056%26epage%3D4066%26doi%3D10.1016%2Fj.bmc.2010.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hardegger, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinnler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anselm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ecabert, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stihle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gsell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plancher, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haap, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span> <span> </span><span class="NLM_article-title">Systematic investigation of halogen bonding in protein-ligand interactions</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">314</span>– <span class="NLM_lpage">318</span>, <span class="refDoi"> DOI: 10.1002/anie.201006781</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fanie.201006781" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1alu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=314-318&author=L.+A.+Hardeggerauthor=B.+Kuhnauthor=B.+Spinnlerauthor=L.+Anselmauthor=R.+Ecabertauthor=M.+Stihleauthor=B.+Gsellauthor=R.+Thomaauthor=J.+Diezauthor=J.+Benzauthor=J.+M.+Plancherauthor=G.+Hartmannauthor=D.+W.+Bannerauthor=W.+Haapauthor=F.+Diederich&title=Systematic+investigation+of+halogen+bonding+in+protein-ligand+interactions&doi=10.1002%2Fanie.201006781"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic Investigation of Halogen Bonding in Protein-Ligand Interactions</span></div><div class="casAuthors">Hardegger, Leo A.; Kuhn, Bernd; Spinnler, Beat; Anselm, Lilli; Ecabert, Robert; Stihle, Martine; Gsell, Bernard; Thoma, Ralf; Diez, Joachim; Benz, Joerg; Plancher, Jean-Marc; Hartmann, Guido; Banner, David W.; Haap, Wolfgang; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">314-318, S314/1-S314/145</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Halogen bonding triggers activity.  Increasing binding affinity was obsd. for a series of covalent human Cathepsin L inhibitors by exchanging an aryl ring H atom with Cl, Br, and I, which undergo halogen bonding with the C=O group of Gly61 in the S3 pocket of the enzyme.  Fluorine, in contrast, strongly avoids halogen bonding.  The strong distance and angle dependence of halogen bonding was confirmed for biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsbCNMQhVu7Vg90H21EOLACvtfcHk0lgD8HJkxhjtVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1alu73N&md5=1a7f2983a386fd133be0663657fc486b</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1002%2Fanie.201006781&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201006781%26sid%3Dliteratum%253Aachs%26aulast%3DHardegger%26aufirst%3DL.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DSpinnler%26aufirst%3DB.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DEcabert%26aufirst%3DR.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DGsell%26aufirst%3DB.%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DDiez%26aufirst%3DJ.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DPlancher%26aufirst%3DJ.%2BM.%26aulast%3DHartmann%26aufirst%3DG.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHaap%26aufirst%3DW.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DSystematic%2520investigation%2520of%2520halogen%2520bonding%2520in%2520protein-ligand%2520interactions%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D314%26epage%3D318%26doi%3D10.1002%2Fanie.201006781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span>, <span class="NLM_string-name">Slade, M.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of spleen tyrosine kinase complexed with 6-((1R,2S)-2-Amino-cyclohexylamino)-4-(6-ethyl-pyridin-2-ylamino)-pyridazine-3-carboxylic acid amide</span>. To be published.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kuglstatter%2C+A.%2C+Slade%2C+M.+Crystal+structure+of+spleen+tyrosine+kinase+complexed+with+6-%28%281R%2C2S%29-2-Amino-cyclohexylamino%29-4-%286-ethyl-pyridin-2-ylamino%29-pyridazine-3-carboxylic+acid+amide.+To+be+published."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520spleen%2520tyrosine%2520kinase%2520complexed%2520with%25206-%2528%25281R%252C2S%2529-2-Amino-cyclohexylamino%2529-4-%25286-ethyl-pyridin-2-ylamino%2529-pyridazine-3-carboxylic%2520acid%2520amide" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="note"><p class="first last">The details of this and related analyes will be published elsewhere.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berman, H.
M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westbrook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weissig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindyalov, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, P. E.</span></span> <span> </span><span class="NLM_article-title">The protein data bank</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1093/nar/28.1.235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1093%2Fnar%2F28.1.235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10592235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2000&pages=235-242&author=H.%0AM.+Bermanauthor=J.+Westbrookauthor=Z.+Fengauthor=G.+Gillilandauthor=T.+N.+Bhatauthor=H.+Weissigauthor=I.+N.+Shindyalovauthor=P.+E.+Bourne&title=The+protein+data+bank&doi=10.1093%2Fnar%2F28.1.235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Data Bank</span></div><div class="casAuthors">Berman, Helen M.; Westbrook, John; Feng, Zukang; Gilliland, Gary; Bhat, T. N.; Weissig, Helge; Shindyalov, Ilya N.; Bourne, Philip E.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The Protein Data Bank (PDB; http://www.rcsb.org/pdb/)is the single worldwide archive of structural data of biol. macromols.  This paper describes the goals of the PDB, the systems in place for data deposition and access, how to obtain further information, and near-term plans for the future development of the resource.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpStGCxT8QzirVg90H21EOLACvtfcHk0lhaMCyvHKWdEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvVKjt7w%253D&md5=227fb393f754be2be375ab727bfd05dc</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F28.1.235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F28.1.235%26sid%3Dliteratum%253Aachs%26aulast%3DBerman%26aufirst%3DH.%2BM.%26aulast%3DWestbrook%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DGilliland%26aufirst%3DG.%26aulast%3DBhat%26aufirst%3DT.%2BN.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DShindyalov%26aufirst%3DI.%2BN.%26aulast%3DBourne%26aufirst%3DP.%2BE.%26atitle%3DThe%2520protein%2520data%2520bank%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2000%26volume%3D28%26spage%3D235%26epage%3D242%26doi%3D10.1093%2Fnar%2F28.1.235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><a href="http://www.chemcomp.com" class="extLink">www.chemcomp.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.chemcomp.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><a href="http://www.eyesopen.com" class="extLink">www.eyesopen.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.eyesopen.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><a href="http://www.schrodinger.com" class="extLink">www.schrodinger.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=www.schrodinger.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jantz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briem, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rarey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, C. D.</span></span> <span> </span><span class="NLM_article-title">Computational macrocyclization: from de novo macrocycle generation to binding affinity estimation</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1866</span>– <span class="NLM_lpage">1872</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700478</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1002%2Fcmdc.201700478" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=28977738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslSktbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1866-1872&author=V.+Wagnerauthor=L.+Jantzauthor=H.+Briemauthor=K.+Sommerauthor=M.+Rareyauthor=C.+D.+Christ&title=Computational+macrocyclization%3A+from+de+novo+macrocycle+generation+to+binding+affinity+estimation&doi=10.1002%2Fcmdc.201700478"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Computational Macrocyclization: From de novo Macrocycle Generation to Binding Affinity Estimation</span></div><div class="casAuthors">Wagner, Vincent; Jantz, Linda; Briem, Hans; Sommer, Kai; Rarey, Matthias; Christ, Clara D.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1866-1872</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Macrocycles play an increasing role in drug discovery, but their synthesis is often demanding.  Computational tools that suggest macrocyclization based on a known binding mode and that est. the binding affinity of these macrocycles could have a substantial impact on the medicinal chem. design process.  For both tasks, we established a workflow with high practical value.  For five diverse pharmaceutical targets we show that the effect of macrocyclization on binding can be calcd. robustly and accurately.  Applying this method to macrocycles designed by LigMac, a search tool for de novo macrocyclization, our results suggest that we have a robust protocol in hand to design macrocycles and prioritize them prior to synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonKcpGd8uDs7Vg90H21EOLACvtfcHk0lhaMCyvHKWdEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslSktbnI&md5=30f49d08b16cd5473ea69de3e975ebee</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700478%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DV.%26aulast%3DJantz%26aufirst%3DL.%26aulast%3DBriem%26aufirst%3DH.%26aulast%3DSommer%26aufirst%3DK.%26aulast%3DRarey%26aufirst%3DM.%26aulast%3DChrist%26aufirst%3DC.%2BD.%26atitle%3DComputational%2520macrocyclization%253A%2520from%2520de%2520novo%2520macrocycle%2520generation%2520to%2520binding%2520affinity%2520estimation%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D1866%26epage%3D1872%26doi%3D10.1002%2Fcmdc.201700478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korb, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M.</span></span> <span> </span><span class="NLM_article-title">Interactive and versatile navigation of structural databases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4257</span>– <span class="NLM_lpage">4266</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01756</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01756" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4257-4266&author=O.+Korbauthor=B.+Kuhnauthor=J.+Hertauthor=N.+Taylorauthor=J.+Coleauthor=C.+Groomauthor=M.+Stahl&title=Interactive+and+versatile+navigation+of+structural+databases&doi=10.1021%2Facs.jmedchem.5b01756"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Interactive and Versatile Navigation of Structural Databases</span></div><div class="casAuthors">Korb, Oliver; Kuhn, Bernd; Hert, Jerome; Taylor, Neil; Cole, Jason; Groom, Colin; Stahl, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4257-4266</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We present CSD-CrossMiner, a novel tool for pharmacophore-based searches in crystal structure databases.  Intuitive pharmacophore queries describing, among others, protein-ligand interaction patterns, ligand scaffolds, or protein environments can be built and modified interactively.  Matching crystal structures are overlaid onto the query and visualized as soon as they are available, enabling the researcher to quickly modify a hypothesis on the fly.  We exemplify the utility of the approach by showing applications relevant to real-world drug discovery projects, including the identification of novel fragments for a specific protein environment or scaffold hopping.  The ability to concurrently search protein-ligand binding sites extd. from the Protein Data Bank (PDB) and small org. mols. from the Cambridge Structural Database (CSD) using the same pharmacophore query further emphasizes the flexibility of CSD-CrossMiner.  We believe that CSD-CrossMiner closes an important gap in mining structural data and will allow users to ext. more value from the growing no. of available crystal structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVHoEyOPb96bVg90H21EOLACvtfcHk0lhaMCyvHKWdEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGms70%253D&md5=1b872969057778cbcc0be80db9bb2bd3</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01756%26sid%3Dliteratum%253Aachs%26aulast%3DKorb%26aufirst%3DO.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DHert%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DN.%26aulast%3DCole%26aufirst%3DJ.%26aulast%3DGroom%26aufirst%3DC.%26aulast%3DStahl%26aufirst%3DM.%26atitle%3DInteractive%2520and%2520versatile%2520navigation%2520of%2520structural%2520databases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4257%26epage%3D4266%26doi%3D10.1021%2Facs.jmedchem.5b01756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekharan, S.</span>; <span class="NLM_string-name">Sykes, R.</span>; <span class="NLM_string-name">Sanschagrin, P.</span>; <span class="NLM_string-name">Cummings, M.</span></span> <span> </span><span class="NLM_article-title">Simple metrics to identify opportunities for macrocyclization of small-molecule ligands</span>. Presented at the 256th National Meeting and Exposition of the American Chemical Society, Boston, MA, <span class="NLM_year">2018</span>; COMP-227.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Sekharan&author=R.+Sykes&author=P.+Sanschagrin&author=M.+Cummings&title=Simple+metrics+to+identify+opportunities+for+macrocyclization+of+small-molecule+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DSekharan%26aufirst%3DS.%26atitle%3DSimple%2520metrics%2520to%2520identify%2520opportunities%2520for%2520macrocyclization%2520of%2520small-molecule%2520ligands%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scoffin, R.</span>; <span class="NLM_string-name">Bauer, M.</span>; <span class="NLM_string-name">Mackey, M.</span>; <span class="NLM_string-name">Sciammetta, S.</span>; <span class="NLM_string-name">Tedesco, G.</span></span> <span> </span><span class="NLM_article-title">Rapid and accessible in silico macrocycle design</span>. Presented at the 256th National Meeting and Exposition of the American Chemical Society, <span class="NLM_year">2018</span>; COMP-226.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+Scoffin&author=M.+Bauer&author=M.+Mackey&author=S.+Sciammetta&author=G.+Tedesco&title=Rapid+and+accessible+in+silico+macrocycle+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DScoffin%26aufirst%3DR.%26atitle%3DRapid%2520and%2520accessible%2520in%2520silico%2520macrocycle%2520design%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Groom, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lightfoot, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. C.</span></span> <span> </span><span class="NLM_article-title">The cambridge structural database</span>. <i>Acta Crystallogr., Sect. B: Struct. Sci., Cryst. Eng. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1107/S2052520616003954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=10.1107%2FS2052520616003954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=27048719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Kntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=171-179&author=C.+R.+Groomauthor=I.+J.+Brunoauthor=M.+P.+Lightfootauthor=S.+C.+Ward&title=The+cambridge+structural+database&doi=10.1107%2FS2052520616003954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">The Cambridge Structural Database</span></div><div class="casAuthors">Groom, Colin R.; Bruno, Ian J.; Lightfoot, Matthew P.; Ward, Suzanna C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section B: Structural Science, Crystal Engineering and Materials</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-179</span>CODEN:
                <span class="NLM_cas:coden">ACSBDA</span>;
        ISSN:<span class="NLM_cas:issn">2052-5206</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The Cambridge Structural Database (CSD) contains a complete record of all published org. and metal-org. small-mol. crystal structures.  The database has been in operation for over 50 years and continues to be the primary means of sharing structural chem. data and knowledge across disciplines.  As well as structures that are made public to support scientific articles, it includes many structures published directly as CSD Communications.  All structures are processed both computationally and by expert structural chem. editors prior to entering the database.  A key component of this processing is the reliable assocn. of the chem. identity of the structure studied with the exptl. data.  This important step helps ensure that data is widely discoverable and readily reusable.  Content is further enriched through selective inclusion of addnl. exptl. data.  Entries are available to anyone through free CSD community web services.  Linking services developed and maintained by the CCDC, combined with the use of std. identifiers, facilitate discovery from other resources.  Data can also be accessed through CCDC and third party software applications and through an application programming interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvlnx06ebv_bVg90H21EOLACvtfcHk0lgPZY7tFj8xwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Kntro%253D&md5=f9c65ab86fc9db429588c95b0da3f9b2</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1107%2FS2052520616003954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052520616003954%26sid%3Dliteratum%253Aachs%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DBruno%26aufirst%3DI.%2BJ.%26aulast%3DLightfoot%26aufirst%3DM.%2BP.%26aulast%3DWard%26aufirst%3DS.%2BC.%26atitle%3DThe%2520cambridge%2520structural%2520database%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520B%253A%2520Struct.%2520Sci.%252C%2520Cryst.%2520Eng.%2520Mater.%26date%3D2016%26volume%3D72%26spage%3D171%26epage%3D179%26doi%3D10.1107%2FS2052520616003954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KEE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KEE','PDB','3KEE'); return false;">PDB: 3KEE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LOX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LOX','PDB','3LOX'); return false;">PDB: 3LOX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4P38" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4P38','PDB','4P38'); return false;">PDB: 4P38</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KJS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3KJS','PDB','3KJS'); return false;">PDB: 3KJS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XU4','PDB','2XU4'); return false;">PDB: 2XU4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FZ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4FZ7','PDB','4FZ7'); return false;">PDB: 4FZ7</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01985&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01985%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-15%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01985" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667985950ff9247f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
